data_1e0z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e0z _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.99 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 3' ' ' VAL . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 40' ' ' MET . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.415 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 99.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 99.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 99.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 99.0 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 99.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 99.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 7' ' ' ASN . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 99.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 23' ' ' LEU . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 99.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 99.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 99.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.446 ' HG3' HG21 ' A' ' 10' ' ' THR . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 99.0 110.124 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.436 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 99.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 99.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 99.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 99.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CB ' ' CB ' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 99.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 99.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 99.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 99.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 99.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 99.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 99.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 99.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 99.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 99.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 99.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 99.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 99.0 110.189 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 99.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 99.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 99.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HB2' HD22 ' A' ' 6' ' ' LEU . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 99.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 99.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 99.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 99.0 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.482 ' CG2' ' HE2' ' A' ' 40' ' ' MET . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 99.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 99.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 99.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 99.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 99.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 99.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.454 ' O ' ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 99.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 99.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 99.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 99.0 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 99.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 99.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 99.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 55' ' ' GLN . 11.9 mm100 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 99.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 99.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 99.0 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 99.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.607 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 99.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 99.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 99.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 99.0 110.999 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 99.0 112.04 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 99.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 99.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 99.0 110.855 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.41 ' O ' HD12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 99.0 109.956 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 99.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 99.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 99.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 99.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 99.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 73' ' ' SER . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 99.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 99.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 99.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 99.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.458 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 99.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 99.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 81' ' ' ASP . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 99.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' HG21 ' A' ' 80' ' ' ILE . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 99.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.507 ' CG ' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 99.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 99.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 99.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 99.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 99.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 88' ' ' LEU . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 99.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 87' ' ' ILE . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 99.0 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 99.0 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 99.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 99.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 99.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 99.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 99.0 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 99.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 99.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 99.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 99.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 99.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.507 HD11 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 99.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 99.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.441 ' SG ' HG21 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 99.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.545 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 99.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 99.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 99.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 99.0 110.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 99.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 99.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 99.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG12 ' HA2' ' A' ' 78' ' ' GLY . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 99.0 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 99.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 99.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 99.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 99.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 99.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 99.0 110.149 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.119 0.485 . . . . 99.0 109.971 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 99.0 110.192 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.99 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.402 HG21 HG21 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 99.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 99.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 99.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 99.0 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 99.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 99.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 99.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 99.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 99.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 99.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 99.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 99.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 99.0 110.251 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 99.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 99.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 99.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 99.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 99.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 99.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.441 HD13 HD23 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 99.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE2' HD11 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 99.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 99.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 99.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 99.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 99.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 99.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 99.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 99.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 99.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 99.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 99.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 99.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 99.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 99.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 99.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 99.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 99.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 99.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 99.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 99.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 99.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' CG ' ' HB1' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 99.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 99.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 99.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 99.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 99.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB1' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 99.0 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 99.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 99.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 99.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 99.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 99.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 99.0 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 99.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 99.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 99.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 99.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 99.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 99.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 99.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 99.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 99.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 99.0 110.267 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 99.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 99.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 99.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 99.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 99.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 99.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.508 HG11 ' CA ' ' A' ' 97' ' ' ASP . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 99.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 99.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 99.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 99.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 99.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 99.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 99.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.446 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 99.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 99.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 99.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 99.0 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 99.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 99.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 99.0 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 99.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 99.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 99.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 99.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 99.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 99.0 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 99.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 99.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.508 ' CA ' HG11 ' A' ' 75' ' ' VAL . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 99.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 99.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 99.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 99.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 99.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 99.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.518 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 99.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 99.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 99.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HB3' HG23 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 99.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.469 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 99.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 99.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 99.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 99.0 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 99.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 99.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 99.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 99.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 99.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 99.0 110.226 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.237 0.541 . . . . 99.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 99.0 110.26 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.452 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.99 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 3' ' ' VAL . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' MET . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' HG13 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 99.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 99.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 99.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 99.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 99.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 99.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 99.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 99.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 99.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 99.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 99.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 99.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.406 ' CA ' ' OD2' ' A' ' 21' ' ' ASP . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 99.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 99.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 99.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 99.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 99.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 99.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 99.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 99.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 99.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 99.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 99.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 99.0 110.059 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 99.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 99.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 99.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 99.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 99.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 99.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 99.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 99.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 99.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 99.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 3' ' ' VAL . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 99.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 99.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 99.0 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 106' ' ' PRO . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 99.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 99.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 99.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 99.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 99.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 99.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 99.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' N ' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 99.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 99.0 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 99.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 99.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 99.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 99.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 99.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 99.0 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 99.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 99.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 99.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 99.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 99.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 99.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 99.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 99.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 99.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 99.0 110.193 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 99.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 99.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 99.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 69' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 99.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 99.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 99.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' CG1' ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 99.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 99.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 99.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 99.0 109.498 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 99.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 106' ' ' PRO . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 99.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 99.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 99.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 99.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 99.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 99.0 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 99.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 99.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.474 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 99.0 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 99.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 99.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 99.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 99.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' A' ' 88' ' ' LEU . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 99.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 99.0 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 99.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 99.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.517 ' OD1' ' CG1' ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 99.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' SER . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 99.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 99.0 110.098 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 99.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 99.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.421 ' C ' HG21 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 99.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.464 HD13 HD11 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 99.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 99.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 99.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.526 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 99.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 99.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 99.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.446 ' O ' HG21 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 99.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 99.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 99.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 99.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 8' ' ' TYR . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 99.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 99.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 99.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 99.0 109.927 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.2 0.524 . . . . 99.0 110.191 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 99.0 110.05 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.99 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' MET . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 99.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 99.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 99.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 99.0 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 99.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 99.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 99.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 99.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 99.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 99.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 99.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 99.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 99.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.458 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 99.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 99.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 99.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 99.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 99.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 99.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 99.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 99.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 99.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 99.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 99.0 110.227 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 99.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 99.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 99.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 99.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 99.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 99.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 99.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 99.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 99.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 99.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 99.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 99.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 99.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 99.0 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 99.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 99.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 99.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 99.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 99.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 99.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 99.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 99.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 99.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 99.0 109.876 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 99.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 99.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 99.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 99.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 99.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.425 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 99.0 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 99.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.641 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 99.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.533 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 99.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 99.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 99.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 99.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 99.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 100' ' ' LEU . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 99.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 99.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 99.0 110.613 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 99.0 111.052 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 99.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 99.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 99.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 99.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 99.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' CG1' ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 99.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 99.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 99.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.512 ' HA2' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 99.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 99.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 99.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 99.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.427 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 99.0 110.569 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 99.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 99.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 99.0 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 99.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.497 HG21 ' N ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 99.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 99.0 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 99.0 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 99.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 99.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 99.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 99.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 99.0 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 99.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 99.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' OD1' ' CG1' ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 99.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 99.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 99.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 88' ' ' LEU . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 99.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 99.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 99.0 109.841 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 99.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 82' ' ' MET . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 99.0 109.777 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 99.0 109.832 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.476 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 99.0 110.435 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 99.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 99.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 99.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.512 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 99.0 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 99.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 99.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 99.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 99.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 99.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 99.0 109.867 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 37.0 m-70 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.367 0.603 . . . . 99.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.471 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 99.0 110.124 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.99 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.439 ' CG2' HG23 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' MET . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 99.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 99.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 99.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 99.0 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' HG13 ' A' ' 114' ' ' VAL . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 99.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 99.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 99.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 99.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 99.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 99.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 99.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 99.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.557 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 99.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 99.0 110.486 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 99.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 99.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 99.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 99.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 99.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 99.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 99.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 99.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 99.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 99.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 99.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 99.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 99.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 99.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 99.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 99.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 99.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 99.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 99.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 99.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.49 ' HE1' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 99.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 99.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG1' ' HE1' ' A' ' 40' ' ' MET . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 99.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 99.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 99.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 99.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 99.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 99.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 99.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 99.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 99.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 99.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 99.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 99.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 99.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 99.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 99.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 99.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 99.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 99.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 99.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 99.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 99.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 99.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 99.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 99.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 99.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 99.0 110.102 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 99.0 111.603 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 99.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 99.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 99.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 99.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 99.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 99.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 99.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 99.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' HG11 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 99.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 99.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 80' ' ' ILE . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 99.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 99.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.464 ' SD ' ' CD1' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 99.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 99.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 99.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 99.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 99.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 88' ' ' LEU . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 99.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 99.0 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 99.0 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 99.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 99.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 99.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 99.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 99.0 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 99.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 99.0 110.252 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 99.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' SER . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 99.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 99.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' CD1' ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 99.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 99.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 99.0 110.473 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.475 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 99.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 99.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 99.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 99.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 1' ' ' PRO . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 99.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 99.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 99.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG11 ' HA2' ' A' ' 78' ' ' GLY . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 99.0 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 99.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 99.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 99.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 99.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 99.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 99.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.4 m-70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.234 0.54 . . . . 99.0 109.876 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 119' ' ' HIS . 16.7 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 99.0 110.038 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.99 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 109' ' ' ASP . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' MET . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 99.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 99.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 99.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 99.0 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 99.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 99.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 32' ' ' LEU . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 99.0 110.014 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 99.0 110.145 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 99.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 99.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 99.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 99.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 99.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 99.0 110.051 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 99.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 99.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 99.0 110.388 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 99.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 99.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 16' ' ' TRP . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 99.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 99.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 99.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 99.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 99.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 99.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 99.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 99.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 99.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 10' ' ' THR . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 99.0 110.111 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 99.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 99.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 99.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 99.0 110.182 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 99.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 99.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.517 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 99.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 99.0 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG1' ' SD ' ' A' ' 40' ' ' MET . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 99.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 99.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 99.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 99.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 99.0 110.564 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 99.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 99.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.53 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 99.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 99.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 99.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 99.0 110.64 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 99.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 99.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 99.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 99.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 99.0 110.262 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 99.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 99.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 99.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 99.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 99.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 99.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 99.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 100' ' ' LEU . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 99.0 109.891 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 99.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' OD1' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 99.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 99.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 99.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 99.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 99.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 99.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 73' ' ' SER . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 99.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 99.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 99.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 99.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 99.0 109.521 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 99.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 48' ' ' ILE . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 99.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 99.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 99.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 99.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 99.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 99.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 99.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 88' ' ' LEU . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 99.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.441 HD11 HG21 ' A' ' 87' ' ' ILE . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 99.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 99.0 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 99.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 99.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 99.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 99.0 109.816 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 99.0 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 99.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 99.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 99.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 92' ' ' GLU . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 99.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 99.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 66' ' ' GLY . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 99.0 109.941 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 99.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 99.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 99.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 99.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HG3' HG23 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 99.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 99.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 99.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 99.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.447 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 99.0 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 76' ' ' LYS . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 99.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 99.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 99.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 99.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 5.7 t-20 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 99.0 110.074 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 99.0 110.447 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 57.9 m-70 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.331 0.586 . . . . 99.0 110.14 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 99.0 110.208 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.99 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' MET . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 99.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 99.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 99.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 99.0 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 99.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 99.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 99.0 109.696 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 99.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 99.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 99.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 99.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 99.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 99.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 23' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 99.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 99.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 99.0 109.808 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 99.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 99.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' GLU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 99.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 17' ' ' ASP . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 99.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 99.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 99.0 110.098 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 99.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 99.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 99.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 99.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 99.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 99.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 99.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 99.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 99.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 99.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 99.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 99.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 99.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' CG2' ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 99.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 99.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 99.0 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG13 ' HE2' ' A' ' 40' ' ' MET . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 99.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 99.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 99.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 99.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 99.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 99.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 99.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 99.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 99.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 55' ' ' GLN . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 99.0 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 99.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 99.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 99.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 99.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 99.0 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 99.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 99.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 99.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 99.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 99.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 99.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 99.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 99.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 99.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 99.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.433 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 99.0 111.082 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 99.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 99.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 99.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 99.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 99.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 99.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 99.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 99.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 99.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 99.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 99.0 110.139 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 99.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 99.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 99.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 99.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 99.0 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 99.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 99.0 110.219 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 99.0 110.234 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 99.0 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 99.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 99.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 99.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 99.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.461 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 99.0 110.396 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 99.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 99.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 99.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 73' ' ' SER . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 99.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.457 ' CD ' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 99.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD13 ' SD ' ' A' ' 82' ' ' MET . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 99.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 99.0 110.563 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.419 ' C ' HG21 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 99.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.574 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 99.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 99.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 99.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 99.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 99.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 99.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 99.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 99.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 99.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 99.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 99.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 99.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 99.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 99.0 110.081 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.415 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 29.3 m-70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.291 0.567 . . . . 99.0 109.808 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 99.0 110.234 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.99 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 99.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 99.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 99.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.558 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 99.0 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.47 ' HA ' HG13 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 99.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 99.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 99.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 99.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 99.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 99.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 99.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 99.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.476 ' CB ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 99.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 99.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 99.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 99.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 99.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 99.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 99.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB2' ' CD1' ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 99.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 99.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 99.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 99.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 99.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 99.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 99.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 99.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 99.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 99.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 99.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 99.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 99.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 99.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 99.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.519 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 99.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 99.0 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 99.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 99.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 99.0 110.344 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 99.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 99.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 99.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.512 HG21 ' CE ' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 99.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 99.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' OE1' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 99.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 99.0 110.219 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 99.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HB2' HD23 ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 99.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 99.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 99.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 99.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 99.0 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 99.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.614 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 99.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 99.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 99.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 99.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 99.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 99.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.468 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 99.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 99.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 99.0 110.272 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 99.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 99.0 109.952 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 99.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 99.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 99.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 99.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 99.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 99.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 99.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 99.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 99.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 105' ' ' SER . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 99.0 110.318 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 99.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 99.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 99.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 99.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 99.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 99.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 99.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 99.0 110.145 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 99.0 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 99.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 99.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 99.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 99.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 99.0 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 99.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 99.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.489 ' CB ' HG11 ' A' ' 75' ' ' VAL . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 99.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 99.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 99' ' ' ARG . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 99.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 99.0 110.324 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 99.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 99.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.468 HG12 ' CA ' ' A' ' 66' ' ' GLY . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 99.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 99.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.46 ' O ' HG21 ' A' ' 80' ' ' ILE . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 99.0 109.849 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 99.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 99.0 110.15 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 99.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 99.0 110.041 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 99.0 110.396 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 99.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 99.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 8' ' ' TYR . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 99.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.611 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 99.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 99.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 99.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.357 0.599 . . . . 99.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 99.0 110.163 179.808 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.99 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 3' ' ' VAL . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 99.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 99.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 99.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 99.0 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 99.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 99.0 109.862 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 99.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 99.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 99.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 99.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 99.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 99.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.443 ' C ' ' CD1' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 99.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 99.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 99.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 99.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 99.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 99.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 99.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 11' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 99.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 99.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 99.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 99.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 99.0 110.346 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 99.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 99.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 99.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 99.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' N ' HD21 ' A' ' 32' ' ' LEU . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 99.0 110.11 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 99.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 99.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 99.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 99.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.558 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 99.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 99.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 99.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 99.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 99.0 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 99.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 99.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 99.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 99.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 99.0 109.977 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 99.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.47 HG22 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 99.0 110.285 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 59' ' ' TRP . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 99.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 99.0 110.076 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 99.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 99.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 99.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 99.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 99.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 99.0 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 99.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.579 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 99.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 99.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 99.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 99.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 99.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 99.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 99.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' C ' HG12 ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 99.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.408 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 99.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 99.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 99.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 99.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 99.0 111.405 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 99.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 99.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 99.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 99.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 99.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' HA2' HG11 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 99.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 99.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 99.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 99.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 99.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 99.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 99.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 99.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 99.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 99.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 99.0 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.465 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 99.0 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 99.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 99.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 99.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG1' ' CZ ' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 99.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 99.0 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 99.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 99.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 99.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 99.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.533 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 99.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 99.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 99.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 99.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.532 HG12 ' CA ' ' A' ' 66' ' ' GLY . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 99.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 99.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' ASP . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 99.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG12 ' A' ' 42' ' ' VAL . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 99.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 99.0 110.405 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 99.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 99.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 99.0 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 99.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 99.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 99.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 99.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 99.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 99.0 110.035 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.35 0.595 . . . . 99.0 109.736 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 8' ' ' TYR . 20.6 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 99.0 110.065 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.99 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 99.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 99.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.611 ' CB ' ' CZ ' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 99.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.592 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.7 t30 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 99.0 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 99.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 99.0 109.966 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' HD23 ' A' ' 32' ' ' LEU . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 99.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 99.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 99.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 99.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 99.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 99.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 99.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 99.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 99.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 99.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 99.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 99.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 11' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 99.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.611 ' CZ ' ' CB ' ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 99.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 99.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 99.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 99.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 99.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 99.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 99.0 110.168 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 99.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD23 ' CG2' ' A' ' 10' ' ' THR . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 99.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 99.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 99.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 99.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 99.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 99.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 99.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 99.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.531 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 99.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 99.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.514 ' CG2' ' CB ' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 99.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 99.0 110.228 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 99.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 99.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 99.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 99.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.465 HG21 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 99.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 99.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' N ' HD21 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 99.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 99.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' CB ' ' HE1' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 99.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 99.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 99.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 99.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 99.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 99.0 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 99.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 99.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 99.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 99.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 99.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 99.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 99.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 99.0 109.907 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 99.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 99.0 110.306 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 99.0 111.343 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 99.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 99.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 99.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 99.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 74' ' ' ILE . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 99.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 99.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 99.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 99.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 99.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 99.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 48' ' ' ILE . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 99.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 99.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.519 ' CE ' HD13 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 99.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 99.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 99.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 99.0 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 99.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 99.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.511 ' N ' HG21 ' A' ' 87' ' ' ILE . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 99.0 109.89 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 99.0 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 99.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 99.0 109.633 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 99.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 HG12 ' CD ' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 99.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 99.0 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 99.0 110.458 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 99.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 99.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 99.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.525 ' CD ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 99.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 ' CE ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 99.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 99.0 110.437 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 99.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.45 HG22 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 99.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 99.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 81' ' ' ASP . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 99.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 99.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 99.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 99.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 99.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 99.0 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 99.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 99.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 99.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 99.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.595 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 99.0 110.287 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 99.0 110.221 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.595 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 65.0 m-70 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.405 0.621 . . . . 99.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 99.0 110.435 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.99 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 99.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 99.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 99.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.548 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 99.0 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.497 ' CE2' HD13 ' A' ' 120' ' ' LEU . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 99.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 99.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' CD1' ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 99.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 99.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 99.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 99.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 99.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 99.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.521 ' CB ' HD22 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 99.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 99.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 99.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 99.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 99.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 99.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 99.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 16' ' ' TRP . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 99.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 99.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 99.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 99.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 99.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 99.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 99.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 99.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 99.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD13 ' CB ' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 99.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 99.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 99.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 99.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 99.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.565 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 99.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 99.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 99.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.558 ' CE ' ' CG2' ' A' ' 42' ' ' VAL . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 99.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 99.0 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.558 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 99.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 99.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 99.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 99.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 99.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 99.0 110.369 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 99.0 110.484 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 99.0 110.503 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 99.0 110.346 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB3' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 99.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 99.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 99.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 99.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 99.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 99.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 99.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 99.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 99.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 99.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 99.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 99.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 99.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 99.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 99.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 99.0 110.545 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 99.0 111.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 99.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 101' ' ' THR . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 99.0 110.173 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 99.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 99.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 99.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.518 HG11 ' CB ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 99.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 99.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 99.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 99.0 109.24 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 99.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 99.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.459 ' CE ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 99.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 99.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 99.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.413 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 99.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 99.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 99.0 110.539 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HB3' ' CE ' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 99.0 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 99.0 109.986 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' O ' HG11 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 99.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 99.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 99.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 99.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' N ' HG11 ' A' ' 93' ' ' VAL . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 99.0 110.012 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 99.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 99.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 99.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 99.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 99.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.508 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 99.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 99.0 109.993 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 99.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 99.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 99.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 99.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 99.0 110.393 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 99.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 99.0 109.748 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 3' ' ' VAL . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 99.0 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 76' ' ' LYS . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 99.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 99.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 8' ' ' TYR . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 99.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 99.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.3 t30 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 99.0 110.02 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 99.0 110.423 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.537 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 88.3 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.244 0.545 . . . . 99.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 99.0 110.164 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.99 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 99.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.547 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 99.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 99.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 99.0 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.493 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 99.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 99.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 99.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 99.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 99.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 99.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 99.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 99.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 99.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 99.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 74' ' ' ILE . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 99.0 110.341 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 99.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 99.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 99.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 99.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 99.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 99.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 99.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 99.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 99.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 99.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 99.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 99.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 99.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 31' ' ' GLY . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 99.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 99.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 99.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 99.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 99.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 99.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 99.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 99.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 99.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 99.0 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 46' ' ' GLU . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 99.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 99.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 99.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 99.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 99.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 99.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.404 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 99.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 99.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 99.0 110.258 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 99.0 109.998 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 99.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 99.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 99.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 99.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 99.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 99.0 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 99.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 99.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 99.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 99.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 99.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 99.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 99.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 99.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 99.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.493 ' CA ' HG12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 99.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 99.0 111.263 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 99.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 99.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 99.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 99.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 99.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 99.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 99.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.492 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 99.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 99.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 99.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 99.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 99.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 99.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 99.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 99.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 99.0 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 99.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 68' ' ' CYS . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 99.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 99.0 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 99.0 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 99.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 99.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 99.0 110.01 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 99.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 99.0 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 99.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 99.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 99.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.517 HG11 ' CD2' ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 99.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 99.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 99.0 110.666 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 99.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' C ' HG21 ' A' ' 103' ' ' ILE . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 99.0 109.994 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD13 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 99.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 99.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 99.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 99.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 99.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 99.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 99.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 99.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 99.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 99.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 99.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 99.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 99.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 99.0 110.232 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 57.5 m-70 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 99.0 109.779 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 99.0 110.184 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HG2' ' OE2' ' A' ' 41' ' ' GLU . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.99 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.487 ' CG2' HG21 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 99.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 99.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 99.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.58 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 99.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 99.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 99.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 99.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 99.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 99.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 99.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 99.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 99.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 99.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 99.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 99.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 99.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 99.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 99.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 99.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 99.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 99.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 99.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB3' ' CG ' ' A' ' 37' ' ' TYR . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 99.0 109.627 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 99.0 109.907 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 99.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 99.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 99.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 10' ' ' THR . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 99.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 99.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 99.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 99.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 99.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 99.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 99.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 99.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 99.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 99.0 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 106' ' ' PRO . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 99.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 99.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 99.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 99.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 99.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 99.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' LEU . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 99.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' C ' ' CD2' ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 99.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 99.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 99.0 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 99.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 99.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 99.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 99.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 99.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 35' ' ' GLU . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 99.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 99.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 99.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 99.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 99.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 99.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 99.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 99.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 103' ' ' ILE . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 99.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 99.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' HA ' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 99.0 110.377 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 99.0 111.297 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 99.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 99.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 99.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 99.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 99.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 99.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 99.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 112' ' ' LYS . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 99.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 99.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' N ' HG12 ' A' ' 111' ' ' VAL . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 99.0 110.056 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 99.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 99.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 99.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 99.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 99.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 99.0 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 99.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 HG21 ' N ' ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 99.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 99.0 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 99.0 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 99.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 99.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 99.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 99.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 93' ' ' VAL . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 99.0 110.537 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 99.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 99.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 99.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' SER . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 99.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 99.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 68' ' ' CYS . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 99.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 99.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 99.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 66' ' ' GLY . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 99.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 99.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 99.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 81' ' ' ASP . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 99.0 110.564 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 99.0 110.373 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 99.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 99.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.476 HG12 ' HA2' ' A' ' 78' ' ' GLY . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 99.0 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 99.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 99.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 99.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 99.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 99.0 110.609 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 99.0 110.163 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.623 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 64.9 m-70 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.31 0.576 . . . . 99.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 99.0 110.511 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.413 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.99 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 40' ' ' MET . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 99.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 99.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 99.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 99.0 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 99.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 99.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.478 ' CG2' HD12 ' A' ' 32' ' ' LEU . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 99.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 99.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 99.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 99.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.561 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 99.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 99.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 99.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 99.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.448 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 99.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 99.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 99.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 99.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 99.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 99.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 99.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 99.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 99.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 99.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 99.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 99.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 99.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 99.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.478 HD12 ' CG2' ' A' ' 10' ' ' THR . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 99.0 110.388 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 99.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 99.0 109.301 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 99.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 99.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 99.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 99.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 99.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 99.0 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.499 HG13 ' CG ' ' A' ' 106' ' ' PRO . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 99.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 99.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 99.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 99.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 99.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 99.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 99.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 99.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 47' ' ' TYR . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 99.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 99.0 110.248 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 99.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 99.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 99.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 99.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 99.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 99.0 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 99.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.647 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 99.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 99.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 99.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 99.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 99.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 99.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 103' ' ' ILE . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 99.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 99.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 99.0 110.271 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 99.0 111.173 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 99.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 99.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 99.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 99.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 99.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 99.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 99.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 99.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 99.0 109.208 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 99.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 99.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 99.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 99.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 99.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 99.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.3 OUTLIER -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 99.0 110.216 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 99.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 99.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 99.0 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' HD13 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 99.0 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 99.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 99.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 ' CG2' ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 99.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 99.0 110.442 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 99.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' O ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 99.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 99.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' SER . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 99.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.525 ' NH2' ' CG2' ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 99.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 99.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 99.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 99.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.448 HG22 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 99.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 99.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 99.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.499 ' CG ' HG13 ' A' ' 42' ' ' VAL . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 99.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 99.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 99.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.423 ' C ' HG21 ' A' ' 111' ' ' VAL . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 99.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 112' ' ' LYS . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 99.0 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 99.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 99.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 99.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 99.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 99.0 110.138 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 99.0 110.368 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.305 0.574 . . . . 99.0 109.708 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 99.0 110.397 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.475 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.99 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 99.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 99.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 99.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 99.0 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 99.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 99.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 99.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 99.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 99.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 99.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 99.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 99.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 99.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 99.0 110.327 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 99.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 99.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 99.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 99.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 99.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 99.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 99.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 99.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 99.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 99.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 99.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 99.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 99.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 99.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 99.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 99.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 99.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 99.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 99.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 99.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 3' ' ' VAL . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 99.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.549 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 99.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 99.0 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' CG2' ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 99.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 99.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 99.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 99.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 99.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 99.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 99.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 99.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 99.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' CB ' ' CG2' ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 99.0 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.549 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 99.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 99.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 99.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 99.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 99.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 99.0 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 99.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 99.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 99.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 99.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 99.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 99.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 99.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 99.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 99.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 99.0 110.263 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 99.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 99.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 99.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 99.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 99.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 99.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 99.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 99.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 99.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 99.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 99.0 110.046 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 99.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 99.0 110.349 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 99.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 99.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 99.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 99.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 99.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 88' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 99.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 87' ' ' ILE . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 99.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 99.0 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' O ' HG11 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 99.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 99.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 99.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' NH1' ' A' ' 99' ' ' ARG . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 99.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 99.0 110.47 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 99.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.537 ' CB ' HG12 ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 99.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 99.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.537 HG12 ' CB ' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 99.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.496 ' NH1' HG22 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 99.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 99.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 99.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 99.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 ' SG ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 99.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 99.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 99.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 99.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 99.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 99.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 99.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 99.0 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 99.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 99.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 99.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 99.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 99.0 110.922 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 99.0 109.859 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.508 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.211 0.529 . . . . 99.0 110.158 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 99.0 110.214 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.99 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 99.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 99.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 99.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 99.0 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 99.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 99.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 99.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.461 HD11 ' CD2' ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 99.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 99.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 99.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 99.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.49 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 99.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 99.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 99.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 99.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 99.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 99.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 99.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 11' ' ' LEU . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 99.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 99.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 99.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 99.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 99.0 110.151 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 99.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 99.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 99.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 99.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 99.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 99.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 99.0 109.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 99.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.554 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 99.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 99.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 99.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 99.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.531 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 99.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 99.0 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 99.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 99.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 99.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 99.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 99.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 99.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 HD11 ' CE ' ' A' ' 40' ' ' MET . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 99.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 99.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 99.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 99.0 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 99.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 99.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 99.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 99.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 99.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 99.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 99.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 99.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 99.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 99.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 99.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 99.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 99.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 103' ' ' ILE . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 99.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 99.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 99.0 110.119 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 99.0 111.052 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 99.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 99.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 99.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 99.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 99.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 99.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 99.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 99.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 99.0 109.273 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 99.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 105' ' ' SER . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 99.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 99.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.408 ' HE3' HD11 ' A' ' 100' ' ' LEU . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 99.0 110.495 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 99.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 99.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 99.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 99.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 99.0 109.803 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 99.0 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.461 ' O ' HD13 ' A' ' 88' ' ' LEU . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 99.0 110.133 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.489 ' O ' HG11 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 99.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 99.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 99.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 99.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' N ' HG11 ' A' ' 93' ' ' VAL . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 99.0 110.2 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 99.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 99.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 99.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 99.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 99.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 104' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 99.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 99.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 99.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 99.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 99.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.451 ' O ' HG21 ' A' ' 80' ' ' ILE . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 99.0 109.544 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HG3' HG23 ' A' ' 42' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 99.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 99.0 110.186 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 99.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 99.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 99.0 110.41 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 99.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 99.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 99.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 99.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.574 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.6 t30 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 99.0 110.316 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 99.0 110.143 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.574 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 30.6 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.08 0.467 . . . . 99.0 109.988 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 99.0 110.105 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.99 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 40' ' ' MET . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 99.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.561 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 99.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 99.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 99.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 99.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 99.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.457 HG22 HD13 ' A' ' 32' ' ' LEU . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 99.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 99.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 99.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 99.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 99.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 99.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.49 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 99.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 99.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 99.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 99.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 99.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 99.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 99.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 11' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 99.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 99.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 99.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 99.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 99.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 99.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 99.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 99.0 110.296 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 99.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 10' ' ' THR . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 99.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 99.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 99.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 99.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 99.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 99.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 99.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 3' ' ' VAL . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 99.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 99.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 99.0 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 99.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 99.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 99.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 99.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 99.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 99.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.45 HG21 ' HE2' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 99.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 99.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 99.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 99.0 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 99.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 99.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 99.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 99.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 99.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 99.0 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 99.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 99.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 99.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 99.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 99.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 99.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 99.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 99.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 99.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 99.0 110.094 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 99.0 111.646 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 99.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 99.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 99.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 99.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 99.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 99.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 99.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 99.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 99.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 99.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 80' ' ' ILE . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 99.0 110.072 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.461 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 99.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.441 ' HE2' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 99.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 99.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 99.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 99.0 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 99.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 100' ' ' LEU . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 99.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 99.0 110.107 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 99.0 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' HG11 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 99.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 99.0 109.956 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 99.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.526 HG22 ' CD ' ' A' ' 99' ' ' ARG . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 99.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 93' ' ' VAL . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 99.0 110.351 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 99.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 99.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 99.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' SER . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 99.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.526 ' CD ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 99.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD11 ' CD1' ' A' ' 103' ' ' ILE . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 99.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 73' ' ' SER . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 99.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.433 ' C ' HG21 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 99.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 99.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 99.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 99.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 99.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 99.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 99.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 99.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 99.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 99.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 99.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 99.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.618 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 99.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 99.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.536 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 99.0 110.627 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 99.0 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 119' ' ' HIS . 44.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 99.0 110.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.99 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 99.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 99.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 99.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.563 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 99.0 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 99.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 99.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 99.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CD1' ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 99.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 99.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 99.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 99.0 110.211 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 99.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 99.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 99.0 109.965 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 99.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 99.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 99.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 99.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 99.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD1' HD11 ' A' ' 11' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 99.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.451 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 99.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 99.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 99.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 99.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 99.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 99.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 99.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 99.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 99.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 99.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 99.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 99.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.563 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 99.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 99.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 99.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 99.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 99.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' C ' HG11 ' A' ' 42' ' ' VAL . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 99.0 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG12 ' HB3' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 99.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 99.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 99.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 99.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 99.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 99.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.507 HG22 ' CE ' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 99.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 99.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 99.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HB3' HG12 ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 99.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 99.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 99.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 99.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 99.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 99.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.474 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 99.0 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 99.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 99.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 99.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 99.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 99.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 99.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 99.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 99.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 99.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 99.0 110.597 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 99.0 111.685 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 99.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 99.0 109.863 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 99.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 99.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 99.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 99.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 99.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 99.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 99.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 99.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 99.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 99.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 99.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 99.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 99.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' HD12 ' A' ' 100' ' ' LEU . 9.2 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 99.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 99.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' N ' ' A' ' 88' ' ' LEU . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 99.0 110.239 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' N ' HG21 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 99.0 110.195 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 99.0 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 99.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 99.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 99.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 99.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 99.0 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 99.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 99.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 99.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 99.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 99.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD12 ' NE2' ' A' ' 85' ' ' GLN . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 99.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 99.0 110.453 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.408 ' C ' HG21 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 99.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 HG12 ' CA ' ' A' ' 66' ' ' GLY . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 99.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 99.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 99.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 99.0 110.046 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 99.0 110.1 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 99.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 99.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 99.0 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 99.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 99.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 99.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 99.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 99.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 99.0 110.48 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.324 0.583 . . . . 99.0 110.009 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 99.0 110.259 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.99 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' MET . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 99.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 99.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 99.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 99.0 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 99.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 99.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 99.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 99.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 99.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 99.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 99.0 109.995 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 99.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 99.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.489 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 99.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 99.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 99.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 99.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 99.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 11' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 99.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 99.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 99.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 99.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 99.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 99.0 110.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 99.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 99.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 99.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 99.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 99.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 99.0 109.279 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 99.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 99.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 99.0 110.189 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 99.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 99.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.547 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 99.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 99.0 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 99.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 99.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 99.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 99.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 99.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 99.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 99.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 99.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 99.0 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' N ' ' HE3' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 99.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 99.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 99.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 99.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 99.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 99.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 99.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 99.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 99.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 99.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 99.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.474 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 99.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 99.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 99.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 99.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 99.0 110.264 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 99.0 111.432 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 99.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 99.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 99.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 99.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 99.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 99.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 99.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 99.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 99.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 99.0 109.911 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 99.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 82' ' ' MET . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 99.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 99.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 99.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.428 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 99.0 110.179 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 99.0 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 99.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 67' ' ' ALA . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 99.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 98' ' ' VAL . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 99.0 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 99.0 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 99.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 99.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 99.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 99.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 99.0 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 99.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 99.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 99.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 99.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 99.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 66' ' ' GLY . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 99.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 99.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 99.0 110.625 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 99.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 99.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 99.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 99.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 99.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 99.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 108' ' ' ALA . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 99.0 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 99.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 99.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 99.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 99.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 99.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 99.0 109.57 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 65.0 m-70 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.12 0.486 . . . . 99.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 99.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.99 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.498 HG23 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 99.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 99.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 99.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.569 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 2.5 t-20 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 99.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 99.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 99.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 99.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 99.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 99.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 99.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 99.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.459 ' HB2' HD22 ' A' ' 23' ' ' LEU . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 99.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 99.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 99.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 99.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 99.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 99.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 99.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 99.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 99.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 99.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 99.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 99.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 99.0 110.132 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 99.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 99.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 99.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 99.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 99.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 99.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 99.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 99.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' HB2' HD22 ' A' ' 6' ' ' LEU . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 99.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 99.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.498 ' CG2' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 99.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 99.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 99.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 99.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 99.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 99.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 99.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 99.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 99.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 99.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 59' ' ' TRP . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 99.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 99.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 99.0 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 99.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 99.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 99.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 99.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 99.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.545 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 99.0 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 99.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 99.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.482 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.535 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 99.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 99.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 99.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 99.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 99.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' N ' HG22 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 99.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 99.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 99.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 99.0 111.209 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 99.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 99.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 99.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 99.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 99.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 99.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 99.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 99.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 99.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 99.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 99.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 99.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 99.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 99.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 99.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 99.0 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 99.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 67' ' ' ALA . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 99.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 99.0 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 99.0 110.166 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 99.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 99.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 99.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.568 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 99.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 99.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 99.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 99.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 99.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 99.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 99.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 99.0 110.218 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 99.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.414 ' C ' HG21 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 99.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 66' ' ' GLY . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 99.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 99.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG11 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 99.0 110.404 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 99.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 99.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 99.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 99.0 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' N ' HG11 ' A' ' 111' ' ' VAL . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 99.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 99.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 99.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 99.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 99.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 99.0 110.103 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.185 0.517 . . . . 99.0 110.331 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 99.0 110.24 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.99 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 3' ' ' VAL . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 40' ' ' MET . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 99.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 99.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 99.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 99.0 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 99.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.448 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 99.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 7' ' ' ASN . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 99.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 23' ' ' LEU . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 99.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 99.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 99.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.446 ' HG3' HG21 ' A' ' 10' ' ' THR . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 99.0 110.124 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.436 ' NE1' ' OD2' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 99.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 99.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 99.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 99.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CB ' ' CB ' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 99.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 99.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 99.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 99.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 99.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 99.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 99.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 99.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 99.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 99.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 99.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 99.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 99.0 110.189 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 99.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.453 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 99.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 99.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HB2' HD22 ' A' ' 6' ' ' LEU . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 99.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 99.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 99.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 99.0 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.482 ' CG2' ' HE2' ' A' ' 40' ' ' MET . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 99.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 99.0 110.303 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 99.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 99.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 99.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 99.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.454 ' O ' ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 99.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 99.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 99.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 55' ' ' GLN . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 99.0 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 99.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 99.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 99.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 55' ' ' GLN . 11.9 mm100 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 99.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 99.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 99.0 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 99.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.607 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 99.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 99.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 99.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 99.0 110.999 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 99.0 112.04 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 99.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 99.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 99.0 110.855 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 99.0 109.956 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 99.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 99.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.467 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 99.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 99.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 99.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 73' ' ' SER . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 99.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 99.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 99.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 99.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 99.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 99.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 81' ' ' ASP . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 99.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' N ' HG21 ' A' ' 80' ' ' ILE . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 99.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.507 ' CG ' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 99.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 99.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 99.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 99.0 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 99.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 88' ' ' LEU . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 99.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 87' ' ' ILE . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 99.0 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 99.0 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 99.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 99.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 99.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 99.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 99.0 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 99.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' O ' HD13 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 99.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.495 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 99.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 99.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 99.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.507 HD11 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 99.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 99.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.441 ' SG ' HG21 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 99.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.545 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 99.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 99.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 99.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 99.0 110.113 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 99.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 99.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 99.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG12 ' HA2' ' A' ' 78' ' ' GLY . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 99.0 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 99.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 99.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 99.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 99.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 99.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.09 -25.34 63.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 99.0 110.149 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 -63.41 -21.84 66.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 99.0 109.971 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -41.48 136.78 1.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 99.0 110.192 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.33 -21.0 65.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 99.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.61 -28.51 65.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 99.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 9.4 mt -96.99 -35.12 10.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 99.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -42.83 -28.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 99.0 110.645 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -65.08 -18.55 65.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.217 -0.927 . . . . 99.0 110.606 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -66.86 -17.65 64.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 99.0 110.451 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -49.78 132.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 99.0 110.201 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.995 -1.002 . . . . 99.0 110.26 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.607 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.99 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.402 HG21 HG21 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 99.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 99.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 99.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 99.0 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 99.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 99.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 99.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 99.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 99.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 99.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 99.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 99.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 99.0 110.251 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 99.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 99.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 99.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 99.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 99.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 99.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 HD13 HD23 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 99.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.58 ' CE2' HD11 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 99.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 99.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 99.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 99.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 99.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 99.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 99.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 99.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 99.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 99.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 99.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 99.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 99.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 99.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 99.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 99.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 99.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 99.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 99.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 99.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 99.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' CG ' ' HB1' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 99.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 99.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 99.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 99.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 99.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB1' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 99.0 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 99.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 99.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 99.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 99.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 99.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.44 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 99.0 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 99.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 99.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 99.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 99.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 99.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 99.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 99.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 99.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 99.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.591 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 99.0 110.267 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 99.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 99.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 99.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 99.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 99.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 99.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.508 HG11 ' CA ' ' A' ' 97' ' ' ASP . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 99.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 99.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 99.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 99.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 99.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 99.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 99.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.446 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 99.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 99.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 99.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 99.0 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 99.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 99.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD2' HG21 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 99.0 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 99.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 99.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 99.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 99.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 99.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 99.0 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 99.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 99.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.508 ' CA ' HG11 ' A' ' 75' ' ' VAL . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 99.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 99.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 99.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.559 HD13 ' S2 ' ' A' ' 130' ' ' FES . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 99.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 99.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.435 ' SG ' HG21 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 99.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.518 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 99.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 99.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 99.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HB3' HG23 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 99.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.469 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 99.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 99.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 99.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 99.0 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 99.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 99.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 99.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 99.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 99.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -84.27 -21.7 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 99.0 110.226 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 -64.72 -29.4 70.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 99.0 110.092 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -46.84 124.99 6.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 99.0 110.26 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.57 -30.69 70.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 99.0 110.326 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.429 ' HB2' HD23 ' A' ' 120' ' ' LEU . 1.4 t80 -62.69 -17.33 60.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 99.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.72 -28.49 10.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 99.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.73 -25.13 67.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 99.0 110.225 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -63.28 -19.71 64.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 99.0 110.418 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.06 22.31 5.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 99.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.527 ' CG2' HG12 ' A' ' 128' ' ' ILE . 13.1 p -73.43 143.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 99.0 110.07 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 HG12 ' CG2' ' A' ' 127' ' ' VAL . 20.5 mm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.936 -1.031 . . . . 99.0 110.137 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.591 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.452 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.99 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 3' ' ' VAL . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' MET . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' HG13 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 99.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 99.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 99.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 99.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 99.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 99.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 99.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 99.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 99.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 99.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 99.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 99.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' CA ' ' OD2' ' A' ' 21' ' ' ASP . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 99.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 99.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 99.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 99.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 99.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 99.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 99.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 99.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 99.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 99.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 99.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 99.0 110.059 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 99.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 99.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 99.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 99.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 99.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 99.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 99.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 99.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 99.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 99.0 110.129 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 3' ' ' VAL . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 99.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 99.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 99.0 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 106' ' ' PRO . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 99.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 99.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 99.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 99.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 99.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 99.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 99.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' N ' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 99.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 99.0 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 99.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 99.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 99.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 99.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 99.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 99.0 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 99.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 99.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 99.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 99.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 99.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 99.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 99.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 99.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 99.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 99.0 110.193 179.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 99.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 99.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 99.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 69' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 99.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 99.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 99.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' CG1' ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 99.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 99.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 99.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 99.0 109.498 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 99.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 106' ' ' PRO . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 99.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 99.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 99.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 99.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 99.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 99.0 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 99.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 99.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.474 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 99.0 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 99.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 99.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 99.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 99.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' A' ' 88' ' ' LEU . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 99.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 99.0 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 99.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 99.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.517 ' OD1' ' CG1' ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 99.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' SER . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 99.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 99.0 110.098 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 99.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 99.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.421 ' C ' HG21 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 99.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.464 HD13 HD11 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 99.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 99.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 99.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.526 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 99.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 99.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 99.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.446 ' O ' HG21 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 99.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 99.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 99.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 99.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 8' ' ' TYR . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 99.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 99.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 99.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -72.84 -19.57 61.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 99.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 -69.21 -21.97 63.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 99.0 110.191 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt -43.56 123.43 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 99.0 110.05 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.73 -32.42 72.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 99.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -70.45 -13.04 61.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 99.0 110.755 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 mt -117.79 -31.04 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 99.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.27 -31.73 67.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 99.0 110.246 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -27.66 66.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 99.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.22 -24.11 62.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 99.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.77 151.26 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 99.0 110.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.948 -1.025 . . . . 99.0 110.293 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.99 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 40' ' ' MET . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 99.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 99.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 99.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 99.0 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 99.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 99.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 99.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 99.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 99.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 99.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 99.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 99.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.565 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 99.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 99.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 99.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 99.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 99.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 99.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 99.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 99.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 99.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 99.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 99.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 99.0 110.227 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 99.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 99.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 99.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 99.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 99.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 99.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 99.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 99.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 99.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 99.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 99.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 99.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 99.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 99.0 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 99.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 99.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 99.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 99.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 99.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 99.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 99.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 99.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 99.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 99.0 109.876 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 99.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 99.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 99.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 99.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 99.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.425 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 99.0 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 99.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.641 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 99.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.533 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 99.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 99.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 99.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 99.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 99.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 100' ' ' LEU . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 99.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 99.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.602 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 99.0 110.613 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 99.0 111.052 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 99.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 99.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 99.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 99.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 99.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' CG1' ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 99.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 99.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 99.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.512 ' HA2' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 99.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 99.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 99.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 105' ' ' SER . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 99.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.427 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 99.0 110.569 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 99.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 99.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 99.0 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 99.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.497 HG21 ' N ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 99.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.52 HD13 ' CD2' ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 99.0 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 99.0 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 99.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 99.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 99.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 99.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 99.0 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 99.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 99.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' OD1' ' CG1' ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 99.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 99.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 99.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 88' ' ' LEU . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 99.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 99.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 99.0 109.841 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 99.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 82' ' ' MET . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 99.0 109.777 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 99.0 109.832 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.476 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 99.0 110.435 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 99.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 99.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 99.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.512 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 99.0 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 76' ' ' LYS . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 99.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 99.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 99.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 99.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 99.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -74.71 -22.02 59.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 99.0 109.867 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.438 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 37.0 m-70 -57.84 -33.14 68.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 99.0 109.702 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.471 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -42.41 137.91 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 99.0 110.124 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.9 OUTLIER -62.96 -28.9 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 99.0 110.161 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -62.81 -38.31 90.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.353 -0.842 . . . . 99.0 110.256 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.48 -14.96 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 99.0 110.107 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 121' ' ' ASP . 2.7 tp-100 -47.68 -24.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.844 . . . . 99.0 110.481 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -68.75 -11.05 59.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 99.0 110.296 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -111.55 -6.8 14.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 99.0 110.193 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.459 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 7.7 p -51.55 123.51 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 99.0 110.147 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.023 -0.989 . . . . 99.0 110.303 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.602 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.99 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.439 ' CG2' HG23 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' MET . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 99.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.548 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 99.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 99.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 99.0 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' HG13 ' A' ' 114' ' ' VAL . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 99.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 99.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 99.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 99.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 99.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 99.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 99.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 99.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.557 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 99.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 99.0 110.486 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 99.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 99.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 99.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 99.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 99.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 99.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 99.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 99.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 99.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 99.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 99.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 99.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 99.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 99.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 99.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 99.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 99.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 99.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 99.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 99.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.49 ' HE1' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 99.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 99.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG1' ' HE1' ' A' ' 40' ' ' MET . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 99.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 99.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 99.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 99.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 99.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 99.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 99.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 99.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 99.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 99.0 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 99.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 99.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 99.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 99.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 99.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 99.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 99.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 99.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 99.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 99.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 99.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 99.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 99.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 99.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 99.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.593 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 99.0 110.102 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 99.0 111.603 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 99.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 99.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 99.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 99.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 99.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 99.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 99.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' O ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 99.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' HA2' HG11 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 99.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 99.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 80' ' ' ILE . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 99.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 99.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.464 ' SD ' ' CD1' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 99.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 99.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 99.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 99.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 99.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 88' ' ' LEU . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 99.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 99.0 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 99.0 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 99.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 99.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 99.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 99.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 99.0 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 99.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 99.0 110.252 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 99.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' SER . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 99.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 99.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' CD1' ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 99.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 99.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 99.0 110.473 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.475 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 99.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 99.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 99.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 99.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 1' ' ' PRO . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 99.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 99.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 99.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG11 ' HA2' ' A' ' 78' ' ' GLY . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 99.0 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 99.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 99.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 99.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 99.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 99.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.37 -19.95 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 99.0 109.914 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.505 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 75.4 m-70 -59.09 -28.33 66.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.327 -0.858 . . . . 99.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 119' ' ' HIS . 16.7 tp -42.91 124.37 3.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 99.0 110.038 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -57.45 -38.66 74.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 99.0 110.543 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -29.06 63.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 99.0 109.996 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 5.2 mt -98.75 -26.81 14.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 99.0 110.104 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 121' ' ' ASP . 12.2 mm-40 -56.74 -29.45 62.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.915 . . . . 99.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.89 -26.56 59.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 99.0 109.964 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.19 -16.33 59.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 99.0 110.002 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.42 -38.48 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 99.0 110.262 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.984 -1.008 . . . . 99.0 110.28 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.593 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.99 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 109' ' ' ASP . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' MET . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 99.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.59 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 99.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 99.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 99.0 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 99.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 99.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 32' ' ' LEU . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 99.0 110.014 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 99.0 110.145 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 99.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 99.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 99.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 99.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 99.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 99.0 110.051 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 99.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 99.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 99.0 110.388 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 99.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 99.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 16' ' ' TRP . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 99.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 99.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 99.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 99.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 99.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 99.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 99.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 99.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 99.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 10' ' ' THR . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 99.0 110.111 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 99.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 99.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 99.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 99.0 110.182 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 99.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 99.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.517 ' SD ' ' CG1' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 99.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 99.0 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG1' ' SD ' ' A' ' 40' ' ' MET . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 99.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 99.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 99.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 99.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 99.0 110.564 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 99.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 99.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.53 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 99.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 99.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 99.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 99.0 110.64 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 99.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 99.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 99.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 99.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 99.0 110.262 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 99.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 99.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 99.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 99.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 99.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 99.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 99.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 100' ' ' LEU . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 99.0 109.891 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 99.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 99.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 99.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 99.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 99.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 99.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 99.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.466 HD12 ' O ' ' A' ' 73' ' ' SER . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 99.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HA ' ' CB ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 99.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 99.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 99.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 99.0 109.521 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 99.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 48' ' ' ILE . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 99.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 99.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 99.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 99.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 99.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 99.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 99.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 88' ' ' LEU . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 99.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.441 HD11 HG21 ' A' ' 87' ' ' ILE . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 99.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 99.0 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 99.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 99.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 99.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 99.0 109.816 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 99.0 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 99.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 99.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 99.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 92' ' ' GLU . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 99.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 99.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 66' ' ' GLY . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 99.0 109.941 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 99.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 99.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 99.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 99.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HG3' HG23 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 99.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 99.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 99.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 99.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.447 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 99.0 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 76' ' ' LYS . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 99.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CB ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 99.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.534 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 99.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 99.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 5.7 t-20 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 99.0 110.074 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -75.49 -25.55 57.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 99.0 110.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.456 ' HG2' ' N ' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 57.9 m-70 -60.05 -33.14 71.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 99.0 110.14 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.37 120.58 2.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 99.0 110.208 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -71.23 -40.13 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 99.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -56.21 -19.33 13.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 99.0 109.932 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.76 -36.14 8.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 99.0 110.333 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -17.12 10.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 99.0 110.36 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -66.89 -27.51 67.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 99.0 110.025 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -101.35 9.18 41.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 99.0 109.923 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -47.29 -34.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 99.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 99.0 110.129 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.613 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.99 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' MET . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 99.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 99.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 99.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 99.0 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 99.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 99.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 99.0 109.696 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 99.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 99.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 99.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 99.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 99.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 99.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 23' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 99.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 99.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 99.0 109.808 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 99.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 99.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 25' ' ' GLU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 99.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 17' ' ' ASP . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 99.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 99.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 99.0 110.098 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 99.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 99.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 99.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 99.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 99.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 99.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 99.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 99.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 99.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 99.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 99.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CG ' ' HB1' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 99.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 99.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' CG2' ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 99.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.544 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 99.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 99.0 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG13 ' HE2' ' A' ' 40' ' ' MET . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 99.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 99.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 99.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 99.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 99.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 99.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.518 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 99.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 99.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 99.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 55' ' ' GLN . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 99.0 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 99.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 99.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 99.0 109.823 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' OE1' ' O ' ' A' ' 51' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 99.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 99.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 99.0 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 99.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 99.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 99.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 99.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 99.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 99.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 99.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 99.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 99.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 99.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.433 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 99.0 111.082 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 99.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 99.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 99.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 99.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 99.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 99.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 99.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 99.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 99.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 99.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 99.0 110.139 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 99.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 99.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 99.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 99.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 99.0 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 99.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 99.0 110.219 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 99.0 110.234 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 99.0 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 99.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 99.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 99.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 99.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 99.0 110.396 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 99.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 99.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 99.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 73' ' ' SER . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 99.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.457 ' CD ' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 99.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD21 ' S2 ' ' A' ' 130' ' ' FES . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 99.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 99.0 110.563 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.419 ' C ' HG21 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 99.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.574 ' HA ' ' CD1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 99.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 99.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 99.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 99.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 99.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 99.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 99.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 99.0 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 99.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 99.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 99.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 99.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 99.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -78.06 -29.45 49.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 99.0 110.081 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.415 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 29.3 m-70 -58.94 -27.47 65.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 99.0 109.808 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.465 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 1.6 mt -46.86 142.0 3.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 99.0 110.234 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.54 -17.93 64.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 99.0 109.986 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -73.05 -33.15 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 99.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 -8.69 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 99.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.401 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 5.5 mm-40 -62.82 -27.8 69.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 99.0 110.039 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.2 -21.23 21.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 99.0 109.794 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.23 3.79 37.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 99.0 110.0 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 10.0 p -50.26 128.62 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 99.0 110.198 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.513 ' OXT' ' CD1' ' A' ' 128' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 99.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.99 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 99.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.505 ' CZ ' ' HA2' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 99.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 99.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.558 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 99.0 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.47 ' HA ' HG13 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 99.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 99.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 99.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 99.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 99.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 99.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 99.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 99.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.476 ' CB ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 99.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 99.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 99.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 99.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 99.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 99.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 99.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB2' ' CD1' ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 99.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 99.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 99.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 99.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 99.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 99.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 99.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 99.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 99.0 110.113 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 99.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 99.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 99.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 99.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 99.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 99.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 99.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.519 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 99.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 99.0 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 106' ' ' PRO . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 99.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 99.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 99.0 110.344 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 99.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 99.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 99.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.512 HG21 ' CE ' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 99.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 99.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' OE1' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 99.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 99.0 110.219 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 99.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HB2' HD23 ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 99.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 99.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 99.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 99.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 99.0 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 99.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.614 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 99.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 99.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 99.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 99.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 99.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 99.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 99.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 99.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.622 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 99.0 110.272 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 99.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 99.0 109.952 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 99.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 99.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 99.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 99.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 99.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 99.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 99.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 99.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 99.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 105' ' ' SER . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 99.0 110.318 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 99.0 110.086 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 99.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 99.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 99.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 99.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 99.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 99.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 99.0 110.145 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 99.0 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 99.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 99.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 99.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 99.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 99.0 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 99.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 99.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.489 ' CB ' HG11 ' A' ' 75' ' ' VAL . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 99.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 99.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 99' ' ' ARG . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 99.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.614 HD21 ' S2 ' ' A' ' 130' ' ' FES . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 99.0 110.324 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 99.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 99.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.468 HG12 ' CA ' ' A' ' 66' ' ' GLY . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 99.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 99.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.46 ' O ' HG21 ' A' ' 80' ' ' ILE . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 99.0 109.849 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 99.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 99.0 110.15 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 99.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 99.0 110.041 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 99.0 110.396 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 99.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 99.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 8' ' ' TYR . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 99.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.611 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 99.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 99.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -79.36 -19.91 49.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 99.0 110.232 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.407 ' O ' ' OE1' ' A' ' 124' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -60.03 -37.22 79.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.423 -0.798 . . . . 99.0 109.846 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 121' ' ' ASP . 9.6 tp -45.77 124.47 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 99.0 110.163 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' HD13 ' A' ' 120' ' ' LEU . 25.1 t0 -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 99.0 110.151 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -65.66 -9.99 32.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 99.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.499 ' CD1' HD22 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -125.14 -22.56 4.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 99.0 110.503 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.407 ' OE1' ' O ' ' A' ' 118' ' ' ALY . 6.7 tp60 -63.36 -22.12 66.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 99.0 110.29 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.73 -18.37 64.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 99.0 110.344 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -66.19 -14.31 61.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 99.0 110.299 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 127' ' ' VAL . 9.8 p -54.21 136.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.902 . . . . 99.0 110.13 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.011 -0.995 . . . . 99.0 110.155 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.622 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.99 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 3' ' ' VAL . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 99.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 99.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 99.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 99.0 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 99.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 99.0 109.862 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 99.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 99.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 99.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 99.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 99.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 99.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.443 ' C ' ' CD1' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 99.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 99.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 99.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 99.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 99.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 99.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 99.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 11' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 99.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 99.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 99.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 99.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 99.0 110.346 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 99.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 99.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 99.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 99.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' N ' HD21 ' A' ' 32' ' ' LEU . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 99.0 110.11 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 99.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 99.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 99.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 99.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.558 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 99.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA2' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 99.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 99.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 99.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 99.0 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 99.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 99.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 99.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 99.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 99.0 109.977 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 99.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.47 HG22 HD11 ' A' ' 48' ' ' ILE . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 99.0 110.285 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 59' ' ' TRP . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 99.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 99.0 110.076 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 99.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 99.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 99.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 99.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 99.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 99.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 99.0 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 99.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.579 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 99.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 99.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 99.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 99.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 99.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 99.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.532 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 99.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' C ' HG12 ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 99.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.408 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 99.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 99.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 99.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 99.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 99.0 111.405 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 99.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 99.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 99.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 99.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.438 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 99.0 110.1 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' HA2' HG11 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 99.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 99.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 99.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 99.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 99.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 99.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 99.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 99.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 99.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 99.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 99.0 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.465 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 99.0 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 99.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 99.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 99.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG1' ' CZ ' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 99.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 99.0 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 99.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 99.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 99.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 99.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.533 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 99.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 99.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 99.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 99.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.532 HG12 ' CA ' ' A' ' 66' ' ' GLY . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 99.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 99.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 81' ' ' ASP . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 99.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG12 ' A' ' 42' ' ' VAL . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 99.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 99.0 110.405 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 99.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 99.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 99.0 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 99.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 99.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 99.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 99.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 99.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -75.92 -23.39 55.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 99.0 110.035 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 -58.07 -28.72 64.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 99.0 109.736 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 8' ' ' TYR . 20.6 tp -49.42 129.99 19.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 99.0 110.065 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -53.24 -22.39 6.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 99.0 110.424 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -71.58 -14.77 62.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 99.0 110.432 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -116.76 -23.41 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 99.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.99 -26.75 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 99.0 110.066 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -64.03 -18.24 64.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 99.0 110.219 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -80.41 -9.86 59.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 99.0 110.124 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.49 155.97 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -0.862 . . . . 99.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.449 ' OXT' HG13 ' A' ' 128' ' ' ILE . 6.1 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 99.0 110.22 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.436 ' S2 ' ' HA3' ' A' ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.99 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 99.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 99.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.611 ' CB ' ' CZ ' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 99.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.592 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.7 t30 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 99.0 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 99.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 99.0 109.966 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' HD23 ' A' ' 32' ' ' LEU . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 99.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 99.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 99.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 99.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 99.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 99.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 99.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 99.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 99.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 99.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 99.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 99.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 11' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 99.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.611 ' CZ ' ' CB ' ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 99.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 99.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 99.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 37' ' ' TYR . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 99.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 99.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 99.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 99.0 110.168 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 99.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD23 ' CG2' ' A' ' 10' ' ' THR . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 99.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 99.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 99.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 99.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 99.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 99.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 99.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 99.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.531 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 99.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 99.0 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.514 ' CG2' ' CB ' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 99.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 99.0 110.228 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 99.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 99.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 99.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 99.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 HG21 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 99.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 HD21 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 99.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' N ' HD21 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 99.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 99.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' CB ' ' HE1' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 99.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 99.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 99.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 99.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 99.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 99.0 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 99.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 99.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 99.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 99.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 99.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 99.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 99.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 99.0 109.907 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 99.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.582 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 99.0 110.306 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 99.0 111.343 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 99.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 99.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 99.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 99.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 74' ' ' ILE . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 99.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 99.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 99.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 99.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 99.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 99.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 48' ' ' ILE . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 99.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 99.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.519 ' CE ' HD13 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 99.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 99.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 99.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 99.0 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 99.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 99.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.511 ' N ' HG21 ' A' ' 87' ' ' ILE . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 99.0 109.89 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 99.0 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 99.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 99.0 109.633 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 99.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 HG12 ' CD ' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 99.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 99.0 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 99.0 110.458 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 99.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 99.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 99.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.525 ' CD ' HG12 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 99.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 ' CE ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 99.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 99.0 110.437 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 99.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.45 HG22 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 99.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 99.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 81' ' ' ASP . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 99.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 99.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 99.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 99.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 99.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 99.0 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 99.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 99.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 99.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 99.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.595 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 99.0 110.287 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -80.17 -23.05 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 99.0 110.221 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' CE ' ' C ' ' A' ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.595 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 65.0 m-70 -59.77 -29.14 67.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.855 . . . . 99.0 109.671 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.85 128.02 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 99.0 110.435 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.27 -21.37 66.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 99.0 109.739 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -76.07 -25.03 55.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 99.0 110.058 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -110.51 -25.75 9.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 99.0 110.08 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.425 ' O ' ' CG2' ' A' ' 127' ' ' VAL . 7.8 tt0 -51.08 -73.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 99.0 110.302 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -46.89 -25.97 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 99.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.62 -19.97 52.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 99.0 110.144 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 124' ' ' GLN . 11.2 m -77.42 -15.54 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 99.0 109.899 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.451 HG13 ' OXT' ' A' ' 128' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.979 -1.01 . . . . 99.0 110.246 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.582 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.99 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 99.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 99.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 99.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 99.0 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.497 ' CE2' HD13 ' A' ' 120' ' ' LEU . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 99.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 99.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' CD1' ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 99.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 99.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 99.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 99.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 99.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 99.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.521 ' CB ' HD22 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 99.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 99.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 99.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 99.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 99.0 110.404 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 99.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 99.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 16' ' ' TRP . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 99.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 99.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 99.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 99.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 99.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 99.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 99.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 99.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 99.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD13 ' CB ' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 99.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 99.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 99.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 99.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 99.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.565 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 99.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 99.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 99.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.558 ' CE ' ' CG2' ' A' ' 42' ' ' VAL . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 99.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 99.0 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.558 ' CG2' ' CE ' ' A' ' 40' ' ' MET . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 99.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 99.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 99.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 99.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 99.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 99.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 99.0 110.369 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 99.0 110.484 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 99.0 110.503 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 99.0 110.346 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB3' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 99.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 99.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 99.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 99.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 99.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 99.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 99.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 99.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 99.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 99.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 99.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 99.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 99.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 99.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 99.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.612 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 99.0 110.545 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 99.0 111.276 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 99.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 101' ' ' THR . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 99.0 110.173 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 99.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 99.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 99.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.518 HG11 ' CB ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 99.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 99.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 99.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 99.0 109.24 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 99.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 99.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.459 ' CE ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 99.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 99.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 99.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.413 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 99.0 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 99.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 99.0 110.539 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HB3' ' CE ' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 99.0 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 99.0 109.986 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' O ' HG11 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 99.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 99.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 99.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 94' ' ' GLU . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 99.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' N ' HG11 ' A' ' 93' ' ' VAL . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 99.0 110.012 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 99.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 99.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' HG11 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 99.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' SER . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 99.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 99.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.594 HD21 ' S2 ' ' A' ' 130' ' ' FES . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 99.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 71' ' ' CYS . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 99.0 109.993 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.48 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 99.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 99.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 99.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' CG ' HG13 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 99.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 99.0 110.393 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 99.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 99.0 109.748 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 3' ' ' VAL . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 99.0 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 76' ' ' LYS . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 99.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 99.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 8' ' ' TYR . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 99.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 99.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.3 t30 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 99.0 110.02 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -78.67 -26.89 45.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 99.0 110.423 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.516 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.537 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 88.3 m-70 -65.31 -18.03 64.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.458 -0.776 . . . . 99.0 110.181 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -53.05 128.33 27.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 99.0 110.164 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.36 -51.24 15.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 99.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -59.87 -24.36 64.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 99.0 110.281 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt -97.88 -28.23 13.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 99.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -65.87 -30.58 71.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 99.0 110.038 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -21.48 64.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 99.0 110.437 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.21 -12.35 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 99.0 110.574 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.51 -36.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 99.0 110.032 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.972 -1.014 . . . . 99.0 110.184 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.612 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.99 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 99.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.547 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 99.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 99.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 99.0 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.493 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 99.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 99.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 99.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 99.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 99.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 99.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 99.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 99.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 99.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 99.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 74' ' ' ILE . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 99.0 110.341 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 99.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 99.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 99.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 99.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 99.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 99.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 99.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 99.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 99.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 99.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 99.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 99.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 99.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 31' ' ' GLY . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 99.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 99.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 99.0 109.655 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 99.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 99.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 99.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 99.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 99.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 99.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 99.0 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 46' ' ' GLU . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 99.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 99.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 99.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 99.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 99.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 99.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.404 ' CG1' ' HD3' ' A' ' 106' ' ' PRO . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 99.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 99.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 99.0 110.258 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 99.0 109.998 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 99.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 99.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 99.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 99.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 99.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.466 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 99.0 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 99.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 99.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 99.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 99.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 99.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 99.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 99.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 99.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 99.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.578 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 99.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 99.0 111.263 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 99.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 99.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 99.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 99.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 99.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 99.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 99.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.492 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 99.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 99.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 99.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.511 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 99.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 99.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 99.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 99.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 99.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 99.0 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 99.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 68' ' ' CYS . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 99.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 99.0 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 99.0 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 99.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 99.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 99.0 110.01 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 99.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 99.0 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 99.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 99.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 99.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 HG11 ' CD2' ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 99.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 99.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.542 HD11 ' S2 ' ' A' ' 130' ' ' FES . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 99.0 110.666 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 99.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' C ' HG21 ' A' ' 103' ' ' ILE . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 99.0 109.994 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD13 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 99.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 99.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 99.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 99.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 99.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 99.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 99.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 99.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 99.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 99.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 99.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 99.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 99.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -74.78 -21.49 59.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 99.0 110.232 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.518 ' HG2' ' N ' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 57.5 m-70 -61.02 -25.83 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 99.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -43.31 159.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 99.0 110.184 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -17.31 60.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.91 . . . . 99.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -77.14 -21.08 54.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.957 . . . . 99.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD12 ' HCA' ' A' ' 118' ' ' ALY . 1.6 mt -105.3 -32.94 8.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 99.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -29.89 69.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 99.0 109.957 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.9 -37.72 14.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 99.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.63 29.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 99.0 110.282 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.3 64.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 99.0 110.182 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.954 -1.022 . . . . 99.0 110.262 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.578 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HG2' ' OE2' ' A' ' 41' ' ' GLU . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.99 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.487 ' CG2' HG21 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 99.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 99.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 99.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.58 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 99.0 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 99.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 99.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 99.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 99.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 99.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 99.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 99.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 99.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.419 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 99.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 99.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 99.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 99.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 99.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 99.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 17' ' ' ASP . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 99.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 99.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 99.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 99.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB3' ' CG ' ' A' ' 37' ' ' TYR . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 99.0 109.627 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 99.0 109.907 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 99.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 99.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 99.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 10' ' ' THR . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 99.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 99.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 99.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 99.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 99.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 99.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 99.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 99.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 99.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 99.0 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 106' ' ' PRO . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 99.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 99.0 110.087 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 99.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 99.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 99.0 110.443 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 99.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' LEU . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 99.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 ' C ' ' CD2' ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 99.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 99.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 99.0 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 99.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 99.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 99.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 99.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 99.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 35' ' ' GLU . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 99.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 99.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 99.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 99.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 99.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 99.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 99.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 99.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 103' ' ' ILE . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 99.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 99.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 99.0 110.377 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 99.0 111.297 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 99.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 99.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 99.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 99.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 99.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 97' ' ' ASP . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 99.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 99.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 112' ' ' LYS . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 99.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 99.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' N ' HG12 ' A' ' 111' ' ' VAL . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 99.0 110.056 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 99.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 99.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 99.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 99.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 99.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 99.0 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 99.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 HG21 ' N ' ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 99.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' N ' HG21 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 99.0 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 99.0 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 99.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 99.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 99.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 99.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 93' ' ' VAL . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 99.0 110.537 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 99.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 99.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 99.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 73' ' ' SER . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 99.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 99.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 68' ' ' CYS . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 99.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 99.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 99.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 66' ' ' GLY . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 99.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 99.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 99.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 81' ' ' ASP . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 99.0 110.564 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 99.0 110.373 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 99.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 99.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.476 HG12 ' HA2' ' A' ' 78' ' ' GLY . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 99.0 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 99.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 99.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 99.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 7' ' ' ASN . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 99.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 99.0 110.609 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -78.35 -27.13 46.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 99.0 110.163 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.482 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.623 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 64.9 m-70 -57.53 -31.57 66.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 99.0 109.792 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -40.88 114.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 99.0 110.511 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -48.17 -26.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 99.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -61.63 -21.75 64.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 99.0 110.24 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -35.62 6.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 99.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.43 -25.58 67.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 99.0 110.235 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -45.31 -34.78 3.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 99.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -58.78 -52.04 67.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 99.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.422 ' C ' HG21 ' A' ' 128' ' ' ILE . 21.3 t -77.0 125.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 99.0 110.356 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG21 ' C ' ' A' ' 127' ' ' VAL . 2.2 pp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.02 -0.99 . . . . 99.0 110.163 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.607 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.413 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.99 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 40' ' ' MET . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 99.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 99.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 99.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 99.0 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 99.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 99.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.478 ' CG2' HD12 ' A' ' 32' ' ' LEU . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 99.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 99.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 99.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 99.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.561 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 99.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 99.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.561 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 99.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 99.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.448 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 99.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 99.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 99.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 99.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 99.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 99.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 99.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 99.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 99.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 99.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 99.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 99.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 99.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 99.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.478 HD12 ' CG2' ' A' ' 10' ' ' THR . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 99.0 110.388 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 99.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 99.0 109.301 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 99.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 99.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 99.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 99.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 99.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 99.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 99.0 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.499 HG13 ' CG ' ' A' ' 106' ' ' PRO . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 99.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 99.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 99.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 99.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 99.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 99.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 99.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 99.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 47' ' ' TYR . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 99.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 99.0 110.248 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 99.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 99.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 99.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 99.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 99.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 99.0 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 99.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.647 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 99.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 99.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 99.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 99.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 99.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 99.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 103' ' ' ILE . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 99.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 99.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.614 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 99.0 110.271 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 99.0 111.173 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 99.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 99.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 99.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 99.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 114' ' ' VAL . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 99.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 99.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 99.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 99.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 99.0 109.208 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 99.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 99.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 99.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 99.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 99.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 99.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.3 OUTLIER -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 99.0 110.216 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 99.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 99.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 99.0 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' HD13 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 99.0 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' HG11 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 99.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 99.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 99.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' CG2' ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 99.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 99.0 110.442 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 99.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' O ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 99.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 99.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 73' ' ' SER . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 99.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.525 ' NH2' ' CG2' ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 99.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 99.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 99.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 99.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.448 HG22 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 99.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 99.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 99.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.499 ' CG ' HG13 ' A' ' 42' ' ' VAL . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 99.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.468 ' O ' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 99.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 99.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.423 ' C ' HG21 ' A' ' 111' ' ' VAL . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 99.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.476 HG11 ' N ' ' A' ' 112' ' ' LYS . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 99.0 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 99.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 99.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 99.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 99.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 99.0 110.138 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -80.36 -26.43 38.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 99.0 110.368 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.51 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 -62.96 -20.41 65.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 99.0 109.708 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.81 152.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 99.0 110.397 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.42 -21.15 64.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 99.0 110.015 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.2 -25.12 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 99.0 110.156 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.01 -27.23 10.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 99.0 110.161 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -66.43 -15.62 63.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 99.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -68.38 -15.62 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 99.0 110.217 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -10.0 43.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 99.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 126.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 99.0 110.077 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.001 -0.999 . . . . 99.0 110.184 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.614 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.475 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.99 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 99.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 99.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 99.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.589 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 99.0 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 99.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 99.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 99.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 99.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 99.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 99.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 99.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 99.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 99.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 99.0 110.327 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 99.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 99.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 99.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 99.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 99.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 99.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 99.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 99.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 99.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 99.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 99.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 99.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 99.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 99.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 99.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 99.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 99.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 99.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 99.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 99.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 99.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 3' ' ' VAL . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 99.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.549 ' CE ' ' HB1' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 99.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 99.0 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 ' CG2' ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 99.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 99.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 99.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 99.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 99.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 99.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 99.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 99.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 99.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' CB ' ' CG2' ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 99.0 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.549 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 99.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 99.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 99.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 99.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 99.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 99.0 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 99.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 99.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' PRO . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 99.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 99.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 99.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 99.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 99.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 99.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 99.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.609 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 99.0 110.263 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 99.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 99.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 99.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 99.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 99.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 99.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 99.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 99.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 99.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 99.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 99.0 110.046 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 99.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 99.0 110.349 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 99.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 99.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 99.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 99.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 99.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 88' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 99.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 87' ' ' ILE . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 99.0 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 99.0 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' O ' HG11 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 99.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 99.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 99.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' NH1' ' A' ' 99' ' ' ARG . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 99.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 99.0 110.47 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 99.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.537 ' CB ' HG12 ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 99.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 99.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.537 HG12 ' CB ' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 99.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.496 ' NH1' HG22 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 99.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 99.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 99.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 99.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 ' SG ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 99.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 99.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 99.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 99.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 99.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 99.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 99.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 ' O ' HG11 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 99.0 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 99.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 99.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 99.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 99.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 99.0 110.922 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -67.9 -15.93 63.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 99.0 109.859 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 -64.88 -30.69 71.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 99.0 110.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HG ' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -53.9 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 99.0 110.214 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -62.66 -25.34 68.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 99.0 110.108 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.498 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -67.03 -21.77 65.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 99.0 110.293 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -25.65 14.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 99.0 110.254 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.451 ' O ' HG23 ' A' ' 127' ' ' VAL . 5.2 tt0 -58.26 -18.22 25.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 99.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.14 -10.13 57.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 99.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' A' ' 122' ' ' TYR . 5.0 mpt_? -94.67 -3.28 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 99.0 110.358 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 124' ' ' GLN . 34.2 m -60.0 131.0 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 99.0 110.269 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 99.0 110.296 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.609 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.99 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 99.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 99.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 99.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 99.0 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 99.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 99.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 99.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.461 HD11 ' CD2' ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 99.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 99.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 99.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 99.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 99.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.49 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 99.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 99.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 99.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 99.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 99.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 99.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 99.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 11' ' ' LEU . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 99.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 99.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 99.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 99.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HB2' ' CD2' ' A' ' 37' ' ' TYR . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 99.0 110.151 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 99.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 99.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 99.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 99.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 99.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 99.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 99.0 109.373 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 99.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.554 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 99.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 99.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 99.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 99.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.531 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 99.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 99.0 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 99.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 99.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 99.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 99.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 99.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 99.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 HD11 ' CE ' ' A' ' 40' ' ' MET . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 99.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 99.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 99.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 99.0 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 99.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 99.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 99.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 99.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 99.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 99.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 99.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 99.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 99.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 99.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 99.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 99.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 99.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 103' ' ' ILE . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 99.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 99.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 99.0 110.119 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 99.0 111.052 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 99.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 99.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 99.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 99.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 99.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.549 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 99.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 99.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 99.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 99.0 109.273 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 99.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 105' ' ' SER . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 99.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 99.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.408 ' HE3' HD11 ' A' ' 100' ' ' LEU . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 99.0 110.495 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 99.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 99.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 99.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 99.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 99.0 109.803 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 99.0 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.461 ' O ' HD13 ' A' ' 88' ' ' LEU . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 99.0 110.133 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.489 ' O ' HG11 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 99.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 99.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 99.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 99.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' N ' HG11 ' A' ' 93' ' ' VAL . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 99.0 110.2 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 99.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 99.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 99.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' SER . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 99.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 99.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 104' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 99.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 99.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 99.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 99.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 99.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.451 ' O ' HG21 ' A' ' 80' ' ' ILE . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 99.0 109.544 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' HG3' HG23 ' A' ' 42' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 99.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 99.0 110.186 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 99.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 99.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 99.0 110.41 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 99.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 99.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 99.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 99.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.574 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.6 t30 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 99.0 110.316 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -74.89 -28.55 60.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 99.0 110.143 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.574 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 30.6 m-70 -61.63 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 99.0 109.988 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -40.16 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 99.0 110.105 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 119' ' ' HIS . 38.0 t0 -42.82 -31.9 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 99.0 110.757 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -8.02 52.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.062 -1.024 . . . . 99.0 110.605 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . 0.4 OUTLIER -128.17 -35.04 2.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 99.0 110.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -48.73 -39.18 23.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 99.0 110.307 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -61.87 -22.37 65.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 99.0 110.298 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -75.85 -22.05 56.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 99.0 110.206 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 68.4 t -64.79 140.46 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 99.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.439 ' OXT' ' CG1' ' A' ' 128' ' ' ILE . 2.2 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.026 -0.988 . . . . 99.0 110.247 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.613 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.99 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 40' ' ' MET . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 99.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.561 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 99.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 99.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 99.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 99.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 99.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.457 HG22 HD13 ' A' ' 32' ' ' LEU . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 99.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 99.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 99.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 99.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 99.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 99.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.49 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 99.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 99.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 99.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 99.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 99.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 99.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 99.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 11' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 99.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 99.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 99.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 99.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 99.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 99.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 99.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 99.0 110.296 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 99.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 10' ' ' THR . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 99.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 99.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 99.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 99.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 99.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 99.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' HA2' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 99.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 3' ' ' VAL . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 99.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 99.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 99.0 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 99.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 99.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 99.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 99.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 99.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 99.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.45 HG21 ' HE2' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 99.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 99.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 99.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 99.0 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 99.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 99.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 99.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 99.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 99.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.558 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 99.0 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 99.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.623 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 99.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 99.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 99.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 99.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 99.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 99.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 99.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 99.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 99.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 99.0 111.646 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 99.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 99.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 99.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 99.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 99.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 99.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 99.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.452 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 99.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 99.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 99.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 80' ' ' ILE . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 99.0 110.072 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.461 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 99.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.441 ' HE2' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 99.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.506 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 99.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 99.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 99.0 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 99.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 100' ' ' LEU . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 99.0 110.044 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 99.0 110.107 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 99.0 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' HG11 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 99.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 99.0 109.956 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 99.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.526 HG22 ' CD ' ' A' ' 99' ' ' ARG . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 99.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 93' ' ' VAL . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 99.0 110.351 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 99.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HB3' ' CG2' ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 99.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 99.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 73' ' ' SER . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 99.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.526 ' CD ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 99.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.543 HD21 ' S2 ' ' A' ' 130' ' ' FES . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 99.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 73' ' ' SER . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 99.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.433 ' C ' HG21 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 99.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 99.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 99.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 99.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 99.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 99.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 99.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 99.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' O ' HG11 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 99.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 99.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 99.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 99.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.618 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 99.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 99.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.536 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -84.56 23.26 1.16 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 99.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 -61.54 -25.22 67.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 99.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 119' ' ' HIS . 44.4 tp -41.53 120.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 99.0 110.229 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' OD1' HD13 ' A' ' 120' ' ' LEU . 18.1 p-10 -48.04 -37.82 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 99.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -18.56 34.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 99.0 110.137 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -16.46 12.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 99.0 109.845 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.17 -21.93 66.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 99.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -12.05 61.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 99.0 110.19 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.33 18.27 14.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 99.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 127' ' ' VAL . 14.8 p -47.05 110.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 99.0 110.237 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.478 ' CG2' ' OXT' ' A' ' 128' ' ' ILE . 21.3 tt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.967 -1.016 . . . . 99.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.543 ' S2 ' HD21 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.99 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 39' ' ' THR . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' MET . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 99.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 99.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 99.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.563 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 99.0 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 99.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 99.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 99.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CD1' ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 99.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 99.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 99.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 99.0 110.211 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 99.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 99.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD12 ' A' ' 11' ' ' LEU . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 99.0 109.965 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 99.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 99.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 99.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 99.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 99.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD1' HD11 ' A' ' 11' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 99.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 99.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 99.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 99.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 99.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 99.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 99.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 99.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 99.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 99.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 99.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 99.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 99.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.563 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 99.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 99.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 99.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 99.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 99.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' C ' HG11 ' A' ' 42' ' ' VAL . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 99.0 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG12 ' HB3' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 99.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 99.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 99.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 99.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 99.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 99.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.507 HG22 ' CE ' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 99.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 99.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 99.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HB3' HG12 ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 99.0 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 99.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 99.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 99.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 99.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 99.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.474 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 99.0 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 99.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 99.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 99.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 99.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 99.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 99.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 99.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 99.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 99.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 99.0 110.597 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 99.0 111.685 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 99.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 99.0 109.863 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 99.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 99.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 99.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 99.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 99.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 99.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 99.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 99.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 99.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 99.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 99.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 99.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 99.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' HD12 ' A' ' 100' ' ' LEU . 9.2 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 99.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 99.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' N ' ' A' ' 88' ' ' LEU . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 99.0 110.239 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' N ' HG21 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 99.0 110.195 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 99.0 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 99.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 99.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 99.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 99.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 99.0 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 99.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 99.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 99.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' SER . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 99.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 99.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD12 ' NE2' ' A' ' 85' ' ' GLN . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 99.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 99.0 110.453 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.408 ' C ' HG21 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 99.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 HG12 ' CA ' ' A' ' 66' ' ' GLY . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 99.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 99.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 99.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 99.0 110.046 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 99.0 110.1 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 99.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 99.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 99.0 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 99.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 99.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 99.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 99.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 99.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.528 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -45.14 -24.15 0.23 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 99.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 -59.17 -31.79 69.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 99.0 110.009 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -50.61 124.13 10.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 99.0 110.259 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -62.94 -37.97 89.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 99.0 110.062 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -60.45 -24.03 64.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 99.0 109.928 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -80.24 -50.31 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 99.0 110.051 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -52.68 -33.53 47.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 99.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -46.76 -32.36 3.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 99.0 110.195 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -31.76 55.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 99.0 110.201 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 128' ' ' ILE . 32.2 t -69.51 -34.36 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 99.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 ' OXT' HG21 ' A' ' 128' ' ' ILE . 20.2 mm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 99.0 110.216 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.624 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.99 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' MET . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 99.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 99.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' ' CE1' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 99.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 99.0 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 99.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 99.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 99.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 99.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 99.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 99.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 99.0 109.995 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 99.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 99.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 99.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.489 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 99.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 99.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 99.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 99.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 99.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 11' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 99.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 99.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 99.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 99.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 99.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 99.0 110.099 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 99.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 99.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 99.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 99.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 99.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 99.0 109.279 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 99.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 99.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 99.0 110.189 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 99.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 99.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.547 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 99.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 99.0 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 99.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 99.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 99.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 99.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 99.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 99.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 99.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 99.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 99.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 99.0 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' N ' ' HE3' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 99.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 99.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 99.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 99.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 99.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CE2' ' CE2' ' A' ' 5' ' ' TYR . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 99.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 99.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 99.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 99.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 99.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 99.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.474 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 99.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 99.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 99.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 99.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.61 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 99.0 110.264 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 99.0 111.432 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 99.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 99.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 99.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 99.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 99.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 99.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 99.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 99.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 99.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 99.0 109.911 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 99.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 82' ' ' MET . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 99.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 99.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 99.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.428 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 99.0 110.179 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 99.0 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 99.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 67' ' ' ALA . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 99.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 98' ' ' VAL . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 99.0 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 99.0 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 99.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 99.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 99.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 99.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 99.0 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 99.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 99.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 99.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 99.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 99.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' A' ' 66' ' ' GLY . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 99.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 99.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 99.0 110.625 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' CD1' ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 99.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 99.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HG3' ' CG1' ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 99.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 99.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 99.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 99.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 108' ' ' ALA . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 99.0 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 99.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 99.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 99.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 99.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 99.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' ALA . . . -70.54 -5.38 28.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 99.0 109.57 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 65.0 m-70 -80.6 -0.66 38.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.407 -0.808 . . . . 99.0 110.61 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp -46.35 147.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 99.0 110.038 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.27 -36.76 71.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 99.0 110.281 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.75 -10.21 55.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 99.0 110.232 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.406 HD21 ' HCA' ' A' ' 118' ' ' ALY . 1.0 OUTLIER -115.33 -32.02 5.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 99.0 110.221 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -45.95 -29.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 99.0 110.281 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.68 -18.33 62.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 99.0 110.37 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.74 25.45 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.957 . . . . 99.0 110.293 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 128' ' ' ILE . 7.3 p -62.44 -34.61 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 99.0 110.166 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.411 HG23 HG12 ' A' ' 127' ' ' VAL . 3.6 tt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.896 -1.049 . . . . 99.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.61 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.99 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.498 HG23 ' CG2' ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 99.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 99.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 99.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.569 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 2.5 t-20 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 99.0 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 99.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 99.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 99.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 99.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 99.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 99.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 99.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 99.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.459 ' HB2' HD22 ' A' ' 23' ' ' LEU . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 99.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 99.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 99.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 99.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 99.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 99.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 99.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 99.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 99.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 99.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 99.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 99.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 99.0 110.132 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 99.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 99.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 99.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 99.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 99.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 99.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 99.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.565 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 99.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' HB2' HD22 ' A' ' 6' ' ' LEU . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 99.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 99.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.498 ' CG2' HG23 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 99.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.53 ' HB3' ' CG1' ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 99.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 99.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 51' ' ' ALA . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 99.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 99.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 99.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 99.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HB2' HG21 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 99.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 99.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 99.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 59' ' ' TRP . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 99.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 99.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 99.0 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB1' ' CE ' ' A' ' 40' ' ' MET . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 99.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 99.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 99.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 99.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 99.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.545 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 99.0 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 99.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 99.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.482 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 99.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 99.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 99.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 99.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 99.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' N ' HG22 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 99.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 99.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 99.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 99.0 111.209 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 99.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 99.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 99.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 99.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' HB ' ' CG1' ' A' ' 114' ' ' VAL . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 99.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 99.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 99.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 99.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 99.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 99.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 99.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 99.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 99.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 99.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 99.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 99.0 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 99.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 67' ' ' ALA . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 99.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 99.0 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 99.0 110.166 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 99.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 99.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 99.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.568 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 99.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 99.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 99.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 99.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 99.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 99.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 99.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.603 HD12 ' S2 ' ' A' ' 130' ' ' FES . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 99.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 99.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.414 ' C ' HG21 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 99.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 66' ' ' GLY . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 99.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 48' ' ' ILE . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 99.0 109.477 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 99.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG11 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 99.0 110.404 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 99.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 99.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 99.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 99.0 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' N ' HG11 ' A' ' 111' ' ' VAL . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 99.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 99.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 99.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.58 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 99.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 99.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -76.0 -17.81 59.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 99.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALY . . . . . 0.456 ' OH ' ' HD3' ' A' ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -72.06 -18.92 61.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 99.0 110.331 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -44.11 120.31 2.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 99.0 110.24 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 2.8 t0 -65.48 -26.85 68.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 99.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB3' HD22 ' A' ' 120' ' ' LEU . 15.7 t80 -72.07 -3.3 22.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 99.0 110.132 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -114.72 -43.92 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 99.0 110.348 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -23.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 99.0 110.187 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -54.08 -20.13 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 99.0 110.089 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -7.06 51.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 99.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.18 -31.86 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 99.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.962 -1.018 . . . . 99.0 110.253 179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' FES . . . . . 0.603 ' S2 ' HD12 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.9900000000000002 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 111' ' ' VAL . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 50.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' OH ' ' CE1' ' A' ' 57' ' ' TYR . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 50.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 50.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.539 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 12.5 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 50.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 50.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.573 HG21 HD13 ' A' ' 32' ' ' LEU . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 50.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 50.0 109.794 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 50.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 50.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 50.0 110.124 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.685 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 50.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 50.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 50.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 50.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 50.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 50.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 50.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 50.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 50.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 50.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 50.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 50.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 50.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 50.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 50.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 10' ' ' THR . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 50.0 110.189 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 50.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 50.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 50.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 50.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.58 ' HE3' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 50.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 12.5 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG22 ' CB ' ' A' ' 51' ' ' ALA . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 10.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 50.0 110.303 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 25.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 10.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 10.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 10.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 59' ' ' TRP . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 10.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 50.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.688 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 12.5 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 10.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 10.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 50.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 62.3 mm-40 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 10.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 12.5 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 10.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.635 ' HB2' HD12 ' A' ' 49' ' ' LEU . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 50.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 10.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 10.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 10.0 110.999 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 10.0 112.04 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 10.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 10.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.688 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 10.0 110.855 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 10.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 25.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 50.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 10.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 10.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.515 ' O ' HD13 ' A' ' 74' ' ' ILE . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 50.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 50.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 50.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 50.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 25.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 50.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 50.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 10.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.683 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 50.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 50.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 50.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 16.66 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 50.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 67' ' ' ALA . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 50.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 88' ' ' LEU . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 12.5 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 12.5 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 10.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 50.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 50.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 10.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 12.5 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 50.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 25.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 50.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 50.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 50.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 10.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 10.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 10.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 50.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 10.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 10.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 50.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 50.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 50.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 50.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 3' ' ' VAL . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 12.5 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 25.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 10.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 50.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 50.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 10.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 50.0 110.149 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.491 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.119 0.485 . . . . 50.0 109.971 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 12.5 110.192 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.9900000000000002 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 50.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 50.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.77 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 50.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.551 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 12.5 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HA ' HG11 ' A' ' 114' ' ' VAL . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 50.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 50.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 50.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 50.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 50.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 50.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 50.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 50.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 50.0 110.251 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 50.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 50.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 50.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 50.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 50.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 50.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD1' HD22 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 50.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.647 ' CE2' HD12 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 50.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 50.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 50.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 50.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 50.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 50.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 50.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 50.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 50.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 50.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 50.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 50.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 50.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 50.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 12.5 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 10.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 50.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 25.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 10.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 10.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 10.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 10.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 50.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 12.5 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 10.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 10.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 50.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 10.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 12.5 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 10.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 50.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 10.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 10.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 10.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 10.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 10.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 10.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 10.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 10.0 110.267 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 25.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 50.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 10.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 10.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 50.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 50.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 50.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 50.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 25.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.783 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 50.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 50.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 10.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 100' ' ' LEU . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 50.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 50.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 50.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 16.66 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 50.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.006 HG23 HD23 ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 50.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.006 HD23 HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 12.5 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 12.5 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 10.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 50.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 50.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 10.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 12.5 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 50.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 25.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 50.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 50.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.746 ' C ' HD22 ' A' ' 100' ' ' LEU . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 50.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 99' ' ' ARG . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 10.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 10.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 10.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.743 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 50.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 10.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 10.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 50.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 50.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 50.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 50.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 12.5 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 25.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 10.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 50.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 50.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 10.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 50.0 110.226 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.237 0.541 . . . . 50.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 12.5 110.26 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.9900000000000002 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 111' ' ' VAL . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 50.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 50.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 50.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 12.5 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 50.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 50.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 50.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 50.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 50.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 50.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 50.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.491 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 50.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 50.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 50.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 50.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 50.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 50.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 50.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 50.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 50.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 50.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HE3' ' CA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 50.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 50.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 50.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 50.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 50.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 50.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 50.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 50.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 50.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 50.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 50.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 50.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 50.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 50.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 12.5 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 46' ' ' GLU . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 10.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 50.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 25.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 10.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 10.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.433 HG13 ' HD3' ' A' ' 106' ' ' PRO . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 10.0 110.293 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 10.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 12.5 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 10.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 10.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 50.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 10.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 12.5 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 10.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 50.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 10.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 10.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 10.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 10.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 10.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 10.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 10.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 10.0 110.193 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 25.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 50.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 10.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 10.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 50.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 74' ' ' ILE . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.892 HG13 ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 50.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 50.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 25.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 10.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 50.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 105' ' ' SER . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 50.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 10.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 50.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 50.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 50.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 16.66 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 50.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.021 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 12.5 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 12.5 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 10.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 50.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 50.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 99' ' ' ARG . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 10.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 12.5 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 50.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 25.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.892 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 50.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 96' ' ' LYS . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 50.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 50.0 110.098 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 HD11 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 10.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 10.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 10.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.605 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 50.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 10.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 10.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.639 ' CG ' HG13 ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 50.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 50.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 50.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 12.5 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 25.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 10.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 50.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 50.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 10.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 50.0 109.927 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.2 0.524 . . . . 50.0 110.191 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 12.5 110.05 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.9900000000000002 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.767 HG22 ' CG1' ' A' ' 111' ' ' VAL . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 50.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 50.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 50.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 12.5 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 50.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 50.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 50.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 50.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 50.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 50.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 50.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 50.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.691 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 50.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 50.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 50.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 50.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 50.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 50.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 50.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 50.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 50.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 50.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 50.0 110.227 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 50.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 50.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 50.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 50.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 50.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 50.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 50.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 50.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.545 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 50.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 50.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 50.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 12.5 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 10.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 50.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 25.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 10.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 10.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 10.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HE3' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 10.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 10.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 50.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 12.5 109.876 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 10.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 10.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 50.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 10.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 12.5 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 10.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.641 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 50.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 10.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 10.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 10.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 10.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 10.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 10.0 110.03 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 10.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 10.0 110.613 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 25.0 111.052 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 50.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 10.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 10.0 111.043 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 50.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 50.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.703 HG13 ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 50.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 50.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 25.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 10.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 50.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 50.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 10.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 50.0 110.569 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 50.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 50.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 16.66 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 50.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.463 HG23 ' HG ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 50.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 12.5 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 12.5 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 10.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 50.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 50.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 10.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 12.5 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 50.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 25.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.703 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 50.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 50.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 50.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 103' ' ' ILE . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 10.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 10.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 49' ' ' LEU . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 10.0 109.841 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 100' ' ' LEU . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 50.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 10.0 109.777 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 10.0 109.832 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 50.0 110.435 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 50.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 50.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 50.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.767 ' CG1' HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 12.5 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 25.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 10.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 50.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 50.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 10.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 50.0 109.867 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 13.1 m80 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.367 0.603 . . . . 50.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 12.5 110.124 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.9900000000000002 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.679 ' CG2' HG22 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 50.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 50.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 50.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 12.5 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.788 ' OH ' HD12 ' A' ' 120' ' ' LEU . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 50.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 50.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 50.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 50.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 50.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 50.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 50.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 50.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 50.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 50.0 110.486 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 50.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 50.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 50.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 50.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 50.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 50.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 50.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 50.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 50.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 50.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 50.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 50.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 50.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 50.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 50.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 50.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 50.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.577 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 50.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 50.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 2' ' ' THR . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 50.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 50.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 12.5 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG12 ' HB1' ' A' ' 51' ' ' ALA . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 10.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 50.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 25.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 10.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 10.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 10.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 10.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 10.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 50.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 12.5 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 50.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 10.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 10.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 12.5 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 10.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 50.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 10.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 10.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 10.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 10.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 10.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 10.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 10.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 10.0 110.102 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 25.0 111.603 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 50.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 10.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 10.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.598 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.664 HD13 HG22 ' A' ' 98' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 50.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.765 ' HB ' HD12 ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 50.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 50.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 25.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 50.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 99' ' ' ARG . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 50.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 10.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 50.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 50.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 50.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 16.66 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 50.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 87' ' ' ILE . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 50.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 12.5 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 12.5 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 10.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 50.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 10.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 12.5 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 50.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 74' ' ' ILE . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 25.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.665 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 50.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.664 HG22 HD13 ' A' ' 74' ' ' ILE . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 50.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 50.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 10.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 10.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 10.0 110.473 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 50.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 10.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HG3' HG21 ' A' ' 42' ' ' VAL . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 50.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 50.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 50.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.792 ' HB ' HG22 ' A' ' 3' ' ' VAL . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 12.5 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 25.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.765 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 10.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 50.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 50.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 10.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 50.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.4 m-70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.234 0.54 . . . . 50.0 109.876 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.788 HD12 ' OH ' ' A' ' 8' ' ' TYR . 16.7 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 12.5 110.038 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.9900000000000002 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB ' ' A' ' 111' ' ' VAL . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 50.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 50.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 50.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 12.5 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 50.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 50.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 50.0 110.014 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 50.0 110.145 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 50.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 50.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 50.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 50.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.52 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 50.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.051 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 50.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 50.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 50.0 110.388 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 50.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 50.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 50.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 50.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 50.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 50.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 50.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 50.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 50.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 50.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 50.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 50.0 110.111 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 50.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 50.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 50.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 50.0 110.182 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 10.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 50.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.645 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 50.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 12.5 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' CB ' ' A' ' 51' ' ' ALA . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 10.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 50.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 25.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 10.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 10.0 110.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 10.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.645 HG23 ' CE ' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 10.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 10.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 50.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.653 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 12.5 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 10.0 110.64 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 10.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 50.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 10.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 10.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 12.5 110.262 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 10.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 50.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 10.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 10.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 10.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 10.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 10.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 10.0 109.891 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 10.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' OD1' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 10.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 25.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.433 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 50.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 10.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 10.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 50.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 74' ' ' ILE . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 50.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 50.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 50.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 25.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 50.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.519 HG13 HG11 ' A' ' 111' ' ' VAL . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 50.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 10.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 50.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 50.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 16.66 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 50.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 87' ' ' ILE . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 50.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 12.5 110.32 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 12.5 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 10.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 50.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 50.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 98' ' ' VAL . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 10.0 109.816 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 12.5 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 50.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 25.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 50.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 50.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 50.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 10.0 109.941 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 10.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 10.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 50.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 10.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 50.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 50.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 50.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 50.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.738 ' HB ' HG22 ' A' ' 3' ' ' VAL . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 12.5 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 25.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 10.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 50.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 50.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 10.0 110.074 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 50.0 110.447 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.408 ' CD2' ' CG ' ' A' ' 116' ' ' ASN . 57.9 m-70 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.331 0.586 . . . . 50.0 110.14 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 12.5 110.208 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.9900000000000002 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 111' ' ' VAL . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 50.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 50.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 50.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 12.5 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.469 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 50.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 50.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 50.0 109.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 50.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 50.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 50.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 50.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 50.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.446 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 50.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 50.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 50.0 109.808 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 50.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 50.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 50.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 23' ' ' LEU . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 50.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 50.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 50.0 110.098 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 50.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 50.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 50.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 50.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 50.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 50.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 50.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 50.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 50.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 50.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 50.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 10.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 50.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.853 ' HE2' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 50.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 12.5 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 10.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 50.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 25.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 10.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 10.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 10.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 40' ' ' MET . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 10.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 61' ' ' PHE . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 10.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 50.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 12.5 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 10.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 10.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 50.0 109.823 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 10.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.659 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 12.5 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 10.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.751 ' CE3' HG21 ' A' ' 101' ' ' THR . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 50.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD2' HD11 ' A' ' 49' ' ' LEU . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 10.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 10.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 10.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 10.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 10.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 10.0 110.45 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 10.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 10.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 25.0 111.082 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 50.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 10.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 10.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 50.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 50.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' OD1' ' A' ' 97' ' ' ASP . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 50.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 50.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 25.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 50.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 80' ' ' ILE . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 50.0 110.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 10.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.487 ' HG2' HD12 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 50.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 50.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 50.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 16.66 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 50.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.498 HG23 ' HG ' ' A' ' 88' ' ' LEU . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 50.0 110.219 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' HG23 ' A' ' 87' ' ' ILE . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 12.5 110.234 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 12.5 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.746 ' O ' HG12 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 10.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 50.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 50.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 10.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 12.5 110.396 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 50.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 25.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.763 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 50.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 92' ' ' GLU . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 50.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 50.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD13 HD11 ' A' ' 103' ' ' ILE . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 10.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.751 HG21 ' CE3' ' A' ' 59' ' ' TRP . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 10.0 110.563 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 10.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.756 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 50.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 10.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 50.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 50.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 50.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 12.5 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 25.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 10.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 50.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 10.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 50.0 110.081 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 29.3 m-70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.291 0.567 . . . . 50.0 109.808 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 12.5 110.234 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.9900000000000002 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 50.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 50.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 50.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 12.5 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.498 ' HA ' HG11 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 50.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 50.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 50.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 50.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 50.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 50.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 50.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 50.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.527 ' HB3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 50.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 50.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 50.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 50.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 50.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 50.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 50.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CB ' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 50.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 50.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 50.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 50.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 50.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 50.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 50.0 110.113 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 50.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 50.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 50.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 50.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 50.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.865 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 50.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 12.5 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 40' ' ' MET . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 10.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 50.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG3' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 25.0 110.344 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 10.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 10.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 10.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 10.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 10.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.863 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 50.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 12.5 110.219 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 10.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 10.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 50.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 10.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 12.5 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 10.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 50.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 59' ' ' TRP . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 10.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.5 ' N ' HD22 ' A' ' 70' ' ' ASN . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 10.0 110.754 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 10.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 10.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 10.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 10.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.653 ' C ' HG21 ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 10.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 10.0 110.272 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 25.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 50.0 109.952 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 10.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 10.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 50.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 74' ' ' ILE . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 50.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 50.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 50.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 25.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 10.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 50.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 50.0 110.318 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.646 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 10.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 50.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 50.0 110.21 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 50.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' ASP . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 16.66 110.212 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.653 HG21 ' C ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 50.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 12.5 110.145 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 12.5 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 10.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 50.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 50.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 10.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 12.5 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 50.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 25.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 50.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 50.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.596 HH12 HD12 ' A' ' 100' ' ' LEU . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 50.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.596 HD12 HH12 ' A' ' 99' ' ' ARG . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 10.0 110.324 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 10.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.589 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 10.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.701 ' O ' HD12 ' A' ' 103' ' ' ILE . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 50.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 10.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 10.0 109.849 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 50.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 50.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 50.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' C ' HG23 ' A' ' 111' ' ' VAL . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 50.0 110.041 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' C ' ' A' ' 110' ' ' GLU . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 12.5 110.396 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 25.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 10.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 ' HB3' ' A' ' 6' ' ' LEU . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 50.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.631 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 50.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 10.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 50.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.357 0.599 . . . . 50.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 12.5 110.163 179.808 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.9900000000000002 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.557 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 50.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 50.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.941 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 50.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.743 ' N ' HD12 ' A' ' 6' ' ' LEU . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 12.5 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.542 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 50.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 50.0 109.862 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 50.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 50.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 50.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 50.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 50.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 50.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.706 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 50.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.592 ' N ' HD11 ' A' ' 11' ' ' LEU . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 50.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 50.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 50.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 50.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 50.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 50.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD23 HD21 ' A' ' 6' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 50.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 50.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 50.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 50.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 50.0 110.346 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 50.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 50.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 50.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 50.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 50.0 110.11 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 50.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 50.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 50.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 50.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 50.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 10.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' OE1' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 50.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.894 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 50.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 12.5 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.725 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 10.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 50.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 25.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 10.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 10.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 10.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 10.0 110.285 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 10.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' N ' HD23 ' A' ' 49' ' ' LEU . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 50.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.725 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 12.5 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.894 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 10.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 10.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 50.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 10.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 12.5 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 10.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 50.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 10.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 10.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 10.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 10.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 10.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.574 ' N ' HG21 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 10.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.412 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 10.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 25.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 50.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 10.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 10.0 111.405 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 50.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 74' ' ' ILE . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 50.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 50.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 50.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 25.0 110.1 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 50.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 50.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 10.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 50.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 50.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.467 HE22 HD11 ' A' ' 103' ' ' ILE . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 16.66 110.153 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 50.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' N ' HG23 ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 12.5 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 12.5 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 10.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 50.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.754 ' HG2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 50.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HD2' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 10.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 12.5 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 50.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 25.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 50.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 50.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.767 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 50.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 10.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 10.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.952 ' SG ' HG23 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 10.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.952 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 50.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 10.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 80' ' ' ILE . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 10.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 50.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 50.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 50.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 50.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 108' ' ' ALA . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 12.5 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 25.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 10.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 50.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 50.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 10.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 50.0 110.035 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.35 0.595 . . . . 50.0 109.736 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.519 HD12 ' OH ' ' A' ' 8' ' ' TYR . 20.6 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 12.5 110.065 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.9900000000000002 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 111' ' ' VAL . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 50.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 50.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.805 HD23 ' CD2' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 50.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.7 t-20 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 12.5 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 50.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 50.0 109.966 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 50.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 50.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 50.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 50.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 50.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 50.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 50.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 50.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 50.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 50.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 50.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 50.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 23' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 50.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.805 ' CD2' HD23 ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 50.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 50.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 50.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 50.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 50.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 50.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 50.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 50.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 50.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 50.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 50.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 50.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 50.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.751 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 50.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 12.5 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 10.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.721 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 50.0 110.228 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 25.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' A' ' 43' ' ' ALA . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 10.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 10.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.535 HG23 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 10.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 10.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' N ' HD23 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 50.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 12.5 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 10.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 10.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 50.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 10.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 12.5 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 10.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 50.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 10.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 10.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 10.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 10.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 10.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 10.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 10.0 110.306 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 25.0 111.343 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 50.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 10.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 10.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 50.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 50.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 50.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 50.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 25.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 50.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' SER . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 50.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 10.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.758 ' CG ' HD12 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 50.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 50.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 50.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 16.66 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 50.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 50.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 12.5 109.89 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 12.5 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 10.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 50.0 109.633 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 50.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 10.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 12.5 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 50.0 110.458 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 25.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 50.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 50.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HD3' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 50.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD12 ' CG ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 10.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 10.0 110.437 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 10.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD13 ' A' ' 100' ' ' LEU . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 50.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 10.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 10.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 50.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 50.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 50.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 50.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 12.5 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 25.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 10.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 50.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 50.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.9 t-20 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 10.0 110.287 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 50.0 110.221 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.442 ' CD2' ' OD1' ' A' ' 116' ' ' ASN . 65.0 m-70 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.405 0.621 . . . . 50.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 12.5 110.435 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.9900000000000002 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 50.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 50.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 23' ' ' LEU . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 50.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 6' ' ' LEU . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 12.5 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HB2' HG12 ' A' ' 114' ' ' VAL . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 50.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 50.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 50.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD13 HD21 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 50.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 50.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 50.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 50.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 50.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 50.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 50.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 50.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 50.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 50.0 110.404 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 50.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 50.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.719 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 50.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 50.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 50.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 50.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 50.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 50.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 50.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 50.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 50.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.749 HD12 ' HB1' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 50.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 50.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 50.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 50.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 50.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 24' ' ' PHE . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 50.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 10.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 50.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 50.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 12.5 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' CB ' ' A' ' 51' ' ' ALA . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 10.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 50.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 25.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 10.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 10.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 42' ' ' VAL . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 10.0 110.369 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 10.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 50.0 110.503 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 12.5 110.346 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 10.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 10.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 50.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 10.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 12.5 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 10.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 50.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HG3' HD21 ' A' ' 116' ' ' ASN . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 10.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 10.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 10.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 10.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.828 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 10.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 10.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 10.0 110.545 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 25.0 111.276 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 50.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 10.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 10.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.791 ' OG ' HD11 ' A' ' 113' ' ' ILE . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 50.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 50.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 50.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 50.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 25.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 10.0 109.24 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 50.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 50.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 10.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.674 ' HE1' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 50.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 50.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 16.66 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 50.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 100' ' ' LEU . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 50.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.674 HD22 ' HE1' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 12.5 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 12.5 109.986 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.88 ' O ' HG12 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 10.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 50.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 50.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.88 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 10.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 12.5 110.012 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 50.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 25.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.821 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 50.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.634 HG13 HD11 ' A' ' 88' ' ' LEU . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 50.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 50.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.828 HD13 ' HA2' ' A' ' 66' ' ' GLY . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 10.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 10.0 109.993 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 10.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.794 ' O ' HG22 ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 50.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 10.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.436 ' CG ' HG11 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 50.0 110.393 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 50.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' C ' HG23 ' A' ' 111' ' ' VAL . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 50.0 109.748 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 12.5 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 25.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.791 HD11 ' OG ' ' A' ' 73' ' ' SER . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 10.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 6' ' ' LEU . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 50.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 50.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.703 HD21 ' HG3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 50.0 110.423 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' A' ' 117' ' ' ALA . 88.3 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.244 0.545 . . . . 50.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 12.5 110.164 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.9900000000000002 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 50.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 50.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.793 HD23 ' CD1' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 50.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' HD12 ' A' ' 6' ' ' LEU . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 12.5 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 120' ' ' LEU . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 50.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 50.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 50.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.647 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 50.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 50.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 50.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 50.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 50.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 50.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 50.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 50.0 110.341 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 50.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 50.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 50.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 50.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' HD13 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 50.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.793 ' CD1' HD23 ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 50.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 50.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 50.0 109.882 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 50.0 110.227 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 50.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 50.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 50.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 50.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 ' HB1' ' A' ' 27' ' ' ALA . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 50.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 50.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 50.0 109.655 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 50.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 50.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 50.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 50.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 50.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 12.5 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 51' ' ' ALA . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 10.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 50.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 25.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 10.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 10.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG23 ' CE ' ' A' ' 40' ' ' MET . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 10.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' A' ' 59' ' ' TRP . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 10.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 50.0 110.258 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 12.5 109.998 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 10.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 10.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 50.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 10.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.556 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 12.5 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 10.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.715 ' HB2' HD13 ' A' ' 49' ' ' LEU . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 50.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 10.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 10.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 10.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 10.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 10.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 10.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 10.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' CA ' HG12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 10.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 25.0 111.263 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 50.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 10.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 10.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 50.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 50.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 50.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 50.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 25.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 50.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 50.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 10.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 50.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' HD12 ' A' ' 103' ' ' ILE . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 50.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 50.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 16.66 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 50.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 50.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.008 HD21 HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 12.5 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 12.5 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 10.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 50.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 50.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 10.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 12.5 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 50.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 25.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 50.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.008 HG12 HD21 ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 50.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.521 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 50.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 103' ' ' ILE . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 10.0 110.666 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 10.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 10.0 109.994 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.493 HD12 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 50.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 10.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 10.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 3' ' ' VAL . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 50.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 50.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 50.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 50.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 12.5 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 25.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 10.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 50.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 50.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.5 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 10.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 50.0 110.232 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.519 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 23.9 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 50.0 109.779 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 12.5 110.184 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.9900000000000002 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.539 ' CG2' HG22 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 50.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 50.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 50.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 12.5 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 50.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 50.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 50.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 50.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 50.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 50.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 50.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 50.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 50.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 50.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 50.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 50.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 50.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 50.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 50.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 23' ' ' LEU . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 50.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 50.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 50.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 50.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 50.0 109.907 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 50.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 50.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 50.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 50.0 110.083 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 50.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 50.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 50.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 50.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 50.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 2' ' ' THR . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 50.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.051 ' HB3' HG13 ' A' ' 3' ' ' VAL . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 50.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 12.5 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.774 HG23 ' HG2' ' A' ' 40' ' ' MET . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 10.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 50.0 110.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 25.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 10.0 110.443 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 10.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 10.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.726 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 10.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.564 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 50.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.649 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 12.5 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.878 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 10.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 10.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 50.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 10.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 10.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 12.5 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 10.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 50.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 10.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 10.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 10.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 10.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 10.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.562 ' O ' ' NE2' ' A' ' 85' ' ' GLN . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 10.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 10.0 110.377 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 25.0 111.297 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 50.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 10.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 10.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 50.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 50.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 50.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 50.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 111' ' ' VAL . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 25.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 10.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 50.0 110.056 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 50.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 10.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 50.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 50.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 50.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 16.66 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 50.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 50.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD12 HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 12.5 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 12.5 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 10.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 50.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 50.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 10.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 12.5 110.537 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 50.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 25.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 50.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 96' ' ' LYS . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 50.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 50.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 103' ' ' ILE . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 10.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 10.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.706 ' SG ' HG23 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 10.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.706 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 50.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 10.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 10.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 50.0 110.564 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 50.0 110.373 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 50.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 108' ' ' ALA . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 12.5 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 25.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 73' ' ' SER . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 10.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 50.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 50.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 10.0 110.609 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 50.0 110.163 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' CE1' ' OD1' ' A' ' 116' ' ' ASN . 24.0 m80 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.31 0.576 . . . . 50.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 12.5 110.511 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.9900000000000002 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 111' ' ' VAL . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 50.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 50.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 50.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 12.5 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 50.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 50.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 50.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 50.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 50.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 50.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 50.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 50.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 50.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.471 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 50.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 50.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 50.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 50.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 50.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 50.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 50.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 50.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 50.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 50.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 50.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 50.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 50.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 50.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 50.0 110.388 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 50.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 50.0 109.301 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 50.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 50.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 50.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 50.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.566 ' HE1' ' HB3' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 50.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 12.5 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 51' ' ' ALA . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 10.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 50.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 25.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 10.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 10.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 10.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 10.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 10.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 50.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 12.5 110.248 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 10.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 10.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 50.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 10.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 10.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 12.5 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 10.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.647 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 50.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 10.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 10.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 10.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 10.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 10.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 10.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 10.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 10.0 110.271 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 25.0 111.173 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 50.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 10.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 10.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 50.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.72 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 50.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 50.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 50.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 25.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.619 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 10.0 109.208 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 50.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.477 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 50.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 10.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 50.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 50.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 50.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 3.9 mt-30 -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 16.66 110.216 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 50.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 50.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 12.5 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 12.5 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.646 ' O ' HG12 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 10.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 50.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 50.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.974 HG21 ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 10.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 12.5 110.442 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 25.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 50.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 50.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.974 ' NH2' HG21 ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 50.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 10.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 10.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HG23 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 10.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.672 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 50.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 10.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 10.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 50.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 50.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 50.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 50.0 110.051 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.619 HG13 ' HA3' ' A' ' 78' ' ' GLY . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 12.5 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 25.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 10.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 50.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 50.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.6 t-20 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 10.0 110.138 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 50.0 110.368 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.305 0.574 . . . . 50.0 109.708 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 12.5 110.397 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.9900000000000002 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 50.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 50.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 50.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.547 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 12.5 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 50.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 50.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 50.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 50.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 50.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 50.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 50.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 50.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 50.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.583 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 50.0 110.327 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 50.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 50.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 50.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 50.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 50.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 50.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 50.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 50.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 50.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 50.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 50.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 50.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 50.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 50.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 50.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 50.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 50.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 50.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 50.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 10.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 50.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.615 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 50.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 12.5 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.948 HG22 ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 10.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 50.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 25.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB3' HG12 ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 10.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 10.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 10.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 10.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 50.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.948 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 12.5 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 10.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 10.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 50.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 10.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 10.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 12.5 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 10.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 50.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.942 ' CE2' HD23 ' A' ' 49' ' ' LEU . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 10.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 10.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 10.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 10.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 10.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.729 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 10.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 10.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 10.0 110.263 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 25.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 50.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 10.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 10.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 50.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 50.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 50.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 50.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 25.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 10.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 108' ' ' ALA . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 50.0 110.046 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 50.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 10.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 50.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 16.66 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 50.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 100' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 50.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 88' ' ' LEU . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 12.5 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 12.5 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.753 ' O ' HG12 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 10.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 50.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 50.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 10.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 12.5 110.47 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 50.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 25.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 50.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 50.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 50.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' HA2' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 10.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 10.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 1.01 ' C ' HD13 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 10.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 50.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 10.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 50.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 50.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 50.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 50.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 12.5 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 25.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 10.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 50.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 50.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 115' ' ' TYR . 1.2 t-20 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 10.0 110.922 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 50.0 109.859 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.526 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.211 0.529 . . . . 50.0 110.158 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 12.5 110.214 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.9900000000000002 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 106' ' ' PRO . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 50.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 50.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.875 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 50.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 12.5 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 50.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 50.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 50.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 50.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 50.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 50.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 50.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 50.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 50.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 50.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 50.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 50.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 50.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 50.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 16' ' ' TRP . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 50.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.875 ' CZ ' HD12 ' A' ' 6' ' ' LEU . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 50.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 50.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 50.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 50.0 110.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 50.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 50.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 50.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 50.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 50.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 50.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 50.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 50.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 50.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 10.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 50.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.778 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 12.5 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 10.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 50.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 25.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 10.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 10.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 49' ' ' LEU . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 10.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 49' ' ' LEU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 10.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 50.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 12.5 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.778 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 10.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 10.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 50.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 10.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 10.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 12.5 109.967 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 10.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.703 ' HB2' HD23 ' A' ' 49' ' ' LEU . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 50.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HD3' HD21 ' A' ' 116' ' ' ASN . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 10.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 10.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 10.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 10.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 10.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 10.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 10.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 10.0 110.119 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 25.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 50.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 10.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 10.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 50.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 50.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 50.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 50.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 25.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.454 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 10.0 109.273 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 50.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 50.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 10.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 50.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 50.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 50.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 16.66 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 50.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.6 ' C ' HD12 ' A' ' 87' ' ' ILE . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 50.0 109.803 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 12.5 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 12.5 110.133 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.898 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 10.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 50.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 50.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 90' ' ' ASP . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 10.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 12.5 110.2 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 50.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 98' ' ' VAL . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 25.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.569 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 50.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 96' ' ' LYS . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 50.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 50.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 66' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 10.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 10.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 10.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 50.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 10.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 10.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HB3' HG21 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 50.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 50.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 50.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 50.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 12.5 110.41 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 25.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 10.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 50.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.601 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 50.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.785 HD21 ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 10.0 110.316 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 50.0 110.143 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 120' ' ' LEU . 30.6 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.08 0.467 . . . . 50.0 109.988 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD22 ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 12.5 110.105 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.9900000000000002 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 3' ' ' VAL . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 50.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 50.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 50.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.614 ' N ' HD23 ' A' ' 6' ' ' LEU . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 12.5 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 50.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 50.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 50.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 50.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 50.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 50.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 50.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.496 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 50.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 50.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 50.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 50.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 50.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 50.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 50.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.862 ' HB3' HD11 ' A' ' 6' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 50.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 50.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 50.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 50.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 50.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 50.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 50.0 110.296 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 50.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 50.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 50.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 50.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 50.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 50.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 50.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 10.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 50.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 50.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 12.5 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 10.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 50.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 25.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 10.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 10.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 10.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.557 HG23 ' CE ' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 10.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 10.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 50.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.572 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 12.5 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 10.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 10.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 50.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 10.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 12.5 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 10.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 50.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 10.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 10.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 10.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 10.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 10.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 10.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 10.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 10.0 110.094 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 25.0 111.646 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 50.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 10.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 10.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.808 ' O ' HD13 ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 50.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 50.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 50.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 25.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 10.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 50.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.072 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 10.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.409 ' HE3' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 50.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 50.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 50.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 16.66 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 50.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 50.0 110.044 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 12.5 110.107 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 12.5 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.808 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 10.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 50.0 109.956 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 50.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 10.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 12.5 110.351 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 50.0 110.176 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 25.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 50.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 96' ' ' LYS . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 50.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.542 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 50.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 103' ' ' ILE . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 10.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 10.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' HG23 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.678 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 50.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 10.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 10.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 50.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 50.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 50.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 50.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.658 ' HB ' HG13 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 12.5 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 25.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 10.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 50.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 50.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 50.0 110.627 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 50.0 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.569 HD11 ' HE2' ' A' ' 96' ' ' LYS . 44.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 12.5 110.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.9900000000000002 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 106' ' ' PRO . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 50.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 50.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.935 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 50.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.919 ' N ' HD12 ' A' ' 6' ' ' LEU . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 12.5 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 50.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 50.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 50.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 50.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 50.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 50.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.404 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 50.0 110.211 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 50.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.596 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 50.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 50.0 109.965 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 50.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 50.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 50.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 50.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 50.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.912 ' HB3' HD21 ' A' ' 6' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 50.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 50.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 50.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 50.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 50.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 50.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 50.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 50.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 50.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.515 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 50.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 50.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 50.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 50.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.587 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 50.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 50.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 50.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.849 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 50.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' HG23 ' A' ' 2' ' ' THR . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 12.5 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 10.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 50.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 25.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 10.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 10.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 10.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG23 ' HE2' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 10.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 10.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 50.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 12.5 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.849 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 10.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 10.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 50.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 10.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 10.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 12.5 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 10.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 50.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 10.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 10.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 10.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 10.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 10.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.441 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 10.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 10.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 10.0 110.597 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 25.0 111.685 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 50.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 10.0 109.863 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 10.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 50.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 73' ' ' SER . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 50.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 50.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 50.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 25.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 50.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 10.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 50.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 50.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 83' ' ' ASP . 2.5 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 16.66 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 50.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 50.0 110.239 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 12.5 110.195 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 12.5 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 10.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 50.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 50.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 10.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 12.5 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 50.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 25.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 50.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' CG ' ' A' ' 92' ' ' GLU . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 50.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 50.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 10.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 10.0 110.453 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 10.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 50.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 10.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HB3' HG21 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 50.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 50.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 50.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 50.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 12.5 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 25.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 10.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 50.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 50.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 10.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 50.0 110.48 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.324 0.583 . . . . 50.0 110.009 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 12.5 110.259 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.9900000000000002 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 111' ' ' VAL . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 50.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 50.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 50.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 6' ' ' LEU . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 12.5 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 50.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 50.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 50.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.627 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 50.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 50.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 50.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 50.0 109.995 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 50.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 50.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.637 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 50.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 11' ' ' LEU . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 50.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 50.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 50.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 50.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 50.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 50.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 50.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 50.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 50.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 50.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 50.0 110.099 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 50.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 50.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 50.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 50.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 50.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 50.0 109.279 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 50.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 50.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 50.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 50.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.612 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 50.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 12.5 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG13 ' HG3' ' A' ' 106' ' ' PRO . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 10.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 50.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 25.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 10.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 10.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 10.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 59' ' ' TRP . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 10.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 50.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 12.5 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 10.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 10.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 50.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 10.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 10.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.591 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 12.5 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 10.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.643 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 50.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 10.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 10.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 10.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.497 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 10.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.467 ' C ' HG21 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 10.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 10.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 10.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 10.0 110.264 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 25.0 111.432 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 50.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 10.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 10.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 50.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 50.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 50.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 50.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 25.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 50.0 109.911 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 50.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 10.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 50.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 50.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 16.66 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 50.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 100' ' ' LEU . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 50.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 100' ' ' LEU . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 12.5 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 12.5 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 10.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 50.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 50.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 10.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 12.5 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 25.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 50.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 50.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.442 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 50.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 88' ' ' LEU . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 10.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 10.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 103' ' ' ILE . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 10.0 110.625 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 50.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.819 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 10.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.77 ' HG3' HG13 ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 50.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 50.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 50.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 50.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 3' ' ' VAL . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 12.5 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 25.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 10.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 50.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 10.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 50.0 109.57 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 46.0 m80 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.12 0.486 . . . . 50.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 12.5 110.038 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.9900000000000002 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 50.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 50.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 50.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.4 t30 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 12.5 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 50.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 50.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 50.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 50.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 50.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 50.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 50.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 50.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.718 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 50.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 50.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 50.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 50.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 50.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 50.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 50.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 50.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 50.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 50.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 50.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 50.0 110.132 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 50.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 50.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 50.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 50.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 50.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 50.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 50.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 50.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 50.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 50.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 50.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 12.5 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.733 HG13 ' HG3' ' A' ' 106' ' ' PRO . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 10.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 50.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 25.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 10.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 10.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 10.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.57 HG23 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 10.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 10.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 50.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 12.5 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.568 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 10.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 10.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 50.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 10.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 10.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.568 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 12.5 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 10.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 50.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.535 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 10.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 10.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 10.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 10.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 10.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 10.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 10.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 10.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 25.0 111.209 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 50.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 10.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 10.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 50.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 50.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 50.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 25.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 10.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 50.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 50.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 50.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 50.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 50.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 16.66 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 50.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.91 HG23 HD23 ' A' ' 88' ' ' LEU . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 50.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.91 HD23 HG23 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 12.5 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 12.5 110.166 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 10.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 50.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 50.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 10.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 12.5 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 50.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 25.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 50.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 50.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 50.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 10.0 110.218 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 10.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 10.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 50.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 10.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.733 ' HG3' HG13 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.416 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 50.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 50.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 50.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 50.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 12.5 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 25.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 10.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 50.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 50.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 10.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 50.0 110.103 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.185 0.517 . . . . 50.0 110.331 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 12.5 110.24 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.9900000000000002 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 111' ' ' VAL . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 50.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' OH ' ' CE1' ' A' ' 57' ' ' TYR . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 50.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 50.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.539 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 12.5 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 50.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 50.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.573 HG21 HD13 ' A' ' 32' ' ' LEU . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 50.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 50.0 109.794 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 50.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 50.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 50.0 110.124 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.685 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 50.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 50.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 50.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 50.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 50.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 50.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 50.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 50.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 50.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 50.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 50.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 50.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 50.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 50.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 50.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 10' ' ' THR . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 50.0 110.189 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 50.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 50.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 50.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 50.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.58 ' HE3' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 50.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 12.5 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG22 ' CB ' ' A' ' 51' ' ' ALA . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 10.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 50.0 110.303 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 25.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 10.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 10.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 10.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 59' ' ' TRP . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 10.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 50.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.688 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 12.5 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 10.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 10.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 50.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 51' ' ' ALA . 62.3 mm-40 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 10.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 12.5 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 10.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.635 ' HB2' HD12 ' A' ' 49' ' ' LEU . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 50.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 10.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 10.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 10.0 110.999 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 10.0 112.04 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 10.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 10.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.688 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 10.0 110.855 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 10.0 109.956 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 25.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 50.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 10.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 10.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.515 ' O ' HD13 ' A' ' 74' ' ' ILE . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 50.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 50.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 50.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 50.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 25.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 50.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 50.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 10.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.683 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 50.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 50.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 50.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 16.66 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 50.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 67' ' ' ALA . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 50.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 88' ' ' LEU . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 12.5 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 12.5 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 10.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 50.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 50.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 10.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 12.5 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 50.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 25.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 50.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 50.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 50.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 10.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 10.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 10.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 50.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 10.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 10.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 50.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 50.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 50.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 50.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 3' ' ' VAL . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 12.5 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 25.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 10.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 50.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 50.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 10.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.09 -25.34 63.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 50.0 110.149 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.491 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 -63.41 -21.84 66.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 50.0 109.971 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -41.48 136.78 1.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 12.5 110.192 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.33 -21.0 65.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 50.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.61 -28.51 65.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 16.66 110.451 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 9.4 mt -96.99 -35.12 10.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 50.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -42.83 -28.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 50.0 110.645 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -65.08 -18.55 65.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.217 -0.927 . . . . 50.0 110.606 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -66.86 -17.65 64.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 50.0 110.451 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -49.78 132.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 50.0 110.201 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.995 -1.002 . . . . 50.0 110.26 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.607 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.9900000000000002 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 50.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 50.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.77 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 50.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.551 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 12.5 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HA ' HG11 ' A' ' 114' ' ' VAL . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 50.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 50.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 50.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 50.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 50.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 50.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 50.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 50.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 50.0 110.251 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 50.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 50.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 50.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 50.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 50.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 50.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD1' HD22 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 50.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.647 ' CE2' HD12 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 50.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 50.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 50.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 50.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 50.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 50.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 50.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 50.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 50.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 50.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 50.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 50.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 50.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 50.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 12.5 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 10.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 50.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 25.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 10.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 10.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 10.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 10.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 50.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 12.5 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 10.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 10.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 50.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 10.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 12.5 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 10.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 50.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 10.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 10.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 10.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 10.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 10.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 10.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 10.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.591 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 10.0 110.267 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 25.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 50.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 10.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 10.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 50.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 50.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 50.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 50.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 25.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.783 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 50.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 50.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 10.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 100' ' ' LEU . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 50.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 50.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 50.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 16.66 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 50.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.006 HG23 HD23 ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 50.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.006 HD23 HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 12.5 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 12.5 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 10.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 50.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 50.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 10.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 12.5 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 50.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 25.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 50.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 50.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.746 ' C ' HD22 ' A' ' 100' ' ' LEU . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 50.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.829 HD12 ' S2 ' ' A' ' 130' ' ' FES . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 10.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 10.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 10.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.743 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 50.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 10.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 10.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 50.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 50.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 50.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 50.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 12.5 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 25.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 10.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 50.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 50.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 10.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -84.27 -21.7 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 50.0 110.226 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 -64.72 -29.4 70.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 50.0 110.092 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -46.84 124.99 6.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 12.5 110.26 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.57 -30.69 70.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 50.0 110.326 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.423 ' HB2' HD22 ' A' ' 120' ' ' LEU . 1.4 t80 -62.69 -17.33 60.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 16.66 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.72 -28.49 10.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 50.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.73 -25.13 67.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -63.28 -19.71 64.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.418 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.06 22.31 5.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 50.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.017 HG22 HG12 ' A' ' 128' ' ' ILE . 13.1 p -73.43 143.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 50.0 110.07 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.017 HG12 HG22 ' A' ' 127' ' ' VAL . 20.5 mm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.936 -1.031 . . . . 50.0 110.137 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.829 ' S2 ' HD12 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.9900000000000002 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 111' ' ' VAL . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 50.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 50.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 50.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 12.5 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 50.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 50.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 50.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 50.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 50.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 50.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 50.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.491 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 50.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 50.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 50.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 50.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 50.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 50.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 50.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 50.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 50.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 50.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HE3' ' CA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 50.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 50.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 50.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 50.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 50.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 50.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 50.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 50.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 50.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 50.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 50.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 50.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 50.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 50.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 12.5 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 46' ' ' GLU . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 10.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 50.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 25.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 10.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 10.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.433 HG13 ' HD3' ' A' ' 106' ' ' PRO . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 10.0 110.293 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 10.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 12.5 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 10.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 10.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 50.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 10.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 12.5 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 10.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 50.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 10.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 10.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 10.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 10.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 10.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 10.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 10.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 10.0 110.193 179.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 25.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 50.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 10.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 10.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 50.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 74' ' ' ILE . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.892 HG13 ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 50.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 50.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 25.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 10.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 50.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 105' ' ' SER . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 50.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 10.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 50.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 50.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 50.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 16.66 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 50.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.021 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 12.5 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 12.5 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 10.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 50.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 50.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 99' ' ' ARG . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 10.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 12.5 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 50.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 25.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.892 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 50.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 96' ' ' LYS . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 50.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 50.0 110.098 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 HD11 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 10.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 10.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 10.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.605 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 50.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 10.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 10.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.639 ' CG ' HG13 ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 50.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 50.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 50.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 12.5 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 25.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 10.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 50.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 50.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 10.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 120' ' ' LEU . . . -72.84 -19.57 61.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 50.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 -69.21 -21.97 63.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 50.0 110.191 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt -43.56 123.43 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 12.5 110.05 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.73 -32.42 72.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 50.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -70.45 -13.04 61.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 16.66 110.755 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 mt -117.79 -31.04 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 50.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.27 -31.73 67.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 50.0 110.246 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -27.66 66.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 50.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.22 -24.11 62.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 50.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.77 151.26 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 50.0 110.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.948 -1.025 . . . . 50.0 110.293 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.9900000000000002 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.767 HG22 ' CG1' ' A' ' 111' ' ' VAL . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 50.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 50.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 50.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 12.5 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 50.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 50.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 50.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 50.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 50.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 50.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 50.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 50.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.691 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 50.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 50.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 50.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 50.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 50.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 50.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 50.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 50.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 50.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 50.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 50.0 110.227 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 50.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 50.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 50.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 50.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 50.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 50.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 50.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 50.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.545 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 50.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 50.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 50.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 12.5 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 10.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 50.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 25.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 10.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 10.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 10.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HE3' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 10.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 10.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 50.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 12.5 109.876 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 10.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 10.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 50.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 10.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 12.5 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 10.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.641 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 50.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 10.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 10.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 10.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 10.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 10.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 10.0 110.03 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 10.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.602 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 10.0 110.613 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 25.0 111.052 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 50.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 10.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 10.0 111.043 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 50.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 50.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.703 HG13 ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 50.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 50.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 25.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 10.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 50.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 50.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 10.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 50.0 110.569 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 50.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 50.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 16.66 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 50.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.463 HG23 ' HG ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 50.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 12.5 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 12.5 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 10.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 50.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 50.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 10.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 12.5 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 50.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 25.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.703 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 50.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 50.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 50.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' S2 ' ' A' ' 130' ' ' FES . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 10.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 10.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 49' ' ' LEU . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 10.0 109.841 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 100' ' ' LEU . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 50.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 10.0 109.777 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 10.0 109.832 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 50.0 110.435 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 50.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 50.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 50.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.767 ' CG1' HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 12.5 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 25.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 10.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 50.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 50.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 10.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -74.71 -22.02 59.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 50.0 109.867 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.438 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 37.0 m-70 -57.84 -33.14 68.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 50.0 109.702 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -42.41 137.91 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 12.5 110.124 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.9 OUTLIER -62.96 -28.9 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 50.0 110.161 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -62.81 -38.31 90.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.353 -0.842 . . . . 16.66 110.256 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.48 -14.96 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 50.0 110.107 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG12 ' A' ' 127' ' ' VAL . 2.7 tp-100 -47.68 -24.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.844 . . . . 50.0 110.481 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -68.75 -11.05 59.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 50.0 110.296 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -111.55 -6.8 14.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 50.0 110.193 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 127' ' ' VAL . 7.7 p -51.55 123.51 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 50.0 110.147 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 6.4 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.023 -0.989 . . . . 50.0 110.303 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.651 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.9900000000000002 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.679 ' CG2' HG22 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 50.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 50.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 50.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 12.5 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.788 ' OH ' HD12 ' A' ' 120' ' ' LEU . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 50.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 50.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 50.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 50.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 50.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 50.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 50.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 50.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 50.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 50.0 110.486 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 50.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 50.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 50.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 50.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 50.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 50.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 50.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 50.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 50.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 50.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 50.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 50.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 50.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 50.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 50.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 50.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 50.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.577 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 50.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 50.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 2' ' ' THR . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 50.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 50.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 12.5 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG12 ' HB1' ' A' ' 51' ' ' ALA . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 10.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 50.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 25.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 10.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 10.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 10.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 10.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 10.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 50.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 12.5 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 50.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 10.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 10.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 12.5 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 10.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 50.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 10.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 10.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 10.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 10.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 10.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 10.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 10.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.593 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 10.0 110.102 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 25.0 111.603 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 50.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 10.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 10.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.598 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.664 HD13 HG22 ' A' ' 98' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 50.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.765 ' HB ' HD12 ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 50.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 50.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 25.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 50.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 99' ' ' ARG . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 50.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 10.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 50.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 50.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 50.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 16.66 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 50.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 87' ' ' ILE . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 50.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 12.5 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 12.5 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 10.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 50.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 10.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 12.5 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 50.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 74' ' ' ILE . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 25.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.665 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 50.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.664 HG22 HD13 ' A' ' 74' ' ' ILE . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 50.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 50.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 10.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 10.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 10.0 110.473 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 50.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 10.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HG3' HG21 ' A' ' 42' ' ' VAL . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 50.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 50.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 50.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.792 ' HB ' HG22 ' A' ' 3' ' ' VAL . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 12.5 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 25.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.765 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 10.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 50.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 50.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 10.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.37 -19.95 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 50.0 109.914 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.505 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 75.4 m-70 -59.09 -28.33 66.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.327 -0.858 . . . . 50.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.788 HD12 ' OH ' ' A' ' 8' ' ' TYR . 16.7 tp -42.91 124.37 3.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 12.5 110.038 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -57.45 -38.66 74.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 50.0 110.543 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -29.06 63.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 16.66 109.996 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 123' ' ' LEU . 5.2 mt -98.75 -26.81 14.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 50.0 110.104 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 121' ' ' ASP . 12.2 mm-40 -56.74 -29.45 62.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.915 . . . . 50.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.89 -26.56 59.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 50.0 109.964 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.19 -16.33 59.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 50.0 110.002 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.42 -38.48 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 50.0 110.262 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.984 -1.008 . . . . 50.0 110.28 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.593 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.9900000000000002 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB ' ' A' ' 111' ' ' VAL . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 50.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 50.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 50.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 12.5 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 50.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 50.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 50.0 110.014 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 50.0 110.145 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 50.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 50.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 50.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 50.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.52 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 50.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.051 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 50.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 50.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 50.0 110.388 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 50.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 50.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 50.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 50.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 50.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 50.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 50.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 50.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 50.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 50.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 50.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 50.0 110.111 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 50.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 50.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 50.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 50.0 110.182 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 10.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 50.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.645 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 50.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 12.5 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' CB ' ' A' ' 51' ' ' ALA . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 10.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 50.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 25.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 10.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 10.0 110.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 10.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.645 HG23 ' CE ' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 10.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 10.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 50.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.653 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 12.5 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 10.0 110.64 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 10.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 50.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 10.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 10.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 12.5 110.262 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 10.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 50.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 10.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 10.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 10.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 10.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 10.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 10.0 109.891 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 10.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 10.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 25.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 50.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 10.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 10.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 50.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 74' ' ' ILE . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 50.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 50.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 50.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 25.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 50.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.519 HG13 HG11 ' A' ' 111' ' ' VAL . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 50.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 10.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 50.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 50.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 16.66 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 50.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 87' ' ' ILE . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 50.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 12.5 110.32 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 12.5 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 10.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 50.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 50.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 98' ' ' VAL . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 10.0 109.816 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 12.5 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 50.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 25.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 50.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 50.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 50.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.839 HD23 ' S2 ' ' A' ' 130' ' ' FES . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 10.0 109.941 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 10.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 10.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 50.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 10.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 50.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 50.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 50.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 50.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.738 ' HB ' HG22 ' A' ' 3' ' ' VAL . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 12.5 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 25.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 10.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 50.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 50.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 10.0 110.074 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -75.49 -25.55 57.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 50.0 110.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.453 ' HG2' ' N ' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.453 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 57.9 m-70 -60.05 -33.14 71.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 50.0 110.14 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.37 120.58 2.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 12.5 110.208 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -71.23 -40.13 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 50.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -56.21 -19.33 13.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 16.66 109.932 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -102.76 -36.14 8.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 50.0 110.333 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.34 -17.12 10.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 50.0 110.36 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -66.89 -27.51 67.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 50.0 110.025 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -101.35 9.18 41.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 50.0 109.923 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 128' ' ' ILE . 10.7 p -47.29 -34.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 50.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' N ' HG13 ' A' ' 127' ' ' VAL . 3.4 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 50.0 110.129 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.839 ' S2 ' HD23 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.9900000000000002 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 111' ' ' VAL . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 50.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 50.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 50.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 12.5 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.469 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 50.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 50.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 50.0 109.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 50.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 50.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 50.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 50.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 50.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.446 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 50.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 50.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 50.0 109.808 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 50.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 50.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 50.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 23' ' ' LEU . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 50.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 50.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 50.0 110.098 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 50.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 50.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 50.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 50.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 50.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 50.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 50.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 50.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 50.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 50.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 50.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 10.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 50.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.853 ' HE2' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 50.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 12.5 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 10.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 50.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 25.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 10.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 10.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 10.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 40' ' ' MET . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 10.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 61' ' ' PHE . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 10.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 50.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 12.5 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 10.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 10.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 50.0 109.823 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 10.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.659 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 12.5 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 10.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.751 ' CE3' HG21 ' A' ' 101' ' ' THR . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 50.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HG3' ' HG3' ' A' ' 118' ' ' ALY . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD2' HD11 ' A' ' 49' ' ' LEU . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 10.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 10.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 10.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 10.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 10.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 10.0 110.45 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 10.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 10.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 25.0 111.082 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 50.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 10.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 10.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 50.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 50.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' OD1' ' A' ' 97' ' ' ASP . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 50.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 50.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 25.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 50.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 80' ' ' ILE . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 50.0 110.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 10.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.487 ' HG2' HD12 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 50.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 50.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 50.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 16.66 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 50.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.498 HG23 ' HG ' ' A' ' 88' ' ' LEU . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 50.0 110.219 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' HG23 ' A' ' 87' ' ' ILE . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 12.5 110.234 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 12.5 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.746 ' O ' HG12 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 10.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 50.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 50.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 10.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 12.5 110.396 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 50.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 25.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.763 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 50.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 92' ' ' GLU . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 50.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 50.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD13 HD11 ' A' ' 103' ' ' ILE . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 10.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.751 HG21 ' CE3' ' A' ' 59' ' ' TRP . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 10.0 110.563 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 10.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.756 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 50.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 10.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 50.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 50.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 50.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 12.5 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 25.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 10.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 50.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 10.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -78.06 -29.45 49.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 50.0 110.081 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 29.3 m-70 -58.94 -27.47 65.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 50.0 109.808 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.6 mt -46.86 142.0 3.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 12.5 110.234 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.54 -17.93 64.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 50.0 109.986 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -73.05 -33.15 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 16.66 110.232 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 -8.69 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 50.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 5.5 mm-40 -62.82 -27.8 69.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 50.0 110.039 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.2 -21.23 21.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 50.0 109.794 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -85.23 3.79 37.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 50.0 110.0 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 127' ' ' VAL . 10.0 p -50.26 128.62 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 50.0 110.198 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.707 HD12 ' OXT' ' A' ' 128' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 50.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.9900000000000002 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 50.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 50.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 50.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 12.5 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.498 ' HA ' HG11 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 50.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 50.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 50.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 50.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 50.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 50.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 50.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 50.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.527 ' HB3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 50.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 50.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 50.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 50.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 50.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 50.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 50.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CB ' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 50.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 50.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 50.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 50.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 50.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 50.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 50.0 110.113 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 50.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 50.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 50.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 50.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 50.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.865 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 50.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 12.5 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 40' ' ' MET . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 10.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 50.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG3' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 25.0 110.344 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 10.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 10.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 10.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 10.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 10.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.863 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 50.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 12.5 110.219 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 10.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 10.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 50.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 10.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 12.5 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 10.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 50.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 59' ' ' TRP . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 10.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.5 ' N ' HD22 ' A' ' 70' ' ' ASN . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 10.0 110.754 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 10.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 10.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 10.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 10.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.653 ' C ' HG21 ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 10.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.622 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 10.0 110.272 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 25.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 50.0 109.952 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 10.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 10.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 50.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 74' ' ' ILE . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 50.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 50.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 50.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 25.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 10.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 50.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 50.0 110.318 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.646 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 10.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 50.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 50.0 110.21 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 50.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' ASP . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 16.66 110.212 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.653 HG21 ' C ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 50.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 12.5 110.145 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 12.5 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 10.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 50.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 50.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 10.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 12.5 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 50.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 25.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 50.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 50.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.596 HH12 HD12 ' A' ' 100' ' ' LEU . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 50.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.596 HD12 HH12 ' A' ' 99' ' ' ARG . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 10.0 110.324 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 10.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.589 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 10.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.701 ' O ' HD12 ' A' ' 103' ' ' ILE . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 50.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 10.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 10.0 109.849 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 50.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 50.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 50.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' C ' HG23 ' A' ' 111' ' ' VAL . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 50.0 110.041 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' C ' ' A' ' 110' ' ' GLU . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 12.5 110.396 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 25.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 10.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 ' HB3' ' A' ' 6' ' ' LEU . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 50.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.631 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 50.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 10.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -79.36 -19.91 49.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 50.0 110.232 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.407 ' O ' ' OE1' ' A' ' 124' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -60.03 -37.22 79.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.423 -0.798 . . . . 50.0 109.846 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 121' ' ' ASP . 9.6 tp -45.77 124.47 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 12.5 110.163 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 120' ' ' LEU . 25.1 t0 -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 50.0 110.151 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -65.66 -9.99 32.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 16.66 110.382 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' CD1' HD23 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -125.14 -22.56 4.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 50.0 110.503 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.407 ' OE1' ' O ' ' A' ' 118' ' ' ALY . 6.7 tp60 -63.36 -22.12 66.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 50.0 110.29 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.73 -18.37 64.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 50.0 110.344 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -66.19 -14.31 61.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 50.0 110.299 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.21 136.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.902 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.011 -0.995 . . . . 50.0 110.155 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.622 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.9900000000000002 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.557 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 50.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 50.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.941 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 50.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.743 ' N ' HD12 ' A' ' 6' ' ' LEU . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 12.5 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 50.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 50.0 109.862 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 50.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 50.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 50.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 50.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 50.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 50.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.706 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 50.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.592 ' N ' HD11 ' A' ' 11' ' ' LEU . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 50.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 50.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 50.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 50.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 50.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 50.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD23 HD21 ' A' ' 6' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 50.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 50.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 50.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 50.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 50.0 110.346 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 50.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 50.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 50.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 50.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 50.0 110.11 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 50.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 50.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 50.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 50.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 50.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 10.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' OE1' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 50.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.894 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 50.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 12.5 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.725 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 10.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 50.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 25.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 10.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 10.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 10.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 10.0 110.285 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 10.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' N ' HD23 ' A' ' 49' ' ' LEU . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 50.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.725 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 12.5 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.894 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 10.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 10.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 50.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 10.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 12.5 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 10.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 50.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 10.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 10.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 10.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 10.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 10.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.574 ' N ' HG21 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 10.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.412 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 10.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 25.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 50.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 10.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 10.0 111.405 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 50.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 74' ' ' ILE . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 50.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 50.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 50.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 25.0 110.1 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 50.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 50.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 10.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 50.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 50.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.467 HE22 HD11 ' A' ' 103' ' ' ILE . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 16.66 110.153 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 50.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' N ' HG23 ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 12.5 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 12.5 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 10.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 50.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.754 ' HG2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 50.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HD2' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 10.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 12.5 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 50.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 25.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 50.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 50.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.767 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 50.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 10.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 10.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.952 ' SG ' HG23 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 10.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.952 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 50.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 10.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 80' ' ' ILE . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 10.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 50.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 50.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 50.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 50.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 108' ' ' ALA . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 12.5 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 25.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 10.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 50.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 50.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 10.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -75.92 -23.39 55.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 50.0 110.035 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 -58.07 -28.72 64.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 50.0 109.736 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.519 HD12 ' OH ' ' A' ' 8' ' ' TYR . 20.6 tp -49.42 129.99 19.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 12.5 110.065 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -53.24 -22.39 6.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 50.0 110.424 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -71.58 -14.77 62.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 16.66 110.432 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -116.76 -23.41 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 50.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.99 -26.75 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 50.0 110.066 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -64.03 -18.24 64.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 50.0 110.219 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -80.41 -9.86 59.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 50.0 110.124 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.49 155.97 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -0.862 . . . . 50.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.433 ' OXT' HG13 ' A' ' 128' ' ' ILE . 6.1 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 50.0 110.22 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.422 ' S2 ' ' HA2' ' A' ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.9900000000000002 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 111' ' ' VAL . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 50.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 50.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.805 HD23 ' CD2' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 50.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 2.7 t-20 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 12.5 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 50.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 50.0 109.966 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 50.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 50.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 50.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 50.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 50.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 50.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 50.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 50.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 50.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 50.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 50.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 50.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 23' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 50.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.805 ' CD2' HD23 ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 50.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 50.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 50.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 50.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 50.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 50.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 50.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 50.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 50.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 50.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 50.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 50.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 50.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.751 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 50.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 12.5 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 10.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.721 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 50.0 110.228 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 25.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' A' ' 43' ' ' ALA . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 10.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 10.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.535 HG23 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 10.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 10.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' N ' HD23 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 50.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 12.5 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 10.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 10.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 50.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 10.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 12.5 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 10.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 50.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 10.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 10.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 10.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 10.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 10.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 10.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.582 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 10.0 110.306 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 25.0 111.343 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 50.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 10.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 10.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 50.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 50.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 50.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 50.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 25.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 50.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' SER . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 50.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 10.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.758 ' CG ' HD12 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 50.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 50.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 50.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 16.66 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 50.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 50.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 12.5 109.89 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 12.5 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 10.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 50.0 109.633 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 50.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 10.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 12.5 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 50.0 110.458 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 25.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 50.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 50.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HD3' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 50.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD12 ' CG ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 10.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 10.0 110.437 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 10.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD13 ' A' ' 100' ' ' LEU . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 50.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 10.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 10.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 50.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 50.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 50.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 50.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 12.5 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 25.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 10.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 50.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 50.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.9 t-20 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 10.0 110.287 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -80.17 -23.05 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 50.0 110.221 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' CE ' ' C ' ' A' ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.473 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 65.0 m-70 -59.77 -29.14 67.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.855 . . . . 50.0 109.671 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.85 128.02 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 12.5 110.435 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.27 -21.37 66.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 50.0 109.739 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -76.07 -25.03 55.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 16.66 110.058 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -110.51 -25.75 9.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 50.0 110.08 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.849 ' O ' HG22 ' A' ' 127' ' ' VAL . 44.9 tt0 -51.08 -73.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 50.0 110.302 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -46.89 -25.97 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 50.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.62 -19.97 52.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 50.0 110.144 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 124' ' ' GLN . 11.2 m -77.42 -15.54 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 50.0 109.899 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.458 ' OXT' HG13 ' A' ' 128' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.979 -1.01 . . . . 50.0 110.246 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.582 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.9900000000000002 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 50.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 50.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 23' ' ' LEU . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 50.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 6' ' ' LEU . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 12.5 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HB2' HG12 ' A' ' 114' ' ' VAL . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 50.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 50.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 50.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD13 HD21 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 50.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 50.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 50.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 50.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 50.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 50.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 50.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 50.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 50.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 50.0 110.404 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 50.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 50.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.719 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 50.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 50.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 50.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 50.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 50.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 50.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 50.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 50.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 50.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.749 HD12 ' HB1' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 50.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 50.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 50.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 50.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 50.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 24' ' ' PHE . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 50.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 10.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 50.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 50.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 12.5 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' CB ' ' A' ' 51' ' ' ALA . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 10.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 50.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 25.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 10.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 10.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 42' ' ' VAL . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 10.0 110.369 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 10.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 50.0 110.503 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 12.5 110.346 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 10.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 10.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 50.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 10.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 12.5 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 10.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 50.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HG3' HD21 ' A' ' 116' ' ' ASN . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 10.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 10.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 10.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 10.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.828 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 10.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 10.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.612 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 10.0 110.545 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 25.0 111.276 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 50.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 10.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 10.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.791 ' OG ' HD11 ' A' ' 113' ' ' ILE . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 50.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 50.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 50.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 50.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 25.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 10.0 109.24 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 50.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 50.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 10.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.674 ' HE1' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 50.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 50.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 16.66 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 50.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 100' ' ' LEU . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 50.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.674 HD22 ' HE1' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 12.5 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 12.5 109.986 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.88 ' O ' HG12 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 10.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 50.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 50.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.88 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 10.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 12.5 110.012 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 50.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 25.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.821 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 50.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.634 HG13 HD11 ' A' ' 88' ' ' LEU . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 50.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 50.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.828 HD13 ' HA2' ' A' ' 66' ' ' GLY . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 10.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 10.0 109.993 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 10.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.794 ' O ' HG22 ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 50.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 10.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' CG ' HG11 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 50.0 110.393 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 50.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' C ' HG23 ' A' ' 111' ' ' VAL . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 50.0 109.748 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 12.5 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 25.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.791 HD11 ' OG ' ' A' ' 73' ' ' SER . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 10.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 6' ' ' LEU . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 50.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 50.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.703 HD21 ' HG3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -78.67 -26.89 45.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 50.0 110.423 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.516 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' A' ' 117' ' ' ALA . 88.3 m-70 -65.31 -18.03 64.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.458 -0.776 . . . . 50.0 110.181 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -53.05 128.33 27.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 12.5 110.164 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.36 -51.24 15.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 50.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -59.87 -24.36 64.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 16.66 110.281 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt -97.88 -28.23 13.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 50.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -65.87 -30.58 71.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 50.0 110.038 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -21.48 64.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 50.0 110.437 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.21 -12.35 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 50.0 110.574 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.51 -36.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 50.0 110.032 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.972 -1.014 . . . . 50.0 110.184 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.631 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.9900000000000002 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 50.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 50.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.793 HD23 ' CD1' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 50.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' HD12 ' A' ' 6' ' ' LEU . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 12.5 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 120' ' ' LEU . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 50.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 50.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 50.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 50.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 50.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 50.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 50.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 50.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 50.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 50.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 50.0 110.341 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 50.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 50.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 50.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 50.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' HD13 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 50.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.793 ' CD1' HD23 ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 50.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 50.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 50.0 109.882 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 50.0 110.227 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 50.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 50.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 50.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 50.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 ' HB1' ' A' ' 27' ' ' ALA . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 50.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 50.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 50.0 109.655 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 50.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 50.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 50.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 50.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 50.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 12.5 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 51' ' ' ALA . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 10.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 50.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 25.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 10.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 10.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG23 ' CE ' ' A' ' 40' ' ' MET . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 10.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' A' ' 59' ' ' TRP . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 10.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 50.0 110.258 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 12.5 109.998 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 10.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 10.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 50.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 10.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.556 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 12.5 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 10.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.715 ' HB2' HD13 ' A' ' 49' ' ' LEU . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 50.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 10.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 10.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 10.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 10.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 10.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 10.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 10.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.578 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 10.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 25.0 111.263 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 50.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 10.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 10.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 50.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 50.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 50.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 50.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 25.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 50.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 50.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 10.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 50.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' HD12 ' A' ' 103' ' ' ILE . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 50.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 50.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 16.66 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 50.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 50.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.008 HD21 HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 12.5 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 12.5 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 10.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 50.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 50.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 10.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 12.5 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 50.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 25.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 50.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.008 HG12 HD21 ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 50.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.521 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 50.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.784 HD13 ' S2 ' ' A' ' 130' ' ' FES . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 10.0 110.666 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 10.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 10.0 109.994 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.493 HD12 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 50.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 10.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 10.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 3' ' ' VAL . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 50.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 50.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 50.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 50.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 12.5 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 25.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 10.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 50.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 50.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.5 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 10.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -74.78 -21.49 59.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 50.0 110.232 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.551 ' HCA' HD13 ' A' ' 123' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.522 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 23.9 m80 -61.02 -25.83 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 50.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -43.31 159.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 12.5 110.184 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -17.31 60.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.91 . . . . 50.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -77.14 -21.08 54.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.957 . . . . 16.66 110.272 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD13 ' HCA' ' A' ' 118' ' ' ALY . 1.6 mt -105.3 -32.94 8.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 50.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -29.89 69.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 50.0 109.957 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.9 -37.72 14.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 50.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.63 29.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 50.0 110.282 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 127' ' ' VAL . 12.1 p -73.3 64.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 50.0 110.182 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.954 -1.022 . . . . 50.0 110.262 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.784 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.9900000000000002 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.539 ' CG2' HG22 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 50.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 50.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 50.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 12.5 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 50.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 50.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 50.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 50.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 50.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 50.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 50.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 50.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 50.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 50.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 50.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 50.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 50.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 50.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 50.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 23' ' ' LEU . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 50.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 50.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 50.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 50.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 50.0 109.907 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 50.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 50.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 50.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 50.0 110.083 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 50.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 50.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 50.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 50.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 50.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 2' ' ' THR . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 50.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.051 ' HB3' HG13 ' A' ' 3' ' ' VAL . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 50.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 12.5 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.774 HG23 ' HG2' ' A' ' 40' ' ' MET . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 10.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 50.0 110.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 25.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 10.0 110.443 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 10.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 10.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.726 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 10.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 50.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.649 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 12.5 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.878 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 10.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 10.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 50.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 10.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 10.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 12.5 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 10.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 50.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 10.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 10.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 10.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 10.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 10.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.562 ' O ' ' NE2' ' A' ' 85' ' ' GLN . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 10.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 10.0 110.377 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 25.0 111.297 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 50.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 10.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 10.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 50.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 50.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 50.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 50.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 111' ' ' VAL . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 25.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 10.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 50.0 110.056 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 50.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 10.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 50.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 50.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 50.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 16.66 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 50.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 50.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD12 HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 12.5 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 12.5 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 10.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 50.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 50.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 10.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 12.5 110.537 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 50.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 25.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 50.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 96' ' ' LYS . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 50.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 50.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.778 HD22 ' S2 ' ' A' ' 130' ' ' FES . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 10.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 10.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.706 ' SG ' HG23 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 10.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.706 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 50.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 10.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 10.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 50.0 110.564 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 50.0 110.373 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 50.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 108' ' ' ALA . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 12.5 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 25.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 73' ' ' SER . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 10.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 50.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 50.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 10.0 110.609 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -78.35 -27.13 46.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 50.0 110.163 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.494 ' HD3' ' HB3' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' CE1' ' OD1' ' A' ' 116' ' ' ASN . 24.0 m80 -57.53 -31.57 66.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 50.0 109.792 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -40.88 114.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 12.5 110.511 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -48.17 -26.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 50.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -61.63 -21.75 64.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 16.66 110.24 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -35.62 6.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 50.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.43 -25.58 67.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 50.0 110.235 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -45.31 -34.78 3.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 50.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -58.78 -52.04 67.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 50.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.0 125.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 50.0 110.356 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.02 -0.99 . . . . 50.0 110.163 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.778 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.9900000000000002 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 111' ' ' VAL . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 50.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 50.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 50.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 12.5 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 50.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 50.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 50.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 50.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 50.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 50.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 50.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 50.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 50.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.471 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 50.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 50.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 50.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 50.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 50.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 50.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 50.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 50.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 50.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 50.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 50.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 50.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 50.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 50.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 50.0 110.388 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 50.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 50.0 109.301 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 50.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 50.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 50.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 50.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.566 ' HE1' ' HB3' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 50.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 12.5 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 51' ' ' ALA . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 10.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 50.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 25.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 10.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 10.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 10.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 10.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 10.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 50.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 12.5 110.248 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 10.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 10.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 50.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 10.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 10.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 12.5 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 10.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.647 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 50.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 10.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 10.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 10.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 10.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 10.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 10.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 10.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.614 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 10.0 110.271 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 25.0 111.173 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 50.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 10.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 10.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 50.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.72 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 50.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 50.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 50.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 25.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.619 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 10.0 109.208 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 50.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.477 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 50.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 10.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 50.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 50.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 50.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 3.9 mt-30 -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 16.66 110.216 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 50.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 50.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 12.5 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 12.5 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.646 ' O ' HG12 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 10.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 50.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 50.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.974 HG21 ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 10.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 12.5 110.442 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 25.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 50.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 50.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.974 ' NH2' HG21 ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 50.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 10.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 10.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HG23 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 10.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.672 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 50.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 10.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 10.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 50.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 50.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 50.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 50.0 110.051 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.619 HG13 ' HA3' ' A' ' 78' ' ' GLY . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 12.5 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 25.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 10.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 50.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 50.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.6 t-20 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 10.0 110.138 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -80.36 -26.43 38.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 50.0 110.368 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.51 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 -62.96 -20.41 65.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 50.0 109.708 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.81 152.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 12.5 110.397 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.42 -21.15 64.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.015 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.2 -25.12 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 16.66 110.156 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.01 -27.23 10.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 50.0 110.161 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -66.43 -15.62 63.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 50.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -68.38 -15.62 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 50.0 110.217 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -10.0 43.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 50.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 126.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 50.0 110.077 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.001 -0.999 . . . . 50.0 110.184 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.614 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.9900000000000002 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 50.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 50.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 50.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.547 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 12.5 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 50.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 50.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 50.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 50.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 50.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 50.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 50.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 50.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 50.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.583 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 50.0 110.327 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 50.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 50.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 50.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 50.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 50.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 50.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 50.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 50.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 50.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 50.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 50.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 50.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 50.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 50.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 50.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 50.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 50.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 50.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 50.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 10.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 50.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.615 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 50.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 12.5 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.948 HG22 ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 10.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 50.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 25.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB3' HG12 ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 10.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 10.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 10.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 10.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 50.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.948 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 12.5 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 10.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 10.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 50.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 10.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 10.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 12.5 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 10.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 50.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.942 ' CE2' HD23 ' A' ' 49' ' ' LEU . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 10.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 10.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 10.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 10.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 10.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.729 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 10.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 10.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.609 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 10.0 110.263 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 25.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 50.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 10.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 10.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 50.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 50.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 50.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 50.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 25.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 10.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 108' ' ' ALA . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 50.0 110.046 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 50.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 10.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 50.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 16.66 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 50.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 100' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 50.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 88' ' ' LEU . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 12.5 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 12.5 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.753 ' O ' HG12 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 10.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 50.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 50.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 10.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 12.5 110.47 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 50.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 25.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 50.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 50.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 50.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' HA2' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 10.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 10.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 1.01 ' C ' HD13 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 10.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 50.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 10.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 50.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 50.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 50.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 50.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 12.5 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 25.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 10.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 50.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 50.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.602 ' ND2' ' CE1' ' A' ' 115' ' ' TYR . 1.2 t-20 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 10.0 110.922 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -67.9 -15.93 63.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 50.0 109.859 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.526 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 -64.88 -30.69 71.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 50.0 110.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -53.9 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 12.5 110.214 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -62.66 -25.34 68.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 50.0 110.108 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.498 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -67.03 -21.77 65.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 16.66 110.293 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.493 ' CD1' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -99.76 -25.65 14.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 50.0 110.254 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 127' ' ' VAL . 12.6 tt0 -58.26 -18.22 25.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.14 -10.13 57.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 50.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' A' ' 122' ' ' TYR . 5.0 mpt_? -94.67 -3.28 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 50.0 110.358 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 124' ' ' GLN . 34.2 m -60.0 131.0 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 50.0 110.269 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 50.0 110.296 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.609 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.9900000000000002 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 106' ' ' PRO . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 50.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 50.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.875 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 50.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 12.5 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 50.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 50.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 50.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 50.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 50.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 50.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 50.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 50.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 50.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 50.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 50.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 50.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 50.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 50.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 16' ' ' TRP . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 50.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.875 ' CZ ' HD12 ' A' ' 6' ' ' LEU . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 50.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 50.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 50.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 50.0 110.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 50.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 50.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 50.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 50.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 50.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 50.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 50.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 50.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 50.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 10.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 50.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.778 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 12.5 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 10.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 50.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 25.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 10.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 10.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 49' ' ' LEU . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 10.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 49' ' ' LEU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 10.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 50.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 12.5 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.778 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 10.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 10.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 50.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 10.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 10.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 12.5 109.967 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 10.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.703 ' HB2' HD23 ' A' ' 49' ' ' LEU . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 50.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HD3' HD21 ' A' ' 116' ' ' ASN . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 10.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 10.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 10.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 10.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 10.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 10.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 10.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 10.0 110.119 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 25.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 50.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 10.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 10.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 50.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 50.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 50.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 50.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 25.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.454 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 10.0 109.273 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 50.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 50.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 10.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 50.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 50.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 50.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 16.66 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 50.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.6 ' C ' HD12 ' A' ' 87' ' ' ILE . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 50.0 109.803 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 12.5 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 12.5 110.133 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.898 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 10.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 50.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 50.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 90' ' ' ASP . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 10.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 12.5 110.2 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 50.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 98' ' ' VAL . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 25.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.569 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 50.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 96' ' ' LYS . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 50.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 50.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 66' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 10.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 10.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 10.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 50.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 10.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 10.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HB3' HG21 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 50.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 50.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 50.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 50.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 12.5 110.41 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 25.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 10.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 50.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.601 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 50.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.785 HD21 ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 10.0 110.316 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -74.89 -28.55 60.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 50.0 110.143 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.495 ' HG3' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 121' ' ' ASP . 30.6 m-70 -61.63 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 50.0 109.988 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD22 ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -40.16 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 12.5 110.105 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 119' ' ' HIS . 38.0 t0 -42.82 -31.9 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 50.0 110.757 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -8.02 52.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.062 -1.024 . . . . 16.66 110.605 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . 0.4 OUTLIER -128.17 -35.04 2.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 50.0 110.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -48.73 -39.18 23.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 50.0 110.307 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -61.87 -22.37 65.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 50.0 110.298 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -75.85 -22.05 56.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 50.0 110.206 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 68.4 t -64.79 140.46 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 50.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.439 ' OXT' ' CG1' ' A' ' 128' ' ' ILE . 2.2 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.026 -0.988 . . . . 50.0 110.247 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.613 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.9900000000000002 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 3' ' ' VAL . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 50.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 50.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 50.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.614 ' N ' HD23 ' A' ' 6' ' ' LEU . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 12.5 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 50.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 50.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 50.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 50.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 50.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 50.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 50.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.496 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 50.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 50.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 50.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 50.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 50.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 50.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 50.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.862 ' HB3' HD11 ' A' ' 6' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 50.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 50.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 50.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 50.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 50.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 50.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 50.0 110.296 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 50.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 50.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 50.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 50.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 50.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 50.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 50.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 10.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 50.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 50.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 12.5 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 10.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 50.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 25.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 10.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 10.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 10.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.557 HG23 ' CE ' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 10.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 10.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 50.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.572 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 12.5 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 10.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 10.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 50.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 10.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 12.5 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 10.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 50.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 10.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 10.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 10.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 10.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 10.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 10.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 10.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 10.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 25.0 111.646 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 50.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 10.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 10.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.808 ' O ' HD13 ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 50.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 50.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 50.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 25.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 10.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 50.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.072 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 10.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.409 ' HE3' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 50.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 50.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 50.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 16.66 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 50.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 50.0 110.044 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 12.5 110.107 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 12.5 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.808 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 10.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 50.0 109.956 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 50.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 10.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 12.5 110.351 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 50.0 110.176 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 25.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 50.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 96' ' ' LYS . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 50.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.542 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 50.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD22 ' S2 ' ' A' ' 130' ' ' FES . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 10.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 10.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' HG23 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.678 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 50.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 10.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 10.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 50.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 50.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 50.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 50.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.658 ' HB ' HG13 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 12.5 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 25.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 10.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 50.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 50.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -84.56 23.26 1.16 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 50.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 -61.54 -25.22 67.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 50.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.569 HD11 ' HE2' ' A' ' 96' ' ' LYS . 44.4 tp -41.53 120.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 12.5 110.229 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.1 p-10 -48.04 -37.82 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 50.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -18.56 34.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 16.66 110.137 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -16.46 12.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 50.0 109.845 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.17 -21.93 66.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 50.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -12.05 61.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 50.0 110.19 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.33 18.27 14.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 50.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 127' ' ' VAL . 14.8 p -47.05 110.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.701 HG23 ' OXT' ' A' ' 128' ' ' ILE . 21.3 tt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.967 -1.016 . . . . 50.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.557 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.9900000000000002 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 106' ' ' PRO . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 50.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 50.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.935 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 50.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.919 ' N ' HD12 ' A' ' 6' ' ' LEU . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 12.5 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 50.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 50.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 50.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 50.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 50.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 50.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.404 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 50.0 110.211 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 50.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.596 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 50.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 50.0 109.965 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 50.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 50.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 50.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 50.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 50.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.912 ' HB3' HD21 ' A' ' 6' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 50.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 50.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 50.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 50.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 50.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 50.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 50.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 50.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 50.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.515 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 50.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 50.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 50.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 50.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 50.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 50.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 50.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.849 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 50.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' HG23 ' A' ' 2' ' ' THR . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 12.5 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 10.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 50.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 25.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 10.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 10.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 10.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG23 ' HE2' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 10.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 10.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 50.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 12.5 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.849 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 10.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 10.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 50.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 10.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 10.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 12.5 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 10.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 50.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 10.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 10.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 10.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 10.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 10.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.441 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 10.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 10.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 10.0 110.597 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' O ' HD21 ' A' ' 123' ' ' LEU . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 25.0 111.685 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 50.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 10.0 109.863 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 10.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 50.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 73' ' ' SER . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 50.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 50.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 50.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 25.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 50.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 10.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 50.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 50.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 83' ' ' ASP . 2.5 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 16.66 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 50.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 50.0 110.239 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 12.5 110.195 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 12.5 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 10.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 50.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 50.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 10.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 12.5 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 50.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 25.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 50.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' CG ' ' A' ' 92' ' ' GLU . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 50.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 50.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' O ' ' HA3' ' A' ' 104' ' ' GLY . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 10.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 10.0 110.453 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 10.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 50.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 10.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HB3' HG21 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 50.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 50.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 50.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 50.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 12.5 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 25.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 10.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 50.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 50.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 10.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -45.14 -24.15 0.23 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 50.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 -59.17 -31.79 69.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 50.0 110.009 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -50.61 124.13 10.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 12.5 110.259 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -62.94 -37.97 89.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 50.0 110.062 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -60.45 -24.03 64.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 16.66 109.928 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -80.24 -50.31 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 50.0 110.051 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -52.68 -33.53 47.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 50.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 4.8 t-20 -46.76 -32.36 3.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 50.0 110.195 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -31.76 55.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 50.0 110.201 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 128' ' ' ILE . 32.2 t -69.51 -34.36 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 50.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 125' ' ' ASN . 20.2 mm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 50.0 110.216 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.624 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.9900000000000002 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 111' ' ' VAL . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 50.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 50.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 50.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 6' ' ' LEU . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 12.5 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 50.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 50.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 50.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.627 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 50.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 50.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 50.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 50.0 109.995 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 50.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 50.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.637 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 50.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 11' ' ' LEU . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 50.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 50.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 50.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 50.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 50.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 50.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 50.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 50.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 50.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 50.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 50.0 110.099 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 50.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 50.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 50.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 50.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 50.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 50.0 109.279 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 50.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 50.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 50.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 50.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.612 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 50.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 12.5 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG13 ' HG3' ' A' ' 106' ' ' PRO . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 10.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 50.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 25.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 10.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 10.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 10.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 59' ' ' TRP . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 10.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 50.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 12.5 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 10.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 10.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 50.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 10.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 10.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.591 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 12.5 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 10.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.643 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 50.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 10.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 10.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 10.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.497 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 10.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' C ' HG21 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 10.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 10.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 10.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.61 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 10.0 110.264 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 25.0 111.432 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 50.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 10.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 10.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 50.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 50.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 50.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 50.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 25.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 50.0 109.911 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 50.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 10.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 50.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 50.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 16.66 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 50.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 100' ' ' LEU . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 50.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 100' ' ' LEU . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 12.5 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 12.5 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 10.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 50.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 50.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 10.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 12.5 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 25.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 50.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 50.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.442 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 50.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 88' ' ' LEU . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 10.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 10.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 103' ' ' ILE . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 10.0 110.625 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 50.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.819 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 10.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.77 ' HG3' HG13 ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 50.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 50.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 50.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 50.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 3' ' ' VAL . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 12.5 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 25.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 10.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 50.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 10.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -70.54 -5.38 28.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 50.0 109.57 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 46.0 m80 -80.6 -0.66 38.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.407 -0.808 . . . . 50.0 110.61 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp -46.35 147.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 12.5 110.038 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.27 -36.76 71.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 50.0 110.281 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.75 -10.21 55.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 16.66 110.232 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.33 -32.02 5.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 50.0 110.221 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -45.95 -29.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 50.0 110.281 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.68 -18.33 62.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 50.0 110.37 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.74 25.45 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.957 . . . . 50.0 110.293 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 128' ' ' ILE . 7.3 p -62.44 -34.61 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 50.0 110.166 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 127' ' ' VAL . 3.6 tt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.896 -1.049 . . . . 50.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.649 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.9900000000000002 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 50.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 50.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 50.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.4 t30 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 12.5 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 50.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 50.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 50.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 50.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 50.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 50.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 50.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 50.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.718 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 50.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 50.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 50.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 50.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 50.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 50.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 50.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 50.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 50.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 50.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 50.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 50.0 110.132 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 50.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 50.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 50.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 50.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 50.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 50.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 50.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 50.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 50.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 50.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 50.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 12.5 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.733 HG13 ' HG3' ' A' ' 106' ' ' PRO . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 10.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 50.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 25.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 10.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 10.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 10.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.57 HG23 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 10.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 10.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 50.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 12.5 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.568 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 10.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 10.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 50.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 10.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 10.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.568 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 12.5 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 10.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 50.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 10.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 10.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 10.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 10.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 10.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 10.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 10.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 10.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 25.0 111.209 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 50.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 10.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 10.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 50.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 50.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 50.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 25.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 10.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 50.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 50.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 50.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 50.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 50.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 16.66 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 50.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.91 HG23 HD23 ' A' ' 88' ' ' LEU . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 50.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.91 HD23 HG23 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 12.5 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 12.5 110.166 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 10.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 50.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 50.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 10.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 12.5 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 50.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 25.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 50.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 50.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 50.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' S2 ' ' A' ' 130' ' ' FES . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 10.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 10.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 10.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 50.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 10.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.733 ' HG3' HG13 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.416 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 50.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 50.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 50.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 50.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 12.5 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 25.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 10.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 50.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 50.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 10.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -76.0 -17.81 59.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 50.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALY . . . . . 0.519 ' O ' ' NE2' ' A' ' 124' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.7 m-70 -72.06 -18.92 61.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 50.0 110.331 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -44.11 120.31 2.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 12.5 110.24 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 2.8 t0 -65.48 -26.85 68.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 50.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.52 ' HB3' HD23 ' A' ' 120' ' ' LEU . 15.7 t80 -72.07 -3.3 22.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 16.66 110.132 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 123' ' ' LEU . 4.6 mt -114.72 -43.92 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 50.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 118' ' ' ALY . 0.0 OUTLIER -48.95 -23.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 50.0 110.187 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -54.08 -20.13 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 50.0 110.089 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -7.06 51.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 50.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.18 -31.86 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 50.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 128' ' ' ILE . 36.5 mm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.962 -1.018 . . . . 50.0 110.253 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' FES . . . . . 0.525 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.9900000000000002 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 111' ' ' VAL . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 50.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' OH ' ' CE1' ' A' ' 57' ' ' TYR . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 50.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 50.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.539 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 12.5 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 50.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 50.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.573 HG21 HD13 ' A' ' 32' ' ' LEU . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 50.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 50.0 109.794 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 50.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 50.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 50.0 110.124 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.685 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 50.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 50.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 50.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 50.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 50.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 50.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 50.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 50.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 50.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 50.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 50.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 50.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 50.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 50.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 50.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 10' ' ' THR . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 50.0 110.189 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 50.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 50.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 50.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 50.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.58 ' HE3' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 50.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 12.5 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG22 ' CB ' ' A' ' 51' ' ' ALA . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 10.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 50.0 110.303 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 25.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 10.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 10.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 10.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 59' ' ' TRP . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 10.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 50.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.688 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 12.5 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 10.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 10.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 50.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . 11.9 mm100 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 10.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 12.5 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 10.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.635 ' HB2' HD12 ' A' ' 49' ' ' LEU . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 50.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 10.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 10.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 10.0 110.999 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 10.0 112.04 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 10.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 10.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.688 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 10.0 110.855 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 10.0 109.956 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 25.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 50.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 10.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 10.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.515 ' O ' HD13 ' A' ' 74' ' ' ILE . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 50.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 50.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 50.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 50.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 25.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 50.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 50.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 10.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.683 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 50.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 50.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 50.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 16.66 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 50.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 67' ' ' ALA . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 50.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 88' ' ' LEU . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 12.5 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 12.5 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 10.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 50.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 50.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 10.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 12.5 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 50.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 25.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 50.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 50.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 50.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 10.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 10.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 10.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 50.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 10.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 10.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 50.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 50.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 50.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 50.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 3' ' ' VAL . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 12.5 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 25.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 10.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 50.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 50.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 10.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 50.0 110.149 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.491 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.119 0.485 . . . . 50.0 109.971 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 12.5 110.192 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.9900000000000002 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 50.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 50.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.77 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 50.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.551 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 12.5 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HA ' HG11 ' A' ' 114' ' ' VAL . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 50.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 50.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 50.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 50.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 50.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 50.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 50.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 50.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 50.0 110.251 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 50.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 50.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 50.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 50.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 50.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 50.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD1' HD22 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 50.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.647 ' CE2' HD12 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 50.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 50.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 50.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 50.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 50.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 50.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 50.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 50.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 50.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 50.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 50.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 50.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 50.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 50.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 12.5 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 10.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 50.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 25.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 10.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 10.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 10.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 10.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 50.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 12.5 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 10.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 10.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 50.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 10.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 12.5 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 10.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 50.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 10.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 10.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 10.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 10.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 10.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 10.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 10.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 10.0 110.267 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 25.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 50.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 10.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 10.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 50.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 50.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 50.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 50.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 25.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.783 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 50.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 50.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 10.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 100' ' ' LEU . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 50.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 50.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 50.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 16.66 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 50.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.006 HG23 HD23 ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 50.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.006 HD23 HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 12.5 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 12.5 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 10.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 50.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 50.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 10.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 12.5 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 50.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 25.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 50.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 50.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.746 ' C ' HD22 ' A' ' 100' ' ' LEU . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 50.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD22 ' C ' ' A' ' 99' ' ' ARG . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 10.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 10.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 10.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.743 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 50.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 10.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 10.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 50.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 50.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 50.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 50.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 12.5 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 25.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 10.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 50.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 50.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 10.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 50.0 110.226 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.237 0.541 . . . . 50.0 110.092 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 12.5 110.26 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.9900000000000002 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 111' ' ' VAL . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 50.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 50.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 50.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 12.5 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 50.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 50.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 50.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 50.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 50.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 50.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 50.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.491 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 50.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 50.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 50.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 50.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 50.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 50.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 50.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 50.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 50.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 50.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HE3' ' CA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 50.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 50.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 50.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 50.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 50.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 50.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 50.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 50.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 50.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 50.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 50.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 50.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 50.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 50.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 12.5 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 46' ' ' GLU . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 10.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 50.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 25.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 10.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 10.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.433 HG13 ' HD3' ' A' ' 106' ' ' PRO . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 10.0 110.293 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 10.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 12.5 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 10.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 10.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 50.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 10.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 12.5 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 10.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 50.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 10.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 10.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 10.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 10.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 10.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 10.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 10.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 10.0 110.193 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 25.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 50.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 10.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 10.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 50.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 74' ' ' ILE . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.892 HG13 ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 50.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 50.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 25.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 10.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 50.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 105' ' ' SER . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 50.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 10.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 50.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 50.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 50.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 16.66 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 50.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.021 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 12.5 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 12.5 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 10.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 50.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 50.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 99' ' ' ARG . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 10.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 12.5 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 50.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 25.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.892 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 50.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 96' ' ' LYS . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 50.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 50.0 110.098 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 HD11 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 10.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 10.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 10.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.605 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 50.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 10.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 10.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.639 ' CG ' HG13 ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 50.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 50.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 50.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 12.5 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 25.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 10.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 50.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 50.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 10.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 50.0 109.927 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.2 0.524 . . . . 50.0 110.191 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 12.5 110.05 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.9900000000000002 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.767 HG22 ' CG1' ' A' ' 111' ' ' VAL . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 50.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 50.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 50.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 12.5 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 50.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 50.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 50.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 50.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 50.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 50.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 50.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 50.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.691 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 50.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 50.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 50.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 50.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 50.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 50.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 50.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 50.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 50.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 50.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 50.0 110.227 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 50.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 50.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 50.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 50.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 50.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 50.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 50.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 50.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.545 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 50.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 50.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 50.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 12.5 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 10.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 50.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 25.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 10.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 10.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 10.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HE3' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 10.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 10.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 50.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 12.5 109.876 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 10.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 10.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 50.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 10.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 12.5 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 10.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.641 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 50.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 10.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 10.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 10.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 10.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 10.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 10.0 110.03 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 10.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 10.0 110.613 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 25.0 111.052 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 50.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 10.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 10.0 111.043 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 50.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 50.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.703 HG13 ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 50.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 50.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 25.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 10.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 50.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 50.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 10.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 50.0 110.569 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 50.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 50.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 16.66 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 50.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.463 HG23 ' HG ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 50.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 12.5 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 12.5 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 10.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 50.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 50.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 10.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 12.5 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 50.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 25.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.703 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 50.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 50.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 50.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 103' ' ' ILE . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 10.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 10.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 49' ' ' LEU . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 10.0 109.841 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 100' ' ' LEU . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 50.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 10.0 109.777 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 10.0 109.832 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 50.0 110.435 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 50.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 50.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 50.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.767 ' CG1' HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 12.5 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 25.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 10.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 50.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 50.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 10.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 50.0 109.867 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 37.0 m-70 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.367 0.603 . . . . 50.0 109.702 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 12.5 110.124 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.9900000000000002 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.679 ' CG2' HG22 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 50.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 50.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 50.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 12.5 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.788 ' OH ' HD12 ' A' ' 120' ' ' LEU . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 50.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 50.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 50.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 50.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 50.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 50.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 50.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 50.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 50.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 50.0 110.486 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 50.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 50.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 50.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 50.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 50.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 50.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 50.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 50.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 50.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 50.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 50.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 50.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 50.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 50.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 50.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 50.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 50.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.577 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 50.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 50.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 2' ' ' THR . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 50.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 50.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 12.5 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG12 ' HB1' ' A' ' 51' ' ' ALA . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 10.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 50.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 25.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 10.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 10.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 10.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 10.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 10.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 50.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 12.5 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 50.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 10.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 10.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 12.5 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 10.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 50.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 10.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 10.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 10.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 10.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 10.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 10.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 10.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 10.0 110.102 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 25.0 111.603 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 50.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 10.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 10.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.598 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.664 HD13 HG22 ' A' ' 98' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 50.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.765 ' HB ' HD12 ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 50.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 50.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 25.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 50.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 99' ' ' ARG . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 50.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 10.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 50.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 50.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 50.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 16.66 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 50.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 87' ' ' ILE . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 50.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 12.5 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 12.5 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 10.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 50.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 10.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 12.5 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 50.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 74' ' ' ILE . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 25.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.665 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 50.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.664 HG22 HD13 ' A' ' 74' ' ' ILE . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 50.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 50.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 10.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 10.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 10.0 110.473 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 50.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 10.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HG3' HG21 ' A' ' 42' ' ' VAL . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 50.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 50.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 50.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.792 ' HB ' HG22 ' A' ' 3' ' ' VAL . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 12.5 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 25.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.765 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 10.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 50.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 50.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 10.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 50.0 109.914 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 75.4 m-70 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.234 0.54 . . . . 50.0 109.876 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.788 HD12 ' OH ' ' A' ' 8' ' ' TYR . 16.7 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 12.5 110.038 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.9900000000000002 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB ' ' A' ' 111' ' ' VAL . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 50.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 50.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 50.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 12.5 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 50.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 50.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 50.0 110.014 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 50.0 110.145 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 50.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 50.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 50.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 50.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.52 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 50.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.051 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 50.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 50.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 50.0 110.388 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 50.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 50.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 50.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 50.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 50.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 50.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 50.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 50.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 50.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 50.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 50.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 50.0 110.111 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 50.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 50.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 50.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 50.0 110.182 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 10.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 50.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.645 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 50.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 12.5 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' CB ' ' A' ' 51' ' ' ALA . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 10.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 50.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 25.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 10.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 10.0 110.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 10.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.645 HG23 ' CE ' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 10.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 10.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 50.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.653 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 12.5 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 10.0 110.64 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 10.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 50.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 10.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 10.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 12.5 110.262 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 10.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 50.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 10.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 10.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 10.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 10.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 10.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 10.0 109.891 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 10.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.433 ' SG ' ' OD1' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 10.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 25.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.433 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 50.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 10.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 10.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 50.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 74' ' ' ILE . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 50.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 50.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 50.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 25.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 50.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.519 HG13 HG11 ' A' ' 111' ' ' VAL . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 50.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 10.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 50.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 50.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 16.66 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 50.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 87' ' ' ILE . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 50.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 12.5 110.32 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 12.5 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 10.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 50.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 50.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 98' ' ' VAL . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 10.0 109.816 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 12.5 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 50.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 25.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 50.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 50.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 50.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 10.0 109.941 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 10.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 10.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 50.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 10.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 50.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 50.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 50.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 50.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.738 ' HB ' HG22 ' A' ' 3' ' ' VAL . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 12.5 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 25.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 10.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 50.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 50.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 5.7 t-20 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 10.0 110.074 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 50.0 110.447 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 57.9 m-70 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.331 0.586 . . . . 50.0 110.14 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 12.5 110.208 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.9900000000000002 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 111' ' ' VAL . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 50.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 50.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 50.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 12.5 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.469 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 50.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 50.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 50.0 109.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 50.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 50.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 50.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 50.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 50.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.446 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 50.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 50.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 50.0 109.808 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 50.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 50.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 50.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 23' ' ' LEU . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 50.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 50.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 50.0 110.098 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 50.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 50.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 50.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 50.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 50.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 50.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 50.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 50.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 50.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 50.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 50.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 10.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 50.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.853 ' HE2' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 50.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 12.5 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 10.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 50.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 25.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 10.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 10.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 10.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 40' ' ' MET . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 10.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 61' ' ' PHE . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 10.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 50.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 12.5 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 10.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 10.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 50.0 109.823 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 10.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.659 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 12.5 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 10.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.751 ' CE3' HG21 ' A' ' 101' ' ' THR . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 50.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD2' HD11 ' A' ' 49' ' ' LEU . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 10.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 10.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 10.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 10.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 10.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 10.0 110.45 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 10.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 10.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 25.0 111.082 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.443 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 50.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 10.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 10.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 50.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 50.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' OD1' ' A' ' 97' ' ' ASP . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 50.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 50.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 25.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 50.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 80' ' ' ILE . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 50.0 110.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 10.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.487 ' HG2' HD12 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 50.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 50.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 50.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 16.66 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 50.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.498 HG23 ' HG ' ' A' ' 88' ' ' LEU . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 50.0 110.219 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' HG23 ' A' ' 87' ' ' ILE . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 12.5 110.234 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 12.5 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.746 ' O ' HG12 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 10.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 50.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 50.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 10.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 12.5 110.396 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 50.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 25.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.763 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 50.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 92' ' ' GLU . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 50.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 50.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD13 HD11 ' A' ' 103' ' ' ILE . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 10.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.751 HG21 ' CE3' ' A' ' 59' ' ' TRP . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 10.0 110.563 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 10.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.756 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 50.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 10.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 50.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 50.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 50.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 12.5 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 25.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 10.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 50.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 10.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 50.0 110.081 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 29.3 m-70 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.291 0.567 . . . . 50.0 109.808 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.6 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 12.5 110.234 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.9900000000000002 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 50.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 50.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 50.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 12.5 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.498 ' HA ' HG11 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 50.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 50.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 50.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 50.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 50.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 50.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 50.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 50.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.527 ' HB3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 50.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 50.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 50.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 50.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 50.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 50.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 50.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CB ' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 50.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 50.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 50.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 50.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 50.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 50.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 50.0 110.113 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 50.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 50.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 50.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 50.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 50.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.865 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 50.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 12.5 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 40' ' ' MET . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 10.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 50.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG3' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 25.0 110.344 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 10.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 10.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 10.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 10.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 10.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.863 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 50.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 12.5 110.219 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 10.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 10.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 50.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 10.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 12.5 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 10.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 50.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 59' ' ' TRP . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 10.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 10.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 10.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 10.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 10.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 10.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.653 ' C ' HG21 ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 10.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 10.0 110.272 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 25.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 50.0 109.952 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 10.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 10.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 50.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 74' ' ' ILE . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 50.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 50.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 50.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 25.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 10.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 50.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 50.0 110.318 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.646 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 10.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 50.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 50.0 110.21 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 50.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' ASP . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 16.66 110.212 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.653 HG21 ' C ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 50.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 12.5 110.145 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 12.5 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 10.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 50.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 50.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 10.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 12.5 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 50.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 25.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 50.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 50.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.596 HH12 HD12 ' A' ' 100' ' ' LEU . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 50.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.596 HD12 HH12 ' A' ' 99' ' ' ARG . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 10.0 110.324 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 10.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.589 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 10.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.701 ' O ' HD12 ' A' ' 103' ' ' ILE . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 50.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 10.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 10.0 109.849 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 50.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 50.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 50.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' C ' HG23 ' A' ' 111' ' ' VAL . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 50.0 110.041 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' C ' ' A' ' 110' ' ' GLU . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 12.5 110.396 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 25.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 10.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 ' HB3' ' A' ' 6' ' ' LEU . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 50.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.631 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 50.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 10.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 50.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.357 0.599 . . . . 50.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 12.5 110.163 179.808 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.9900000000000002 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.557 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 50.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 50.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.941 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 50.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.743 ' N ' HD12 ' A' ' 6' ' ' LEU . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 12.5 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.542 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 50.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 50.0 109.862 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 50.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 50.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 50.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 50.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 50.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 50.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.706 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 50.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.592 ' N ' HD11 ' A' ' 11' ' ' LEU . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 50.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 50.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 50.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 50.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 50.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 50.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD23 HD21 ' A' ' 6' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 50.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 50.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 50.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 50.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 50.0 110.346 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 50.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 50.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 50.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 50.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 50.0 110.11 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 50.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 50.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 50.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 50.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 50.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 10.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' OE1' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 50.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.894 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 50.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 12.5 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.725 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 10.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 50.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 25.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 10.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 10.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 10.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 10.0 110.285 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 10.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' N ' HD23 ' A' ' 49' ' ' LEU . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 50.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.725 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 12.5 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.894 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 10.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 10.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 50.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 10.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 12.5 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 10.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 50.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 10.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 10.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 10.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 10.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 10.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.574 ' N ' HG21 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 10.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.412 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 10.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 25.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 50.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 10.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 10.0 111.405 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 50.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 74' ' ' ILE . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 50.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 50.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 50.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 25.0 110.1 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 50.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 50.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 10.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 50.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 50.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.467 HE22 HD11 ' A' ' 103' ' ' ILE . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 16.66 110.153 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 50.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' N ' HG23 ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 12.5 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 12.5 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 10.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 50.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.754 ' HG2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 50.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HD2' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 10.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 12.5 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 50.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 25.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 50.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 50.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.767 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 50.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 10.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 10.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.952 ' SG ' HG23 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 10.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.952 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 50.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 10.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 80' ' ' ILE . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 10.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 50.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 50.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 50.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 50.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 108' ' ' ALA . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 12.5 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 25.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 10.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 50.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 50.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 10.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 50.0 110.035 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.35 0.595 . . . . 50.0 109.736 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.519 HD12 ' OH ' ' A' ' 8' ' ' TYR . 20.6 tp . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 12.5 110.065 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.9900000000000002 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 111' ' ' VAL . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 50.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 50.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.805 HD23 ' CD2' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 50.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.7 t30 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 12.5 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 50.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.42 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 50.0 109.966 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 50.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 50.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 50.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 50.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 50.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 50.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 50.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 50.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 50.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 50.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 50.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 50.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 23' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 50.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.805 ' CD2' HD23 ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 50.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 50.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 50.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 50.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 50.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 50.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 50.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 50.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 50.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 50.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 50.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 50.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 50.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.751 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 50.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 12.5 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 10.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.721 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 50.0 110.228 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 25.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' A' ' 43' ' ' ALA . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 10.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 10.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.535 HG23 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 10.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 10.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' N ' HD23 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 50.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 12.5 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 10.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 10.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 50.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 10.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 12.5 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 10.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 50.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 10.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 10.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 10.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 10.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 10.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 10.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 10.0 110.306 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 25.0 111.343 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 50.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 10.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 10.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 50.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 50.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 50.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 50.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 25.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 50.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' SER . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 50.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 10.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.758 ' CG ' HD12 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 50.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 50.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 50.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 16.66 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 50.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 50.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 12.5 109.89 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 12.5 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 10.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 50.0 109.633 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 50.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 10.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 12.5 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 50.0 110.458 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 25.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 50.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 50.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HD3' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 50.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD12 ' CG ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 10.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 10.0 110.437 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 10.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD13 ' A' ' 100' ' ' LEU . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 50.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 10.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 10.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 50.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 50.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 50.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 50.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 12.5 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 25.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 10.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 50.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 50.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.595 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 10.0 110.287 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 50.0 110.221 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.595 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 65.0 m-70 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.405 0.621 . . . . 50.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 12.5 110.435 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.9900000000000002 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 50.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 50.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 23' ' ' LEU . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 50.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 6' ' ' LEU . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 12.5 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HB2' HG12 ' A' ' 114' ' ' VAL . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 50.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 50.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 50.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD13 HD21 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 50.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 50.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 50.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 50.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 50.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 50.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 50.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 50.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 50.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 50.0 110.404 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 50.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 50.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.719 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 50.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 50.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 50.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 50.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 50.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 50.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 50.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 50.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 50.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.749 HD12 ' HB1' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 50.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 50.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 50.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 50.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 50.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 24' ' ' PHE . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 50.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 10.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 50.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 50.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 12.5 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' CB ' ' A' ' 51' ' ' ALA . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 10.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 50.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 25.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 10.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 10.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 42' ' ' VAL . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 10.0 110.369 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 10.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 50.0 110.503 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 12.5 110.346 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 10.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 10.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 50.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 10.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 12.5 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 10.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 50.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 10.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 10.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 10.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 10.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.828 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 10.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 10.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 10.0 110.545 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 25.0 111.276 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 50.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 10.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 10.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.791 ' OG ' HD11 ' A' ' 113' ' ' ILE . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 50.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 50.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 50.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 50.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 25.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 10.0 109.24 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 50.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 50.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 10.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.674 ' HE1' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 50.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 50.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 16.66 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 50.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 100' ' ' LEU . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 50.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.674 HD22 ' HE1' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 12.5 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 12.5 109.986 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.88 ' O ' HG12 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 10.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 50.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 50.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.88 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 10.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 12.5 110.012 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 50.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 25.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.821 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 50.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.634 HG13 HD11 ' A' ' 88' ' ' LEU . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 50.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 50.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.828 HD13 ' HA2' ' A' ' 66' ' ' GLY . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 10.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 10.0 109.993 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 10.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.794 ' O ' HG22 ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 50.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 10.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.436 ' CG ' HG11 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 50.0 110.393 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 50.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.447 ' C ' HG23 ' A' ' 111' ' ' VAL . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 50.0 109.748 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 12.5 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 25.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.791 HD11 ' OG ' ' A' ' 73' ' ' SER . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 10.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 6' ' ' LEU . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 50.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 50.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.3 t30 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 50.0 110.423 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.537 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 88.3 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.244 0.545 . . . . 50.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 12.5 110.164 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.9900000000000002 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 50.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 50.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.793 HD23 ' CD1' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 50.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' HD12 ' A' ' 6' ' ' LEU . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 12.5 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 120' ' ' LEU . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 50.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 50.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 50.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.647 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 50.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 50.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 50.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 50.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 50.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 50.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 50.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 50.0 110.341 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 50.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 50.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 50.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 50.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' HD13 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 50.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.793 ' CD1' HD23 ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 50.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 50.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 50.0 109.882 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 50.0 110.227 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 50.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 50.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 50.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 50.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 ' HB1' ' A' ' 27' ' ' ALA . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 50.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 50.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 50.0 109.655 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 50.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 50.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 50.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 50.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 50.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 12.5 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 51' ' ' ALA . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 10.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 50.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 25.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 10.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 10.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG23 ' CE ' ' A' ' 40' ' ' MET . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 10.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' A' ' 59' ' ' TRP . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 10.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 50.0 110.258 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 12.5 109.998 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 10.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 10.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 50.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 10.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.556 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 12.5 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 10.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.715 ' HB2' HD13 ' A' ' 49' ' ' LEU . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 50.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 10.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 10.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 10.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 10.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 10.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 10.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 10.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' CA ' HG12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 10.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 25.0 111.263 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 50.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 10.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 10.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 50.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 50.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 50.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 50.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 25.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 50.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 50.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 10.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 50.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' HD12 ' A' ' 103' ' ' ILE . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 50.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 50.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 16.66 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 50.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 50.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.008 HD21 HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 12.5 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 12.5 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 10.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 50.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 50.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 10.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 12.5 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 50.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 25.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 50.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.008 HG12 HD21 ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 50.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.521 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 50.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 103' ' ' ILE . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 10.0 110.666 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 10.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 10.0 109.994 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.493 HD12 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 50.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 10.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 10.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 3' ' ' VAL . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 50.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 50.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 50.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 50.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 12.5 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 25.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 10.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 50.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 50.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 10.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 50.0 110.232 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.519 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 57.5 m-70 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 50.0 109.779 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 12.5 110.184 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.9900000000000002 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.539 ' CG2' HG22 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 50.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 50.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 50.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 12.5 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 50.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 50.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 50.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 50.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 50.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 50.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 50.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 50.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 50.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 50.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 50.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 50.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 50.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 50.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 50.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 23' ' ' LEU . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 50.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 50.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 50.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 50.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 50.0 109.907 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 50.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 50.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 50.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 50.0 110.083 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 50.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 50.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 50.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 50.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 50.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 2' ' ' THR . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 50.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.051 ' HB3' HG13 ' A' ' 3' ' ' VAL . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 50.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 12.5 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.774 HG23 ' HG2' ' A' ' 40' ' ' MET . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 10.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 50.0 110.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 25.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 10.0 110.443 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 10.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 10.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.726 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 10.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.564 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 50.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.649 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 12.5 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.878 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 10.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 10.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 50.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 10.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 10.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 12.5 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 10.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 50.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 10.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 10.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 10.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 10.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 10.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 103' ' ' ILE . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 10.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 10.0 110.377 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 25.0 111.297 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 50.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 10.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 10.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 50.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 50.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 50.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 50.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 111' ' ' VAL . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 25.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 10.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 50.0 110.056 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 50.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 10.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 50.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 50.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 50.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 16.66 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 50.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 50.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD12 HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 12.5 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 12.5 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 10.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 50.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 50.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 10.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 12.5 110.537 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 50.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 25.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 50.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 96' ' ' LYS . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 50.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 50.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 103' ' ' ILE . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 10.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 10.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.706 ' SG ' HG23 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 10.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.706 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 50.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 10.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 10.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 50.0 110.564 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 50.0 110.373 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 50.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 108' ' ' ALA . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 12.5 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 25.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 73' ' ' SER . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 10.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 50.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 50.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 10.0 110.609 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 50.0 110.163 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.623 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 64.9 m-70 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.31 0.576 . . . . 50.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 12.5 110.511 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.9900000000000002 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 111' ' ' VAL . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 50.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 50.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 50.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 12.5 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 50.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 50.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 50.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 50.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 50.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 50.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 50.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 50.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 50.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.471 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 50.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 50.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 50.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 50.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 50.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 50.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 50.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 50.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 50.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 50.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 50.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 50.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 50.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 50.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 50.0 110.388 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 50.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 50.0 109.301 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 50.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 50.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 50.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 50.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.566 ' HE1' ' HB3' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 50.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 12.5 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 51' ' ' ALA . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 10.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 50.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 25.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 10.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 10.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 10.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 10.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 10.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 50.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 12.5 110.248 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 10.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 10.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 50.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 10.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 10.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 12.5 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 10.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.647 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 50.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 10.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 10.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 10.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 10.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 10.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 10.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 10.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 10.0 110.271 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 25.0 111.173 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 50.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 10.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 10.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 50.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.72 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 50.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 50.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 50.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 25.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.619 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 10.0 109.208 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 50.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.477 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 50.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 10.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 50.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 50.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 50.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.3 OUTLIER -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 16.66 110.216 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 50.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 50.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 12.5 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 12.5 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.646 ' O ' HG12 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 10.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 50.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 50.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.974 HG21 ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 10.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 12.5 110.442 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 25.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 50.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 50.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.974 ' NH2' HG21 ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 50.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 10.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 10.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HG23 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 10.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.672 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 50.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 10.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 10.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 50.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 50.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 50.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 50.0 110.051 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.619 HG13 ' HA3' ' A' ' 78' ' ' GLY . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 12.5 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 25.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 10.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 50.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 50.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 10.0 110.138 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 50.0 110.368 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.305 0.574 . . . . 50.0 109.708 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 12.5 110.397 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.9900000000000002 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 50.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 50.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 50.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.547 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 12.5 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 50.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 50.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 50.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 50.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 50.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 50.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 50.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 50.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 50.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.583 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 50.0 110.327 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 50.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 50.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 50.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 50.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 50.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 50.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 50.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 50.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 50.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 50.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 50.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 50.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 50.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 50.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 50.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 50.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 50.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 50.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 50.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 10.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 50.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.615 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 50.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 12.5 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.948 HG22 ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 10.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 50.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 25.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB3' HG12 ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 10.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 10.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 10.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 10.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 50.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.948 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 12.5 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 10.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 10.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 50.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 10.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 10.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 12.5 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 10.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 50.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.942 ' CE2' HD23 ' A' ' 49' ' ' LEU . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 10.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 10.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 10.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 10.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 10.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.729 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 10.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 10.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 10.0 110.263 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 25.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 50.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 10.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 10.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 50.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 50.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 50.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 50.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 25.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 10.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 108' ' ' ALA . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 50.0 110.046 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 50.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 10.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 50.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 16.66 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 50.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 100' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 50.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 88' ' ' LEU . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 12.5 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 12.5 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.753 ' O ' HG12 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 10.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 50.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 50.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 10.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 12.5 110.47 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 50.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 25.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 50.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 50.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 50.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' HA2' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 10.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 10.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 1.01 ' C ' HD13 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 10.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 50.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 10.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 50.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 50.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 50.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 50.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 12.5 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 25.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 10.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 50.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 50.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.563 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 10.0 110.922 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 50.0 109.859 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.526 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.211 0.529 . . . . 50.0 110.158 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 12.5 110.214 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.9900000000000002 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 106' ' ' PRO . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 50.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 50.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.875 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 50.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 12.5 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 50.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 50.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 50.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 50.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 50.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 50.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 50.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 50.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 50.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 50.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 50.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 50.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 50.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 50.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 16' ' ' TRP . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 50.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.875 ' CZ ' HD12 ' A' ' 6' ' ' LEU . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 50.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 50.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 50.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 50.0 110.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 50.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 50.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 50.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 50.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 50.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 50.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 50.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 50.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 50.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 10.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 50.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.778 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 12.5 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 10.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 50.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 25.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 10.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 10.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 49' ' ' LEU . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 10.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 49' ' ' LEU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 10.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 50.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 12.5 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.778 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 10.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 10.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 50.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 10.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 10.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 12.5 109.967 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 10.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.703 ' HB2' HD23 ' A' ' 49' ' ' LEU . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 50.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 10.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 10.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 10.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 10.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 10.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 10.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 10.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 10.0 110.119 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 25.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 50.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 10.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 10.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 50.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 50.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 50.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 50.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 25.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.454 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 10.0 109.273 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 50.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 50.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 10.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 50.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 50.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 50.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 16.66 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 50.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.6 ' C ' HD12 ' A' ' 87' ' ' ILE . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 50.0 109.803 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 12.5 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 12.5 110.133 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.898 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 10.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 50.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 50.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 90' ' ' ASP . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 10.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 12.5 110.2 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 50.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 98' ' ' VAL . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 25.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.569 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 50.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 96' ' ' LYS . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 50.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 50.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 66' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 10.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 10.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 10.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 50.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 10.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 10.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HB3' HG21 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 50.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 50.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 50.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 50.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 12.5 110.41 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 25.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 10.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 50.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.601 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 50.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.574 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.6 t30 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 10.0 110.316 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 50.0 110.143 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.574 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 30.6 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.08 0.467 . . . . 50.0 109.988 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD22 ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 12.5 110.105 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.9900000000000002 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 3' ' ' VAL . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 50.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 50.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 50.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.614 ' N ' HD23 ' A' ' 6' ' ' LEU . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 12.5 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 50.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 50.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 50.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 50.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 50.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 50.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 50.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.496 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 50.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 50.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 50.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 50.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 50.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 50.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 50.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.862 ' HB3' HD11 ' A' ' 6' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 50.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 50.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 50.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 50.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 50.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 50.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 50.0 110.296 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 50.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 50.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 50.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 50.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 50.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 50.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 50.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 10.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 50.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 50.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 12.5 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 10.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 50.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 25.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 10.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 10.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 10.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.557 HG23 ' CE ' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 10.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 10.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 50.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.572 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 12.5 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 10.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 10.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 50.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 10.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 12.5 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 10.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 50.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 10.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 10.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 10.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 10.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 10.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 10.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 10.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 10.0 110.094 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 25.0 111.646 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 50.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 10.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 10.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.808 ' O ' HD13 ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 50.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 50.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 50.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 25.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 10.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 50.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.072 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 10.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.409 ' HE3' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 50.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 50.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 50.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 16.66 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 50.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 50.0 110.044 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 12.5 110.107 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 12.5 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.808 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 10.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 50.0 109.956 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 50.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 10.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 12.5 110.351 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 50.0 110.176 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 25.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 50.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 96' ' ' LYS . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 50.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.542 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 50.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 103' ' ' ILE . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 10.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 10.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' HG23 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.678 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 50.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 10.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 10.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 50.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 50.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 50.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 50.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.658 ' HB ' HG13 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 12.5 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 25.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 10.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 50.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 50.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 50.0 110.627 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 50.0 109.805 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.569 HD11 ' HE2' ' A' ' 96' ' ' LYS . 44.4 tp . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 12.5 110.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.9900000000000002 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 106' ' ' PRO . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 50.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 50.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.935 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 50.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.919 ' N ' HD12 ' A' ' 6' ' ' LEU . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 12.5 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 50.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 50.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 50.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 50.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 50.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 50.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.404 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 50.0 110.211 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 50.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.596 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 50.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 50.0 109.965 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 50.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 50.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 50.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 50.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 50.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.912 ' HB3' HD21 ' A' ' 6' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 50.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 50.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 50.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 50.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 50.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 50.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 50.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 50.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 50.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.515 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 50.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 50.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 50.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 50.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.587 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 50.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 50.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 50.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.849 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 50.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' HG23 ' A' ' 2' ' ' THR . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 12.5 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 10.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 50.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 25.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 10.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 10.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 10.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.607 HG23 ' HE2' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 10.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 10.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 50.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 12.5 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.849 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 10.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 10.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 50.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 10.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 10.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 12.5 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 10.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 50.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 10.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 10.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 10.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 10.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 10.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.441 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 10.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 10.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 10.0 110.597 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 25.0 111.685 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 50.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 10.0 109.863 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 10.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 50.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 73' ' ' SER . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 50.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 50.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 50.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 25.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 50.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 10.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 50.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 50.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 HE22 HD22 ' A' ' 100' ' ' LEU . 9.2 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 16.66 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 50.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 50.0 110.239 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 12.5 110.195 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 12.5 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 10.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 50.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 50.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 10.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 12.5 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 50.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 25.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 50.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' CG ' ' A' ' 92' ' ' GLU . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 50.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 50.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.547 HD22 HE22 ' A' ' 85' ' ' GLN . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 10.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 10.0 110.453 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 10.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 50.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 10.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HB3' HG21 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 50.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 50.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 50.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 50.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 12.5 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 25.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 10.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 50.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 50.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 10.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 50.0 110.48 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.324 0.583 . . . . 50.0 110.009 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 12.5 110.259 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.9900000000000002 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 111' ' ' VAL . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 50.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 50.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 50.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 6' ' ' LEU . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 12.5 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 50.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 50.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 50.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.627 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 50.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 50.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 50.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 50.0 109.995 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 50.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 50.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.637 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 50.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 11' ' ' LEU . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 50.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 50.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 50.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 50.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 50.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 50.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 50.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 50.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 50.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 50.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 50.0 110.099 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 50.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 50.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 50.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 50.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 50.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 50.0 109.279 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 50.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 50.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 50.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 50.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.612 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 50.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 12.5 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG13 ' HG3' ' A' ' 106' ' ' PRO . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 10.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 50.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 25.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 10.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 10.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 10.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 59' ' ' TRP . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 10.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 50.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 12.5 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 10.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 10.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 50.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 10.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 10.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.591 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 12.5 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 10.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.643 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 50.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 10.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 10.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 10.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.497 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 10.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.467 ' C ' HG21 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 10.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 10.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 10.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 10.0 110.264 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 25.0 111.432 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 50.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 10.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 10.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 50.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 50.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 50.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 50.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 25.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 50.0 109.911 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 50.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 10.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 50.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 50.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 16.66 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 50.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 100' ' ' LEU . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 50.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 100' ' ' LEU . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 12.5 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 12.5 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 10.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 50.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 50.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 10.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 12.5 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 25.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 50.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 50.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.442 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 50.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 88' ' ' LEU . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 10.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 10.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 103' ' ' ILE . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 10.0 110.625 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 50.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.819 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 10.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.77 ' HG3' HG13 ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 50.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 50.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 50.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 50.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 3' ' ' VAL . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 12.5 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 25.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 10.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 50.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 10.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 50.0 109.57 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 65.0 m-70 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.12 0.486 . . . . 50.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 12.5 110.038 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.9900000000000002 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 50.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 50.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 50.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 2.5 t-20 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 12.5 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 50.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 50.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 50.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 50.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 50.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 50.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 50.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 50.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.718 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 50.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 50.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 50.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 50.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 50.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 50.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 50.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 50.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 50.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 50.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 50.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 50.0 110.132 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 50.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 50.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 50.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 50.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 50.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 50.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 50.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 50.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 50.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 50.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 50.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 12.5 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.733 HG13 ' HG3' ' A' ' 106' ' ' PRO . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 10.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 50.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 25.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 10.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 10.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 10.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.57 HG23 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 10.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 10.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 50.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 12.5 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.568 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 10.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 10.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 50.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 10.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 10.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.568 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 12.5 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 10.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 50.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.535 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 10.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 10.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 10.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 10.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 10.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 10.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 10.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 10.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 25.0 111.209 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 50.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 10.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 10.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 50.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 50.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 50.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 25.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 10.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 50.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 50.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 50.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 50.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 50.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 16.66 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 50.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.91 HG23 HD23 ' A' ' 88' ' ' LEU . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 50.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.91 HD23 HG23 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 12.5 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 12.5 110.166 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 10.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 50.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 50.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 10.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 12.5 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 50.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 25.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 50.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 50.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 50.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 10.0 110.218 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 10.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 10.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 50.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 10.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.733 ' HG3' HG13 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.416 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 50.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 50.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 50.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 50.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 12.5 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 25.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 10.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 50.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 50.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 10.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 50.0 110.103 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.185 0.517 . . . . 50.0 110.331 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 12.5 110.24 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.7 Cg_endo . . . . . 0 N--CA 1.489 1.212 0 N-CA-C 110.359 -0.67 . . . . 4.9900000000000002 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.6 m -118.04 137.1 53.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 3.73 110.613 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 111' ' ' VAL . 19.2 t -142.55 164.49 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 10.0 109.699 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.9 tt0 -130.87 109.8 10.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 50.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' OH ' ' CE1' ' A' ' 57' ' ' TYR . 42.0 p90 -87.29 145.0 26.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.971 . . . . 50.0 110.575 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -133.75 144.28 48.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 50.0 110.124 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.539 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 3.5 t-20 -76.82 109.54 10.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 12.5 110.279 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 8.7 t80 -57.11 -35.22 69.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.102 -0.999 . . . . 50.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.6 tm-20 -63.29 -39.7 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -0.793 . . . . 50.0 109.735 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.573 HG21 HD13 ' A' ' 32' ' ' LEU . 53.9 m -62.41 -37.21 84.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.323 -0.861 . . . . 50.0 109.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.04 -40.45 95.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 50.0 109.794 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.19 -55.8 5.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 50.0 109.868 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -45.49 -55.03 6.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 50.0 109.974 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -68.34 -23.4 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 50.0 110.124 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.81 35.18 51.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.685 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -86.8 -170.16 2.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -1.192 . . . . 50.0 110.271 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 23' ' ' LEU . 39.9 m-20 -101.56 170.06 8.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 50.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.2 ttp -74.75 -42.69 57.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 50.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -142.54 12.44 1.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 50.0 110.312 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 6.6 t0 -79.3 -57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 50.0 110.353 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -79.8 5.48 13.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.945 . . . . 50.0 110.298 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER 52.22 50.29 18.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 50.0 110.015 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.819 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.75 -42.68 2.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 50.0 110.52 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 32.1 m-85 -56.47 -19.97 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.2 -0.938 . . . . 50.0 110.102 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -108.45 -49.54 3.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -0.856 . . . . 50.0 110.171 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -67.21 -22.6 65.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 50.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' LEU . . . -61.62 -39.01 89.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 50.0 110.036 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.6 -22.63 46.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 50.0 109.997 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -90.93 -11.82 37.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 50.0 110.118 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.81 -23.11 24.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 50.0 110.002 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 31.98 77.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.466 -1.454 . . . . 50.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 10' ' ' THR . 11.7 mt -59.07 -172.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -1.123 . . . . 50.0 110.189 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.35 140.0 57.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.87 . . . . 50.0 110.177 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -61.57 -25.72 65.67 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mp0 -76.35 2.91 12.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -1.154 . . . . 50.0 110.274 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 82.4 m-20 -115.98 -46.38 2.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 50.0 110.288 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 36.7 t80 -132.95 139.46 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 50.0 110.412 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.95 166.12 29.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -90.02 114.43 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.092 . . . . 50.0 110.074 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.58 ' HE3' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -89.83 122.35 32.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 50.0 110.495 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.45 116.12 31.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 12.5 110.027 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG22 ' CB ' ' A' ' 51' ' ' ALA . 60.8 t -135.17 126.94 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 10.0 110.333 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -79.45 169.51 17.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 50.0 110.303 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -68.28 123.09 19.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 25.0 110.158 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.15 43.31 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.466 -1.454 . . . . 10.0 109.466 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.2 mm-40 -105.91 132.16 52.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -1.145 . . . . 10.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CE1' ' HA ' ' A' ' 103' ' ' ILE . 11.6 m-85 -71.6 135.73 47.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 10.0 110.31 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.492 HG23 ' HE3' ' A' ' 40' ' ' MET . 17.4 mt -54.62 -70.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 10.0 110.369 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' ' 59' ' ' TRP . 2.0 tt -42.86 -25.83 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 10.0 110.518 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 7.2 mm-40 -79.8 -52.68 7.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -0.959 . . . . 50.0 110.436 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.688 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.72 -37.9 85.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 12.5 110.81 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -77.14 -33.23 56.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 10.0 110.257 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.9 tt0 -65.23 -28.84 69.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 10.0 109.936 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.72 -8.79 57.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.785 . . . . 50.0 110.093 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . 11.9 mm100 -103.03 -27.46 12.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 10.0 110.382 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.07 2.25 4.27 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.578 ' CE1' ' OH ' ' A' ' 5' ' ' TYR . 23.8 m-85 -76.89 153.44 34.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.26 . . . . 12.5 110.307 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.1 p30 -120.48 136.85 54.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 10.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.635 ' HB2' HD12 ' A' ' 49' ' ' LEU . 13.6 m95 -135.69 149.72 69.86 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.921 . . . . 50.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.8 Cg_endo -73.1 137.83 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.966 1.508 . . . . 10.0 109.539 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.504 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 16.9 p90 -158.99 148.76 19.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 10.0 110.363 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.1 m -144.25 -58.51 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.389 -0.819 . . . . 10.0 110.299 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.39 -37.37 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 10.0 110.999 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 59.21 30.01 19.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.889 -1.132 . . . . 10.0 112.04 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.57 2.22 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.188 -0.945 . . . . 10.0 110.223 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.13 38.35 30.09 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.668 -1.373 . . . . 10.0 109.668 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.688 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.12 5.68 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -1.223 . . . . 10.0 110.855 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.65 -173.36 3.76 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 10.0 109.956 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.19 11.82 8.21 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.894 -1.129 . . . . 25.0 111.629 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -57.44 -37.66 73.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.919 -1.113 . . . . 50.0 110.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.499 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 19.4 p -87.24 13.26 9.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 10.0 109.83 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -44.47 151.55 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.807 0.813 . . . . 10.0 111.665 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.515 ' O ' HD13 ' A' ' 74' ' ' ILE . 6.7 m -138.87 -162.57 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.671 -0.643 . . . . 50.0 109.38 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 40.9 mm -148.04 72.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 50.0 110.403 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 75' ' ' VAL . 14.5 p -48.81 113.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.989 . . . . 50.0 109.931 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.1 tmtt? -83.69 -11.06 57.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.016 -1.053 . . . . 50.0 110.419 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 6.7 tt0 -178.3 167.13 1.91 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.259 -0.901 . . . . 25.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 87.32 -162.53 33.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.28 143.9 29.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.162 . . . . 50.0 110.156 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.61 146.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 50.0 110.211 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 30.7 t70 -95.54 134.52 38.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 10.0 110.333 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.683 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -108.51 -179.88 4.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 50.0 110.044 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -98.14 -176.74 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 50.0 110.336 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 74.97 0.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 50.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.68 166.23 4.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 16.66 110.22 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -162.1 78.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 50.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.688 HG21 ' HA ' ' A' ' 67' ' ' ALA . 1.6 pp -84.61 -25.21 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 50.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 88' ' ' LEU . 45.0 mt -78.49 164.4 24.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 12.5 109.953 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -96.27 133.27 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.981 . . . . 12.5 110.477 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.9 p-10 -43.95 -33.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 10.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -57.14 -37.43 72.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 50.0 109.459 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' ASP . 26.7 mt-10 -74.8 -30.81 61.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 50.0 109.647 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.63 -14.76 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 10.0 110.076 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.81 -33.11 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 12.5 110.348 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 5.8 tm-20 -96.26 -22.77 17.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -0.937 . . . . 50.0 110.657 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 mttt -124.3 -9.88 7.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 25.0 110.433 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER 58.94 41.19 21.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.957 . . . . 50.0 110.087 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' SER . 6.1 t -89.29 149.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 50.0 110.708 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.38 177.45 9.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 50.0 110.189 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.683 HD12 ' CG ' ' A' ' 82' ' ' MET . 1.2 mt -96.22 107.8 20.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 10.0 110.032 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -24.84 46.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 10.0 110.727 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 103' ' ' ILE . 26.7 p -75.04 -29.93 60.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 10.0 110.35 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' TYR . 1.2 pp -134.34 33.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.144 -0.972 . . . . 50.0 110.306 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.92 137.99 12.34 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.917 -1.273 . . . . 10.0 109.917 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.14 147.04 50.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 10.0 109.858 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.66 130.29 16.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.871 1.458 . . . . 10.0 110.503 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -104.53 -7.15 19.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 50.0 110.113 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.28 172.08 7.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 50.0 109.992 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.15 -61.64 1.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 50.0 110.106 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -105.17 130.35 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 50.0 109.929 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 3' ' ' VAL . 18.4 t -142.33 144.18 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 12.5 110.76 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.1 mmtm -111.22 137.76 48.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 25.0 109.632 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.593 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.2 tt -160.15 143.99 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.136 -0.977 . . . . 10.0 110.901 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -97.59 138.34 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 50.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.609 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -99.39 158.39 15.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 50.0 110.363 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 9.8 t-20 72.84 54.68 0.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.397 -0.814 . . . . 10.0 110.206 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.09 -25.34 63.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 50.0 110.149 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.491 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 52.9 m-70 -63.41 -21.84 66.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 50.0 109.971 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -41.48 136.78 1.69 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 12.5 110.192 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.33 -21.0 65.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 50.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.61 -28.51 65.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 16.66 110.451 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 9.4 mt -96.99 -35.12 10.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 50.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -42.83 -28.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 50.0 110.645 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -65.08 -18.55 65.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.217 -0.927 . . . . 50.0 110.606 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -66.86 -17.65 64.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 50.0 110.451 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -49.78 132.79 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 50.0 110.201 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.995 -1.002 . . . . 50.0 110.26 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.607 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 N-CA-C 110.546 -0.598 . . . . 4.9900000000000002 110.546 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 39' ' ' THR . 42.0 m -113.15 131.0 56.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 3.73 110.049 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 40' ' ' MET . 30.3 t -133.69 115.21 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 10.0 110.456 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.79 117.41 23.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 50.0 110.053 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 7.4 p90 -91.22 148.73 22.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 50.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.77 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -136.17 139.97 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 50.0 109.991 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.551 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 50.1 t-20 -74.84 120.83 20.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 12.5 110.378 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HA ' HG11 ' A' ' 114' ' ' VAL . 40.2 t80 -55.8 -32.67 63.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.053 -1.029 . . . . 50.0 109.27 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -62.68 -43.01 99.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 50.0 109.603 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.3 m -57.37 -29.26 63.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.81 . . . . 50.0 109.837 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -65.33 -48.06 74.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 50.0 109.707 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -75.11 -39.91 60.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.822 . . . . 50.0 109.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.49 -56.44 18.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 50.0 109.866 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -28.57 61.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 50.0 109.764 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.89 39.41 38.82 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.618 -1.393 . . . . 50.0 109.618 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -171.64 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.154 -1.204 . . . . 50.0 110.251 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.9 OUTLIER -89.29 174.07 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.144 -0.973 . . . . 50.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 mtm -73.72 -42.9 60.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 50.0 110.441 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 2.5 p30 -150.47 11.17 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.95 . . . . 50.0 110.93 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 12.4 t70 -79.97 -51.33 9.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 50.0 109.894 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 6.32 11.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 50.0 110.053 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 23' ' ' LEU . 4.9 m-20 49.61 51.1 17.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.855 . . . . 50.0 110.069 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' CD1' HD22 ' A' ' 11' ' ' LEU . 7.0 mt -44.1 -41.36 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.451 -0.781 . . . . 50.0 110.193 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.647 ' CE2' HD12 ' A' ' 6' ' ' LEU . 57.7 m-85 -53.76 -24.51 15.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 50.0 109.728 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -44.59 6.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.468 -0.77 . . . . 50.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -28.11 62.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -0.947 . . . . 50.0 110.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -22.14 31.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 50.0 109.939 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.2 -28.51 65.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 50.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.87 -21.6 57.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 50.0 110.013 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.99 -63.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 50.0 110.065 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.04 57.43 0.48 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 50.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 3.9 mm? -72.57 164.0 27.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -1.104 . . . . 50.0 110.326 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 146.98 40.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 50.0 110.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -29.66 72.86 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 2.8 mt-10 -73.96 -0.53 16.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.275 -1.132 . . . . 50.0 110.305 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 1.6 m-20 -117.87 -51.21 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.334 -0.854 . . . . 50.0 110.174 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 9.5 t80 -129.24 134.25 47.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 50.0 110.056 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 168.55 166.79 28.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 1.3 m -85.77 128.27 34.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.175 . . . . 50.0 110.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -101.55 82.18 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 50.0 110.356 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -75.74 110.16 9.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 12.5 110.115 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 18.2 m -132.91 163.12 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 10.0 110.383 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.71 150.25 46.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 50.0 110.348 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -60.62 117.46 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 25.0 110.223 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.64 8.16 52.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.46 -1.456 . . . . 10.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 tp10 -87.71 110.54 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -1.174 . . . . 10.0 110.205 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.05 114.2 0.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.242 -0.912 . . . . 10.0 110.266 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 49' ' ' LEU . 20.9 mt -40.42 -71.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 10.0 110.523 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -41.34 -37.22 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.793 . . . . 10.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -52.4 9.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 50.0 109.909 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.597 ' HB2' ' CG ' ' A' ' 46' ' ' GLU . . . -55.09 -40.07 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 12.5 109.929 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 59' ' ' TRP . . . -80.05 -26.65 39.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 10.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -63.97 -30.73 71.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 10.0 110.085 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.73 -16.71 60.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 50.0 110.504 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -93.37 -23.05 18.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 10.0 110.497 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.82 17.14 8.1 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-85 -77.06 -169.94 1.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.24 . . . . 12.5 110.013 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -146.89 131.59 17.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 10.0 110.503 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 10.2 m95 -139.25 139.33 22.65 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 50.0 109.96 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 44.1 Cg_endo -71.37 138.64 33.24 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.892 1.47 . . . . 10.0 110.136 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 8.2 p90 -167.0 151.47 7.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 10.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 t -140.33 -58.57 0.54 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 10.0 110.163 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -72.19 -38.39 69.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.389 -0.819 . . . . 10.0 110.789 -179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.5 mtp180 58.67 30.6 20.13 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.01 -1.056 . . . . 10.0 111.917 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.63 2.5 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 10.0 110.286 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.743 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 80.18 38.4 18.68 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.918 -1.273 . . . . 10.0 109.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.91 5.89 5.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.937 -1.331 . . . . 10.0 111.585 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.591 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.16 -176.49 4.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.641 -1.287 . . . . 10.0 110.267 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -122.07 9.72 9.96 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.025 -1.047 . . . . 25.0 111.291 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -57.35 -38.64 74.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.04 -1.037 . . . . 50.0 110.042 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 13.4 p -88.85 13.17 13.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.261 -0.899 . . . . 10.0 109.937 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.4 151.1 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 10.0 111.404 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -134.71 -166.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.662 -0.649 . . . . 50.0 109.263 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 21.9 mm -145.89 82.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 50.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.9 p -51.38 126.78 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.404 -0.81 . . . . 50.0 110.259 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 112' ' ' LYS . 7.0 tmtt? -88.53 -10.7 47.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 50.0 109.8 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER 170.38 146.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.853 . . . . 25.0 110.29 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.783 ' HA3' HG22 ' A' ' 111' ' ' VAL . . . 111.86 -159.94 13.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -145.24 129.6 17.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -1.173 . . . . 50.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -111.11 142.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.884 . . . . 50.0 109.932 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.09 153.15 26.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 10.0 110.353 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.526 ' SD ' HD23 ' A' ' 100' ' ' LEU . 6.0 ptm -166.8 167.74 14.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 50.0 110.085 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.54 135.57 57.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 50.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 165.9 4.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 50.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 179.7 -146.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 16.66 110.046 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -146.47 35.05 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 50.0 110.146 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.006 HG23 HD23 ' A' ' 88' ' ' LEU . 5.1 tp -90.16 -24.32 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 50.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.006 HD23 HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -148.8 174.16 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 12.5 110.297 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 m -116.44 155.98 27.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 12.5 110.259 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.02 -37.34 14.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 10.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 10.3 mm-40 -61.43 -36.71 81.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.915 . . . . 50.0 110.275 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 3.5 tt0 -61.25 -32.83 72.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 50.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -76.28 -36.81 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 10.0 110.029 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -31.73 22.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 12.5 110.137 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 41.6 tp10 -98.62 -42.26 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 50.0 110.494 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -96.65 -7.45 34.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 25.0 110.728 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.6 m-20 46.97 25.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.027 . . . . 50.0 109.833 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 9.8 p -97.62 144.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 50.0 110.873 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.746 ' C ' HD22 ' A' ' 100' ' ' LEU . 1.5 mmt180 -147.3 -161.31 1.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.413 -0.804 . . . . 50.0 109.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.829 HD12 ' S2 ' ' A' ' 130' ' ' FES . 3.5 mm? -113.95 115.24 27.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 10.0 110.141 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 p -81.95 -25.07 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 10.0 110.287 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.517 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.6 p -77.45 -28.0 52.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 10.0 110.375 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.743 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.9 pt -134.42 33.95 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 50.0 110.397 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 82' ' ' MET . . . -128.05 150.6 18.45 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.924 -1.27 . . . . 10.0 109.924 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.05 150.12 72.19 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.116 . . . . 10.0 109.854 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.7 Cg_endo -72.82 128.34 13.18 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.969 1.51 . . . . 10.0 110.664 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.82 -25.86 11.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 50.0 110.218 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -89.79 140.29 29.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 50.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -50.37 -67.82 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 50.0 110.142 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 10.9 pt-20 -96.44 121.62 38.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 50.0 109.933 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 31.7 t -145.1 146.65 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 12.5 110.495 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -121.95 144.03 49.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 25.0 110.075 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.2 tt -160.12 154.96 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 10.0 110.457 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 6' ' ' LEU . 58.5 t -106.0 127.8 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.407 -0.808 . . . . 50.0 109.98 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -89.56 155.24 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 50.0 110.134 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.9 t-20 74.32 55.97 0.09 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 10.0 110.208 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -84.27 -21.7 31.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 50.0 110.226 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.496 ' NE2' ' OD1' ' A' ' 116' ' ' ASN . 64.6 m-70 -64.72 -29.4 70.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 50.0 110.092 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -46.84 124.99 6.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.266 -0.896 . . . . 12.5 110.26 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -61.57 -30.69 70.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 50.0 110.326 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.423 ' HB2' HD22 ' A' ' 120' ' ' LEU . 1.4 t80 -62.69 -17.33 60.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 16.66 110.208 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.6 mt -105.72 -28.49 10.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 50.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.73 -25.13 67.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 50.0 110.225 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -63.28 -19.71 64.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.418 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.06 22.31 5.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 50.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.017 HG22 HG12 ' A' ' 128' ' ' ILE . 13.1 p -73.43 143.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 50.0 110.07 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.017 HG12 HG22 ' A' ' 127' ' ' VAL . 20.5 mm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.936 -1.031 . . . . 50.0 110.137 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.829 ' S2 ' HD12 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.3 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 N-CA-C 110.283 -0.699 . . . . 4.9900000000000002 110.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 m -112.94 142.55 45.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 3.73 110.427 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 111' ' ' VAL . 44.7 t -141.37 174.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.316 -0.865 . . . . 10.0 109.949 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 3' ' ' VAL . 20.6 tt0 -135.28 120.02 18.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 50.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE1' ' CA ' ' A' ' 38' ' ' GLY . 9.0 p90 -99.11 147.85 24.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.251 -0.905 . . . . 50.0 110.627 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -138.42 146.13 41.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -0.778 . . . . 50.0 109.974 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 51.8 t30 -76.88 112.73 13.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.095 -1.003 . . . . 12.5 110.429 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 120' ' ' LEU . 34.8 t80 -57.15 -28.26 62.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 50.0 110.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -68.49 -40.4 80.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 50.0 109.981 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 18.0 m -63.86 -38.78 92.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 50.0 109.78 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 23' ' ' LEU . 14.2 tp -67.52 -34.62 77.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 50.0 109.697 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.28 -51.87 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.831 . . . . 50.0 109.744 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -52.67 -54.65 30.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 50.0 109.898 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -30.99 70.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.37 -0.831 . . . . 50.0 110.088 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.83 54.67 8.08 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.318 -1.513 . . . . 50.0 109.318 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.491 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.8 m0 -112.17 178.41 4.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 50.0 110.487 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.455 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 65.3 m-20 -110.74 135.58 51.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 50.0 110.043 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.0 mtp -65.61 -25.52 67.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 50.0 110.496 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 -41.78 7.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 50.0 110.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -78.17 -57.55 3.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 50.0 110.383 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 79.0 m-20 -75.82 -21.91 56.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 50.0 110.644 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.29 52.73 14.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 50.0 109.869 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 HD13 ' A' ' 11' ' ' LEU . 1.6 mp -47.12 -31.36 3.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 50.0 110.441 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 14.9 m-85 -62.53 -11.61 17.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 50.0 110.099 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -119.11 -45.3 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 50.0 110.248 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HE3' ' CA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.73 -28.17 69.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 50.0 110.343 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.18 -15.14 13.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 50.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.59 -21.1 49.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 50.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -104.77 -2.04 25.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 50.0 110.34 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.47 -44.87 10.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 50.0 110.346 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 43.22 2.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.507 -1.437 . . . . 50.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -82.51 175.73 9.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.222 -1.164 . . . . 50.0 110.162 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.28 168.48 19.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 50.0 110.028 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.02 -31.41 43.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 50.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 6.4 mp0 -67.42 -11.02 56.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -1.154 . . . . 50.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 9.2 m-20 -106.68 -44.57 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 50.0 110.16 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -135.58 137.42 41.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 50.0 110.129 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' CA ' ' CE1' ' A' ' 5' ' ' TYR . . . 169.47 -175.3 43.75 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 5.9 m -104.87 130.04 53.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 50.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.547 ' HE3' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -97.16 137.49 36.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 50.0 110.328 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -124.14 118.06 26.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 12.5 110.054 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' HB3' ' A' ' 46' ' ' GLU . 1.8 p -161.62 132.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 10.0 110.151 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.45 170.78 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 50.0 110.425 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -67.66 122.37 17.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 25.0 110.12 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.37 -14.14 15.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.781 ' HB3' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -102.55 109.33 20.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -1.163 . . . . 10.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -51.28 123.56 9.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 10.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.433 HG13 ' HD3' ' A' ' 106' ' ' PRO . 80.9 mt -44.86 -49.81 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 10.0 110.293 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.2 tt -43.89 -50.71 7.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 10.0 110.233 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.35 -45.11 81.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 50.0 110.175 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -54.89 -54.68 39.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 12.5 110.244 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -71.94 -27.58 62.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.544 -0.722 . . . . 10.0 110.401 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 7.1 tt0 -61.57 -28.9 69.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 10.0 109.93 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.15 -7.45 55.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 50.0 109.932 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -104.28 -30.83 9.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 10.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.92 2.17 5.25 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 35.9 m-85 -76.16 137.98 40.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -1.175 . . . . 12.5 110.032 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 19.5 p30 -110.07 137.47 47.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 10.0 110.572 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.64 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.1 m95 -131.56 142.95 47.17 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 50.0 109.784 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.17 133.85 23.83 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.871 1.459 . . . . 10.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 6.0 p90 -159.12 150.53 20.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 10.0 110.036 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.63 -58.72 0.73 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.211 -0.931 . . . . 10.0 110.345 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.34 -37.31 57.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.326 -0.859 . . . . 10.0 110.713 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 1.4 mtm105 55.73 30.97 16.57 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.015 -1.053 . . . . 10.0 111.912 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.48 2.58 2.26 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.202 -0.936 . . . . 10.0 110.26 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.95 38.31 16.16 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.237 -1.145 . . . . 10.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.09 5.76 5.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.895 -1.356 . . . . 10.0 111.604 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.17 -174.34 3.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.708 -1.245 . . . . 10.0 110.193 179.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -124.14 11.11 8.8 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.906 -1.121 . . . . 25.0 111.613 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.16 -39.14 74.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.963 -1.086 . . . . 50.0 110.127 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.0 p -87.83 11.08 16.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.194 -0.941 . . . . 10.0 110.009 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 155.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.396 -0.815 . . . . 10.0 111.431 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 45.4 m -139.88 -162.38 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.747 -0.595 . . . . 50.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 74' ' ' ILE . 20.8 mm -149.68 77.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 110.277 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.892 HG13 ' OD1' ' A' ' 97' ' ' ASP . 7.7 p -48.96 119.59 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.341 -0.85 . . . . 50.0 110.214 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -87.36 -11.13 50.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 50.0 110.343 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.51 144.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 25.0 110.156 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 103.67 -172.51 21.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 10.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -133.44 159.03 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 50.0 110.101 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 105' ' ' SER . 10.6 mt -139.61 139.7 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 50.0 110.264 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER -89.83 161.29 16.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 10.0 110.161 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -155.35 132.09 10.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 50.0 110.197 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.3 OUTLIER -48.98 176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 50.0 110.303 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mtm -74.93 82.63 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 50.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 175.6 109.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 16.66 109.868 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.57 118.52 6.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.227 -0.921 . . . . 50.0 110.52 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.021 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -73.72 -23.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 109.512 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -80.18 -176.47 5.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.344 -0.847 . . . . 12.5 110.36 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 p -127.25 161.8 27.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 12.5 110.257 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.15 -39.94 66.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 10.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -56.7 -33.57 66.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 50.0 109.558 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -74.68 -34.52 62.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 50.0 109.647 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 99' ' ' ARG . 77.6 t -79.38 -18.07 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 10.0 110.001 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -103.33 -33.55 9.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 12.5 110.363 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 2.6 mm-40 -107.09 -10.89 15.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.975 . . . . 50.0 110.43 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 6.4 tptt -120.2 -16.65 8.47 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.195 -0.941 . . . . 25.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.892 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.2 m-20 61.59 21.1 11.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.356 -0.84 . . . . 50.0 110.717 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 96' ' ' LYS . 18.3 m -87.73 152.57 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.004 -1.06 . . . . 50.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.606 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -150.96 -161.43 1.34 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.848 . . . . 50.0 110.098 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD13 HD11 ' A' ' 103' ' ' ILE . 29.0 mt -114.79 112.64 23.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 10.0 110.108 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 49' ' ' LEU . 12.8 m -82.27 -26.36 33.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 10.0 110.827 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 103' ' ' ILE . 25.5 p -77.63 -34.81 53.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 10.0 110.826 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.605 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -133.24 33.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.136 -0.977 . . . . 50.0 110.407 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -118.98 138.73 13.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.544 -1.422 . . . . 10.0 109.544 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.15 142.79 35.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 10.0 110.172 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.639 ' CG ' HG13 ' A' ' 42' ' ' VAL . 48.8 Cg_endo -74.87 140.95 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.049 1.552 . . . . 10.0 110.554 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' ALA . . . -111.36 -72.01 0.74 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 50.0 110.093 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' ALA . . . -42.93 141.72 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.37 -0.831 . . . . 50.0 110.371 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -46.44 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 50.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -89.68 134.13 34.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 50.0 110.038 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 3' ' ' VAL . 41.6 t -146.8 149.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -0.935 . . . . 12.5 110.626 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 76' ' ' LYS . 9.2 mttp -124.7 141.84 51.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 25.0 109.787 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.3 tt -160.15 151.49 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 10.0 110.33 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 2.8 t -101.61 133.76 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 50.0 109.55 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -96.12 161.92 13.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 50.0 110.418 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 72.11 49.91 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.373 -0.829 . . . . 10.0 110.635 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 120' ' ' LEU . . . -72.84 -19.57 61.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.115 -0.991 . . . . 50.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 78.1 m-70 -69.21 -21.97 63.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 50.0 110.191 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 mt -43.56 123.43 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 12.5 110.05 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.73 -32.42 72.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 50.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -70.45 -13.04 61.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 16.66 110.755 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 mt -117.79 -31.04 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.062 . . . . 50.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.27 -31.73 67.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.134 -0.979 . . . . 50.0 110.246 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -27.66 66.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 50.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.22 -24.11 62.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 50.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -65.77 151.26 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 50.0 110.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.948 -1.025 . . . . 50.0 110.293 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.452 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 46.1 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 N-CA-C 110.363 -0.668 . . . . 4.9900000000000002 110.363 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 109' ' ' ASP . 50.3 m -94.52 105.88 17.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 3.73 109.962 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.767 HG22 ' CG1' ' A' ' 111' ' ' VAL . 71.4 t -111.75 108.33 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 10.0 110.263 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 112' ' ' LYS . 1.1 pt-20 -81.68 120.73 25.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 50.0 110.078 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 27.5 p90 -95.5 150.41 20.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 50.0 110.85 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -140.64 126.62 19.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 50.0 109.757 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' ASP . 38.6 p-10 -58.45 123.14 15.16 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.036 -1.04 . . . . 12.5 110.354 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 24.1 t80 -55.93 -17.05 5.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 50.0 109.921 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.3 tt0 -66.76 -47.06 73.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 50.0 110.265 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.514 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 42.5 m -60.05 -29.3 68.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.7 tp -71.09 -49.52 43.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 50.0 109.998 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.91 -42.44 24.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 50.0 110.111 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 13.7 t70 -54.1 -44.19 71.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 50.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' THR . 3.5 mm-40 -87.59 -27.84 22.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 50.0 110.253 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.0 38.18 16.43 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.377 -1.489 . . . . 50.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -88.88 179.68 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -1.19 . . . . 50.0 110.281 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.691 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -89.33 -171.75 3.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 50.0 110.29 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.5 mtt -74.83 -53.24 9.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 50.0 110.412 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.5 9.43 2.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 50.0 110.422 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 76.7 m-20 -77.16 -47.86 19.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -0.974 . . . . 50.0 110.143 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 72.4 m-20 -80.14 7.49 9.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 50.0 110.564 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 48.3 51.93 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 50.0 110.016 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.1 mp -44.66 -43.14 8.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.386 -0.821 . . . . 50.0 110.629 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 58.8 m-85 -57.8 -26.64 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 50.0 110.343 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -44.74 10.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 50.0 110.359 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -64.69 -33.48 76.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 50.0 110.307 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.35 70.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 50.0 110.227 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.85 -31.14 71.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 50.0 110.101 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -84.66 -21.07 30.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 50.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -29.46 29.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 50.0 110.21 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.71 58.45 3.81 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.372 -1.491 . . . . 50.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 32' ' ' LEU . 1.4 mm? -81.79 -177.07 6.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -1.146 . . . . 50.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.36 170.95 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 50.0 110.149 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -82.76 -28.65 37.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.459 -1.457 . . . . 50.0 109.459 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 28.1 mt-10 -74.84 -0.15 17.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 50.0 110.196 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 3.4 m-20 -117.55 -51.44 2.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 50.0 110.196 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.545 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 10.2 t80 -128.76 142.99 50.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 50.0 110.124 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 159.66 176.81 32.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -96.84 124.83 40.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.291 -1.123 . . . . 50.0 110.16 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.724 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -94.83 77.98 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 50.0 110.36 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.27 114.38 11.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.973 . . . . 12.5 109.788 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG2' ' HG3' ' A' ' 106' ' ' PRO . 5.4 m -133.68 156.23 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 10.0 110.426 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.77 149.09 36.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 50.0 110.074 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.77 120.23 11.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 25.0 110.27 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.34 12.83 53.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 10.0 109.432 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -93.14 138.94 31.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -1.114 . . . . 10.0 110.366 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.2 m-85 -64.61 117.15 6.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 10.0 110.117 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HE3' ' A' ' 40' ' ' MET . 44.5 mt -44.32 -63.61 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.227 -0.921 . . . . 10.0 110.639 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 53' ' ' GLU . 8.1 tp -50.2 -40.95 48.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 10.0 110.529 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -77.36 -36.83 53.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.044 -1.035 . . . . 50.0 110.256 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.9 80.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 12.5 109.876 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.724 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.78 -24.69 41.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.517 -0.739 . . . . 10.0 109.803 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 4.7 tt0 -64.85 -42.43 94.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.848 . . . . 10.0 109.803 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.87 -1.54 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.519 -0.738 . . . . 50.0 109.942 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -24.9 14.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 10.0 110.059 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.34 8.66 7.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.563 -1.415 . . . . 10.0 109.563 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.7 m-85 -89.05 162.11 16.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -1.146 . . . . 12.5 110.033 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.0 p-10 -127.29 136.42 51.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 10.0 110.463 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.641 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.9 m95 -135.98 148.8 66.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 50.0 109.776 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.2 Cg_endo -72.6 133.18 20.03 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.901 1.474 . . . . 10.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 13.6 p90 -159.09 148.88 18.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.938 . . . . 10.0 110.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.1 m -144.31 -58.51 0.38 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.234 -0.916 . . . . 10.0 110.735 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.61 -41.36 46.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.893 . . . . 10.0 111.387 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.509 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 2.4 mtm180 57.04 30.74 18.71 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.892 -1.13 . . . . 10.0 111.851 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.55 2.69 2.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 10.0 110.263 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.92 38.26 14.05 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.03 -1.228 . . . . 10.0 110.03 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.98 7.64 5.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.933 -1.334 . . . . 10.0 111.587 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.602 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -143.85 -179.6 6.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.667 -1.27 . . . . 10.0 110.613 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.63 12.69 9.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.039 -1.038 . . . . 25.0 111.052 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.32 -39.5 75.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.1 -1.0 . . . . 50.0 110.0 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 13.9 p -88.38 11.01 17.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 10.0 109.615 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.15 153.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.544 -0.723 . . . . 10.0 111.043 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.3 t -136.06 -162.23 1.25 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 50.0 109.84 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.777 ' O ' HG22 ' A' ' 74' ' ' ILE . 5.4 mm -149.28 75.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 50.0 109.956 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.703 HG13 ' OD1' ' A' ' 97' ' ' ASP . 14.7 p -51.23 116.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.334 -0.854 . . . . 50.0 110.371 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -80.88 -16.5 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 50.0 110.379 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.94 166.98 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 25.0 110.664 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 111' ' ' VAL . . . 93.0 -146.64 18.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 10.0 109.574 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -158.99 128.23 5.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.268 -1.137 . . . . 50.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.14 138.23 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 50.0 110.411 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 35.6 t0 -96.09 159.9 14.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.875 . . . . 10.0 109.698 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -160.17 -173.41 4.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 50.0 110.569 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -88.81 -168.03 2.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 50.0 110.137 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -47.74 177.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 50.0 110.41 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 131.16 10.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 16.66 110.277 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -136.0 -36.42 0.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 50.0 110.401 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.463 HG23 ' HG ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -81.48 -24.18 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 50.0 110.355 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.528 ' CD1' HD21 ' A' ' 100' ' ' LEU . 16.4 mt -109.56 152.58 25.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 12.5 110.302 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -111.5 154.26 24.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 12.5 110.21 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -55.09 -36.39 65.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 10.0 110.016 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.04 -31.64 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.817 . . . . 50.0 109.789 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -66.82 -32.32 73.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 50.0 109.97 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.1 -29.36 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 10.0 110.008 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -94.9 -36.26 11.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 12.5 110.566 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -95.91 -27.57 15.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 50.0 110.567 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -110.71 -13.4 14.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.958 . . . . 25.0 110.253 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.703 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.8 m-20 57.54 23.27 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 50.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 73' ' ' SER . 35.2 m -90.28 154.71 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.993 . . . . 50.0 110.935 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 166.23 31.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.469 -0.77 . . . . 50.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD13 ' S2 ' ' A' ' 130' ' ' FES . 15.0 mt -98.36 108.22 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 10.0 110.368 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -74.07 -22.28 59.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 10.0 110.011 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 49' ' ' LEU . 26.6 p -67.4 -32.37 73.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.22 -0.925 . . . . 10.0 109.841 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 100' ' ' LEU . 1.1 pt -129.64 28.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 50.0 110.062 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.07 154.16 16.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 10.0 109.777 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.0 152.23 69.72 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.355 -1.086 . . . . 10.0 109.832 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HG3' ' CG2' ' A' ' 42' ' ' VAL . 44.0 Cg_endo -70.55 133.06 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.911 1.479 . . . . 10.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -115.56 -11.68 11.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 50.0 110.435 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.31 159.02 21.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 50.0 110.398 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 2' ' ' THR . 6.7 m-20 -62.42 -76.25 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 50.0 110.162 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.94 120.48 31.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 50.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.767 ' CG1' HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -132.06 161.54 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.115 -0.991 . . . . 12.5 110.235 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 27.2 mttt -129.02 135.02 48.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 25.0 109.649 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.02 151.45 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.027 . . . . 10.0 111.189 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -106.09 133.39 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 50.0 109.111 179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -96.28 155.22 16.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.342 -0.849 . . . . 50.0 110.424 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.7 t-20 73.42 55.15 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 10.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -74.71 -22.02 59.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 50.0 109.867 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.438 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 37.0 m-70 -57.84 -33.14 68.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 50.0 109.702 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HG ' ' CZ ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -42.41 137.91 1.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -0.815 . . . . 12.5 110.124 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.9 OUTLIER -62.96 -28.9 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 50.0 110.161 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -62.81 -38.31 90.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.353 -0.842 . . . . 16.66 110.256 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.48 -14.96 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 50.0 110.107 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG12 ' A' ' 127' ' ' VAL . 2.7 tp-100 -47.68 -24.76 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.844 . . . . 50.0 110.481 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -68.75 -11.05 59.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.166 -0.959 . . . . 50.0 110.296 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -111.55 -6.8 14.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 50.0 110.193 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 127' ' ' VAL . 7.7 p -51.55 123.51 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 50.0 110.147 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 6.4 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.023 -0.989 . . . . 50.0 110.303 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.651 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 108' ' ' ALA . 49.2 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 N-CA-C 110.228 -0.72 . . . . 4.9900000000000002 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.679 ' CG2' HG22 ' A' ' 39' ' ' THR . 46.5 m -103.81 123.54 47.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 3.73 110.244 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 111' ' ' VAL . 60.8 t -121.12 124.41 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 10.0 110.054 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 1.7 tt0 -82.79 112.8 19.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.105 -0.997 . . . . 50.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.7 p90 -88.46 144.59 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 50.0 110.352 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.622 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -134.51 138.8 44.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 50.0 109.841 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 45.2 t30 -73.53 115.89 13.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.098 -1.001 . . . . 12.5 110.377 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.788 ' OH ' HD12 ' A' ' 120' ' ' LEU . 20.0 t80 -58.33 -21.72 50.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 50.0 110.268 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 8.8 tt0 -71.09 -40.96 71.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 50.0 109.853 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -62.46 -34.69 77.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 50.0 109.932 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 11' ' ' LEU . 8.3 tp -66.65 -46.54 75.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 50.0 109.812 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -76.29 -50.72 13.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 50.0 109.924 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -48.96 -56.01 10.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 50.0 110.03 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HG2' ' CE2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -68.22 -16.05 63.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 50.0 109.954 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.64 95.17 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.492 -1.443 . . . . 50.0 109.492 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CH2' ' HE2' ' A' ' 26' ' ' LYS . 30.5 m0 -91.16 -178.9 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 50.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -93.83 171.24 9.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 50.0 110.486 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 ttp -76.63 -42.06 43.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 50.0 110.45 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -129.05 -14.38 4.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 50.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.97 -44.4 54.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.981 -1.074 . . . . 50.0 110.476 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -77.88 -10.07 59.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 50.0 110.55 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER 42.94 54.75 4.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 50.0 110.079 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 23' ' ' LEU . 2.5 mp -48.66 -43.88 37.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 50.0 110.46 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.2 m-85 -55.52 -27.76 50.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 50.0 110.004 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -39.49 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 50.0 110.026 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' HE2' ' CH2' ' A' ' 16' ' ' TRP . 0.1 OUTLIER -76.92 -27.32 54.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 50.0 110.247 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -64.25 -11.35 30.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 50.0 110.087 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.92 -27.17 49.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 50.0 110.177 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.01 -13.89 49.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 50.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.1 -66.39 0.93 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 50.0 110.338 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 106.28 34.28 3.2 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.266 -1.534 . . . . 50.0 109.266 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLY . 3.4 mt -49.5 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -1.106 . . . . 50.0 110.363 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 164.1 2.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.861 . . . . 50.0 110.326 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.85 -32.04 30.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.448 -1.461 . . . . 50.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.93 2.26 15.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 50.0 110.141 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.577 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 45.9 m-20 -112.82 -48.23 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 50.0 110.118 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.547 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 16.7 t80 -133.2 140.59 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 50.0 110.434 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.69 170.12 28.14 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.679 HG22 ' CG2' ' A' ' 2' ' ' THR . 1.5 m -94.38 116.0 28.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -1.158 . . . . 50.0 110.202 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -87.05 135.53 33.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 50.0 110.149 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -116.38 89.94 3.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 12.5 110.275 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG12 ' HB1' ' A' ' 51' ' ' ALA . 3.1 m -108.37 154.99 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 10.0 110.201 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -78.8 167.94 20.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 50.0 110.034 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.66 115.27 7.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 25.0 110.23 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.3 6.97 47.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.332 -1.507 . . . . 10.0 109.332 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 1.7 tt0 -90.93 110.66 21.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.135 . . . . 10.0 110.211 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 50' ' ' GLU . 27.7 m-85 -45.37 118.57 1.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 10.0 109.996 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mt -43.65 -70.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 10.0 110.443 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -42.54 -40.85 2.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.163 -0.961 . . . . 10.0 110.232 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 47' ' ' TYR . 1.5 tp10 -74.71 -48.38 26.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 50.0 110.348 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -50.82 -53.84 28.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.155 -0.965 . . . . 12.5 110.338 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -65.98 -36.04 82.22 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.458 -0.776 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 2.3 tt0 -51.91 -41.1 61.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 10.0 110.054 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.61 -15.52 61.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.521 -0.737 . . . . 50.0 109.862 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -96.04 -26.46 15.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 10.0 110.046 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.37 10.39 6.66 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.682 -1.367 . . . . 10.0 109.682 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 36.6 m-85 -78.32 160.21 27.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.149 -1.206 . . . . 12.5 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -124.94 135.67 53.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 10.0 110.298 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 11.1 m95 -134.89 149.19 69.85 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.223 -0.923 . . . . 50.0 110.197 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 46.2 Cg_endo -74.0 135.51 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.927 1.488 . . . . 10.0 109.53 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 17.7 p90 -159.1 150.82 20.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.109 -0.995 . . . . 10.0 110.408 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.1 OUTLIER -144.1 -58.57 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 10.0 110.255 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -78.61 -27.91 45.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 10.0 111.051 -179.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.9 31.06 2.16 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.956 -1.09 . . . . 10.0 111.809 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.3 2.51 2.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 10.0 110.662 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 103' ' ' ILE . . . 78.11 38.33 26.47 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.85 -1.167 . . . . 10.0 110.375 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.9 5.85 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.054 -1.262 . . . . 10.0 111.296 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.593 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -139.35 -174.57 3.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.813 -1.179 . . . . 10.0 110.102 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -123.66 10.68 9.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 25.0 111.603 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -57.51 -38.86 75.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 50.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.0 p -88.83 13.05 13.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 10.0 109.981 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.01 157.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.438 -0.789 . . . . 10.0 111.51 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.598 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -141.88 -165.23 1.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.664 HD13 HG22 ' A' ' 98' ' ' VAL . 42.6 mm -147.32 69.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.992 -1.068 . . . . 50.0 110.129 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.765 ' HB ' HD12 ' A' ' 113' ' ' ILE . 8.1 p -45.98 110.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.222 -0.924 . . . . 50.0 109.821 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.29 -18.23 43.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 50.0 110.837 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -166.08 161.96 17.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.062 -1.023 . . . . 25.0 110.645 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 86.31 -171.27 43.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -132.6 146.33 51.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -1.135 . . . . 50.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 99' ' ' ARG . 19.0 mt -137.25 137.0 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.343 -0.848 . . . . 50.0 110.169 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.01 152.49 23.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 10.0 110.334 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -135.59 -177.67 4.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 50.0 110.276 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' GLN . 2.3 t0 -62.29 158.73 16.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 50.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.97 70.51 0.06 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.917 . . . . 50.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.1 pt20 -178.97 135.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 16.66 110.176 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -139.02 126.06 21.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 50.0 110.362 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 87' ' ' ILE . 5.3 tp -86.88 -29.07 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 50.0 110.187 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -82.78 -174.57 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 12.5 110.27 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.0 p -101.09 158.49 15.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 12.5 110.116 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -60.94 -36.51 79.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 10.0 110.341 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -58.47 -31.71 68.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 50.0 110.066 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -72.05 -34.18 68.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 50.0 109.936 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 78.8 t -72.77 -31.11 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 10.0 109.982 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -31.97 12.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 12.5 110.11 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 20.3 tp10 -90.51 -58.83 2.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 50.0 110.156 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' HD12 ' A' ' 74' ' ' ILE . 18.4 mmtm -85.43 -9.44 57.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 25.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.665 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.7 OUTLIER 57.99 31.15 20.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 50.0 109.871 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.664 HG22 HD13 ' A' ' 74' ' ' ILE . 93.2 t -91.5 164.32 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.967 . . . . 50.0 110.721 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -170.04 -152.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -0.78 . . . . 50.0 109.861 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 82' ' ' MET . 16.2 mt -112.24 111.98 23.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 10.0 110.074 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.7 p -82.28 -25.9 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.833 . . . . 10.0 110.583 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.767 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.9 p -76.94 -33.81 57.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 10.0 110.473 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pt -125.46 33.51 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 50.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.6 146.96 17.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.62 146.98 64.21 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 10.0 110.1 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HG3' HG21 ' A' ' 42' ' ' VAL . 47.2 Cg_endo -73.08 148.51 44.83 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 10.0 110.553 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.2 -15.65 5.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.335 -0.853 . . . . 50.0 110.404 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -102.47 161.35 13.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 50.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.17 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.142 -0.974 . . . . 50.0 110.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.73 123.15 34.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 50.0 109.934 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.792 ' HB ' HG22 ' A' ' 3' ' ' VAL . 26.3 t -131.11 156.91 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -0.92 . . . . 12.5 110.384 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.6 mmmm -126.74 136.11 52.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.311 -0.868 . . . . 25.0 109.839 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.765 HD12 ' HB ' ' A' ' 75' ' ' VAL . 1.1 tt -160.19 142.55 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 10.0 110.79 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.7 t -93.66 132.46 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 50.0 109.228 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -93.95 160.69 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 50.0 110.542 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.7 OUTLIER 67.67 46.84 1.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.554 -0.717 . . . . 10.0 110.427 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -70.37 -19.95 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 50.0 109.914 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.505 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.477 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 75.4 m-70 -59.09 -28.33 66.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.327 -0.858 . . . . 50.0 109.876 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.788 HD12 ' OH ' ' A' ' 8' ' ' TYR . 16.7 tp -42.91 124.37 3.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 12.5 110.038 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -57.45 -38.66 74.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 50.0 110.543 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.39 -29.06 63.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 16.66 109.996 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 123' ' ' LEU . 5.2 mt -98.75 -26.81 14.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 50.0 110.104 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 121' ' ' ASP . 12.2 mm-40 -56.74 -29.45 62.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.915 . . . . 50.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -56.89 -26.56 59.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 50.0 109.964 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.19 -16.33 59.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 50.0 110.002 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -74.42 -38.48 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 50.0 110.262 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.984 -1.008 . . . . 50.0 110.28 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.593 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.8 Cg_endo . . . . . 0 N--CA 1.489 1.213 0 N-CA-C 110.378 -0.662 . . . . 4.9900000000000002 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 1.2 m -108.39 137.21 46.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 3.73 110.261 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' HB ' ' A' ' 111' ' ' VAL . 71.5 t -134.92 117.63 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 10.0 110.06 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.4 tt0 -85.32 109.99 18.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 50.0 110.324 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 10.3 p90 -90.23 144.38 25.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 50.0 110.385 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -134.05 140.7 46.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.857 . . . . 50.0 110.058 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 46.6 t-20 -72.22 116.46 12.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 12.5 110.318 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 39.0 t80 -55.77 -23.79 31.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 50.0 109.938 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -41.34 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 50.0 110.022 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -61.83 -29.17 69.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -0.862 . . . . 50.0 110.014 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.7 tt -66.92 -43.43 83.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -0.978 . . . . 50.0 110.145 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.71 -39.97 29.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 50.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -60.75 -53.34 58.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 50.0 110.169 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HG3' ' CZ3' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -71.81 -26.41 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 50.0 110.268 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.66 44.83 11.75 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.401 -1.479 . . . . 50.0 109.401 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.52 ' CZ3' ' HG3' ' A' ' 14' ' ' GLN . 1.0 OUTLIER -97.43 -179.93 4.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -1.148 . . . . 50.0 110.13 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -98.2 -178.47 4.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 50.0 110.051 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -79.93 -48.23 13.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 50.0 110.274 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 18.5 p-10 -138.0 4.43 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 50.0 110.405 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 32.4 t0 -78.95 -61.32 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 50.0 110.388 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 23.7 m-20 -80.03 7.07 9.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 50.0 110.373 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 21' ' ' ASP . 2.0 m-20 44.23 53.4 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.948 . . . . 50.0 109.99 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -43.1 -37.48 2.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.84 . . . . 50.0 110.334 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 6' ' ' LEU . 31.6 m-85 -53.66 -21.61 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 50.0 109.871 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.42 -36.14 8.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.37 -0.831 . . . . 50.0 110.215 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -75.8 -25.14 56.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 50.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -30.68 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.929 . . . . 50.0 110.002 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.06 -16.67 62.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 50.0 110.096 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.03 -16.43 43.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 50.0 109.968 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.69 -33.1 11.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 50.0 110.016 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.93 40.94 8.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 50.0 109.706 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -60.04 -171.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.272 -1.134 . . . . 50.0 110.111 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -70.57 163.49 26.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 50.0 109.899 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.48 -40.32 28.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 50.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.26 63.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 50.0 110.622 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 98.7 m-20 -90.49 -43.99 9.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 50.0 110.492 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -137.5 123.44 20.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 50.0 110.182 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 179.46 164.49 32.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.494 -1.443 . . . . 10.0 109.494 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.8 m -88.58 115.4 26.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -1.117 . . . . 50.0 110.109 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.645 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -83.11 153.3 24.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 50.0 110.369 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.7 118.77 12.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 12.5 109.739 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' CB ' ' A' ' 51' ' ' ALA . 2.9 m -135.56 148.55 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.174 -0.954 . . . . 10.0 110.503 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.03 146.63 31.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 50.0 109.907 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.93 115.45 1.4 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 25.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 108.11 13.72 18.8 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.166 -1.574 . . . . 10.0 109.166 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.76 111.63 20.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -1.1 . . . . 10.0 110.564 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 38.1 m-85 -51.26 131.94 28.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 10.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.645 HG23 ' CE ' ' A' ' 40' ' ' MET . 8.1 mt -51.72 -60.54 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 10.0 110.678 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.54 ' HG ' ' CG ' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -45.52 -35.11 3.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 10.0 110.632 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.81 -47.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 50.0 110.541 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.653 ' CB ' HG12 ' A' ' 42' ' ' VAL . . . -62.24 -42.48 99.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 12.5 110.799 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -77.18 -29.5 54.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.415 -0.803 . . . . 10.0 110.64 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.55 -35.04 79.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 10.0 110.319 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.68 -16.11 63.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.33 -0.856 . . . . 50.0 110.472 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -93.13 -23.23 18.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.017 . . . . 10.0 110.241 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.34 -10.41 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.632 -1.387 . . . . 10.0 109.632 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 17.1 m-30 -70.7 145.54 50.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -1.163 . . . . 12.5 110.262 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.7 p30 -118.22 140.88 49.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 10.0 110.3 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.8 m95 -133.94 148.86 69.91 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 50.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.3 Cg_endo -73.08 132.89 18.77 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.937 1.493 . . . . 10.0 109.833 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 9.0 p90 -162.33 153.13 17.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.08 -1.013 . . . . 10.0 110.197 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -144.26 -58.53 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 10.0 110.311 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -73.09 -39.51 65.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.399 -0.813 . . . . 10.0 111.06 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 12.9 mtp180 57.49 30.62 18.97 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.995 -1.066 . . . . 10.0 111.78 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.58 2.7 2.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -0.999 . . . . 10.0 110.421 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.5 38.28 14.96 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.891 -1.284 . . . . 10.0 109.891 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.26 12.89 5.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.241 . . . . 10.0 111.613 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -147.99 179.31 7.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.677 -1.264 . . . . 10.0 110.323 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -120.46 11.4 11.38 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.997 -1.064 . . . . 25.0 111.353 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 7.1 m120 -57.55 -34.81 69.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 50.0 110.06 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 16.1 p -92.47 13.26 20.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 10.0 109.944 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.51 149.88 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 10.0 111.395 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -133.97 -164.56 1.52 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.728 -0.608 . . . . 50.0 109.525 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 74' ' ' ILE . 25.6 mm -149.58 75.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 50.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -48.52 131.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 50.0 110.246 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -104.22 -3.38 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.253 -0.904 . . . . 50.0 109.891 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 2.6 tt0 176.65 151.71 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.29 -0.882 . . . . 25.0 110.062 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.04 -177.71 41.59 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.521 -1.432 . . . . 10.0 109.521 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -131.62 134.44 46.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -1.14 . . . . 50.0 110.24 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.519 HG13 HG11 ' A' ' 111' ' ' VAL . 18.8 mt -112.89 133.66 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 50.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 105' ' ' SER . 26.0 t0 -83.94 143.91 29.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 10.0 110.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -140.32 159.52 42.02 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 50.0 110.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.502 ' OD1' ' CD1' ' A' ' 103' ' ' ILE . 43.6 p-10 -80.11 154.72 27.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 50.0 110.302 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.1 mmm -52.92 148.93 6.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 50.0 109.867 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -170.49 -178.42 2.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 16.66 110.639 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -145.44 19.16 1.53 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.379 -0.826 . . . . 50.0 109.72 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 87' ' ' ILE . 7.0 tp -83.39 -25.67 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 50.0 110.477 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mp -124.93 -169.97 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 12.5 110.32 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -130.7 152.7 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 12.5 110.063 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -36.92 75.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 10.0 110.279 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.18 -32.74 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 50.0 109.941 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -68.09 -36.64 80.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 50.0 109.762 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 98' ' ' VAL . 22.0 t -80.04 -27.26 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.855 . . . . 10.0 109.816 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.93 -36.96 22.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 12.5 110.44 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.53 -40.47 5.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 50.0 111.159 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -85.01 -14.9 45.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.022 -1.048 . . . . 25.0 111.169 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 5.0 m-20 60.38 22.57 12.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.081 -1.012 . . . . 50.0 110.134 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 93' ' ' VAL . 12.5 p -90.53 153.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 50.0 110.613 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 -169.11 2.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 50.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.839 HD23 ' S2 ' ' A' ' 130' ' ' FES . 4.7 mp -113.03 110.32 20.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 10.0 109.941 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 p -80.69 -24.52 38.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 10.0 110.583 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.8 p -70.3 -29.27 65.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.122 -0.986 . . . . 10.0 110.298 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.53 29.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 50.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.77 151.46 16.86 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 81' ' ' ASP . 16.7 t -132.43 146.38 61.29 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.284 -1.127 . . . . 10.0 110.064 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HB3' HG21 ' A' ' 3' ' ' VAL . 46.4 Cg_endo -72.43 140.99 34.28 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.988 1.52 . . . . 10.0 110.676 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.11 -15.76 11.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 50.0 110.253 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -99.31 148.41 24.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 50.0 110.365 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 15.7 p-10 -52.09 -32.87 36.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 50.0 110.038 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 2' ' ' THR . 9.1 tp10 -138.32 118.9 13.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 50.0 110.087 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.738 ' HB ' HG22 ' A' ' 3' ' ' VAL . 61.7 t -130.7 110.54 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 12.5 110.346 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 38.7 mttt -81.52 141.28 33.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 25.0 110.059 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 1.3 tt -160.17 159.07 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 10.0 110.642 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -104.62 136.63 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 50.0 109.239 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -100.6 154.69 18.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 50.0 110.512 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 5.7 t-20 73.75 56.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.626 -0.671 . . . . 10.0 110.074 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -75.49 -25.55 57.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.905 . . . . 50.0 110.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.453 ' HG2' ' N ' ' A' ' 119' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.463 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 57.9 m-70 -60.05 -33.14 71.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 50.0 110.14 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.37 120.58 2.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 12.5 110.208 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -71.23 -40.13 71.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 50.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -56.21 -19.33 13.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 16.66 109.932 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 123' ' ' LEU . 0.5 OUTLIER -102.76 -36.14 8.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 50.0 110.333 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -17.12 10.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 50.0 110.36 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -66.89 -27.51 67.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 50.0 110.025 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -101.35 9.18 41.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 50.0 109.923 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 128' ' ' ILE . 10.7 p -47.29 -34.37 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.349 -0.844 . . . . 50.0 110.27 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' N ' HG13 ' A' ' 127' ' ' VAL . 3.4 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 50.0 110.129 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.839 ' S2 ' HD23 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 46.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 N-CA-C 110.29 -0.696 . . . . 4.9900000000000002 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' MET . 21.6 m -113.76 135.62 53.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 3.73 110.367 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 111' ' ' VAL . 55.7 t -137.03 119.67 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 10.0 109.803 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 0.7 OUTLIER -79.83 110.58 15.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.162 -0.961 . . . . 50.0 110.678 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 57' ' ' TYR . 41.5 p90 -90.3 137.89 31.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 50.0 110.216 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.6 OUTLIER -127.01 130.97 51.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 50.0 109.983 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 43.8 t30 -65.37 122.68 17.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 12.5 110.655 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.469 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 35.3 t80 -59.98 -33.09 71.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 50.0 109.716 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -35.22 79.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 50.0 109.885 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 69.0 m -62.89 -42.14 99.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 50.0 109.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 17' ' ' ASP . 10.9 tp -62.58 -40.6 97.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 50.0 109.675 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 -41.0 26.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.827 . . . . 50.0 110.098 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.85 -40.23 96.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 50.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -81.45 -17.92 47.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 50.0 110.082 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.04 29.1 65.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 50.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER -82.91 178.08 8.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -1.124 . . . . 50.0 110.14 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.446 ' O ' ' CD1' ' A' ' 11' ' ' LEU . 5.1 m-20 -84.84 -171.63 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 50.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.1 mmm -73.08 -53.93 9.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 50.0 109.932 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 8.7 p-10 -154.51 20.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.385 -0.822 . . . . 50.0 109.808 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -77.58 -49.23 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 50.0 110.248 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 1.9 p30 -80.07 14.35 1.89 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 50.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 18.0 m-20 51.53 51.68 16.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.94 -1.1 . . . . 50.0 110.051 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 23' ' ' LEU . 1.9 mp -39.13 -44.89 1.23 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.579 -0.701 . . . . 50.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 38.3 m-85 -54.37 -24.0 17.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 50.0 110.123 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.42 -32.21 12.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 50.0 110.098 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -31.97 39.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 50.0 110.16 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.575 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . . . -58.74 -27.02 64.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 50.0 110.051 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.52 -13.21 61.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 50.0 110.157 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.09 6.55 31.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 50.0 110.214 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 -3.37 19.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 50.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.55 34.63 82.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 50.0 109.338 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.81 166.83 8.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -1.141 . . . . 50.0 110.225 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.75 165.3 24.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 50.0 110.201 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -81.04 -21.52 62.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.462 -1.455 . . . . 50.0 109.462 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.95 0.2 21.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -1.174 . . . . 50.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 52.1 m-20 -122.06 -48.75 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.223 -0.923 . . . . 50.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.0 t80 -127.95 137.61 52.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 50.0 110.096 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 163.55 176.78 35.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.597 -1.401 . . . . 10.0 109.597 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -93.89 135.2 35.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -1.1 . . . . 50.0 110.139 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.853 ' HE2' HG23 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -104.27 151.24 23.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 50.0 110.147 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 1' ' ' PRO . 14.0 pt-20 -135.52 113.19 10.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 12.5 110.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 3.3 p -153.86 136.42 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 10.0 110.144 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.84 159.89 30.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 50.0 110.494 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' CG ' ' HA ' ' A' ' 107' ' ' ALA . 2.5 mt-10 -61.57 121.06 11.8 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 25.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.54 -12.3 8.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.361 -1.495 . . . . 10.0 109.361 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -106.33 104.14 13.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -1.132 . . . . 10.0 110.158 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.619 ' CD1' ' HA ' ' A' ' 103' ' ' ILE . 26.2 m-85 -42.94 124.26 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 10.0 110.281 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.853 HG23 ' HE2' ' A' ' 40' ' ' MET . 94.3 mt -46.51 -50.32 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 10.0 109.978 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 61' ' ' PHE . 8.4 tt -46.4 -39.64 10.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 10.0 109.819 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.98 -53.29 6.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 50.0 110.397 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -54.11 -40.94 67.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 12.5 110.616 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 57' ' ' TYR . . . -80.04 -32.53 39.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.327 -0.858 . . . . 10.0 110.496 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 30.4 tt0 -62.76 -36.47 83.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 10.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HB3' ' OE1' ' A' ' 55' ' ' GLN . . . -64.43 -16.25 62.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.78 . . . . 50.0 109.823 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 4.4 mp0 -95.96 -17.88 20.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.388 -0.82 . . . . 10.0 110.086 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.88 -11.34 7.83 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.393 -1.483 . . . . 10.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.659 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 10.8 m-30 -65.65 147.24 53.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -1.186 . . . . 12.5 110.083 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 t0 -118.44 137.23 53.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 10.0 110.229 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.751 ' CE3' HG21 ' A' ' 101' ' ' THR . 14.0 m95 -132.74 142.79 46.08 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 50.0 110.089 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HG3' ' HG3' ' A' ' 118' ' ' ALY . 46.1 Cg_endo -73.39 135.66 22.73 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.995 1.524 . . . . 10.0 110.165 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD2' HD11 ' A' ' 49' ' ' LEU . 8.6 p90 -159.14 154.02 24.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.905 . . . . 10.0 109.954 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.35 -58.58 0.41 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.825 . . . . 10.0 110.547 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.48 -28.59 46.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 10.0 111.06 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 49.34 31.05 3.54 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.073 -1.017 . . . . 10.0 111.997 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.38 2.42 2.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.091 -1.005 . . . . 10.0 110.832 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 80.43 38.36 17.91 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.788 -1.196 . . . . 10.0 110.45 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.6 15.98 5.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.045 -1.268 . . . . 10.0 111.11 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.616 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -151.56 177.91 9.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.888 -1.132 . . . . 10.0 110.338 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.96 10.31 13.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.977 -1.077 . . . . 25.0 111.082 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.443 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 1.9 m120 -57.45 -29.72 64.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 50.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 14.8 p -100.69 13.13 35.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 10.0 110.116 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.55 153.55 0.36 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.802 . . . . 10.0 111.336 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -131.8 -161.07 1.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.614 -0.679 . . . . 50.0 109.496 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.0 mm -147.47 71.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.251 -0.906 . . . . 50.0 110.268 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.763 HG13 ' OD1' ' A' ' 97' ' ' ASP . 12.3 p -46.2 120.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.291 -0.881 . . . . 50.0 110.102 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -89.34 -11.74 42.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 50.0 110.45 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 174.17 157.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.128 -0.982 . . . . 25.0 110.353 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.03 -152.65 19.9 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.31 131.97 10.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -1.169 . . . . 50.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 80' ' ' ILE . 54.9 mt -108.27 149.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 50.0 110.139 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.9 110.43 21.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 10.0 110.395 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.487 ' HG2' HD12 ' A' ' 100' ' ' LEU . 1.5 mtm -74.9 165.95 24.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 50.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -93.85 -177.79 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -0.97 . . . . 50.0 110.442 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -63.71 75.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.294 -0.879 . . . . 50.0 110.356 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.4 OUTLIER 175.66 157.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 16.66 110.391 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.465 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -150.47 85.37 1.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 50.0 110.054 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.498 HG23 ' HG ' ' A' ' 88' ' ' LEU . 4.8 tp -86.66 -24.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 50.0 110.219 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' HG23 ' A' ' 87' ' ' ILE . 1.3 mp -89.59 -178.0 5.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 12.5 110.234 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.1 157.35 21.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 12.5 110.076 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.746 ' O ' HG12 ' A' ' 93' ' ' VAL . 63.9 m-20 -57.39 -49.46 76.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 10.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -54.62 -20.34 7.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.873 . . . . 50.0 109.745 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.766 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -79.97 -39.95 29.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 50.0 109.937 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.5 p -76.74 -15.9 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.791 . . . . 10.0 110.171 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.55 -32.38 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.897 . . . . 12.5 110.396 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.4 tt0 -98.22 -33.36 11.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 50.0 110.53 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.631 ' HB3' HG13 ' A' ' 98' ' ' VAL . 2.6 tptt -107.08 -10.2 15.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 25.0 110.428 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.763 ' OD1' HG13 ' A' ' 75' ' ' VAL . 1.9 m-20 56.53 27.97 13.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.128 -0.982 . . . . 50.0 110.402 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.766 HG21 ' HG2' ' A' ' 92' ' ' GLU . 32.3 m -93.46 159.4 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 50.0 110.823 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -161.34 -160.43 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.476 -0.765 . . . . 50.0 110.12 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD13 HD11 ' A' ' 103' ' ' ILE . 2.0 mt -109.99 112.31 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 10.0 110.075 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.751 HG21 ' CE3' ' A' ' 59' ' ' TRP . 3.2 m -82.14 -25.34 34.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 10.0 110.563 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.2 p -77.55 -32.0 53.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 10.0 110.386 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.756 HD11 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -129.3 33.35 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 50.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.03 140.25 12.0 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.615 -1.394 . . . . 10.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.4 p -130.75 145.86 59.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -1.219 . . . . 10.0 110.18 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.53 ' HD3' ' CG1' ' A' ' 48' ' ' ILE . 47.3 Cg_endo -72.86 138.13 28.15 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.044 1.55 . . . . 10.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 44' ' ' GLU . . . -110.03 -39.97 4.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.241 -0.912 . . . . 50.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -69.85 150.27 47.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 50.0 110.279 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 110' ' ' GLU . 3.1 p30 -59.65 -42.51 92.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 50.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER -122.72 113.27 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 50.0 110.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.863 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 96.8 t -132.65 148.59 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 12.5 110.284 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -118.34 140.34 49.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 25.0 110.156 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 10.1 tt -160.11 147.29 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 10.0 110.322 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -93.96 134.28 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 50.0 109.694 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -93.95 151.48 19.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 50.0 109.752 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.5 t30 73.24 54.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.417 -0.802 . . . . 10.0 110.169 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -78.06 -29.45 49.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 50.0 110.081 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 29.3 m-70 -58.94 -27.47 65.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 50.0 109.808 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 120' ' ' LEU . 1.6 mt -46.86 142.0 3.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 12.5 110.234 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.54 -17.93 64.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 50.0 109.986 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -73.05 -33.15 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 16.66 110.232 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 -8.69 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 50.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 5.5 mm-40 -62.82 -27.8 69.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 50.0 110.039 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -56.2 -21.23 21.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 50.0 109.794 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -85.23 3.79 37.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 50.0 110.0 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 127' ' ' VAL . 10.0 p -50.26 128.62 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 50.0 110.198 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.707 HD12 ' OXT' ' A' ' 128' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 50.0 110.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.616 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 46.0 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 110.435 -0.64 . . . . 4.9900000000000002 110.435 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' ASP . 4.2 m -110.36 134.2 52.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 3.73 110.215 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' MET . 11.2 t -129.14 114.75 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 10.0 110.204 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -80.63 119.42 23.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 50.0 110.341 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 38' ' ' GLY . 24.2 p90 -97.98 146.32 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 50.0 110.518 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -137.95 143.32 40.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.461 -0.774 . . . . 50.0 110.216 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 66.3 t30 -76.59 119.94 21.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 12.5 110.759 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.498 ' HA ' HG11 ' A' ' 114' ' ' VAL . 14.0 t80 -60.98 -35.78 77.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 50.0 109.795 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -63.68 -33.15 75.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 50.0 109.937 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.5 m -65.28 -38.63 90.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 50.0 110.163 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 17' ' ' ASP . 16.1 tp -66.26 -38.69 88.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 50.0 110.15 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.38 -48.41 14.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 50.0 110.165 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 5.6 t70 -55.82 -55.13 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 50.0 110.433 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.6 OUTLIER -64.96 -22.76 67.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 50.0 110.414 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.45 40.67 22.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.169 -1.572 . . . . 50.0 109.169 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.527 ' HB3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.02 -170.29 2.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.445 -1.032 . . . . 50.0 110.394 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.516 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -99.25 -178.33 3.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 50.0 109.865 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 mtt -75.41 -54.79 6.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.94 . . . . 50.0 110.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.82 6.35 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.859 . . . . 50.0 110.315 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 39.7 t0 -71.41 -49.21 44.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.172 -0.955 . . . . 50.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' OD2' ' NE1' ' A' ' 16' ' ' TRP . 0.9 OUTLIER -80.02 -1.19 38.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 50.0 110.191 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER 49.08 52.63 14.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 50.0 109.932 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CB ' HD11 ' A' ' 6' ' ' LEU . 1.8 mp -40.31 -37.54 0.67 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.748 . . . . 50.0 110.435 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 31.0 m-85 -58.02 -15.39 8.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 50.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.33 -45.05 3.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 50.0 110.318 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -68.98 -22.77 64.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.94 . . . . 50.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HB1' ' CD2' ' A' ' 37' ' ' TYR . . . -64.08 -27.48 69.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.941 . . . . 50.0 110.372 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.58 59.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -0.949 . . . . 50.0 110.291 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -117.52 8.95 13.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 50.0 110.106 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.36 -39.91 4.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 50.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.37 0.66 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.21 154.61 18.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -1.127 . . . . 50.0 110.113 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -55.5 136.76 49.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 50.0 110.163 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -59.7 -33.09 76.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.474 -1.45 . . . . 50.0 109.474 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.8 OUTLIER -64.74 -10.19 25.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -1.11 . . . . 50.0 110.143 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 88.0 m-20 -103.63 -54.25 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.376 -0.827 . . . . 50.0 110.206 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 22.5 t80 -123.41 144.08 49.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 50.0 110.177 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 165.11 172.33 32.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -89.45 124.27 34.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -1.164 . . . . 50.0 110.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.865 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -97.15 83.46 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 50.0 110.372 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.13 103.72 0.25 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 12.5 109.738 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 40' ' ' MET . 23.4 t -116.96 129.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 10.0 110.323 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . . . -75.01 148.23 40.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 50.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG3' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -61.69 117.75 6.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 25.0 110.344 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.02 -1.16 51.34 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.703 -1.359 . . . . 10.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -101.61 134.04 45.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -1.178 . . . . 10.0 110.302 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -57.95 123.4 15.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 10.0 110.297 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 40' ' ' MET . 92.0 mt -43.1 -64.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 10.0 110.738 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -43.48 -45.67 6.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.928 . . . . 10.0 110.471 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.863 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -61.68 -38.76 88.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 50.0 110.174 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.4 -59.05 5.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 12.5 110.219 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.4 -14.13 61.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.598 -0.688 . . . . 10.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 87.1 tt0 -69.44 -37.24 77.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 10.0 110.101 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 -5.88 43.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.482 -0.761 . . . . 50.0 110.167 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -101.98 -31.13 10.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 10.0 110.454 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.92 13.86 3.56 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 m-85 -85.67 147.4 26.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.037 -1.272 . . . . 12.5 110.04 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.6 t0 -114.66 138.64 50.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.946 . . . . 10.0 110.46 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' ' HB2' ' A' ' 115' ' ' TYR . 16.8 m95 -134.97 155.39 79.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 50.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 45.7 Cg_endo -73.07 132.71 18.54 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.865 1.455 . . . . 10.0 109.729 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 59' ' ' TRP . 9.9 m-85 -158.91 148.28 18.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 10.0 109.844 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 t -144.29 -58.68 0.38 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 10.0 110.754 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.49 -32.21 28.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 10.0 111.007 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.62 30.92 11.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.025 -1.047 . . . . 10.0 111.9 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.54 2.65 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 10.0 110.5 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 77.21 38.14 30.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.739 -1.344 . . . . 10.0 109.739 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.653 ' C ' HG21 ' A' ' 87' ' ' ILE . . . -125.62 5.77 7.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -1.211 . . . . 10.0 111.082 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.622 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.94 -176.49 4.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.877 -1.14 . . . . 10.0 110.272 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.22 9.99 8.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.93 -1.106 . . . . 25.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -23.12 60.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 50.0 109.952 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 14.7 p -101.67 13.17 35.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 10.0 109.819 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.03 150.84 0.15 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.788 0.804 . . . . 10.0 111.535 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 6.8 m -137.98 -165.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.687 -0.633 . . . . 50.0 109.501 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 74' ' ' ILE . 8.6 mm -147.83 77.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.976 . . . . 50.0 110.247 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -52.89 115.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.237 -0.914 . . . . 50.0 110.069 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -83.41 -14.8 51.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.986 -1.071 . . . . 50.0 110.468 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -179.54 151.88 0.48 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 25.0 110.326 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.05 -144.73 18.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.309 -1.517 . . . . 10.0 109.309 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.674 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 1.7 tt0 -168.91 101.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -1.203 . . . . 50.0 110.237 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.7 mt -85.92 142.85 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 50.0 110.318 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.646 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 6.7 t70 -91.72 148.93 21.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 10.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.479 ' SD ' ' NE2' ' A' ' 86' ' ' GLN . 2.7 ptt? -135.17 173.27 11.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 50.0 110.519 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.9 OUTLIER -104.05 163.56 12.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 50.0 110.21 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -69.58 63.84 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.218 -0.926 . . . . 50.0 110.136 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' ASP . 3.1 pt20 -171.49 60.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 16.66 110.212 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.479 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 12.1 pt20 -107.61 150.13 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.242 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.653 HG21 ' C ' ' A' ' 67' ' ' ALA . 2.2 pp -87.56 -22.86 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 50.0 109.944 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -93.35 -171.74 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 12.5 110.145 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -123.99 169.42 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 12.5 110.288 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -37.3 68.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 10.0 110.249 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 12.4 pt-20 -54.88 -22.26 14.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 50.0 109.741 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -39.3 42.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.436 -0.79 . . . . 50.0 110.016 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.9 -11.03 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.312 -0.868 . . . . 10.0 110.178 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.37 -37.72 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 12.5 110.562 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 1.2 mm-40 -98.42 -14.77 19.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.139 -0.976 . . . . 50.0 110.271 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mttm -129.43 -6.05 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 25.0 110.508 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 15.5 m-20 50.06 27.07 2.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.063 . . . . 50.0 109.931 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 73' ' ' SER . 30.4 t -88.91 127.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.219 -0.925 . . . . 50.0 110.644 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.596 HH12 HD12 ' A' ' 100' ' ' LEU . 12.3 mmm180 -135.14 167.12 21.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -0.769 . . . . 50.0 109.689 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.596 HD12 HH12 ' A' ' 99' ' ' ARG . 0.9 OUTLIER -97.39 116.23 29.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 10.0 110.324 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.13 -18.07 44.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 10.0 110.371 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.589 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 24.4 p -76.29 -32.07 58.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 10.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.701 ' O ' HD12 ' A' ' 103' ' ' ILE . 2.1 pp -134.53 31.97 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 50.0 110.303 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.26 140.7 13.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.765 -1.334 . . . . 10.0 109.765 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.4 p -120.42 153.95 56.35 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.087 . . . . 10.0 109.849 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -71.76 139.27 33.34 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.853 1.449 . . . . 10.0 110.66 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' GLU . . . -124.36 15.1 8.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 50.0 109.945 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 1' ' ' PRO . . . -146.08 143.52 29.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 50.0 110.15 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 2' ' ' THR . 2.9 m-20 -46.76 -74.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 50.0 110.152 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' C ' HG23 ' A' ' 111' ' ' VAL . 29.2 mt-10 -88.49 135.43 33.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 50.0 110.041 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG23 ' C ' ' A' ' 110' ' ' GLU . 60.2 t -147.5 126.17 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 12.5 110.396 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' LYS . 4.1 mptt -103.56 136.72 42.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 25.0 109.936 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.2 tt -160.17 148.25 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 10.0 110.492 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 ' HB3' ' A' ' 6' ' ' LEU . 96.8 t -104.21 131.63 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 50.0 109.492 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.631 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -95.27 160.37 14.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 50.0 110.542 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 2.1 t-20 74.97 53.94 0.07 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.736 . . . . 10.0 110.257 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -79.36 -19.91 49.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.96 -1.088 . . . . 50.0 110.232 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.407 ' O ' ' OE1' ' A' ' 124' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -60.03 -37.22 79.14 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.423 -0.798 . . . . 50.0 109.846 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 121' ' ' ASP . 9.6 tp -45.77 124.47 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 12.5 110.163 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.511 ' N ' HD12 ' A' ' 120' ' ' LEU . 25.1 t0 -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 50.0 110.151 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -65.66 -9.99 32.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 16.66 110.382 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' CD1' HD23 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -125.14 -22.56 4.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 50.0 110.503 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.407 ' OE1' ' O ' ' A' ' 118' ' ' ALY . 6.7 tp60 -63.36 -22.12 66.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 50.0 110.29 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -67.73 -18.37 64.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 50.0 110.344 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -66.19 -14.31 61.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 50.0 110.299 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.21 136.88 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.902 . . . . 50.0 110.13 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.011 -0.995 . . . . 50.0 110.155 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.622 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 106' ' ' PRO . 45.1 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 N-CA-C 110.478 -0.624 . . . . 4.9900000000000002 110.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m -94.15 151.97 19.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.73 110.196 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 4' ' ' GLU . 41.7 t -144.21 170.39 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 10.0 110.258 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.557 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -139.39 118.98 13.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 50.0 110.167 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 38.7 p90 -103.8 133.95 47.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 50.0 110.691 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.941 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.02 120.03 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 50.0 109.775 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.743 ' N ' HD12 ' A' ' 6' ' ' LEU . 45.9 t30 -54.13 124.0 14.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -0.858 . . . . 12.5 110.971 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' CD1' ' HB2' ' A' ' 119' ' ' HIS . 10.3 t80 -64.66 -37.99 89.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 50.0 109.753 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HG2' ' CG ' ' A' ' 119' ' ' HIS . 4.3 mm-40 -58.89 -28.61 66.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 50.0 109.862 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.8 m -68.3 -31.57 71.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 50.0 109.713 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD22 ' A' ' 23' ' ' LEU . 11.1 tp -76.46 -46.09 28.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 50.0 109.841 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -48.8 61.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 50.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.45 -55.86 29.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 50.0 109.708 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -63.44 -18.37 63.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 50.0 109.8 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.45 22.91 76.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.553 -1.419 . . . . 50.0 109.553 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.706 ' HB3' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -84.19 -171.52 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -1.162 . . . . 50.0 110.227 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.592 ' N ' HD11 ' A' ' 11' ' ' LEU . 80.1 m-20 -118.2 176.99 4.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 50.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mtt -76.97 -54.27 6.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.118 -0.989 . . . . 50.0 110.546 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.92 -6.93 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 50.0 110.573 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.56 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -69.61 -68.62 0.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.199 -0.938 . . . . 50.0 110.34 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -80.06 9.33 5.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.939 . . . . 50.0 110.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER 49.05 51.73 15.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 50.0 110.178 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD23 HD21 ' A' ' 6' ' ' LEU . 7.5 tp -41.11 -61.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.465 -0.772 . . . . 50.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 3.9 m-85 -44.06 -27.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 50.0 109.651 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -99.37 -43.15 6.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 50.0 110.536 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -8.63 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 50.0 110.351 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.97 -22.26 42.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 50.0 110.346 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.8 -19.86 43.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 50.0 110.402 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -95.24 -10.26 30.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.243 -0.911 . . . . 50.0 110.143 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.8 -27.85 16.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 50.0 110.084 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.79 57.29 2.45 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.614 -1.394 . . . . 50.0 109.614 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.2 -179.28 6.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -1.197 . . . . 50.0 110.11 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.52 158.42 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 50.0 109.984 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.42 -27.53 47.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.417 -1.473 . . . . 50.0 109.417 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 57' ' ' TYR . 29.1 tt0 -76.79 -25.22 53.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -1.171 . . . . 50.0 109.671 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -84.34 -47.7 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 50.0 109.848 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 23.8 t80 -130.99 144.06 51.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 50.0 110.055 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 5' ' ' TYR . . . 162.42 173.5 31.18 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 10.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' OE1' ' A' ' 4' ' ' GLU . 89.7 m -93.88 126.12 38.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 50.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.894 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -92.67 142.34 27.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 50.0 110.287 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.57 114.67 17.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 12.5 110.109 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.725 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 1.7 p -146.48 150.71 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 10.0 110.132 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.28 157.14 29.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 50.0 110.495 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.04 120.43 14.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.88 . . . . 25.0 110.152 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.98 -12.66 11.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.188 -1.565 . . . . 10.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 42' ' ' VAL . 18.7 mt-10 -96.83 123.52 40.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -1.078 . . . . 10.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -47.69 124.96 7.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 10.0 110.455 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 mt -49.96 -59.81 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 10.0 110.285 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.3 tt -48.73 -37.15 18.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 10.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' N ' HD23 ' A' ' 49' ' ' LEU . 4.0 tp10 -71.48 -49.77 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 50.0 110.076 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.725 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -59.53 -53.69 55.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 12.5 110.329 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.894 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -63.73 -33.57 75.95 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.453 -0.779 . . . . 10.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 24.9 tt0 -64.04 -26.82 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 10.0 109.646 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.49 -23.56 60.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.471 -0.768 . . . . 50.0 109.923 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -86.65 -12.31 48.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.845 . . . . 10.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.55 1.3 19.97 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.467 -1.453 . . . . 10.0 109.467 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.506 ' CZ ' ' CZ ' ' A' ' 5' ' ' TYR . 19.1 m-30 -78.0 131.86 37.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -1.097 . . . . 12.5 110.142 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 1.6 t70 -102.97 139.56 38.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 10.0 110.377 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 27.4 m95 -132.29 145.41 57.21 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.253 -0.904 . . . . 50.0 110.321 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 47.0 Cg_endo -73.49 138.4 26.95 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.003 1.528 . . . . 10.0 110.041 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.465 ' CD1' ' HD3' ' A' ' 64' ' ' ARG . 43.3 p90 -159.03 151.66 21.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 10.0 109.949 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.7 p -144.14 -58.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.128 -0.982 . . . . 10.0 110.753 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.15 -34.32 56.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 10.0 111.24 -178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HD3' ' CD1' ' A' ' 61' ' ' PHE . 14.2 mtm-85 59.23 30.38 20.12 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.878 -1.139 . . . . 10.0 111.974 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.72 2.61 2.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 10.0 110.341 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.574 ' N ' HG21 ' A' ' 103' ' ' ILE . . . 75.15 38.26 40.41 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 87' ' ' ILE . . . -130.79 22.35 5.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -1.192 . . . . 10.0 111.255 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.412 ' N ' HG12 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -150.73 -171.78 4.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.832 -1.167 . . . . 10.0 110.269 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.05 7.05 7.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.971 -1.081 . . . . 25.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.58 -35.89 70.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.045 -1.035 . . . . 50.0 110.241 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 14.9 p -94.58 13.24 24.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 10.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.98 156.85 0.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.376 -0.828 . . . . 10.0 111.405 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.628 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.3 OUTLIER -142.53 -161.08 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 50.0 109.619 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 74' ' ' ILE . 17.9 mm -146.4 77.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 50.0 110.211 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.4 p -49.61 117.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.385 -0.822 . . . . 50.0 110.179 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -83.79 -14.94 50.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 50.0 110.405 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 178.89 173.64 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 25.0 110.1 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 77.83 -160.2 48.41 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.24 147.9 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.243 . . . . 50.0 110.273 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 105' ' ' SER . 78.3 mt -116.07 144.07 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 50.0 110.073 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -90.47 135.41 33.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 10.0 110.523 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.34 -171.36 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.074 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -117.07 -178.11 3.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 50.0 110.396 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 127.96 33.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 50.0 110.364 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.467 HE22 HD11 ' A' ' 103' ' ' ILE . 8.9 pt20 -163.57 -163.35 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 16.66 110.153 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -171.12 30.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 50.0 110.351 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 88' ' ' LEU . 8.9 tp -87.89 -40.77 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.921 . . . . 50.0 110.504 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' N ' HG23 ' A' ' 87' ' ' ILE . 3.7 pp -96.15 166.51 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 12.5 110.401 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.476 ' HB3' ' OE1' ' A' ' 92' ' ' GLU . 2.0 t -106.34 148.66 27.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 12.5 110.057 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.63 -49.76 76.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 10.0 110.355 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -19.18 6.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.885 . . . . 50.0 109.889 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.754 ' HG2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -78.49 -39.27 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 50.0 110.128 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HD2' ' A' ' 99' ' ' ARG . 6.6 t -72.21 -24.59 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 10.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.37 -51.28 5.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 12.5 110.468 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -88.94 -42.84 11.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 50.0 110.542 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -87.83 -5.99 58.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.113 -0.992 . . . . 25.0 110.489 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 75' ' ' VAL . 13.8 m-20 47.17 23.73 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 50.0 110.194 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 92' ' ' GLU . 12.4 p -78.71 159.85 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 50.0 110.885 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.767 ' HD2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -172.07 157.3 4.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.522 -0.736 . . . . 50.0 109.971 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 mt -96.92 108.4 21.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 10.0 110.169 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.3 p -80.01 -19.83 46.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 10.0 110.513 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.952 ' SG ' HG23 ' A' ' 103' ' ' ILE . 19.2 p -69.85 -29.57 66.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.102 -0.999 . . . . 10.0 110.357 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.952 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -130.36 24.02 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 50.0 110.358 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.76 12.87 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.746 -1.342 . . . . 10.0 109.746 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 80' ' ' ILE . 96.7 p -112.38 157.03 41.23 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.375 -1.073 . . . . 10.0 109.953 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.0 Cg_endo -72.33 143.05 38.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.86 1.453 . . . . 10.0 110.49 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -117.02 -75.64 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 50.0 110.329 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -50.84 171.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.407 -0.808 . . . . 50.0 110.405 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 1' ' ' PRO . 13.9 t70 -73.45 -66.99 0.62 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 50.0 110.232 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -98.58 108.51 21.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 50.0 110.056 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 108' ' ' ALA . 21.1 t -122.85 143.19 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 12.5 110.266 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 76' ' ' LYS . 1.6 mptp? -119.6 144.56 47.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 25.0 110.206 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 73' ' ' SER . 4.8 tt -160.11 141.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 10.0 110.195 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.941 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -85.96 135.71 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.314 -0.866 . . . . 50.0 109.447 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.98 150.34 20.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 50.0 110.053 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.1 t-20 72.9 53.26 0.14 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.44 -0.788 . . . . 10.0 110.112 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.628 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -75.92 -23.39 55.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 50.0 110.035 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.496 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 67.8 m-70 -58.07 -28.72 64.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 50.0 109.736 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.519 HD12 ' OH ' ' A' ' 8' ' ' TYR . 20.6 tp -49.42 129.99 19.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 12.5 110.065 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -53.24 -22.39 6.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 50.0 110.424 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -71.58 -14.77 62.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 16.66 110.432 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -116.76 -23.41 8.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 50.0 110.186 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -54.99 -26.75 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 50.0 110.066 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -64.03 -18.24 64.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 50.0 110.219 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -80.41 -9.86 59.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.866 . . . . 50.0 110.124 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.49 155.97 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -0.862 . . . . 50.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.433 ' OXT' HG13 ' A' ' 128' ' ' ILE . 6.1 pt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 50.0 110.22 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.422 ' S2 ' ' HA2' ' A' ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 N-CA-C 110.39 -0.658 . . . . 4.9900000000000002 110.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 137.88 52.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 3.73 110.341 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.893 HG22 ' HB ' ' A' ' 111' ' ' VAL . 73.2 t -133.65 124.71 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 10.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.3 OUTLIER -83.06 127.84 33.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 50.0 110.54 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' CE2' ' OH ' ' A' ' 57' ' ' TYR . 50.7 p90 -103.81 131.82 50.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 50.0 110.355 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.805 HD23 ' CD2' ' A' ' 24' ' ' PHE . 2.5 tp -129.04 117.34 20.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 50.0 109.87 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 64.7 t30 -55.7 124.05 16.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.154 -0.966 . . . . 12.5 110.859 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE1' ' CD1' ' A' ' 120' ' ' LEU . 15.6 t80 -60.31 -35.04 74.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 50.0 109.778 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' HB3' ' ND2' ' A' ' 7' ' ' ASN . 1.6 tt0 -63.28 -34.59 78.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 50.0 109.966 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 3.4 m -58.08 -38.92 77.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 50.0 109.417 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 11.5 tp -65.27 -42.09 93.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.455 -0.778 . . . . 50.0 109.563 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 13' ' ' ASP . 7.7 m-20 -79.1 -54.76 5.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 50.0 110.317 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 12' ' ' ASP . 28.9 t0 -43.32 -62.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 50.0 110.063 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -22.39 66.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 50.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.08 43.65 13.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -98.79 -163.52 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -1.221 . . . . 50.0 110.585 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.06 167.22 10.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.69 . . . . 50.0 110.186 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -56.95 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.282 -0.886 . . . . 50.0 109.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -125.87 -0.7 7.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.773 . . . . 50.0 110.101 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 4.5 t0 -76.04 -60.04 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 50.0 110.037 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' OD2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t70 -79.49 4.24 16.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 50.0 110.125 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER 50.59 50.88 18.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 50.0 110.347 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 23' ' ' LEU . 11.6 tp -43.92 -52.81 6.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.826 . . . . 50.0 109.959 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.805 ' CD2' HD23 ' A' ' 6' ' ' LEU . 3.2 m-85 -44.46 -29.47 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 50.0 109.416 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -93.65 -46.67 7.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 50.0 109.787 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -70.88 -12.78 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 50.0 109.945 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -74.8 -15.77 60.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 50.0 109.758 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.46 35.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 50.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -26.92 26.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.412 -0.805 . . . . 50.0 109.957 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -81.63 -37.66 27.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 50.0 110.168 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.07 50.27 7.83 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.61 -1.396 . . . . 50.0 109.61 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -69.02 167.29 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 50.0 109.886 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -45.72 126.25 6.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.009 . . . . 50.0 110.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.62 -20.47 12.08 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.405 -1.478 . . . . 50.0 109.405 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -76.05 -11.8 60.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -1.091 . . . . 50.0 110.232 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' CA ' ' HB2' ' A' ' 7' ' ' ASN . 1.1 m-20 -106.5 -46.87 3.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.852 . . . . 50.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 33.4 t80 -126.94 147.73 50.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 50.0 110.311 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 153.87 174.49 24.11 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.645 -1.382 . . . . 10.0 109.645 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 24.3 m -94.51 127.2 40.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -1.094 . . . . 50.0 110.282 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.751 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 tmm? -92.03 165.18 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 50.0 109.8 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -137.74 115.36 11.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 12.5 110.431 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 51' ' ' ALA . 4.4 p -156.84 143.06 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 10.0 110.029 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.721 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . . . -76.29 155.14 34.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 50.0 110.228 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -65.16 117.75 8.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 25.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.46 -12.79 7.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' A' ' 43' ' ' ALA . 51.4 mt-10 -102.26 116.95 33.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -1.103 . . . . 10.0 110.047 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 -43.31 127.15 4.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 10.0 110.277 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.535 HG23 ' CE ' ' A' ' 40' ' ' MET . 10.9 mt -54.23 -42.48 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.317 -0.864 . . . . 10.0 110.274 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -54.19 -40.79 67.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 10.0 110.191 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' N ' HD23 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -76.7 -46.16 26.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 50.0 110.77 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -63.47 -45.35 91.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 12.5 110.561 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -72.43 -29.7 63.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.379 -0.826 . . . . 10.0 110.373 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 3.0 tm-20 -65.76 -33.8 76.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.888 . . . . 10.0 109.83 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.99 -10.75 59.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.485 -0.759 . . . . 50.0 109.813 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.05 -11.75 24.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.817 . . . . 10.0 110.226 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.78 28.18 3.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.568 ' OH ' ' CE2' ' A' ' 5' ' ' TYR . 23.1 m-85 -114.82 147.34 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -1.119 . . . . 12.5 110.251 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 9.5 p-10 -119.56 135.46 54.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 10.0 109.708 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.16 147.2 63.97 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 50.0 110.522 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 47.9 Cg_endo -73.67 133.81 19.29 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.142 1.601 . . . . 10.0 110.096 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 8.7 p90 -159.0 151.94 22.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 10.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -58.58 0.41 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.834 . . . . 10.0 110.387 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.4 -37.75 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 10.0 111.038 -179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 68.1 mtp180 57.97 30.85 19.8 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.894 -1.129 . . . . 10.0 111.984 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.8 2.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 10.0 110.354 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 100' ' ' LEU . . . 79.44 38.48 21.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.29 10.03 6.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.935 -1.332 . . . . 10.0 111.324 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.582 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -146.2 -175.1 4.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.775 -1.203 . . . . 10.0 110.306 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.91 9.56 8.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.907 -1.12 . . . . 25.0 111.343 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -57.47 -28.91 63.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 50.0 110.396 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 14.9 p -99.12 9.54 43.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.187 -0.945 . . . . 10.0 110.065 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -40.49 155.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.383 -0.823 . . . . 10.0 111.265 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -143.0 -166.88 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.612 -0.68 . . . . 50.0 109.62 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 19.3 mm -147.88 89.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.111 -0.993 . . . . 50.0 109.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -57.59 127.61 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 50.0 110.364 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -102.55 2.34 36.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.116 -0.99 . . . . 50.0 109.933 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER 172.76 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 25.0 109.91 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 100.05 -169.29 21.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.95 111.39 5.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -1.186 . . . . 50.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 105' ' ' SER . 50.6 mt -85.3 147.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.881 . . . . 50.0 110.339 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -90.4 145.31 25.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 10.0 110.169 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.758 ' CG ' HD12 ' A' ' 100' ' ' LEU . 5.4 tmm? -147.7 119.51 8.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 50.0 110.084 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -54.11 153.81 4.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.169 -0.957 . . . . 50.0 110.322 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.495 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 4.5 ptt? -47.68 136.11 10.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 50.0 110.407 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -157.91 165.34 35.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.823 . . . . 16.66 109.879 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.02 21.09 9.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.016 . . . . 50.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -86.6 -32.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 50.0 109.828 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.6 mt -126.12 -170.43 2.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 12.5 109.89 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.48 143.44 50.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.896 . . . . 12.5 110.316 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -41.36 71.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 10.0 109.956 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 1.8 tt0 -57.6 -31.84 66.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 50.0 109.633 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -66.8 -28.54 68.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 50.0 109.584 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 99' ' ' ARG . 40.7 t -78.06 -33.85 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 10.0 110.003 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.76 -33.62 15.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 12.5 110.056 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 7.4 tt0 -98.74 -22.3 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.898 . . . . 50.0 110.458 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 92' ' ' GLU . 2.7 tptt -118.79 -13.7 9.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 25.0 110.221 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 17.1 m-20 58.51 24.83 12.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.281 -0.887 . . . . 50.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.5 p -95.1 145.15 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.037 -1.039 . . . . 50.0 110.347 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HD3' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -150.59 -163.58 1.81 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 50.0 110.168 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD12 ' CG ' ' A' ' 82' ' ' MET . 4.9 mt -110.09 113.75 26.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 10.0 110.174 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -81.23 -23.07 38.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 10.0 110.437 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 103' ' ' ILE . 24.2 p -77.71 -34.73 52.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 10.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.627 HD11 HD13 ' A' ' 100' ' ' LEU . 1.1 pt -132.93 29.95 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 50.0 110.2 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -119.01 142.86 17.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.256 -1.538 . . . . 10.0 109.256 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.4 m -131.77 153.65 81.54 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 10.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 48.8 Cg_endo -73.69 137.63 25.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.007 1.53 . . . . 10.0 110.555 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.49 -15.26 13.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -0.899 . . . . 50.0 110.16 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.58 174.2 5.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 50.0 110.149 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -70.08 -74.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 50.0 109.999 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.35 121.7 31.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.903 . . . . 50.0 110.086 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 3' ' ' VAL . 3.3 t -137.59 102.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 12.5 110.443 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HD2' ' CD1' ' A' ' 24' ' ' PHE . 10.1 mtmt -83.22 146.84 28.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.183 -0.948 . . . . 25.0 109.579 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.5 tt -160.09 147.56 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 10.0 110.856 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.2 t -90.31 127.63 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.294 -0.879 . . . . 50.0 109.226 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.53 145.77 24.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 50.0 110.385 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.595 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 75.09 58.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.707 -0.62 . . . . 10.0 110.287 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -80.17 -23.05 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 50.0 110.221 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' CE ' ' C ' ' A' ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.595 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 65.0 m-70 -59.77 -29.14 67.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.855 . . . . 50.0 109.671 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.85 128.02 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 12.5 110.435 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.27 -21.37 66.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 50.0 109.739 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -76.07 -25.03 55.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 16.66 110.058 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.5 OUTLIER -110.51 -25.75 9.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.834 . . . . 50.0 110.08 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.849 ' O ' HG22 ' A' ' 127' ' ' VAL . 7.8 tt0 -51.08 -73.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.339 -0.851 . . . . 50.0 110.302 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -46.89 -25.97 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 50.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.62 -19.97 52.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 50.0 110.144 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.849 HG22 ' O ' ' A' ' 124' ' ' GLN . 11.2 m -77.42 -15.54 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 50.0 109.899 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.458 ' OXT' HG13 ' A' ' 128' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.979 -1.01 . . . . 50.0 110.246 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.582 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.43 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo . . . . . 0 N--CA 1.488 1.17 0 N-CA-C 110.364 -0.668 . . . . 4.9900000000000002 110.364 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.24 120.83 43.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 3.73 110.159 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' MET . 21.9 t -123.11 126.88 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 10.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 13.3 tp10 -84.37 125.78 32.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 50.0 110.217 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 34' ' ' GLY . 53.7 p90 -101.37 152.44 20.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 50.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' CB ' ' A' ' 23' ' ' LEU . 3.9 tp -147.04 126.32 13.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.491 -0.756 . . . . 50.0 110.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 6' ' ' LEU . 47.2 t-20 -63.08 122.32 15.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.202 -0.936 . . . . 12.5 110.813 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HB2' HG12 ' A' ' 114' ' ' VAL . 18.6 t80 -62.59 -36.84 84.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.895 . . . . 50.0 109.905 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -33.48 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 50.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.511 HG21 HD13 ' A' ' 32' ' ' LEU . 90.3 m -63.49 -39.27 94.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 50.0 109.903 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD13 HD21 ' A' ' 23' ' ' LEU . 4.9 tp -63.05 -44.27 96.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 50.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -56.56 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 50.0 110.054 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -44.97 -49.13 11.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 50.0 109.793 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' THR . 1.8 tt0 -74.18 -23.47 59.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 50.0 109.91 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.07 35.87 42.65 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.635 -1.386 . . . . 50.0 109.635 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -85.41 -178.06 6.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -1.196 . . . . 50.0 110.129 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -84.93 179.64 7.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.208 -0.932 . . . . 50.0 110.317 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -54.04 7.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 50.0 110.443 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.91 6.23 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 50.0 110.337 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' CB ' ' A' ' 17' ' ' ASP . 61.8 t0 -80.11 -46.76 15.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 50.0 110.404 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.7 m-20 -79.51 5.15 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 50.0 110.401 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 25' ' ' GLU . 28.3 m-20 42.06 54.82 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 50.0 110.295 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.719 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.1 mp -38.85 -54.28 1.63 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.69 . . . . 50.0 110.566 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 6' ' ' LEU . 33.4 m-85 -43.4 -27.55 0.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 50.0 109.585 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -95.75 -44.96 7.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 50.0 110.675 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -20.42 61.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.208 -0.932 . . . . 50.0 110.509 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -69.39 -10.57 58.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 50.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.79 -17.62 35.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 50.0 110.161 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.8 -17.3 31.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 50.0 110.311 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.45 -20.03 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 50.0 110.473 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.78 36.34 48.06 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.366 -1.493 . . . . 50.0 109.366 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.749 HD12 ' HB1' ' A' ' 27' ' ' ALA . 96.7 mt -53.25 176.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 50.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.34 154.03 29.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 50.0 110.319 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 5' ' ' TYR . . . -65.79 -22.63 70.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.239 -1.544 . . . . 50.0 109.239 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.16 2.82 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 50.0 109.981 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 72.7 m-20 -123.51 -52.55 1.82 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 50.0 110.194 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' CZ ' ' O ' ' A' ' 24' ' ' PHE . 10.8 t80 -132.33 148.01 52.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.973 . . . . 50.0 110.269 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' C ' ' CE1' ' A' ' 5' ' ' TYR . . . 155.22 -172.69 33.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.422 -1.471 . . . . 10.0 109.422 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 126.86 39.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 50.0 109.945 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.6 ttp -106.74 128.35 54.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 50.0 110.389 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -106.69 118.48 36.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 12.5 109.81 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' CB ' ' A' ' 51' ' ' ALA . 78.7 t -121.61 124.88 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 10.0 110.655 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.28 133.61 53.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 50.0 109.885 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -55.04 112.72 1.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 25.0 110.243 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.64 5.87 27.34 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.45 154.64 24.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.147 -1.208 . . . . 10.0 110.426 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -78.21 134.84 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.299 -0.875 . . . . 10.0 110.243 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 42' ' ' VAL . 27.2 mm -48.62 -60.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.87 . . . . 10.0 110.369 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 50' ' ' GLU . 1.5 tt -44.59 -41.64 6.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 10.0 110.484 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.27 -46.71 22.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.935 . . . . 50.0 110.503 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -56.33 -42.77 78.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 12.5 110.346 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -79.97 -24.24 41.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 10.0 110.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.11 -31.02 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 10.0 109.754 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.04 -18.04 64.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.463 -0.773 . . . . 50.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -98.69 -22.25 16.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 10.0 110.232 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.08 -7.49 8.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 21.8 m-85 -63.25 129.0 38.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -1.142 . . . . 12.5 110.307 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 3.6 p30 -102.09 140.79 35.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -0.914 . . . . 10.0 110.28 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 19.9 m95 -132.11 143.98 51.24 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.24 -0.913 . . . . 50.0 110.429 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.66 137.43 24.98 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.003 1.528 . . . . 10.0 109.9 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.6 p90 -159.08 153.25 23.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 10.0 110.144 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 53.1 p -142.66 -58.6 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.361 -0.837 . . . . 10.0 110.079 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -75.86 -41.4 52.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.432 -0.792 . . . . 10.0 110.807 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 62.02 28.61 17.33 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.002 -1.061 . . . . 10.0 112.079 178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.6 2.24 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.078 -1.014 . . . . 10.0 110.4 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.828 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 82.28 38.41 12.9 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.953 -1.259 . . . . 10.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.24 6.09 5.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.004 -1.292 . . . . 10.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.612 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -140.65 -179.27 5.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.657 -1.277 . . . . 10.0 110.545 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.76 9.61 13.04 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.013 -1.054 . . . . 25.0 111.276 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -57.46 -33.72 68.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 50.0 110.363 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.1 p -99.85 3.6 44.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 10.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' ARG . . . -44.25 153.9 0.13 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.416 -0.802 . . . . 10.0 111.313 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.791 ' OG ' HD11 ' A' ' 113' ' ' ILE . 21.7 p -133.64 -163.2 1.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.738 . . . . 50.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 34.5 mm -147.61 74.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -0.874 . . . . 50.0 109.696 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 97' ' ' ASP . 2.5 p -41.85 121.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.852 . . . . 50.0 110.261 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 112' ' ' LYS . 12.8 tmtt? -88.32 -16.24 33.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.255 -0.903 . . . . 50.0 109.969 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.46 132.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 25.0 110.158 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 122.54 179.08 15.78 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.24 -1.544 . . . . 10.0 109.24 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -122.98 138.62 54.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 50.0 110.224 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.78 131.24 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 50.0 110.319 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER -81.29 128.9 34.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 10.0 110.323 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.674 ' HE1' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.22 154.65 30.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 50.0 110.032 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -99.78 -171.81 2.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 50.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.62 127.7 26.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 50.0 110.181 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' HG2' ' HG2' ' A' ' 82' ' ' MET . 3.1 pp0? -168.56 156.8 8.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 16.66 110.33 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -127.81 -3.36 5.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 50.0 110.297 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 100' ' ' LEU . 9.7 tp -77.1 -22.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 50.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.674 HD22 ' HE1' ' A' ' 82' ' ' MET . 0.4 OUTLIER -124.56 171.71 9.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 12.5 110.747 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.89 153.34 40.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.509 -0.745 . . . . 12.5 109.986 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.88 ' O ' HG12 ' A' ' 93' ' ' VAL . 25.3 t0 -50.39 -40.73 50.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 10.0 110.339 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -58.63 -25.83 63.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 50.0 110.164 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 97' ' ' ASP . 50.1 mm-40 -76.21 -33.41 59.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.887 . . . . 50.0 110.251 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.88 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -79.23 -18.47 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 10.0 110.001 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -101.65 -44.04 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 12.5 110.012 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -86.74 -34.26 19.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 50.0 110.182 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -111.99 -7.75 14.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 25.0 110.386 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.821 ' O ' HG12 ' A' ' 75' ' ' VAL . 3.2 m-20 50.49 21.06 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 50.0 110.215 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.634 HG13 HD11 ' A' ' 88' ' ' LEU . 9.3 p -94.09 157.7 2.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.054 -1.029 . . . . 50.0 111.138 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -165.77 178.94 6.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.624 -0.672 . . . . 50.0 109.42 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.828 HD13 ' HA2' ' A' ' 66' ' ' GLY . 19.8 mt -98.65 107.66 20.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.047 -1.033 . . . . 10.0 110.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -30.65 71.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 10.0 109.993 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' HG12 ' A' ' 103' ' ' ILE . 21.0 p -77.68 -17.52 57.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 10.0 109.881 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.794 ' O ' HG22 ' A' ' 103' ' ' ILE . 15.2 mm -134.31 30.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 50.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -118.94 143.03 17.21 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.621 -1.392 . . . . 10.0 109.621 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 81' ' ' ASP . 85.4 p -129.36 129.16 23.24 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.29 -1.124 . . . . 10.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' CG ' HG11 ' A' ' 42' ' ' VAL . 45.9 Cg_endo -71.52 120.57 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.955 1.503 . . . . 10.0 110.22 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.5 -31.73 9.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.0 110.459 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -80.58 150.02 29.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 50.0 110.393 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 50.0 109.944 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.447 ' C ' HG23 ' A' ' 111' ' ' VAL . 20.8 tt0 -85.72 129.0 34.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 50.0 109.748 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.2 t -148.04 149.5 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.01 . . . . 12.5 110.535 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 4' ' ' GLU . 65.3 mttt -125.2 143.3 51.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.402 -0.811 . . . . 25.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.791 HD11 ' OG ' ' A' ' 73' ' ' SER . 6.2 tt -160.1 144.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.971 . . . . 10.0 110.444 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 6' ' ' LEU . 12.1 t -93.95 125.12 46.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.403 -0.811 . . . . 50.0 109.636 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -89.71 158.32 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 50.0 109.955 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.3 t30 72.49 53.43 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 118' ' ' ALY . . . -78.67 -26.89 45.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 50.0 110.423 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.516 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.537 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 88.3 m-70 -65.31 -18.03 64.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.458 -0.776 . . . . 50.0 110.181 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -53.05 128.33 27.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.103 -0.998 . . . . 12.5 110.164 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.36 -51.24 15.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.915 . . . . 50.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -59.87 -24.36 64.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 16.66 110.281 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt -97.88 -28.23 13.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 50.0 110.097 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -65.87 -30.58 71.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 50.0 110.038 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -21.48 64.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 50.0 110.437 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.21 -12.35 41.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.114 -0.991 . . . . 50.0 110.574 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.51 -36.02 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 50.0 110.032 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.972 -1.014 . . . . 50.0 110.184 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.631 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 45.5 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 N-CA-C 110.457 -0.632 . . . . 4.9900000000000002 110.457 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 109' ' ' ASP . 14.8 m -109.92 113.29 25.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 3.73 110.087 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 111' ' ' VAL . 11.7 t -108.91 124.08 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 10.0 110.17 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' OE1' ' HG2' ' A' ' 112' ' ' LYS . 8.1 tt0 -92.94 122.27 35.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 50.0 110.176 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.547 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 22.9 p90 -99.5 142.35 31.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 50.0 110.881 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.793 HD23 ' CD1' ' A' ' 24' ' ' PHE . 1.5 tp -135.88 112.96 10.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.555 -0.716 . . . . 50.0 109.358 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.529 ' N ' HD12 ' A' ' 6' ' ' LEU . 34.9 p-10 -51.67 125.53 15.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 12.5 110.898 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 120' ' ' LEU . 51.1 t80 -60.68 -19.18 57.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 50.0 109.613 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 1.5 mp0 -62.09 -43.05 99.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 50.0 109.74 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 7' ' ' ASN . 8.8 m -61.35 -38.34 86.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.336 -0.853 . . . . 50.0 109.717 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD13 ' CD1' ' A' ' 23' ' ' LEU . 11.9 tp -66.88 -46.52 74.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 50.0 109.744 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -39.02 61.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 50.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 27.4 t0 -60.76 -49.42 77.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.098 -1.001 . . . . 50.0 109.858 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -25.38 54.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 50.0 109.839 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.37 50.27 39.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.491 -1.444 . . . . 50.0 109.491 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -113.42 -168.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -1.119 . . . . 50.0 110.327 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 20' ' ' ASP . 91.5 m-20 -87.57 169.0 12.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 50.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.69 -35.09 45.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -0.826 . . . . 50.0 110.341 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -126.53 -25.85 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.945 . . . . 50.0 110.48 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 17' ' ' ASP . 0.3 OUTLIER -55.24 -70.12 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 50.0 110.026 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' ASP . 23.6 t70 -70.92 -6.04 35.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 50.0 109.937 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER 42.69 54.37 4.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 50.0 110.334 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' HD13 ' A' ' 11' ' ' LEU . 1.4 mt -43.22 -37.76 2.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 50.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.793 ' CD1' HD23 ' A' ' 6' ' ' LEU . 13.5 m-85 -44.33 -28.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 50.0 109.16 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -43.77 6.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.666 -0.646 . . . . 50.0 109.979 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.13 -29.56 70.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 50.0 109.882 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -63.04 -30.63 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 50.0 110.227 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.14 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.91 . . . . 50.0 110.244 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 9.2 t0 -84.57 -15.58 45.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 50.0 110.231 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.67 -19.51 18.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -0.905 . . . . 50.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 32' ' ' LEU . . . 75.32 34.28 51.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.412 -1.475 . . . . 50.0 109.412 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 ' HB1' ' A' ' 27' ' ' ALA . 44.0 mt -51.6 -178.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 50.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.85 160.03 29.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 50.0 110.224 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.84 -35.63 34.92 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.655 -1.378 . . . . 50.0 109.655 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.71 -8.66 56.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -1.15 . . . . 50.0 110.192 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 7' ' ' ASN . 10.3 m-20 -97.97 -46.46 5.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 50.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 19.5 t80 -132.31 138.03 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.912 . . . . 50.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . 163.96 -176.81 39.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.43 -1.468 . . . . 10.0 109.43 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.68 144.99 25.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.191 . . . . 50.0 110.225 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 52' ' ' ALA . 1.7 ttp -120.53 85.88 2.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 50.0 110.391 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 1.3 pp20? -63.2 113.79 3.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 12.5 109.986 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 51' ' ' ALA . 36.2 t -119.33 144.73 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 10.0 110.531 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . . . -79.98 145.95 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 50.0 110.076 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -53.83 120.09 5.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 25.0 110.25 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.83 12.24 80.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 17.8 tp10 -96.81 125.43 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.127 -1.219 . . . . 10.0 110.194 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -50.5 126.15 14.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.875 . . . . 10.0 110.481 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG23 ' CE ' ' A' ' 40' ' ' MET . 60.9 mt -49.84 -52.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 10.0 110.219 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' A' ' 59' ' ' TRP . 22.1 tp -49.41 -42.8 43.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.872 . . . . 10.0 110.497 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 1.8 tt0 -72.99 -41.53 64.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 50.0 110.258 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -56.43 -49.19 75.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 12.5 109.998 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.739 ' HB2' ' SD ' ' A' ' 40' ' ' MET . . . -80.02 -33.17 39.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 10.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 1.3 tm-20 -53.08 -31.67 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 10.0 109.74 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.61 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 50.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HB2' ' CD2' ' A' ' 57' ' ' TYR . 3.9 mm100 -105.08 -12.2 16.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 10.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 17.97 9.92 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.458 -1.457 . . . . 10.0 109.458 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.556 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 45.5 m-85 -90.01 125.17 35.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -1.169 . . . . 12.5 110.203 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -97.72 139.57 33.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.302 -0.874 . . . . 10.0 110.065 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.715 ' HB2' HD13 ' A' ' 49' ' ' LEU . 22.7 m95 -130.31 149.65 73.95 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 50.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 43.5 Cg_endo -72.46 133.2 20.31 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.014 1.533 . . . . 10.0 109.857 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.9 p90 -159.03 152.04 22.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 10.0 110.212 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.489 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -144.32 -58.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 10.0 110.115 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.38 -40.76 42.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 10.0 111.17 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 13.4 mtp180 62.65 29.03 16.85 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.879 -1.138 . . . . 10.0 112.019 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.62 2.61 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.046 -1.034 . . . . 10.0 110.309 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.82 38.3 20.29 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.845 -1.302 . . . . 10.0 109.845 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -126.69 5.92 6.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.141 -1.211 . . . . 10.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.578 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -141.07 -175.12 4.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.814 -1.179 . . . . 10.0 110.288 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.29 11.35 8.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 25.0 111.263 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.489 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 12.3 m120 -57.46 -34.83 69.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 50.0 109.96 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 20.2 p -88.76 13.14 13.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.423 -0.798 . . . . 10.0 109.707 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . . . -42.57 158.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.725 0.774 . . . . 10.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.681 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 0.9 OUTLIER -153.42 -167.09 2.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.632 -0.668 . . . . 50.0 109.519 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 96' ' ' LYS . 20.7 mm -146.84 91.29 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 50.0 109.965 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG23 HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -58.78 125.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 50.0 110.375 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' CE1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -98.45 0.23 44.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.041 -1.037 . . . . 50.0 110.164 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' CB ' ' HD3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 172.01 152.66 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.273 -0.892 . . . . 25.0 110.368 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 90.83 171.73 43.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.56 -1.416 . . . . 10.0 109.56 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.81 130.3 53.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 50.0 110.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 99' ' ' ARG . 52.2 mt -105.21 131.35 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 50.0 110.343 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 105' ' ' SER . 56.7 t0 -80.14 134.29 36.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 10.0 110.058 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.495 ' SD ' ' NE2' ' A' ' 85' ' ' GLN . 3.4 ptt? -125.54 156.16 39.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 50.0 110.287 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' OD1' HD12 ' A' ' 103' ' ' ILE . 10.5 p-10 -95.85 -168.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 50.0 110.139 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -58.9 139.02 57.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 50.0 110.161 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' NE2' ' SD ' ' A' ' 82' ' ' MET . 13.7 pt20 -177.49 138.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 16.66 110.366 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -120.31 23.98 10.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 50.0 109.929 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 67' ' ' ALA . 10.5 tp -89.27 -33.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.414 -0.804 . . . . 50.0 110.346 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.008 HD21 HG12 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -110.11 169.31 8.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 12.5 110.341 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.46 144.79 43.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 12.5 110.041 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 18.6 p-10 -54.0 -36.53 63.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 10.0 110.392 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -60.53 -37.55 81.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 50.0 110.048 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 2.4 mt-10 -71.27 -27.43 63.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 50.0 110.01 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.1 -35.69 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 10.0 109.991 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -97.72 -29.26 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 12.5 110.367 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -95.61 -39.53 9.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 50.0 110.566 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -101.54 -5.95 24.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 25.0 110.465 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 11.9 m-20 56.68 24.64 9.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.151 -0.968 . . . . 50.0 110.06 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.008 HG12 HD21 ' A' ' 88' ' ' LEU . 53.1 t -87.25 145.36 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.191 -0.943 . . . . 50.0 110.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.521 ' CD ' ' HB ' ' A' ' 80' ' ' ILE . 1.4 mtt-85 -160.94 170.52 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.535 -0.728 . . . . 50.0 109.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.784 HD13 ' S2 ' ' A' ' 130' ' ' FES . 28.1 mt -105.02 115.51 30.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.082 -1.011 . . . . 10.0 110.666 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.0 p -78.31 -15.96 58.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 10.0 109.822 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 31.7 p -72.8 -30.55 64.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 10.0 109.994 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.493 HD12 ' OD1' ' A' ' 83' ' ' ASP . 1.3 pp -134.4 21.25 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 50.0 110.221 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.13 144.91 17.51 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.613 -1.395 . . . . 10.0 109.613 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ASP . 27.5 p -130.81 146.93 64.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -1.138 . . . . 10.0 110.192 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 3' ' ' VAL . 47.8 Cg_endo -73.54 137.81 25.85 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.934 1.491 . . . . 10.0 110.339 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -115.49 -28.74 6.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 50.0 110.203 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.46 174.89 9.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.96 . . . . 50.0 110.222 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -73.24 -75.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 50.0 109.996 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -83.1 119.75 24.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 50.0 109.88 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.6 t -135.55 95.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 12.5 110.467 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 76' ' ' LYS . 7.2 mtpt -86.57 143.65 27.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 25.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 75' ' ' VAL . 3.9 tt -160.27 145.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.374 -0.829 . . . . 10.0 110.313 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 6' ' ' LEU . 4.3 t -82.75 129.76 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.163 -0.961 . . . . 50.0 109.38 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -95.52 143.97 26.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 50.0 110.433 -179.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER 74.47 58.33 0.08 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.515 -0.74 . . . . 10.0 110.369 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -74.78 -21.49 59.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -0.948 . . . . 50.0 110.232 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.551 ' HCA' HD13 ' A' ' 123' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.522 ' N ' ' HG2' ' A' ' 118' ' ' ALY . 57.5 m-70 -61.02 -25.83 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 50.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -43.31 159.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 12.5 110.184 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -17.31 60.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.91 . . . . 50.0 110.308 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -77.14 -21.08 54.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.957 . . . . 16.66 110.272 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD13 ' HCA' ' A' ' 118' ' ' ALY . 1.6 mt -105.3 -32.94 8.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 50.0 110.145 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -29.89 69.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 50.0 109.957 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.9 -37.72 14.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 50.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.63 29.93 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.83 . . . . 50.0 110.282 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 127' ' ' VAL . 12.1 p -73.3 64.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 50.0 110.182 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.954 -1.022 . . . . 50.0 110.262 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.784 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.249 0 N-CA-C 110.275 -0.702 . . . . 4.9900000000000002 110.275 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.539 ' CG2' HG22 ' A' ' 39' ' ' THR . 88.9 m -113.86 142.54 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 3.73 110.518 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.051 HG13 ' HB3' ' A' ' 40' ' ' MET . 2.2 p -153.16 120.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.847 . . . . 10.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -79.91 112.02 16.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.028 . . . . 50.0 111.249 -179.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.1 p90 -87.82 150.21 23.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 50.0 110.059 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 0.8 OUTLIER -135.88 145.4 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.267 -0.896 . . . . 50.0 110.56 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . 36.9 t-20 -73.65 124.03 25.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 12.5 110.415 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 56.0 t80 -58.53 -32.84 69.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 50.0 110.021 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.25 -36.69 83.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 50.0 110.225 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 36' ' ' ASP . 91.8 m -65.55 -23.76 66.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.925 . . . . 50.0 109.688 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -75.07 -46.26 35.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -0.751 . . . . 50.0 109.934 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD2' ' CZ ' ' A' ' 8' ' ' TYR . 69.4 m-20 -74.0 -49.59 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.403 -0.81 . . . . 50.0 109.96 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -52.5 -49.73 64.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 50.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 16' ' ' TRP . 26.8 mm-40 -78.82 -13.02 60.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 50.0 110.07 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.27 33.74 81.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 50.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 14' ' ' GLN . 17.0 m0 -88.96 168.38 12.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -1.095 . . . . 50.0 110.323 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -88.79 -163.3 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 50.0 109.951 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.21 -50.48 27.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 50.0 110.179 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.9 21.1 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.89 . . . . 50.0 110.297 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.24 -50.79 15.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 50.0 110.303 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 8.0 m-20 -80.03 -105.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.153 -0.967 . . . . 50.0 110.105 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -141.15 47.36 1.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.071 . . . . 50.0 109.523 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 23' ' ' LEU . 4.0 mm? -46.53 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.622 -0.674 . . . . 50.0 110.789 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 45.9 m-85 -63.21 -9.24 10.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 50.0 110.636 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.03 -56.47 3.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.082 -1.012 . . . . 50.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -68.09 -30.79 70.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 50.0 110.307 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.07 -31.01 60.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 50.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -81.22 -11.43 59.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -0.796 . . . . 50.0 109.907 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.02 4.34 10.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 50.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.34 -25.25 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 50.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 60.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 50.0 109.411 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.0 mt -102.83 161.96 13.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 50.0 110.083 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 36' ' ' ASP . 2.2 t0 -61.97 158.43 16.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 50.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.33 -41.0 98.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.303 -1.519 . . . . 50.0 109.303 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.3 OUTLIER -70.79 -4.19 22.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.466 -1.02 . . . . 50.0 110.068 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -96.61 -41.23 8.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 50.0 110.42 -179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 17.0 t80 -147.06 142.26 27.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.098 -1.001 . . . . 50.0 110.565 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.64 161.68 11.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.614 -1.395 . . . . 10.0 109.614 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' CG2' ' A' ' 2' ' ' THR . 0.3 OUTLIER -81.64 121.98 27.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 50.0 109.92 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.051 ' HB3' HG13 ' A' ' 3' ' ' VAL . 17.3 ttm -92.53 143.42 26.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.065 -1.022 . . . . 50.0 109.72 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' OE2' ' HG2' ' A' ' 1' ' ' PRO . 5.9 tp10 -116.65 92.97 4.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 12.5 110.351 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.774 HG23 ' HG2' ' A' ' 40' ' ' MET . 22.0 t -113.07 114.85 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 10.0 110.034 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB3' ' OE1' ' A' ' 46' ' ' GLU . . . -74.64 157.75 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 50.0 110.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.14 114.78 3.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 25.0 110.049 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.93 10.22 18.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -122.08 124.2 43.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -1.085 . . . . 10.0 110.443 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.9 m-85 -57.43 123.28 14.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 10.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' SD ' ' A' ' 40' ' ' MET . 66.0 mt -48.85 -63.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 10.0 110.655 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.726 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.5 tt -43.7 -38.62 3.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.108 -0.995 . . . . 10.0 110.75 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -71.21 -50.1 36.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.118 -0.988 . . . . 50.0 110.32 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.649 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -47.27 -44.24 22.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 12.5 110.048 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.878 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -79.0 -31.48 44.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.771 . . . . 10.0 110.032 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 10.0 109.764 179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.92 -15.37 60.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 50.0 109.904 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.72 -18.52 21.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 10.0 110.056 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.58 17.21 7.13 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.396 -1.482 . . . . 10.0 109.396 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.491 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 19.4 m-85 -90.3 147.83 23.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -1.139 . . . . 12.5 110.209 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.534 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 7.5 t70 -116.86 137.63 52.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 10.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 14.7 m95 -131.4 153.82 81.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.132 -0.98 . . . . 50.0 110.153 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -72.3 132.88 20.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.931 1.49 . . . . 10.0 110.33 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 7.8 p90 -159.43 150.78 20.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 10.0 110.004 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -144.13 -58.59 0.38 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.25 -0.906 . . . . 10.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.9 OUTLIER -78.34 -40.9 35.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 10.0 110.64 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.7 mtp180 60.62 30.57 19.82 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.071 -1.018 . . . . 10.0 111.892 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.68 2.63 2.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 10.0 110.203 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 103' ' ' ILE . . . 82.03 38.53 13.17 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.25 12.82 5.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.919 -1.342 . . . . 10.0 111.596 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.607 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.6 OUTLIER -148.7 -179.14 6.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.218 . . . . 10.0 110.377 179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.25 11.79 10.88 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.084 -1.01 . . . . 25.0 111.297 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.57 -38.3 74.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.061 . . . . 50.0 109.831 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.3 p -88.11 11.96 14.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.37 -0.831 . . . . 10.0 109.83 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -45.77 156.55 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.761 0.791 . . . . 10.0 111.292 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -136.46 -159.44 0.96 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.68 -0.638 . . . . 50.0 109.784 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.8 mm -149.48 76.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 50.0 109.725 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.1 p -52.43 118.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.419 -0.8 . . . . 50.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.6 mmtp -89.93 -13.88 35.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.968 -1.083 . . . . 50.0 110.351 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' HG13 ' A' ' 111' ' ' VAL . 1.8 mt-10 179.77 167.29 1.2 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.16 -0.963 . . . . 25.0 110.545 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 85.96 -149.74 23.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.497 -1.441 . . . . 10.0 109.497 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -157.56 149.61 22.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 50.0 110.056 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 105' ' ' SER . 6.6 mt -124.82 143.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 50.0 110.229 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 15.5 t0 -84.23 130.26 34.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.347 -0.845 . . . . 10.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.503 ' SD ' ' NH1' ' A' ' 99' ' ' ARG . 3.0 ttp -122.01 -171.78 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 50.0 110.124 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -120.76 178.96 4.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 50.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.4 mmt -79.94 125.34 29.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.291 -0.88 . . . . 50.0 110.277 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -171.01 -167.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 16.66 110.106 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.7 12.75 2.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.906 . . . . 50.0 110.157 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 88' ' ' LEU . 6.6 tp -73.15 -25.38 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 50.0 110.407 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD12 HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -145.73 141.47 28.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 12.5 110.192 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.91 176.31 5.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 12.5 110.233 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.745 ' O ' HG12 ' A' ' 93' ' ' VAL . 33.7 t0 -65.94 -38.23 88.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 10.0 110.455 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.48 -24.04 53.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.966 . . . . 50.0 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -35.97 36.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 50.0 110.16 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.9 p -80.02 -15.46 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 10.0 110.63 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -99.82 -49.88 4.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 12.5 110.537 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.14 -30.06 24.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -0.928 . . . . 50.0 110.045 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -107.04 -15.53 14.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 25.0 110.076 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER 56.9 21.67 6.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -0.854 . . . . 50.0 109.87 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 96' ' ' LYS . 96.5 t -85.1 160.69 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.173 -0.954 . . . . 50.0 110.874 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' NH1' ' SD ' ' A' ' 82' ' ' MET . 0.0 OUTLIER -168.03 171.13 9.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.517 -0.739 . . . . 50.0 109.598 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.778 HD22 ' S2 ' ' A' ' 130' ' ' FES . 74.8 mt -101.76 107.62 18.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 10.0 110.347 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 59.1 p -77.19 -21.0 54.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.407 -0.808 . . . . 10.0 110.507 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.706 ' SG ' HG23 ' A' ' 103' ' ' ILE . 23.9 p -74.38 -33.29 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 10.0 110.02 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.706 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.2 pp -127.2 30.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.831 . . . . 50.0 110.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.92 148.91 16.84 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.591 -1.404 . . . . 10.0 109.591 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -124.64 172.56 5.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.301 -1.117 . . . . 10.0 110.197 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HG3' ' O ' ' A' ' 42' ' ' VAL . 47.2 Cg_endo -74.55 145.83 33.86 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.96 1.505 . . . . 10.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.95 -8.24 6.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 50.0 110.564 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -131.86 162.14 31.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 50.0 110.373 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' GLU . 2.9 p30 -63.21 -42.75 99.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 50.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 2' ' ' THR . 5.9 mt-10 -129.78 124.61 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 109.78 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 108' ' ' ALA . 23.3 t -135.78 153.63 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 12.5 110.744 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 76' ' ' LYS . 5.7 mttt -118.92 136.43 54.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.425 -0.797 . . . . 25.0 109.424 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 73' ' ' SER . 2.7 tt -160.04 150.74 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 10.0 110.818 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.58 132.66 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 50.0 109.575 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -94.91 161.11 14.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.111 -0.993 . . . . 50.0 110.369 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.623 ' ND2' ' CD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 74.33 55.25 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.494 -0.754 . . . . 10.0 110.609 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -78.35 -27.13 46.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.132 -0.98 . . . . 50.0 110.163 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.494 ' HD3' ' HB3' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.623 ' CD2' ' ND2' ' A' ' 116' ' ' ASN . 64.9 m-70 -57.53 -31.57 66.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 50.0 109.792 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -40.88 114.8 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 12.5 110.511 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -48.17 -26.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 50.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -61.63 -21.75 64.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.864 . . . . 16.66 110.24 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -35.62 6.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 50.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.43 -25.58 67.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.207 -0.933 . . . . 50.0 110.235 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -45.31 -34.78 3.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 50.0 110.309 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -58.78 -52.04 67.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 50.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.0 125.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 50.0 110.356 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.02 -0.99 . . . . 50.0 110.163 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.778 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 49.0 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 110.109 -0.766 . . . . 4.9900000000000002 110.109 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.73 124.66 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 3.73 110.418 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 111' ' ' VAL . 16.7 t -137.69 109.39 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 10.0 109.701 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 8.4 tt0 -80.02 123.29 27.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 50.0 110.216 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 46.9 p90 -97.33 137.45 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 50.0 110.414 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.881 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -126.52 132.12 51.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 50.0 109.905 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 41.1 t30 -60.2 124.6 20.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 12.5 110.609 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB2' ' CG1' ' A' ' 114' ' ' VAL . 24.8 t80 -58.19 -34.43 70.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 50.0 109.743 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -67.23 -34.34 77.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 50.0 109.843 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 22.9 m -62.75 -32.92 74.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 50.0 109.675 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 11' ' ' LEU . 1.9 tt -65.73 -42.91 90.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.843 . . . . 50.0 109.746 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.87 -48.38 16.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.822 . . . . 50.0 110.049 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.72 -56.51 16.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 50.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 2.3 tt0 -62.63 -35.49 79.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 50.0 110.093 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.72 31.91 9.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.548 -1.421 . . . . 50.0 109.548 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CZ3' ' HG2' ' A' ' 14' ' ' GLN . 1.2 m-90 -95.78 -170.69 2.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.287 -1.125 . . . . 50.0 110.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -116.1 -167.83 1.33 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 50.0 110.315 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.471 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 2.5 mmt -74.61 -43.92 53.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.335 -0.853 . . . . 50.0 110.521 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 49.3 p-10 -152.52 20.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 50.0 110.244 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 17' ' ' ASP . 4.4 t0 -69.11 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 50.0 110.301 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.14 -105.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 50.0 110.387 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -170.45 40.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.164 -0.96 . . . . 50.0 108.521 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 6' ' ' LEU . 9.1 mt -35.13 -58.74 0.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.719 -0.673 . . . . 50.0 111.34 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 37.7 m-85 -54.32 -29.46 47.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.047 -1.033 . . . . 50.0 110.031 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -91.27 -50.54 5.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 50.0 109.786 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -63.21 -18.95 64.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 50.0 109.857 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -62.33 -30.27 71.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 50.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.28 -18.22 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 50.0 109.859 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.1 m-20 -106.04 8.55 32.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 50.0 109.983 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.95 7.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 50.0 110.118 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.03 58.59 3.67 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.39 -1.484 . . . . 50.0 109.39 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.66 169.94 10.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -1.116 . . . . 50.0 110.388 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -60.13 169.14 1.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 50.0 110.437 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.31 -28.68 24.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.301 -1.519 . . . . 50.0 109.301 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER -77.54 -8.54 57.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -1.139 . . . . 50.0 109.97 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.56 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 21.2 m-20 -106.39 -47.27 3.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 50.0 110.093 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 19.8 t80 -129.98 141.5 50.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 50.0 110.21 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 160.92 164.6 16.1 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.394 . . . . 10.0 109.616 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 91.2 m -82.01 132.36 35.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 50.0 110.081 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.566 ' HE1' ' HB3' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -103.71 132.85 49.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.938 . . . . 50.0 110.29 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.37 114.41 28.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 12.5 109.884 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 51' ' ' ALA . 7.5 t -126.16 103.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.158 -0.964 . . . . 10.0 110.472 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 44' ' ' GLU . . . -64.28 128.22 34.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 50.0 109.901 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 43' ' ' ALA . 3.2 tm-20 -41.74 114.36 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -0.824 . . . . 25.0 110.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.16 12.13 18.54 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.976 -1.65 . . . . 10.0 108.976 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -119.94 110.88 17.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.311 -1.111 . . . . 10.0 110.396 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 48' ' ' ILE . 4.8 m-30 -44.33 125.67 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.942 . . . . 10.0 109.961 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' TYR . 6.5 mt -41.19 -57.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 10.0 110.282 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.9 tp -50.1 -33.53 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 10.0 109.923 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' GLU . 7.0 tt0 -78.41 -51.22 10.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 50.0 110.259 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -49.21 -47.97 45.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 12.5 110.248 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -77.92 -34.33 51.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.422 -0.799 . . . . 10.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 8.5 tt0 -59.36 -32.66 70.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 10.0 109.665 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.01 2.2 24.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 50.0 110.024 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -115.2 -36.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.337 -0.852 . . . . 10.0 110.264 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.79 33.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.941 -1.264 . . . . 10.0 109.941 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 43.4 m-85 -112.26 142.59 44.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.262 . . . . 12.5 109.978 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.8 m-20 -113.65 134.57 54.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 10.0 110.246 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.647 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 13.2 m95 -129.24 154.64 80.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 50.0 110.194 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.1 Cg_endo -72.36 136.65 26.83 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.095 1.576 . . . . 10.0 110.03 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 11.4 p90 -159.08 150.49 20.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.073 -1.017 . . . . 10.0 110.342 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -144.18 -58.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 10.0 110.148 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.446 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -76.68 -39.49 51.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 10.0 110.668 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 ttp180 61.03 28.54 18.3 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.948 -1.095 . . . . 10.0 112.18 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.55 2.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.103 -0.998 . . . . 10.0 110.386 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 81.15 38.49 15.09 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.042 -1.223 . . . . 10.0 110.042 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -129.01 11.28 6.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.046 -1.267 . . . . 10.0 111.391 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.614 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.62 -179.73 6.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.822 -1.174 . . . . 10.0 110.271 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -119.89 11.05 11.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 25.0 111.173 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -57.5 -39.04 75.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.979 . . . . 50.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.2 p -87.12 13.08 10.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.329 -0.857 . . . . 10.0 109.78 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -44.4 154.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.442 -0.786 . . . . 10.0 111.36 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 p -136.92 -162.22 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 50.0 109.574 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.72 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.3 mm -147.3 76.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.249 -0.907 . . . . 50.0 109.842 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 97' ' ' ASP . 6.8 p -56.99 119.61 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 50.0 110.332 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' LYS . 8.8 mmtt -91.63 -11.24 37.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.931 -1.106 . . . . 50.0 110.283 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -173.21 -177.06 1.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 25.0 110.005 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.619 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 67.04 174.63 6.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.208 -1.557 . . . . 10.0 109.208 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -125.33 123.71 40.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -1.23 . . . . 50.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.477 ' HB ' ' HD3' ' A' ' 99' ' ' ARG . 68.8 mt -101.51 134.28 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 50.0 109.948 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 105' ' ' SER . 5.6 t70 -97.01 139.74 32.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 10.0 110.329 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.4 mtp -124.41 -170.18 2.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -0.888 . . . . 50.0 110.164 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.94 178.93 5.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 50.0 110.343 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 tmm? -75.72 76.65 2.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 50.0 110.17 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 86' ' ' GLN . 0.3 OUTLIER -156.47 -75.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 16.66 110.216 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 2.5 tt0 64.5 98.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.214 -0.929 . . . . 50.0 110.254 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 67' ' ' ALA . 10.7 mm -75.9 -34.73 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 50.0 110.156 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -87.69 176.46 7.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 12.5 110.206 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.7 t -93.53 172.57 8.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 12.5 110.112 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.646 ' O ' HG12 ' A' ' 93' ' ' VAL . 10.2 t0 -63.08 -50.87 68.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 10.0 110.182 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.07 -22.83 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 50.0 109.323 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -78.74 -45.64 20.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.487 -0.758 . . . . 50.0 109.571 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.974 HG21 ' NH2' ' A' ' 99' ' ' ARG . 4.3 p -75.44 -17.14 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 10.0 110.128 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.12 -49.15 5.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 12.5 110.442 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.54 -42.7 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 50.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -81.99 -19.86 39.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.113 -0.992 . . . . 25.0 110.321 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.598 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.4 m-20 57.86 28.39 15.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 50.0 110.438 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 98' ' ' VAL . 11.5 m -97.37 121.45 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.084 -1.01 . . . . 50.0 110.719 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.974 ' NH2' HG21 ' A' ' 93' ' ' VAL . 13.1 mtp85 -128.46 178.06 6.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.469 -0.769 . . . . 50.0 109.726 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 100' ' ' LEU . 10.3 mp -98.76 113.37 25.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 10.0 110.071 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 69.1 p -82.25 -26.44 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.826 . . . . 10.0 110.743 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.672 ' SG ' HG23 ' A' ' 103' ' ' ILE . 22.0 p -69.12 -26.39 64.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 10.0 110.425 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.672 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -134.37 29.23 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 50.0 110.393 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.34 146.37 16.76 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.663 -1.375 . . . . 10.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -126.49 148.7 65.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.345 -1.091 . . . . 10.0 109.873 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.11 141.9 40.82 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.049 1.552 . . . . 10.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -121.54 6.05 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.857 . . . . 50.0 110.135 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -126.33 141.17 52.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 50.0 110.092 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.96 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.207 -0.933 . . . . 50.0 110.094 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -86.1 121.11 28.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 50.0 110.051 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.619 HG13 ' HA3' ' A' ' 78' ' ' GLY . 48.8 t -137.32 152.92 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.943 . . . . 12.5 110.473 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.8 mttt -125.31 136.41 53.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 25.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 8.1 tt -160.14 155.66 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 10.0 110.653 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -107.09 145.31 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.42 -0.8 . . . . 50.0 109.168 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.27 152.57 22.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 50.0 110.476 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 75.95 59.13 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.713 -0.617 . . . . 10.0 110.138 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -80.36 -26.43 38.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.241 -0.912 . . . . 50.0 110.368 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.51 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' N ' ' O ' ' A' ' 117' ' ' ALA . 67.7 m-70 -62.96 -20.41 65.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 50.0 109.708 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -42.81 152.2 0.11 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 12.5 110.397 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.42 -21.15 64.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 50.0 110.015 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.2 -25.12 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 16.66 110.156 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.01 -27.23 10.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 50.0 110.161 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -66.43 -15.62 63.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 50.0 110.209 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -68.38 -15.62 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 50.0 110.217 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -10.0 43.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 50.0 110.224 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 126.72 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.92 . . . . 50.0 110.077 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.001 -0.999 . . . . 50.0 110.184 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.614 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' HB2' ' O ' ' A' ' 108' ' ' ALA . 47.6 Cg_endo . . . . . 0 N--CA 1.489 1.237 0 N-CA-C 110.428 -0.643 . . . . 4.9900000000000002 110.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 m -93.06 145.07 24.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 3.73 110.037 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.8 t -140.88 -177.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 10.0 110.092 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.8 tt0 -144.23 132.51 21.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.268 -0.895 . . . . 50.0 110.278 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CZ ' ' A' ' 57' ' ' TYR . 10.5 p90 -105.03 135.21 46.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.153 -0.967 . . . . 50.0 110.418 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.624 ' O ' HG13 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -128.88 134.86 48.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 50.0 109.864 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.547 ' HA ' ' CE2' ' A' ' 115' ' ' TYR . 47.0 t-20 -72.85 118.3 15.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 12.5 110.684 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 5.4 t80 -57.82 -33.71 68.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 50.0 109.83 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 5.9 mt-10 -59.4 -41.21 88.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.868 . . . . 50.0 109.535 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -59.0 -31.76 69.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.339 -0.851 . . . . 50.0 109.493 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -64.77 -46.22 83.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 50.0 109.606 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.87 -46.47 16.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.405 -0.81 . . . . 50.0 109.979 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -45.72 -57.1 4.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 50.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -75.9 -18.97 59.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 50.0 109.857 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.63 37.4 67.79 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.646 -1.381 . . . . 50.0 109.646 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.03 -171.54 3.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.169 -1.195 . . . . 50.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.583 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -87.36 -179.63 6.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 50.0 110.327 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.3 mtt -79.26 -51.03 10.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 50.0 110.292 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 3.3 p-10 -141.13 6.73 1.97 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 50.0 110.642 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.9 -43.05 22.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 50.0 110.259 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.21 2.43 21.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 50.0 110.305 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 47.54 51.79 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 50.0 109.976 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.2 mp -45.1 -37.63 4.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 50.0 110.183 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE2' HD12 ' A' ' 6' ' ' LEU . 63.0 m-85 -58.01 -16.79 13.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 50.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -105.77 -49.78 3.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 50.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -26.75 65.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 50.0 110.016 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -59.29 -35.24 73.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 50.0 110.032 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.98 65.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 50.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.11 -12.36 26.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 50.0 110.068 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -28.73 26.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 50.0 110.256 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 48.4 4.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.582 -1.407 . . . . 50.0 109.582 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.15 158.04 25.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -1.091 . . . . 50.0 110.127 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.83 142.39 48.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 50.0 110.113 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -52.99 -20.7 8.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' CH2' ' A' ' 59' ' ' TRP . 33.9 mt-10 -76.29 1.69 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.166 . . . . 50.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 7' ' ' ASN . 62.1 m-20 -127.79 -51.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 50.0 109.536 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 19.8 t80 -129.45 133.9 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.343 -0.848 . . . . 50.0 109.8 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 170.1 164.75 26.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.297 -1.521 . . . . 10.0 109.297 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLU . 23.3 m -83.79 138.65 33.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -1.174 . . . . 50.0 110.059 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.615 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 2.3 ttm -105.74 143.44 33.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 50.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -111.99 101.43 9.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 12.5 109.952 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.948 HG22 ' CB ' ' A' ' 51' ' ' ALA . 14.3 t -115.21 127.71 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 10.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.52 179.46 2.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 50.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.56 119.58 17.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.153 -0.967 . . . . 25.0 110.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.07 12.87 75.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' HB3' HG12 ' A' ' 42' ' ' VAL . 6.0 tp10 -91.35 109.46 20.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -1.135 . . . . 10.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 66.1 m-85 -44.9 133.04 6.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 10.0 110.183 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 80' ' ' ILE . 25.7 mt -51.52 -59.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.972 . . . . 10.0 109.958 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -42.95 -40.3 2.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 10.0 109.904 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -70.03 -44.93 68.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 50.0 110.408 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.948 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -61.99 -46.12 90.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 12.5 110.662 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -69.64 -51.62 33.26 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.403 -0.81 . . . . 10.0 110.259 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -55.31 -39.55 70.07 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.406 -0.808 . . . . 10.0 109.689 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.35 59.93 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.525 -0.734 . . . . 50.0 109.526 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -94.93 -32.92 12.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.463 -0.773 . . . . 10.0 110.045 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.74 -1.44 2.89 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.76 -1.209 . . . . 10.0 110.314 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.667 ' CZ ' ' CE2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -97.36 112.39 24.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.844 -1.386 . . . . 12.5 109.856 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.79 61.97 2.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 10.0 110.76 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.709 ' CZ3' ' CE2' ' A' ' 115' ' ' TYR . 5.8 m95 -52.65 165.66 0.53 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 50.0 109.63 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' O ' ' CG ' ' A' ' 61' ' ' PHE . 44.3 Cg_endo -69.85 149.93 67.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.708 1.373 . . . . 10.0 111.038 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.942 ' CE2' HD23 ' A' ' 49' ' ' LEU . 35.9 m-85 -159.55 147.67 17.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -0.79 . . . . 10.0 109.526 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -144.39 -59.24 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.931 -1.105 . . . . 10.0 111.217 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -82.41 -39.2 22.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 10.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 11.2 mtm105 57.65 30.53 18.98 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.922 -1.112 . . . . 10.0 111.852 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.64 2.71 2.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.139 -0.975 . . . . 10.0 110.328 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.729 ' HA2' HD13 ' A' ' 100' ' ' LEU . . . 81.07 38.3 15.89 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.854 -1.165 . . . . 10.0 110.232 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.51 9.96 5.61 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.923 -1.339 . . . . 10.0 111.659 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.609 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -145.36 -173.77 4.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.706 -1.246 . . . . 10.0 110.263 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.96 10.04 8.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.806 -1.184 . . . . 25.0 111.444 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' CB ' ' OG ' ' A' ' 62' ' ' SER . 7.7 m120 -57.47 -29.5 64.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.04 -1.037 . . . . 50.0 110.119 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 12.4 p -101.36 -6.07 24.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 10.0 110.142 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 71' ' ' CYS . . . -39.02 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 10.0 110.833 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 2.2 m -142.43 -162.24 1.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.779 . . . . 50.0 109.654 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 31.6 mm -141.89 71.69 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.405 -0.81 . . . . 50.0 109.771 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 75' ' ' VAL . 12.7 p -41.35 116.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 50.0 110.132 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 112' ' ' LYS . 10.0 tmtt? -85.45 -5.99 59.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.039 . . . . 50.0 110.548 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.474 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER 173.39 169.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 25.0 110.529 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 90.53 -149.35 20.08 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.4 -1.48 . . . . 10.0 109.4 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 108' ' ' ALA . 2.3 tt0 -160.85 139.85 10.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 50.0 110.046 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.619 HD13 HD11 ' A' ' 48' ' ' ILE . 72.9 mt -127.17 151.13 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 50.0 110.221 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.57 154.87 21.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 10.0 110.349 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 -169.51 3.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.91 . . . . 50.0 110.422 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -101.56 171.64 7.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.372 -0.83 . . . . 50.0 110.376 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 2.7 mtt -70.47 121.64 18.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.337 -0.852 . . . . 50.0 110.194 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' MET . 1.2 mm100 -161.29 168.68 23.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 16.66 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -120.22 37.09 4.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.897 . . . . 50.0 110.197 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 100' ' ' LEU . 8.0 tp -72.47 -23.09 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 50.0 110.289 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 88' ' ' LEU . 4.0 pp -148.3 175.16 11.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 12.5 110.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -112.14 156.44 22.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.176 -0.953 . . . . 12.5 110.361 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.753 ' O ' HG12 ' A' ' 93' ' ' VAL . 37.0 t0 -48.85 -43.09 38.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 10.0 110.196 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 95' ' ' GLU . 72.8 mt-10 -57.68 -25.33 60.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.177 -0.952 . . . . 50.0 109.908 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -73.17 -38.22 66.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 50.0 110.279 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -77.68 -19.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 10.0 110.385 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.69 -28.64 11.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 12.5 110.47 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -100.76 -34.15 9.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.091 -1.006 . . . . 50.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' HB3' ' CG1' ' A' ' 98' ' ' VAL . 1.7 mmpt? -111.74 -12.23 13.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 25.0 110.537 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER 57.5 34.87 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.155 -0.966 . . . . 50.0 110.274 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 96' ' ' LYS . 2.2 m -92.63 159.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.033 -1.042 . . . . 50.0 110.859 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.491 ' NH1' HG21 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -172.38 168.61 5.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.6 -0.687 . . . . 50.0 109.461 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' HA2' ' A' ' 66' ' ' GLY . 15.7 mt -94.96 115.43 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 10.0 110.21 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.1 p -77.81 -24.42 48.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 10.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 1.01 ' C ' HD13 ' A' ' 103' ' ' ILE . 18.3 p -69.55 -33.22 72.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 10.0 110.24 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 102' ' ' CYS . 1.3 mm -121.85 27.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.84 -1.162 . . . . 50.0 109.919 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.86 140.62 12.29 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.318 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -125.67 144.12 47.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.401 -1.058 . . . . 10.0 109.578 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' A' ' 1' ' ' PRO . 45.6 Cg_endo -72.81 132.44 18.55 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.882 1.464 . . . . 10.0 110.692 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -110.71 -26.28 9.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 50.0 110.019 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -79.33 149.19 31.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 50.0 109.947 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -57.33 -43.77 83.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 50.0 110.317 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.71 130.69 53.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 50.0 110.051 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 3' ' ' VAL . 14.8 t -142.26 149.9 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 12.5 110.815 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -127.12 145.41 50.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.478 -0.764 . . . . 25.0 109.42 179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 75' ' ' VAL . 4.4 tt -160.0 165.04 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 10.0 110.848 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 6' ' ' LEU . 25.7 t -121.33 125.12 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 50.0 109.827 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.709 ' CE2' ' CZ3' ' A' ' 59' ' ' TRP . 1.5 p90 -84.43 172.3 11.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 50.0 110.112 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.563 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 68.97 41.04 1.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.152 -0.968 . . . . 10.0 110.922 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 73' ' ' SER . . . -67.9 -15.93 63.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 50.0 109.859 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.526 ' CD2' ' HG3' ' A' ' 9' ' ' GLU . 54.2 m-70 -64.88 -30.69 71.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 50.0 110.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -53.9 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 12.5 110.214 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -62.66 -25.34 68.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 50.0 110.108 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.498 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -67.03 -21.77 65.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 16.66 110.293 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.493 ' CD1' HD13 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -99.76 -25.65 14.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 50.0 110.254 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.671 ' O ' HG22 ' A' ' 127' ' ' VAL . 5.2 tt0 -58.26 -18.22 25.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 50.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.14 -10.13 57.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 50.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' A' ' 122' ' ' TYR . 5.0 mpt_? -94.67 -3.28 49.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 50.0 110.358 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 124' ' ' GLN . 34.2 m -60.0 131.0 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 50.0 110.269 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 50.0 110.296 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.609 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.499 ' CG ' ' O ' ' A' ' 42' ' ' VAL . 47.7 Cg_endo . . . . . 0 N--CA 1.489 1.255 0 N-CA-C 110.404 -0.652 . . . . 4.9900000000000002 110.404 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' ASP . 3.0 m -97.57 125.21 42.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 3.73 110.345 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 106' ' ' PRO . 94.2 t -129.86 107.25 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 10.0 109.982 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -80.33 113.1 18.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.942 . . . . 50.0 110.377 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' C ' ' A' ' 37' ' ' TYR . 33.6 p90 -85.04 142.5 29.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.102 -0.999 . . . . 50.0 110.364 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.875 HD12 ' CZ ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -129.58 135.06 48.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 50.0 110.476 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 29.8 t30 -69.22 119.59 13.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.052 -1.03 . . . . 12.5 110.408 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CZ ' HD22 ' A' ' 120' ' ' LEU . 42.8 t80 -53.86 -29.34 40.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 50.0 109.628 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -30.85 71.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 50.0 109.792 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.8 m -66.52 -39.82 88.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.392 -0.818 . . . . 50.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 23' ' ' LEU . 13.8 tp -65.05 -40.82 95.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.112 -0.993 . . . . 50.0 110.192 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.47 -49.02 15.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 50.0 110.169 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -52.47 -61.56 2.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 50.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.91 -31.37 71.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 50.0 110.047 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.29 7.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.539 -1.424 . . . . 50.0 109.539 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -111.96 -168.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -1.161 . . . . 50.0 110.249 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.74 -177.13 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 50.0 110.41 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtt -76.85 -51.31 11.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 50.0 110.39 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.63 8.39 2.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 50.0 110.355 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.48 -58.94 3.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 50.0 110.15 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' CZ2' ' A' ' 16' ' ' TRP . 2.9 t70 -80.1 11.89 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 50.0 110.65 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 25' ' ' GLU . 45.3 m-20 49.59 52.51 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 50.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 16' ' ' TRP . 9.5 mp -38.36 -45.13 0.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.61 -0.681 . . . . 50.0 111.17 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.875 ' CZ ' HD12 ' A' ' 6' ' ' LEU . 87.1 m-85 -54.96 -27.21 41.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.107 -0.996 . . . . 50.0 109.997 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' ASP . 13.5 tt0 -85.9 -38.77 17.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 50.0 110.006 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -21.8 43.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 50.0 110.39 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.04 -22.91 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 50.0 110.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.89 60.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 50.0 110.172 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -4.07 41.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.0 110.413 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.95 -31.13 10.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 50.0 110.448 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.03 48.36 40.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.221 -1.552 . . . . 50.0 109.221 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mt -74.79 -171.29 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 50.0 110.408 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 56.9 m-20 -59.43 153.83 18.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.304 -0.873 . . . . 50.0 110.349 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.1 -46.48 16.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.373 -1.491 . . . . 50.0 109.373 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -11.29 23.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.408 -1.054 . . . . 50.0 109.908 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 48.5 m-20 -89.88 -52.58 4.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 50.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 3.6 t80 -130.38 140.47 50.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 50.0 110.248 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 166.57 175.7 37.03 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.504 -1.439 . . . . 10.0 109.504 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m -91.51 134.78 34.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -1.104 . . . . 50.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.778 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -118.12 99.29 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.934 . . . . 50.0 110.099 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -94.68 115.39 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 12.5 110.137 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 1' ' ' PRO . 3.7 m -128.29 145.09 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 10.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.89 121.47 11.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 50.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -44.74 117.23 1.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 25.0 110.184 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.78 -7.18 13.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -98.35 144.94 27.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -1.144 . . . . 10.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 m-85 -73.44 135.41 44.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.2 -0.937 . . . . 10.0 110.355 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 49' ' ' LEU . 6.4 mm -47.72 -67.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 10.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 49' ' ' LEU . 2.1 tm? -42.93 -35.81 1.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 10.0 110.309 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 1.2 tm-20 -77.82 -51.09 11.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 50.0 110.577 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -63.69 -47.68 80.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 12.5 110.75 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.778 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -70.18 -29.79 66.75 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.419 -0.801 . . . . 10.0 110.651 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 49' ' ' LEU . 2.7 tm-20 -68.3 -31.15 70.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 10.0 109.923 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.37 -12.11 60.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 50.0 110.263 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -98.41 -25.5 14.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 10.0 110.37 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.37 15.13 3.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.842 -1.303 . . . . 10.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 21.0 m-85 -82.94 -178.67 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -1.201 . . . . 12.5 109.967 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -142.59 131.57 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.059 -1.025 . . . . 10.0 110.577 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.703 ' HB2' HD23 ' A' ' 49' ' ' LEU . 8.2 m95 -137.88 147.22 55.8 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 50.0 110.077 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 71' ' ' CYS . 48.0 Cg_endo -73.49 139.95 29.3 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.022 1.538 . . . . 10.0 110.153 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 59' ' ' TRP . 7.4 p90 -169.35 151.12 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 10.0 110.324 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -144.13 -58.71 0.38 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.298 -0.876 . . . . 10.0 109.998 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -71.09 -41.38 70.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.411 -0.806 . . . . 10.0 110.8 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 4.6 mtp180 57.01 30.31 17.94 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.045 -1.034 . . . . 10.0 111.748 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.59 2.77 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 10.0 110.339 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.556 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 82.83 38.34 11.85 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.946 -1.262 . . . . 10.0 109.946 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 5.78 5.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.991 -1.3 . . . . 10.0 111.662 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -141.18 -177.05 4.93 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.711 -1.243 . . . . 10.0 110.119 179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . . . -125.38 10.58 7.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.98 -1.075 . . . . 25.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -57.55 -37.45 73.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.052 -1.03 . . . . 50.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 11.3 p -89.9 11.52 20.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 10.0 110.196 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -48.43 157.99 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.777 . . . . 10.0 111.549 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -137.27 -162.89 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 50.0 109.891 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.665 ' O ' HG22 ' A' ' 74' ' ' ILE . 24.2 mm -148.75 70.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 50.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 97' ' ' ASP . 8.0 p -45.02 128.38 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.206 -0.934 . . . . 50.0 110.353 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' LYS . 9.9 mmmt -97.39 -6.45 34.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.066 -1.021 . . . . 50.0 109.985 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER 173.21 162.11 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 25.0 110.251 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.454 ' HA3' HG13 ' A' ' 111' ' ' VAL . . . 92.88 -171.26 32.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.273 -1.531 . . . . 10.0 109.273 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -135.45 132.34 37.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -1.179 . . . . 50.0 109.988 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -110.34 143.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 50.0 110.435 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.46 139.3 30.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 10.0 109.958 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 ttm -140.57 154.55 46.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 50.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -65.95 179.54 0.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 50.0 110.157 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 84' ' ' MET . 2.0 ptt? -74.95 77.66 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.301 -0.875 . . . . 50.0 110.263 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 84' ' ' MET . 4.6 tp60 -163.9 158.56 19.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 16.66 109.989 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -160.5 89.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 50.0 110.331 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.6 ' C ' HD12 ' A' ' 87' ' ' ILE . 1.9 pp -70.1 -23.49 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 50.0 109.803 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -94.49 -179.01 4.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 12.5 109.97 179.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.3 t -96.4 159.64 14.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 12.5 110.133 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.898 ' O ' HG12 ' A' ' 93' ' ' VAL . 5.5 m-20 -58.77 -43.72 90.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 10.0 110.177 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -56.2 -24.68 43.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 50.0 109.772 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -76.54 -38.9 54.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 50.0 109.99 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 90' ' ' ASP . 9.7 p -74.94 -15.82 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 10.0 109.865 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.19 -36.85 6.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.813 . . . . 12.5 110.2 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.14 -40.34 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 50.0 110.43 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HG2' HG23 ' A' ' 98' ' ' VAL . 10.3 tttp -95.54 -0.94 51.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 25.0 110.316 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.569 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER 41.56 39.77 1.19 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 50.0 110.163 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 96' ' ' LYS . 25.7 t -86.62 155.67 3.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.177 -0.952 . . . . 50.0 110.547 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.523 ' NH1' ' CG2' ' A' ' 93' ' ' VAL . 1.1 tpt180 -160.79 169.59 22.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.508 -0.745 . . . . 50.0 109.748 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.556 HD23 ' HA2' ' A' ' 66' ' ' GLY . 10.1 mp -97.45 107.74 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 10.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -32.9 74.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.965 . . . . 10.0 110.051 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 103' ' ' ILE . 15.2 p -77.64 -14.72 59.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 10.0 109.916 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 103' ' ' ILE . 9.9 mm -133.78 17.59 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.251 -0.905 . . . . 50.0 110.56 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 100' ' ' LEU . . . -124.85 137.42 10.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.419 -1.372 . . . . 10.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.1 m -123.87 142.14 38.69 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.44 -1.035 . . . . 10.0 109.544 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.554 ' HB3' HG21 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -70.13 119.21 6.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.893 1.47 . . . . 10.0 110.584 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.06 -40.51 9.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 50.0 110.217 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.558 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -74.49 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.42 -0.8 . . . . 50.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 2' ' ' THR . 0.4 OUTLIER -72.72 -73.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 50.0 110.003 179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -89.17 109.62 20.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 50.0 110.055 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.558 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 51.5 t -127.95 137.96 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.943 . . . . 12.5 110.41 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 76' ' ' LYS . 12.5 mttm -109.01 139.76 43.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 25.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.4 tt -160.13 153.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -0.921 . . . . 10.0 110.823 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -101.3 139.17 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.384 -0.823 . . . . 50.0 109.037 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.601 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -103.53 158.34 16.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 50.0 110.736 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.574 ' ND2' ' NE2' ' A' ' 119' ' ' HIS . 1.6 t30 74.89 57.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 10.0 110.316 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -74.89 -28.55 60.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 50.0 110.143 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.495 ' HG3' ' HG3' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.574 ' NE2' ' ND2' ' A' ' 116' ' ' ASN . 30.6 m-70 -61.63 -23.96 66.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.893 . . . . 50.0 109.988 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD22 ' CZ ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -40.16 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.45 -0.781 . . . . 12.5 110.105 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 119' ' ' HIS . 38.0 t0 -42.82 -31.9 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.329 -0.857 . . . . 50.0 110.757 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -8.02 52.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.062 -1.024 . . . . 16.66 110.605 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . 0.4 OUTLIER -128.17 -35.04 2.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.987 . . . . 50.0 110.299 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -48.73 -39.18 23.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.976 . . . . 50.0 110.307 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -61.87 -22.37 65.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 50.0 110.298 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -75.85 -22.05 56.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 50.0 110.206 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 68.4 t -64.79 140.46 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.187 -0.946 . . . . 50.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.439 ' OXT' ' CG1' ' A' ' 128' ' ' ILE . 2.2 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.026 -0.988 . . . . 50.0 110.247 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.613 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 46.6 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 N-CA-C 110.424 -0.645 . . . . 4.9900000000000002 110.424 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 44.8 m -109.08 141.32 41.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 3.73 110.19 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.658 HG13 ' HB ' ' A' ' 111' ' ' VAL . 3.3 t -131.16 173.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 10.0 110.001 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 3' ' ' VAL . 7.4 tt0 -147.47 111.91 5.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 50.0 110.116 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 20.5 p90 -95.48 143.4 26.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 50.0 110.469 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.52 138.05 40.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 50.0 110.506 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.614 ' N ' HD23 ' A' ' 6' ' ' LEU . 49.5 t-20 -69.48 116.0 9.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.061 -1.024 . . . . 12.5 109.767 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 7.9 t80 -62.61 -38.36 89.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 50.0 110.247 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -30.44 65.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 50.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 7' ' ' ASN . 2.9 m -67.63 -32.7 73.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 50.0 109.984 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' CD1' ' A' ' 23' ' ' LEU . 12.9 tp -68.67 -45.38 71.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 50.0 110.323 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD2' ' CE1' ' A' ' 8' ' ' TYR . 13.0 m-20 -76.52 -46.83 24.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 50.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -50.31 -61.16 2.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 50.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -61.89 -33.24 73.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 50.0 110.084 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.64 32.31 8.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.494 -1.442 . . . . 50.0 109.494 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.496 ' CD1' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -96.59 -174.91 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 50.0 110.229 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 20' ' ' ASP . 9.1 t70 -108.92 151.16 26.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 50.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -71.57 -11.16 60.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 50.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 39.7 t0 -136.61 -30.0 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 50.0 110.763 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' CB ' ' HB3' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -71.31 -53.77 13.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.005 . . . . 50.0 110.566 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 15.4 t70 -78.82 -7.12 57.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.951 . . . . 50.0 110.639 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' LEU . 40.2 m-20 49.02 51.62 15.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.021 . . . . 50.0 110.057 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.862 ' HB3' HD11 ' A' ' 6' ' ' LEU . 17.9 mt -43.35 -42.7 4.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.33 -0.856 . . . . 50.0 110.358 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 41.0 m-85 -56.27 -16.86 6.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 50.0 110.021 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -107.37 -47.42 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.868 . . . . 50.0 110.438 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' CG ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.91 -19.6 61.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 50.0 110.48 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 26' ' ' LYS . . . -69.35 -8.82 49.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 50.0 110.211 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.81 40.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.182 -0.949 . . . . 50.0 110.141 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 -9.38 14.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 50.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -97.1 -23.91 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 50.0 110.296 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.17 40.45 5.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.454 -1.459 . . . . 50.0 109.454 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -64.31 138.47 58.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -1.172 . . . . 50.0 110.155 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -45.63 151.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 50.0 110.015 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -69.2 -23.75 76.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.665 -1.374 . . . . 50.0 109.665 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 3.1 mt-10 -74.29 -29.78 61.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -1.224 . . . . 50.0 109.913 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . 86.2 m-20 -86.52 -47.0 9.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.447 -0.783 . . . . 50.0 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 31.4 t80 -133.27 144.28 49.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.004 -1.06 . . . . 50.0 110.789 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 5' ' ' TYR . . . 163.43 151.27 6.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.364 -1.495 . . . . 10.0 109.364 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 4' ' ' GLU . 49.3 m -79.89 120.77 24.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -1.232 . . . . 50.0 109.699 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.557 ' CE ' HG23 ' A' ' 48' ' ' ILE . 0.8 OUTLIER -93.54 79.8 4.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 50.0 110.685 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.3 tt0 -80.16 114.7 19.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 12.5 109.602 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 3.9 m -131.56 173.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.109 -0.994 . . . . 10.0 110.652 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -79.43 174.17 11.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 50.0 110.247 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.96 117.89 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 25.0 110.223 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.5 5.41 57.87 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.527 -1.429 . . . . 10.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 51' ' ' ALA . 3.1 mm-40 -81.67 103.55 11.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -1.168 . . . . 10.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -50.61 127.54 18.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 10.0 110.252 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.557 HG23 ' CE ' ' A' ' 40' ' ' MET . 18.2 mt -44.27 -71.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 10.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 12.9 tp -41.8 -39.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.879 . . . . 10.0 110.455 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -78.0 -43.77 28.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 50.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.572 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -59.57 -50.1 75.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.906 . . . . 12.5 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -73.11 -27.53 61.75 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.444 -0.785 . . . . 10.0 110.251 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -59.77 -42.06 92.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 10.0 110.24 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.88 -13.42 56.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 50.0 110.146 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.58 -30.66 12.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 10.0 110.111 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.6 27.44 1.6 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.803 -1.319 . . . . 10.0 109.803 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 27.2 m-85 -93.68 165.21 12.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.154 -1.204 . . . . 12.5 110.113 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 43.8 t0 -131.81 136.06 47.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 10.0 110.506 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 12.0 m95 -135.99 156.83 76.84 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 50.0 110.302 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 46.4 Cg_endo -73.35 134.99 21.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.116 1.587 . . . . 10.0 109.902 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 21.2 p90 -159.08 154.53 25.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.145 -0.972 . . . . 10.0 110.216 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.3 -58.5 0.38 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 10.0 110.038 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 1.4 p -81.43 -40.25 23.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 10.0 110.841 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 0.0 OUTLIER 63.58 28.73 15.23 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.974 -1.079 . . . . 10.0 112.003 178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.57 2.5 2.23 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.1 -1.0 . . . . 10.0 110.291 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.97 38.22 16.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.997 -1.241 . . . . 10.0 109.997 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -130.28 14.83 5.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.973 -1.31 . . . . 10.0 111.651 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.484 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.7 OUTLIER -148.17 -173.77 4.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.748 -1.22 . . . . 10.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.23 10.2 8.03 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.858 -1.151 . . . . 25.0 111.646 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -57.53 -39.09 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.947 -1.096 . . . . 50.0 109.941 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 16.5 p -86.34 13.02 8.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 10.0 109.784 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -43.7 150.87 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.421 -0.8 . . . . 10.0 111.546 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.808 ' O ' HD13 ' A' ' 74' ' ' ILE . 78.4 p -140.04 -167.48 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 73' ' ' SER . 39.3 mm -146.49 80.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 50.0 109.935 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.8 p -52.74 122.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.327 -0.858 . . . . 50.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -86.38 -12.4 49.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.983 -1.073 . . . . 50.0 109.956 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 76' ' ' LYS . 1.3 tt0 -176.4 168.24 2.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 25.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.67 167.0 25.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.268 -1.533 . . . . 10.0 109.268 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -112.81 142.92 44.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -1.14 . . . . 50.0 110.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.67 156.2 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.072 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 7.1 t0 -103.8 134.54 46.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.342 -0.849 . . . . 10.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.409 ' HE3' ' HG3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.49 -178.3 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 50.0 110.137 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -80.15 149.57 30.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 50.0 110.259 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 97.99 1.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.292 -0.88 . . . . 50.0 110.236 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.11 -158.66 0.6 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 16.66 110.168 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -137.57 42.28 2.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -0.949 . . . . 50.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -81.81 -23.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 50.0 110.044 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -176.34 3.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 12.5 110.107 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.1 m -134.14 140.9 46.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 12.5 110.284 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.808 ' O ' HG12 ' A' ' 93' ' ' VAL . 1.2 m-20 -46.93 -48.28 21.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 10.0 110.274 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 49.6 mt-10 -56.44 -25.72 51.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 50.0 109.956 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -76.46 -35.2 58.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -0.849 . . . . 50.0 110.228 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.808 HG12 ' O ' ' A' ' 90' ' ' ASP . 4.2 p -80.06 -19.48 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 10.0 110.38 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -98.86 -38.49 9.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 12.5 110.351 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -93.35 -44.38 8.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 50.0 110.176 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 98' ' ' VAL . 6.6 mttt -98.0 -9.98 25.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.89 . . . . 25.0 110.295 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 49.83 35.12 8.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.179 -0.95 . . . . 50.0 109.874 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 96' ' ' LYS . 70.8 t -88.68 167.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.118 -0.988 . . . . 50.0 110.842 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.542 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -175.02 -176.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.432 -0.792 . . . . 50.0 109.98 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD22 ' S2 ' ' A' ' 130' ' ' FES . 18.7 mt -102.5 107.72 18.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -0.976 . . . . 10.0 110.136 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 p -78.55 -24.45 45.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 10.0 110.454 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.678 ' SG ' HG23 ' A' ' 103' ' ' ILE . 28.3 p -73.55 -28.64 61.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.678 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.1 pp -132.83 27.18 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 50.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 81' ' ' ASP . . . -121.44 135.07 10.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 10.0 109.749 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.8 154.4 52.83 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 10.0 109.8 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.23 128.05 13.38 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.942 1.496 . . . . 10.0 110.351 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.2 -31.79 8.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.383 -0.823 . . . . 50.0 110.218 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.71 169.86 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 50.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -68.57 -79.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 50.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.33 125.25 33.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.044 -1.035 . . . . 50.0 109.62 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.658 ' HB ' HG13 ' A' ' 3' ' ' VAL . 4.1 t -136.14 126.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 12.5 110.807 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' LYS . 36.8 mttm -106.17 143.91 33.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.878 . . . . 25.0 109.762 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 5.4 tt -160.06 150.96 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 10.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 3.0 t -102.51 124.71 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 50.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.628 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -92.08 158.16 16.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.923 -1.111 . . . . 50.0 110.784 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.653 ' O ' ' CD2' ' A' ' 119' ' ' HIS . 2.6 m-20 81.59 66.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.181 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 119' ' ' HIS . . . -84.56 23.26 1.16 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.148 -0.97 . . . . 50.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.739 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 13.1 p80 -61.54 -25.22 67.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 50.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.569 HD11 ' HE2' ' A' ' 96' ' ' LYS . 44.4 tp -41.53 120.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 12.5 110.229 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.1 p-10 -48.04 -37.82 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 50.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.88 -18.56 34.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 16.66 110.137 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -16.46 12.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 50.0 109.845 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.17 -21.93 66.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 50.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -12.05 61.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 50.0 110.19 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.33 18.27 14.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 50.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 127' ' ' VAL . 14.8 p -47.05 110.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.701 HG23 ' OXT' ' A' ' 128' ' ' ILE . 21.3 tt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.967 -1.016 . . . . 50.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.557 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 N-CA-C 110.303 -0.691 . . . . 4.9900000000000002 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 110' ' ' GLU . 81.5 m -107.79 119.52 39.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 3.73 110.229 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 106' ' ' PRO . 59.0 t -113.33 114.31 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 10.0 109.974 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -85.76 116.04 23.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 50.0 110.415 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.552 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 54.6 p90 -94.79 148.91 21.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.202 -0.936 . . . . 50.0 110.462 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.935 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -145.99 125.47 13.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.22 -0.925 . . . . 50.0 109.949 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.919 ' N ' HD12 ' A' ' 6' ' ' LEU . 48.3 t30 -61.9 120.8 11.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.384 -0.822 . . . . 12.5 111.748 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.698 ' CD1' ' CD2' ' A' ' 119' ' ' HIS . 0.9 OUTLIER -61.4 -33.51 73.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 50.0 109.336 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 mt-10 -59.27 -37.85 78.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 50.0 109.701 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 35.1 m -60.82 -36.47 79.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 50.0 109.528 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 23' ' ' LEU . 2.6 tp -68.42 -41.6 80.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.464 -0.772 . . . . 50.0 109.855 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.31 -43.61 27.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 50.0 110.194 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -64.24 -48.01 77.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.949 . . . . 50.0 110.053 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.404 ' HG2' ' CD2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -70.6 -12.59 61.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 50.0 110.211 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.93 31.06 78.4 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.29 -1.524 . . . . 50.0 109.29 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.596 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -84.14 -177.17 6.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -1.105 . . . . 50.0 110.154 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.18 179.4 5.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 50.0 109.965 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -55.67 5.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 50.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -126.58 -7.45 6.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 50.0 110.203 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -54.47 28.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 50.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 16' ' ' TRP . 15.8 m-20 -79.59 -4.33 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 50.0 110.471 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 23' ' ' LEU . 33.7 m-20 46.08 54.1 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 50.0 109.781 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.912 ' HB3' HD21 ' A' ' 6' ' ' LEU . 6.7 mt -38.82 -49.79 1.65 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.609 -0.682 . . . . 50.0 110.523 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' OH ' ' A' ' 37' ' ' TYR . 26.0 m-85 -42.95 -28.03 0.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 50.0 109.44 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.3 mt-10 -99.79 -53.74 3.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.565 -0.709 . . . . 50.0 110.062 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -62.93 -20.84 65.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 50.0 110.207 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.11 -13.9 62.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 50.0 110.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.92 -27.45 28.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 50.0 110.081 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -88.57 -34.51 17.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 50.0 110.175 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.59 71.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.817 . . . . 50.0 110.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.98 65.88 1.28 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.648 -1.381 . . . . 50.0 109.648 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.515 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -93.33 151.02 20.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -1.127 . . . . 50.0 110.233 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -60.21 151.24 27.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -0.862 . . . . 50.0 110.229 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' ' CE1' ' A' ' 5' ' ' TYR . . . -66.38 -16.58 65.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.363 -1.495 . . . . 50.0 109.363 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 39.0 tt0 -78.42 -8.07 58.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -1.222 . . . . 50.0 109.977 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 37.3 m-20 -114.09 -50.71 2.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 50.0 110.138 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' C ' ' CE1' ' A' ' 5' ' ' TYR . 8.7 t80 -128.22 150.65 49.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.322 -0.861 . . . . 50.0 110.107 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 155.46 158.13 8.61 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.433 -1.467 . . . . 10.0 109.433 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.47 ' CG2' ' CG2' ' A' ' 2' ' ' THR . 40.0 m -82.96 118.65 23.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -1.155 . . . . 50.0 110.135 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.849 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -91.54 89.69 7.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.146 -0.971 . . . . 50.0 110.458 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' HG2' HG23 ' A' ' 2' ' ' THR . 30.4 mt-10 -87.39 111.06 20.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 12.5 109.851 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 51' ' ' ALA . 4.9 m -133.77 168.48 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.087 -1.008 . . . . 10.0 110.513 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' GLU . . . -74.07 141.46 45.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 50.0 110.067 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.73 119.94 7.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 25.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.86 8.26 30.21 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.654 -1.378 . . . . 10.0 109.654 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 43' ' ' ALA . 2.0 tm-20 -97.79 133.71 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -1.167 . . . . 10.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 44.3 m-85 -62.53 119.42 9.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 10.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.607 HG23 ' HE2' ' A' ' 40' ' ' MET . 18.7 mm -41.42 -67.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.291 -0.881 . . . . 10.0 110.765 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 1.9 tt -45.57 -40.26 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 10.0 110.64 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' TYR . 1.1 tt0 -73.78 -43.0 60.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.232 -0.917 . . . . 50.0 110.296 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -58.37 -49.18 78.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 12.5 110.536 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.849 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -75.67 -30.45 59.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.406 -0.808 . . . . 10.0 110.477 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 81.2 tt0 -61.4 -32.34 72.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.188 -0.945 . . . . 10.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.3 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 50.0 109.967 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -107.48 -10.76 15.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 10.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.18 -9.94 15.23 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.712 -1.355 . . . . 10.0 109.712 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.605 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 18.8 m-30 -72.36 140.21 48.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -1.226 . . . . 12.5 110.384 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.9 t70 -116.28 137.65 51.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 10.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 9.6 m95 -130.87 162.11 57.29 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 50.0 110.057 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 44.5 Cg_endo -72.78 143.21 36.86 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.977 1.514 . . . . 10.0 109.928 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 9.9 p90 -165.61 149.59 8.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.156 -0.965 . . . . 10.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.22 -58.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.394 -0.816 . . . . 10.0 110.185 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 10.0 110.984 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 3.5 mmt85 58.15 31.04 20.24 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.001 -1.062 . . . . 10.0 111.821 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.5 2.75 2.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 10.0 110.304 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.441 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 82.89 38.3 11.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.127 -1.189 . . . . 10.0 110.127 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -129.27 9.5 5.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.917 -1.343 . . . . 10.0 111.799 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.624 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.5 OUTLIER -147.69 -174.74 4.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.618 -1.301 . . . . 10.0 110.597 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' O ' HD21 ' A' ' 123' ' ' LEU . . . -125.35 12.33 8.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.896 -1.127 . . . . 25.0 111.685 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -57.47 -37.03 72.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.054 . . . . 50.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 17.8 p -89.16 13.22 13.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 10.0 109.863 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . . . -44.65 150.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.837 0.827 . . . . 10.0 111.979 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -138.44 -164.01 1.56 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 50.0 109.454 179.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 73' ' ' SER . 43.7 mm -148.02 86.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 50.0 109.945 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.1 p -60.29 118.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.345 -0.847 . . . . 50.0 110.477 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' LYS . 1.4 tptt -93.13 -4.07 52.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.064 -1.022 . . . . 50.0 110.493 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER 178.52 166.86 0.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.135 -0.978 . . . . 25.0 110.641 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 111' ' ' VAL . . . 80.0 -175.25 55.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.515 -1.434 . . . . 10.0 109.515 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -132.79 131.2 40.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 50.0 109.994 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 81' ' ' ASP . 15.0 mt -107.11 164.42 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 50.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 80' ' ' ILE . 5.7 t0 -109.01 126.67 53.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 10.0 110.046 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.28 172.66 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 50.0 110.25 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 25.6 m-20 -93.4 167.93 11.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 50.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.23 122.65 23.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 50.0 110.205 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 HE22 HD22 ' A' ' 100' ' ' LEU . 9.2 pt20 -174.57 166.21 3.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 16.66 110.347 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -118.47 27.67 8.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 50.0 110.303 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -80.1 -24.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 50.0 110.239 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.44 149.15 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 12.5 110.195 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -98.75 153.62 18.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 12.5 110.316 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.81 -47.4 85.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 10.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -18.27 12.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 50.0 110.202 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 2.1 tp10 -77.58 -41.52 38.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 50.0 110.3 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.09 -24.68 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.915 . . . . 10.0 110.594 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -86.96 -37.61 17.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.147 -0.971 . . . . 12.5 110.644 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.98 -20.73 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 50.0 110.517 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' O ' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -115.53 -18.94 10.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.02 -1.05 . . . . 25.0 110.531 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 60.01 33.67 21.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.151 -0.968 . . . . 50.0 109.506 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' CG ' ' A' ' 92' ' ' GLU . 14.9 p -89.39 139.73 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 50.0 111.064 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -139.85 178.84 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.586 -0.696 . . . . 50.0 109.466 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.547 HD22 HE22 ' A' ' 85' ' ' GLN . 1.1 mp -103.47 110.08 21.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 10.0 110.13 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 HG21 ' A' ' 48' ' ' ILE . 1.9 p -79.91 -30.16 39.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.85 . . . . 10.0 110.453 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' A' ' 103' ' ' ILE . 29.8 p -68.3 -33.6 74.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 10.0 110.251 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -130.56 26.36 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 50.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 100' ' ' LEU . . . -129.51 139.0 10.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.488 -1.445 . . . . 10.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 24.5 m -124.84 157.99 64.29 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 10.0 110.205 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HB3' HG21 ' A' ' 3' ' ' VAL . 47.1 Cg_endo -73.47 145.39 37.77 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.052 1.554 . . . . 10.0 110.37 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -122.69 -24.97 4.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.89 . . . . 50.0 110.046 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 50.0 110.1 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 -93.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 50.0 110.256 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' GLU . 6.9 pt-20 -81.7 99.63 9.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 50.0 110.101 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 21.7 t -109.97 124.65 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 12.5 110.322 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 76' ' ' LYS . 3.2 mttp -95.42 142.68 27.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -0.95 . . . . 25.0 110.256 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 18.2 tt -159.98 160.08 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 10.0 110.302 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 6' ' ' LEU . 1.1 t -116.59 137.79 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 50.0 109.544 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -106.52 151.1 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 50.0 109.858 179.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 3.6 m-20 103.34 22.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 123.777 0.831 . . . . 10.0 110.045 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . . . -45.14 -24.15 0.23 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.126 -0.984 . . . . 50.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.528 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.698 ' CD2' ' CD1' ' A' ' 8' ' ' TYR . 22.7 p80 -59.17 -31.79 69.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 50.0 110.009 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' ND1' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -50.61 124.13 10.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 12.5 110.259 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -62.94 -37.97 89.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 50.0 110.062 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -60.45 -24.03 64.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 16.66 109.928 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -80.24 -50.31 10.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 50.0 110.051 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -52.68 -33.53 47.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 50.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -46.76 -32.36 3.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 50.0 110.195 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -31.76 55.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 50.0 110.201 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 128' ' ' ILE . 32.2 t -69.51 -34.36 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 50.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 125' ' ' ASN . 20.2 mm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.979 -1.01 . . . . 50.0 110.216 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.624 ' S2 ' ' O ' ' A' ' 68' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 110.335 -0.679 . . . . 4.9900000000000002 110.335 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.1 m -129.98 127.91 40.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 3.73 110.272 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.847 HG22 ' HB ' ' A' ' 111' ' ' VAL . 79.7 t -120.61 116.32 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 10.0 110.154 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.752 ' HG3' HG23 ' A' ' 39' ' ' THR . 2.6 tt0 -84.42 118.05 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 50.0 110.332 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 5' ' ' TYR . 24.6 p90 -93.03 141.75 28.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 50.0 110.662 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -130.3 119.75 23.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.385 -0.822 . . . . 50.0 109.764 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.738 ' N ' HD12 ' A' ' 6' ' ' LEU . 39.1 t-20 -51.52 123.82 10.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.816 . . . . 12.5 111.354 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 119' ' ' HIS . 40.8 t80 -60.46 -34.96 74.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 50.0 109.55 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -60.14 -37.03 78.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.437 -0.789 . . . . 50.0 109.748 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 7' ' ' ASN . 99.6 m -56.97 -28.84 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 50.0 109.559 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.627 HD21 ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -71.71 -51.82 20.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 50.0 109.711 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.06 -18.42 50.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.444 -0.785 . . . . 50.0 109.857 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . 4.9 t0 -75.37 -50.01 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.373 -0.829 . . . . 50.0 110.119 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 32' ' ' LEU . 3.4 mm-40 -81.6 -14.44 56.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 50.0 109.995 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.45 47.88 26.32 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.621 -1.392 . . . . 50.0 109.621 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.507 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 3.2 m0 -110.47 162.96 14.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -1.168 . . . . 50.0 110.329 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.637 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 t0 -63.33 -176.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 50.0 110.612 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 11' ' ' LEU . 1.4 ttp -76.7 -55.14 5.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 50.0 110.405 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -131.46 2.15 4.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 50.0 110.352 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -79.15 -45.05 20.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.93 . . . . 50.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.43 -2.34 28.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 50.0 110.149 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' GLU . 0.9 OUTLIER 51.84 50.75 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 50.0 110.165 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.4 mp -41.82 -53.57 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.532 -0.73 . . . . 50.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 11.4 m-85 -44.05 -27.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 50.0 109.399 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ASP . 5.1 tt0 -99.79 -43.31 6.48 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.081 -0.648 . . . . 50.0 109.939 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -73.18 -18.34 61.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 50.0 109.974 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.37 -30.66 53.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 50.0 110.063 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . . . -71.64 -34.29 69.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 50.0 110.099 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -17.09 60.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 50.0 109.98 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 32' ' ' LEU . . . -90.77 -15.59 29.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 50.0 110.206 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.36 54.08 8.16 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.444 -1.462 . . . . 50.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 30' ' ' ALA . 3.6 mm? -75.84 163.09 27.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -1.207 . . . . 50.0 110.313 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.74 155.64 3.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 50.0 110.278 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.72 -37.71 57.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.279 -1.529 . . . . 50.0 109.279 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.1 mt-10 -69.32 -7.14 34.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 50.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 79.9 m-20 -105.08 -49.58 3.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -0.829 . . . . 50.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 28.1 t80 -127.28 122.44 33.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 50.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.527 ' N ' ' CE1' ' A' ' 5' ' ' TYR . . . -176.68 177.94 48.01 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.752 HG23 ' HG3' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -102.5 123.19 45.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -1.144 . . . . 50.0 110.36 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.612 ' CE ' ' HB2' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -88.8 149.85 23.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 50.0 109.804 179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -128.2 115.78 18.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.995 . . . . 12.5 110.381 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG13 ' HG3' ' A' ' 106' ' ' PRO . 5.9 p -155.58 142.44 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 10.0 110.126 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.79 152.9 35.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.885 . . . . 50.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.7 124.11 20.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 25.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.93 -15.37 10.33 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.478 -1.449 . . . . 10.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.79 127.49 47.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 10.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 21.2 m-85 -51.9 125.6 15.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 10.0 110.114 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 50' ' ' GLU . 55.9 mt -49.18 -64.54 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.879 . . . . 10.0 110.526 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 59' ' ' TRP . 7.2 tt -42.65 -25.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 10.0 110.591 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -79.92 -56.36 4.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 50.0 110.709 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.09 -35.46 73.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 12.5 110.867 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 40' ' ' MET . . . -78.67 -46.85 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 10.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 tt0 -58.1 -27.36 63.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 10.0 109.926 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.26 -15.89 59.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 50.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -97.19 -19.07 18.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -0.839 . . . . 10.0 110.229 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.56 4.94 6.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.721 -1.352 . . . . 10.0 109.721 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.591 ' HD2' ' HB1' ' A' ' 52' ' ' ALA . 14.3 m-30 -78.32 173.66 12.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -1.166 . . . . 12.5 110.119 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.543 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 2.4 m-20 -142.75 134.02 26.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.271 -0.893 . . . . 10.0 110.446 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.643 ' N ' ' CD1' ' A' ' 59' ' ' TRP . 6.6 m95 -137.5 149.16 64.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 50.0 109.899 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' CYS . 45.8 Cg_endo -72.88 139.98 31.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.926 1.487 . . . . 10.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CD1' ' HD2' ' A' ' 64' ' ' ARG . 26.6 p90 -160.41 150.56 18.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.27 -0.894 . . . . 10.0 110.258 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -144.26 -58.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 10.0 110.273 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' SG ' ' N ' ' A' ' 64' ' ' ARG . 0.8 OUTLIER -77.1 -41.41 42.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 10.0 110.607 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.497 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 64.54 27.86 13.38 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 10.0 112.459 178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' C ' HG21 ' A' ' 103' ' ' ILE . . . -138.76 2.74 2.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.951 -1.093 . . . . 10.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 103' ' ' ILE . . . 81.14 38.23 15.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.659 -1.376 . . . . 10.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -125.1 5.9 7.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -1.233 . . . . 10.0 111.11 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.61 ' O ' ' S2 ' ' A' ' 130' ' ' FES . 0.8 OUTLIER -143.0 -177.51 5.38 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.943 -1.098 . . . . 10.0 110.264 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -121.73 11.69 10.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.935 -1.103 . . . . 25.0 111.432 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.51 -39.18 75.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.017 -1.052 . . . . 50.0 109.931 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 15.1 p -88.47 12.79 13.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 10.0 109.704 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -46.06 154.08 0.27 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.795 0.807 . . . . 10.0 111.569 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 68.3 m -148.56 144.28 27.18 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 50.0 108.915 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 1.3 mp -92.9 95.97 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 50.0 110.296 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.7 p -60.76 119.31 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.313 -0.867 . . . . 50.0 109.965 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -91.08 -5.18 55.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.926 -1.109 . . . . 50.0 110.639 -179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 176.12 174.14 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.04 . . . . 25.0 110.523 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.56 -163.51 54.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.736 -1.346 . . . . 10.0 109.736 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 3.1 tt0 -152.19 126.81 9.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 50.0 109.911 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.819 HG23 ' O ' ' A' ' 105' ' ' SER . 11.6 mt -99.27 149.27 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 50.0 110.394 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 4.7 t70 -97.7 159.64 14.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 10.0 109.916 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 4.0 ptt? -168.46 137.28 2.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.977 . . . . 50.0 110.509 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -45.53 145.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.4 -0.812 . . . . 50.0 110.079 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.27 133.91 56.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 50.0 110.179 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -153.38 -165.33 2.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 16.66 110.469 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.46 25.16 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 50.0 110.065 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 100' ' ' LEU . 4.9 tp -79.49 -24.63 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 50.0 110.377 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 100' ' ' LEU . 5.4 mt -130.76 -170.61 2.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.112 -0.993 . . . . 12.5 110.279 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.69 154.36 51.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 12.5 110.227 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -59.52 -43.54 93.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 10.0 110.13 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -55.33 -28.9 56.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 50.0 109.547 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 96' ' ' LYS . 2.7 mt-10 -75.86 -29.63 58.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.428 -0.795 . . . . 50.0 109.58 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' ASP . 52.2 t -76.5 -26.63 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.456 -0.778 . . . . 10.0 109.688 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -97.6 -37.29 9.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.421 -0.799 . . . . 12.5 109.754 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -90.77 -39.01 12.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 50.0 110.283 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -105.08 -4.83 21.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.002 . . . . 25.0 110.389 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 74' ' ' ILE . 3.8 m-20 47.15 25.73 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 50.0 110.406 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 73' ' ' SER . 7.8 p -81.59 167.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 50.0 111.207 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.442 ' N ' HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -178.87 171.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.665 -0.647 . . . . 50.0 109.49 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 88' ' ' LEU . 20.0 mt -110.53 114.59 28.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.067 -1.02 . . . . 10.0 110.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.3 p -82.43 -17.84 43.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 10.0 110.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 103' ' ' ILE . 31.9 p -71.85 -30.95 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 10.0 110.625 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.585 HD13 ' HA3' ' A' ' 66' ' ' GLY . 1.1 pt -129.85 22.43 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.006 . . . . 50.0 110.294 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.04 142.45 13.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.505 -1.438 . . . . 10.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.819 ' O ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -121.74 165.69 19.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.252 -1.146 . . . . 10.0 110.159 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.77 ' HG3' HG13 ' A' ' 42' ' ' VAL . 45.4 Cg_endo -71.76 130.29 16.73 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.034 1.544 . . . . 10.0 110.378 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . . . -106.76 -23.7 12.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 50.0 110.162 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -100.88 -168.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 50.0 110.085 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.92 -70.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 50.0 110.384 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.68 89.55 4.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 50.0 110.299 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 3' ' ' VAL . 17.8 t -94.36 127.9 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 12.5 110.205 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 76' ' ' LYS . 11.9 mttm -107.42 139.58 41.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 25.0 110.128 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 75' ' ' VAL . 0.8 OUTLIER -160.09 152.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 10.0 110.498 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -91.8 127.17 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 50.0 109.007 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.622 ' CE2' ' ND2' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -89.92 158.95 17.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 50.0 110.62 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.622 ' ND2' ' CE2' ' A' ' 115' ' ' TYR . 21.3 m-20 66.94 52.2 0.92 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.261 0.553 . . . . 10.0 110.5 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -70.54 -5.38 28.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.106 -0.996 . . . . 50.0 109.57 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 65.0 m-70 -80.6 -0.66 38.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.407 -0.808 . . . . 50.0 110.61 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 18.4 tp -46.35 147.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.065 -1.022 . . . . 12.5 110.038 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.27 -36.76 71.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 50.0 110.281 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.75 -10.21 55.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.286 -0.884 . . . . 16.66 110.232 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.33 -32.02 5.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 50.0 110.221 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -45.95 -29.25 1.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 50.0 110.281 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.68 -18.33 62.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 50.0 110.37 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.74 25.45 7.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.957 . . . . 50.0 110.293 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG22 ' A' ' 128' ' ' ILE . 7.3 p -62.44 -34.61 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 50.0 110.166 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 127' ' ' VAL . 3.6 tt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.896 -1.049 . . . . 50.0 110.22 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.649 ' S2 ' HD22 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 110.26 -0.708 . . . . 4.9900000000000002 110.26 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 39' ' ' THR . 0.2 OUTLIER -122.81 142.24 50.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.333 -0.854 . . . . 3.73 110.481 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 40' ' ' MET . 11.5 p -143.67 118.36 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.31 -0.869 . . . . 10.0 109.737 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' CD1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -82.51 108.36 15.85 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 50.0 110.991 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 38' ' ' GLY . 39.0 p90 -85.74 138.4 32.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 50.0 109.592 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -126.82 150.51 49.15 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 50.0 110.59 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.593 ' HB2' ' CB ' ' A' ' 36' ' ' ASP . 2.5 t-20 -76.29 125.57 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 12.5 110.805 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' CE2' HD12 ' A' ' 120' ' ' LEU . 22.5 t80 -63.5 -38.75 92.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.356 -0.84 . . . . 50.0 109.955 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 3.8 mm-40 -66.03 -25.52 67.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 50.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -71.14 -34.73 71.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 50.0 109.911 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.97 -44.08 81.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 50.0 110.01 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.77 -49.14 26.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.97 . . . . 50.0 110.054 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 8.9 t0 -53.99 -55.93 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 50.0 110.12 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.78 -33.11 74.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -0.864 . . . . 50.0 110.135 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 29.71 29.21 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.505 -1.438 . . . . 50.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 21' ' ' ASP . 38.1 m0 -89.57 -179.55 5.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -1.125 . . . . 50.0 110.285 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.718 ' O ' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -97.78 -176.25 3.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 50.0 110.265 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -41.19 51.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 50.0 110.273 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -137.81 3.31 2.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 50.0 110.579 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -80.01 -50.15 10.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 50.0 110.421 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' ASP . 8.9 m-20 -79.87 2.41 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 50.0 110.39 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' ASP . 71.6 m-20 42.88 53.97 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 50.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 17' ' ' ASP . 2.0 mp -45.26 -49.24 12.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 50.0 110.268 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 6' ' ' LEU . 47.5 m-85 -54.88 -21.22 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 50.0 109.897 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 22' ' ' ASP . 2.1 tt0 -103.29 -47.1 4.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 50.0 110.049 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -31.38 67.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 50.0 110.128 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 23' ' ' LEU . . . -65.36 -30.49 71.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 50.0 109.882 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB2' ' OH ' ' A' ' 37' ' ' TYR . . . -72.62 -19.05 61.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 50.0 110.132 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -85.61 -15.1 43.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 50.0 110.112 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.65 -33.61 8.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 50.0 110.159 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 58.67 2.3 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.431 . . . . 50.0 109.521 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -177.55 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -1.162 . . . . 50.0 110.017 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -60.76 129.28 40.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 50.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' ' OH ' ' A' ' 5' ' ' TYR . . . -53.03 -39.91 57.88 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.771 -1.332 . . . . 50.0 109.771 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' O ' ' CZ ' ' A' ' 115' ' ' TYR . 1.2 mt-10 -61.86 -19.39 62.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -1.101 . . . . 50.0 110.393 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 5.7 m-20 -94.04 -49.84 5.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.264 -0.898 . . . . 50.0 110.396 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 t80 -126.69 140.25 52.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 50.0 110.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 5' ' ' TYR . . . 171.06 151.36 7.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.419 -1.472 . . . . 10.0 109.419 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.787 HG22 HG22 ' A' ' 2' ' ' THR . 0.7 OUTLIER -81.69 117.35 21.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.149 . . . . 50.0 109.977 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 mtp -87.89 128.01 35.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.081 -1.012 . . . . 50.0 109.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -104.94 105.71 15.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.985 . . . . 12.5 110.362 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.733 HG13 ' HG3' ' A' ' 106' ' ' PRO . 2.0 p -144.94 126.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 10.0 110.131 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.92 148.86 36.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.305 -0.872 . . . . 50.0 110.376 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -51.43 118.84 3.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 25.0 110.025 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.74 -14.49 6.37 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.174 -1.57 . . . . 10.0 109.174 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -106.78 128.26 54.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 10.0 109.993 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 15.2 m-85 -55.56 118.38 4.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 10.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.57 HG23 ' HE2' ' A' ' 40' ' ' MET . 62.9 mt -42.97 -72.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 10.0 110.53 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 49' ' ' LEU . 2.9 tt -41.55 -30.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.404 -0.81 . . . . 10.0 110.366 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . 19.4 tt0 -75.52 -40.7 56.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 50.0 110.211 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 42' ' ' VAL . . . -59.34 -55.25 37.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 12.5 110.195 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.568 ' HB1' ' HB2' ' A' ' 57' ' ' TYR . . . -68.41 -27.75 66.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 10.0 109.989 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 29.4 tt0 -54.79 -58.55 7.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -0.894 . . . . 10.0 109.692 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.61 30.71 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.523 -0.736 . . . . 50.0 109.697 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 57' ' ' TYR . 1.2 tp60 -87.75 -25.51 23.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 10.0 110.001 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.58 21.34 3.99 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.436 -1.466 . . . . 10.0 109.436 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.568 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 44.5 m-85 -106.6 141.13 38.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 12.5 110.04 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' C ' ' CD1' ' A' ' 59' ' ' TRP . 31.7 t0 -104.14 142.24 34.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 10.0 110.605 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 115' ' ' TYR . 31.4 m95 -137.2 152.1 72.93 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 50.0 110.283 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' ' HA ' ' A' ' 116' ' ' ASN . 49.5 Cg_endo -73.96 132.81 17.37 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 124.173 1.617 . . . . 10.0 109.674 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 10.1 p90 -164.35 150.75 11.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 10.0 110.152 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -144.08 -58.56 0.39 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.33 -0.856 . . . . 10.0 110.299 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 62' ' ' SER . 0.8 OUTLIER -74.63 -38.83 62.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 10.0 110.806 -179.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' N ' ' SG ' ' A' ' 63' ' ' CYS . 1.3 tpp180 61.9 29.16 17.77 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.894 -1.129 . . . . 10.0 112.078 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -138.73 2.6 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 10.0 110.318 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' CA ' HG12 ' A' ' 103' ' ' ILE . . . 78.34 38.27 25.77 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.296 . . . . 10.0 109.859 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HD13 ' A' ' 87' ' ' ILE . . . -127.81 9.41 6.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.046 -1.267 . . . . 10.0 111.376 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.76 -173.11 3.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.9 -1.125 . . . . 10.0 110.353 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -125.24 8.28 7.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.123 -0.986 . . . . 25.0 111.209 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.31 -39.39 75.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.03 -1.044 . . . . 50.0 110.263 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 18.3 p -86.19 13.18 8.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 10.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . -41.56 150.37 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.737 0.779 . . . . 10.0 111.497 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -135.37 -164.61 1.56 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.298 -0.63 . . . . 50.0 109.298 179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.778 ' O ' HG22 ' A' ' 74' ' ' ILE . 6.7 mm -146.2 74.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 50.0 109.954 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 97' ' ' ASP . 9.7 p -45.71 109.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 50.0 109.797 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -81.59 -8.38 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.008 . . . . 50.0 110.59 -179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER 172.72 153.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 25.0 110.246 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 -139.15 14.41 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.451 -1.46 . . . . 10.0 109.451 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -173.74 140.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -1.148 . . . . 50.0 110.36 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 105' ' ' SER . 2.5 mp -108.8 147.07 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 50.0 109.857 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' SER . 8.5 t0 -83.01 111.4 18.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 10.0 110.505 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -100.06 -174.77 2.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 50.0 109.859 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -118.55 161.96 19.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.15 -0.968 . . . . 50.0 110.377 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.5 mmt -64.31 120.72 12.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.363 -0.836 . . . . 50.0 110.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.79 -161.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 16.66 110.351 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -142.3 25.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 50.0 110.05 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.91 HG23 HD23 ' A' ' 88' ' ' LEU . 4.4 tp -88.23 -22.61 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 50.0 110.404 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.91 HD23 HG23 ' A' ' 87' ' ' ILE . 1.3 pp -160.53 173.77 15.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 12.5 110.288 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -141.19 158.57 43.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 12.5 110.166 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 32.0 t70 -47.91 -24.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 10.0 110.167 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.66 -41.02 73.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.799 -1.188 . . . . 50.0 109.107 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -80.05 -26.84 39.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 50.0 109.431 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.8 OUTLIER -80.12 -20.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 10.0 109.324 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -103.05 -44.75 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 12.5 110.175 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -87.62 -20.07 26.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 50.0 110.094 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 92' ' ' GLU . 9.2 mttm -123.51 -9.18 7.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 25.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.723 ' O ' HG12 ' A' ' 75' ' ' VAL . 4.7 m-20 56.76 19.85 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 50.0 110.461 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' SER . 24.4 t -80.84 153.84 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 50.0 110.531 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.84 160.79 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.42 -0.8 . . . . 50.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' S2 ' ' A' ' 130' ' ' FES . 47.2 mt -101.11 109.37 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 10.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.8 p -82.2 -22.53 35.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 10.0 110.244 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 103' ' ' ILE . 27.8 p -64.04 -31.15 72.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.284 -0.885 . . . . 10.0 110.125 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' SG ' ' A' ' 102' ' ' CYS . 1.5 pp -131.67 21.65 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 50.0 110.166 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -121.53 144.41 16.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 10.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -115.78 173.38 3.02 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -1.146 . . . . 10.0 110.134 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.733 ' HG3' HG13 ' A' ' 42' ' ' VAL . 46.4 Cg_endo -74.02 122.35 7.58 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.942 1.496 . . . . 10.0 110.441 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.416 ' HB2' ' N ' ' A' ' 81' ' ' ASP . . . -98.37 -22.97 15.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 50.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 111' ' ' VAL . . . -117.76 174.16 6.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.149 -0.969 . . . . 50.0 110.148 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' THR . 0.8 OUTLIER -68.32 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 50.0 110.239 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 2' ' ' THR . 4.7 mm-40 -90.19 99.68 12.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 50.0 110.08 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' CG2' ' HB3' ' A' ' 108' ' ' ALA . 86.7 t -107.04 148.3 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 12.5 110.355 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 4' ' ' GLU . 16.5 mttm -113.89 136.3 53.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 25.0 110.002 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 2.1 tt -157.77 143.6 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 10.0 110.548 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.543 ' CG1' ' HB ' ' A' ' 74' ' ' ILE . 1.0 OUTLIER -97.74 129.65 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 50.0 109.487 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -92.64 163.09 13.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 50.0 110.099 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.3 t-20 71.08 49.08 0.35 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.306 -0.871 . . . . 10.0 110.33 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 72' ' ' ALA . . . -76.0 -17.81 59.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.052 -1.03 . . . . 50.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALY . . . . . 0.445 ' OH ' ' HD3' ' A' ' 118' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 71.7 m-70 -72.06 -18.92 61.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 50.0 110.331 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -44.11 120.31 2.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 12.5 110.24 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 2.8 t0 -65.48 -26.85 68.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 50.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.52 ' HB3' HD23 ' A' ' 120' ' ' LEU . 15.7 t80 -72.07 -3.3 22.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 16.66 110.132 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 123' ' ' LEU . 4.6 mt -114.72 -43.92 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.942 . . . . 50.0 110.348 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -23.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.965 . . . . 50.0 110.187 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -54.08 -20.13 6.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 50.0 110.089 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -7.06 51.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 50.0 110.227 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.18 -31.86 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 50.0 110.207 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 128' ' ' ILE . 36.5 mm . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.962 -1.018 . . . . 50.0 110.253 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' FES . . . . . 0.525 ' S2 ' HD13 ' A' ' 100' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_